,pdbx_caspflag,pdbx_descriptor,title,pdbx_keywords,text,paper_title,pdbx_model_details,pdbx_model_type_details,Hchain,Lchain,antigen_chain,antigen_type,antigen_name,short_header,date,compound,organism,heavy_species,light_species,antigen_species,authors,method,pmid
7N4J,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2173.,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, SARS-COV-2, WRAIR-2173, RECEPTOR BINDING DOMAIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",LOW-DOSE IN VIVO PROTECTION AND NEUTRALIZATION ACROSS SARS-COV-2 VARIANTS BY MONOCLONAL ANTIBODY COMBINATIONS.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,10/06/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2173.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SANKHALA, R.S., JOYCE, M.G.",X-RAY DIFFRACTION,NONE
7KMI,N,,LY-COV481 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY NEUTRALIZING SARS-COV-2, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX","THE NEUTRALIZING ANTIBODY, LY-COV555, PROTECTS AGAINST SARS-COV-2 INFECTION IN NONHUMAN PRIMATES.",,,A,B,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,11/02/20,LY-COV481 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HENDLE, J., PUSTILNIK, A., SAUDER, J.M., COLEMAN, K.A., BOYLES, J.S., DICKINSON, C.D.",X-RAY DIFFRACTION,NONE
7COE,N,,CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF MERS-COV AND KNIH90-F1 FAB COMPLEX,IMMUNE SYSTEM,"RBD, FAB, COMPLEX, IMMUNE SYSTEM",THE STRUCTURE OF A NOVEL ANTIBODY AGAINST THE SPIKE PROTEIN INHIBITS MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTIONS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,08/04/21,CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF MERS-COV AND KNIH90-F1 FAB COMPLEX,HOMO SAPIENS; MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"LEE, J.Y., SONG, J.Y., LEE, H.S., HONG, E., JANG, T.H.",X-RAY DIFFRACTION,NONE
7WCR,N,,RBD-1 OF SARS-COV-2 BETA SPIKE IN COMPLEX WITH S5D2 FAB,VIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, BETA VARIANT, B.1.351 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MAPPING CROSS-VARIANT NEUTRALIZING SITES ON THE SARS-COV-2 SPIKE PROTEIN.,,,A,B,A,PROTEIN,HEAVY CHAIN OF S5D2 FAB,VIRAL PROTEIN,02/02/22,RBD-1 OF SARS-COV-2 BETA SPIKE IN COMPLEX WITH S5D2 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y.F., CONG, Y.",ELECTRON MICROSCOPY,NONE
7JVA,N,"S2A4 FAB HEAVY CHAIN, S2A4 FAB LIGHT CHAIN, SARS-COV-2 SPIKE GLYCOPROTEIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING DOMAIN AND FAB VARIABLE DOMAINS),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,H,L,A,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/20/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING DOMAIN AND FAB VARIABLE DOMAINS),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., TORTORICI, M.A., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",ELECTRON MICROSCOPY,NONE
7R8O,N,,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C548,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR BINDING DOMAIN, RBD, NEUTRALIZING ANTIBODY, COVID-19, SPIKE, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,M,N,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C548,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DELAITSCH, A.T., BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7BEJ,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 1),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 1),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7ND8,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-384 FAB,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN, IMMUNE SYSTEM",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-384 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7DCC,N,"THE HEAVY CHAIN OF 3C1 FAB, SPIKE GLYCOPROTEIN, THE LIGHT CHAIN OF 3C1 FAB","S-3C1-F3B STRUCTURE, ALL THE THREE RBDS ARE IN THE UP CONFORMATION AND EACH OF THEM ASSOCIATES WITH A 3C1 FAB",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,A,F,K,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,12/02/20,"S-3C1-F3B STRUCTURE, ALL THE THREE RBDS ARE IN THE UP CONFORMATION AND EACH OF THEM ASSOCIATES WITH A 3C1 FAB",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., LIU, C.X.",ELECTRON MICROSCOPY,NONE
7F0X,N,,A SARS-COV-2 NEUTRALIZING ANTIBODY,VIRAL PROTEIN/ANTIVIRAL PROTEIN,"NEUTRALIZING ANTIBODY, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX","A SARS-COV-2 NEUTRALIZING
ANTIBODY",,,B,B,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,06/15/22,A SARS-COV-2 NEUTRALIZING ANTIBODY,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, G., LI, X., GUO, Y., WANG, Y., YUAN, S.",X-RAY DIFFRACTION,NONE
7RNJ,N,,S2P6 FAB FRAGMENT BOUND TO THE SARS-COV/SARS-COV-2 SPIKE STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM","COVID-19, SARS-COV-2, NEUTRALIZING MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, ANTIVIRAL PROTEIN, IMMUNE SYSTEM",BROAD BETACORONAVIRUS NEUTRALIZATION BY A STEM HELIX-SPECIFIC HUMAN ANTIBODY.,,,H,L,B,PEPTIDE,SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM",08/11/21,S2P6 FAB FRAGMENT BOUND TO THE SARS-COV/SARS-COV-2 SPIKE STEM HELIX PEPTIDE,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SNELL, G., CZUDNOCHOWSKI, N., CROLL, T.I., NIX, J.C., CORTI, D., CAMERONI, E., PINTO, D., BELTRAMELLO, M., SAUER, M.M., VEESLER, D.",X-RAY DIFFRACTION,NONE
7NDD,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN, IMMUNE SYSTEM",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,F,G,A,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7X7V,N,,"CRYO-EM STRUCTURE OF SARS-COV SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","CRYO-EM STRUCTURE OF SARS-COV SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/17/22,"CRYO-EM STRUCTURE OF SARS-COV SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"SUN, H., LIU, L., ZHANG, T., ZHENG, Q., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
6CK9,N,,CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM,VIRAL PROTEIN,"HIV-1 ENVELOPE FUSION GLYCOPROTEIN, VIRAL PROTEIN",A UNIVERSAL APPROACH TO OPTIMIZE THE FOLDING AND STABILITY OF PREFUSION-CLOSED HIV-1 ENVELOPE TRIMERS.,,,H,L,G,PROTEIN,GP120 OF ENVELOPE GLYCOPROTEIN GP160,VIRAL PROTEIN,02/27/18,CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"LAI, Y.-T., KWONG, P.D.",X-RAY DIFFRACTION,NONE
7CHE,N,"BD-236 FAB HEAVY CHAIN, BD-236 FAB LIGHT CHAIN, SARS-COV-2 RECEPTOR BINDING DOMAIN, BD-368-2 FAB HEAVY CHAIN, BD-368-2 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,"MAB, ANTIVIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURALLY RESOLVED SARS-COV-2 ANTIBODY SHOWS HIGH EFFICACY IN SEVERELY INFECTED HAMSTERS AND PROVIDES A POTENT COCKTAIL PAIRING STRATEGY.,,,H,L,R,PROTEIN,SARS-COV-2 RECEPTOR BINDING DOMAIN,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,07/05/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XIAO, J., ZHU, Q.",X-RAY DIFFRACTION,NONE
7JV4,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, S2H13 FAB HEAVY CHAIN, S2H13 FAB LIGHT CHAIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,F,G,C,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/20/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., TORTORICI, M.A., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",ELECTRON MICROSCOPY,NONE
7Z1D,N,,NANOBODY H11-H6 BOUND TO RBD,ANTIVIRAL PROTEIN,"SPIKE, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",STRUCTURE OF H11-H6 BOUND TO RBD,,,F,,E,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,01/08/09,NANOBODY H11-H6 BOUND TO RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,,,,"MIKOLAJEK, H., NAISMITH, J.H.",X-RAY DIFFRACTION,NONE
7L2C,N,,CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD),IMMUNE SYSTEM/VIRAL PROTEIN,"COVID-19, SARS-COV-2, VIRAL PROTEIN, SPIKE GLYCOPROTEIN, N-TERMINAL DOMAIN, NTD, NEUTRALIZING ANTIBODY, 2-51, FAB, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES DIRECTED AGAINST SPIKE N-TERMINAL DOMAIN TARGET A SINGLE SUPERSITE.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,02/10/21,CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CERUTTI, G., REDDEM, E.R., SHAPIRO, L.",X-RAY DIFFRACTION,NONE
6ZBP,N,"SPIKE GLYCOPROTEIN, H11-H4",H11-H4 COMPLEX WITH SARS-COV-2,ANTIVIRAL PROTEIN,"COMPLEX, LLAMA, NANOBODY, ANTIBODY, SARS-COV-2, ANTIVIRAL PROTEIN",H11-D4 COMPLEX WITH SARS-COV-2 RBD,,,F,,E,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,06/08/20,H11-H4 COMPLEX WITH SARS-COV-2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,,,,"NAISMITH, J.H., HUO, J., MIKOLAJEK, H., WARD, P., DUMOUX, M., OWENS, R.J., LEBAS, A.",X-RAY DIFFRACTION,NONE
6ZDH,N,,SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB,VIRAL PROTEIN,"EY6A, RBD, SPIKE GLYCOPROTEIN, SARS-COV-2, HUMAN NEUTRALIZING ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM",STRUCTURAL BASIS FOR THE NEUTRALIZATION OF SARS-COV-2 BY AN ANTIBODY FROM A CONVALESCENT PATIENT.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/14/20,SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHOU, D., ZHAO, Y., FRY, E.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7SN2,N,,STRUCTURE OF HUMAN SARS-COV-2 NEUTRALIZING ANTIBODY C1C-A3 FAB,IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING ANTIBODY, NEUTRALIZATION ESCAPE, IMMUNE SYSTEM",STRUCTURAL BASIS FOR CONTINUED ANTIBODY EVASION BY THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,12/08/21,STRUCTURE OF HUMAN SARS-COV-2 NEUTRALIZING ANTIBODY C1C-A3 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PAN, J., ABRAHAM, J., YANG, P., SHANKAR, S.",ELECTRON MICROSCOPY,NONE
7LY3,N,"SPIKE PROTEIN S1, S2M28 FAB HEAVY CHAIN, S2M28 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",N-TERMINAL DOMAIN ANTIGENIC MAPPING REVEALS A SITE OF VULNERABILITY FOR SARS-COV-2.,,,F,E,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7MW6,N,,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH THREE RBDS UP IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 2,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","DEVELOPMENT, STRUCTURE AND FUNCTION OF POTENT MONOSPECIFIC AND BISPECIFIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE SARS-COV-2 AND ITS MUTANT VARIANT",,,D,E,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/16/22,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH THREE RBDS UP IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HU, Y., XIONG, Y.",ELECTRON MICROSCOPY,NONE
6PSC,N,SCFV-M204 ANTIBODY,ANTIBODY SCFV-M204 TRIMERIC STATE,IMMUNE SYSTEM,"ANTI-TAU-OLIGOMER SCFV ANTIBODY, IMMUNE SYSTEM",CRYSTAL STRUCTURE OF A CONFORMATIONAL ANTIBODY THAT BINDS TAU OLIGOMERS AND INHIBITS PATHOLOGICAL SEEDING BY EXTRACTS FROM DONORS WITH ALZHEIMER'S DISEASE.,,,C,C,,,,IMMUNE SYSTEM,06/17/20,ANTIBODY SCFV-M204 TRIMERIC STATE,ORYCTOLAGUS CUNICULUS,ORYCTOLAGUS CUNICULUS,,,"ABSKHARON, R., SAWAYA, M.R., SEIDLER, P.M., CASCIO, D., EISENBERG, D.S.",X-RAY DIFFRACTION,NONE
7NXB,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY EVASION BY THE P.1 STRAIN OF SARS-COV-2.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/07/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7NEH,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, N501Y MUTATION, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",REDUCED NEUTRALIZATION OF SARS-COV-2 B.1.1.7 VARIANT BY CONVALESCENT AND VACCINE SERA.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7WC0,N,,CRYSTAL STRUCTURE OF FAB REGION OF TAU-2212 NEUTRALIZING SARS-COV-2,IMMUNE SYSTEM,IMMUNE SYSTEM,CONFORMATIONAL FLEXIBILITY IN NEUTRALIZATION OF SARS-COV-2 BY NATURALLY ELICITED ANTI-SARS-COV ANTIBODIES,,,H,L,,,,IMMUNE SYSTEM,08/10/22,CRYSTAL STRUCTURE OF FAB REGION OF TAU-2212 NEUTRALIZING SARS-COV-2,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"XIANG, Y., LI, R., MA, B.",X-RAY DIFFRACTION,NONE
7NLL,N,,SARS-COV-2 SPIKE RBD (DIMER) IN COMPLEX WITH TWO FU2 NANOBODIES,VIRAL PROTEIN,"NANOBODY, SPIKE, COMPLEX, DIMER, VIRAL PROTEIN",A BISPECIFIC MONOMERIC NANOBODY INDUCES SPIKE TRIMER DIMERS AND NEUTRALIZES SARS-COV-2 IN VIVO.,,,A,,D,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,02/02/22,SARS-COV-2 SPIKE RBD (DIMER) IN COMPLEX WITH TWO FU2 NANOBODIES,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DAS, H., HALLBERG, B.M.",ELECTRON MICROSCOPY,NONE
7WK8,N,,SARS-COV-2 OMICRON SPIKE PROTEIN SD1 IN COMPLEX WITH S3H3 FAB,VIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, OMICRON VARIANT, B.1.1.529 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MOLECULAR BASIS OF RECEPTOR BINDING AND ANTIBODY NEUTRALIZATION OF OMICRON.,,,C,D,A | B,PROTEIN | PEPTIDE,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,01/26/22,SARS-COV-2 OMICRON SPIKE PROTEIN SD1 IN COMPLEX WITH S3H3 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HONG, Q., CONG, Y.",ELECTRON MICROSCOPY,NONE
7RA8,N,,SARS-COV-2 S GLYCOPROTEIN IN COMPLEX WITH S2X259 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, FAB S2X259, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",BROAD SARBECOVIRUS NEUTRALIZATION BY A HUMAN MONOCLONAL ANTIBODY.,,,C,D,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,SARS-COV-2 S GLYCOPROTEIN IN COMPLEX WITH S2X259 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"VEESLER, D., TORTORICI, M.A., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
8DI5,N,,CRYO-EM STRUCTURE OF SARS-COV-2 BETA (B.1.351) SPIKE PROTEIN IN COMPLEX WITH VH DOMAIN F6 (FOCUSED REFINEMENT OF RBD AND VH F6),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VH DOMAIN, F6, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT AND BROAD NEUTRALIZATION OF SARS-COV-2 VARIANTS OF CONCERN (VOCS) INCLUDING OMICRON SUB-LINEAGES BA.1 AND BA.2 BY BIPARATOPIC HUMAN VH DOMAINS.,,,H,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,CRYO-EM STRUCTURE OF SARS-COV-2 BETA (B.1.351) SPIKE PROTEIN IN COMPLEX WITH VH DOMAIN F6 (FOCUSED REFINEMENT OF RBD AND VH F6),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., SAVILLE, J.W., MANNAR, D., BEREZUK, A.M., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
6UDA,N,"CH505.N279K.G458Y.SOSIP.664 GP120, CH235 UCA HEAVY CHAIN FAB, CH505.N279K.G458Y.SOSIP.664 GP41, CH235 UCA LIGHT CHAIN FAB",CRYO-EM STRUCTURE OF CH235UCA BOUND TO MAN5-ENRICHED CH505.N279K.G458Y.SOSIP.664,VIRAL PROTEIN/IMMUNE SYSTEM,"CH235 LINEAGE, CH505 VIRUS, VACCINE DESIGN, CRYO-EM, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",NEUTRALIZATION-GUIDED DESIGN OF HIV-1 ENVELOPE TRIMERS WITH HIGH AFFINITY FOR THE UNMUTATED COMMON ANCESTER OF CH235 LINEAGE CD4BS BROADLY NEUTRALIZING ANTIBODIES.,,,K,L,I,PROTEIN,CH505.N279K.G458Y.SOSIP.664 GP120,VIRAL PROTEIN/IMMUNE SYSTEM,09/19/19,CRYO-EM STRUCTURE OF CH235UCA BOUND TO MAN5-ENRICHED CH505.N279K.G458Y.SOSIP.664,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"HENDERSON, R., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7K3Q,N,"FAB FRAGMENT OF S2E12 MONOCLONAL ANTIBODY, HEAVY CHAIN, FAB FRAGMENT OF S2E12 MONOCLONAL ANTIBODY, LIGHT CHAIN",AN ULTRA-POTENT HUMAN NEUTRALIZING ANTIBODY LOCKS THE SARS-COV-2 SPIKE IN THE CLOSED CONFORMATION,IMMUNE SYSTEM,"SARS-COV-2, NEUTRALIZING MAB, ANTIVIRAL PROTEIN, IMMUNE SYSTEM",ULTRAPOTENT HUMAN ANTIBODIES PROTECT AGAINST SARS-COV-2 CHALLENGE VIA MULTIPLE MECHANISMS.,,,H,L,,,,IMMUNE SYSTEM,09/12/20,AN ULTRA-POTENT HUMAN NEUTRALIZING ANTIBODY LOCKS THE SARS-COV-2 SPIKE IN THE CLOSED CONFORMATION,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"SNELL, G., CZUDNOCHOWSKI, N., NG, C.",X-RAY DIFFRACTION,NONE
7ORA,N,,CRYSTAL STRUCTURE OF THE T478K MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND COVOX-253 FABS,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, B.1.617 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",REDUCED NEUTRALIZATION OF SARS-COV-2 B.1.617 BY VACCINE AND CONVALESCENT SERUM.,,,H,L,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,07/07/21,CRYSTAL STRUCTURE OF THE T478K MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND COVOX-253 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7E3B,N,,SARS-COV-2 SPIKE IN COMPLEX WITH THE AB5 NEUTRALIZING ANTIBODY (FOCUSED REFINEMENT ON FAB-RBD),VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, SARS-COV-2, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THREE EPITOPE-DISTINCT HUMAN ANTIBODIES FROM RENMAB MICE NEUTRALIZE SARS-COV-2 AND COOPERATIVELY MINIMIZE THE ESCAPE OF MUTANTS.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/01/21,SARS-COV-2 SPIKE IN COMPLEX WITH THE AB5 NEUTRALIZING ANTIBODY (FOCUSED REFINEMENT ON FAB-RBD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, C.",ELECTRON MICROSCOPY,NONE
7N3E,N,,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C032,IMMUNE SYSTEM,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,H,L,,,,IMMUNE SYSTEM,08/04/21,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C032,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"FLYAK, A.I., BJORKMAN, P.J., BARNES, C.O.",X-RAY DIFFRACTION,NONE
7NKT,N,"SURFACE GLYCOPROTEIN, NEUTRALIZING NANOBODY NM1226",RBD DOMAIN OF SARS-COV2 IN COMPLEX WITH NEUTRALIZING NANOBODY NM1226,VIRAL PROTEIN,"RBD, SARS-COV2, NEUTRALIZING NANOBODY, COMPLEX, NM1226, VIRAL PROTEIN",NEUTROBODYPLEX-MONITORING SARS-COV-2 NEUTRALIZING IMMUNE RESPONSES USING NANOBODIES.,,,B,,A,PROTEIN,UNKNOWN,VIRAL PROTEIN,01/08/09,RBD DOMAIN OF SARS-COV2 IN COMPLEX WITH NEUTRALIZING NANOBODY NM1226,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,,,,"OSTERTAG, E., ZOCHER, G., STEHLE, T.",X-RAY DIFFRACTION,NONE
7P78,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODY#15 AND SYBODY#68 IN A 1UP/1UP-OUT/1DOWN CONFORMATION,VIRAL PROTEIN,"SARS-COV-2 SPIKE PROTEIN SYBODY, VIRAL PROTEIN",BIPARATOPIC SYBODIES NEUTRALIZE SARS-COV-2 VARIANTS OF CONCERN AND MITIGATE DRUG RESISTANCE.,,,H,,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/04/21,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODY#15 AND SYBODY#68 IN A 1UP/1UP-OUT/1DOWN CONFORMATION,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WALTER, J.D., HUTTER, C.A.J., GARAEVA, A.A., SCHERER, M., ZIMMERMANN, I., WYSS, M., RHEINBERGER, J., RUEDIN, Y., EARP, J.C., EGLOFF, P., SORGENFREI, M., HUERLIMANN, L.M., GONDA, I., MEIER, G., REMM, S., THAVARASAH, S., ZIMMER, G., SLOTBOOM, D.J., PAULINO, C., PLATTET, P., SEEGER, M.A.",ELECTRON MICROSCOPY,NONE
7Z7X,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 NANOBODY COMPLEX,ANTIVIRAL PROTEIN,"COMPLEX, SPIKE GLYCOPROTEIN, NANOBODY H11-H6, ANTIVIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 NANOBODY COMPLEX,,,D,,A,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",ANTIVIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 NANOBODY COMPLEX,ESCHERICHIA VIRUS T4; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ESCHERICHIA VIRUS T4 ","WECKENER, M., NAISMITH, J.H.",ELECTRON MICROSCOPY,NONE
7CDI,N,,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH RBD,VIRAL PROTEIN,"SPIKE, RECEPTOR BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN",ANTIBODY NEUTRALIZATION OF SARS-COV-2 THROUGH ACE2 RECEPTOR MIMICRY.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/19/20,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHANG, L., GE, J., WANG, R.",X-RAY DIFFRACTION,NONE
7VND,N,,"STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113 (UUD-STATE, STATE 2)",VIRAL PROTEIN,"SARS-COV-2, NANOBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN",A NON-ACE2 COMPETING HUMAN SINGLE-DOMAIN ANTIBODY CONFERS BROAD NEUTRALIZATION AGAINST SARS-COV-2 AND CIRCULATING VARIANTS.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,11/24/21,"STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113 (UUD-STATE, STATE 2)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, Z., WANG, Y., KONG, Y., JIN, Y., WU, Y., YING, T.",ELECTRON MICROSCOPY,NONE
7V26,N,,XG005-BOUND SARS-COV-2 S,VIRAL PROTEIN,"SARS-COC-2, SPIKE, ANTIBODIES, VIRAL PROTEIN",AN ULTRAPOTENT PAN-BETA-CORONAVIRUS LINEAGE B ( BETA-COV-B) NEUTRALIZING ANTIBODY LOCKS THE RECEPTOR-BINDING DOMAIN IN CLOSED CONFORMATION BY TARGETING ITS CONSERVED EPITOPE.,,,E,F,E,PROTEIN,XG005 HEAVY CHAIN,VIRAL PROTEIN,10/20/21,XG005-BOUND SARS-COV-2 S,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., SUN, L., CHEN, Z.G.",ELECTRON MICROSCOPY,NONE
7SOA,N,,SARS-COV-2 S NTD B.1.617.2 DELTA VARIANT + S2L20 LOCAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"DELTA, SPIKE, ANTIBODY, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MOLECULAR BASIS OF IMMUNE EVASION BY THE DELTA AND KAPPA SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/17/21,SARS-COV-2 S NTD B.1.617.2 DELTA VARIANT + S2L20 LOCAL REFINEMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
2G75,,"IGG HEAVY CHAIN, IGG LIGHT CHAIN",CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY,IMMUNE SYSTEM,"SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM",STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY.,,,A,B,,,,IMMUNE SYSTEM,02/27/06,CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"PRABAKARAN, P., GAN, J.H., FENG, Y., ZHU, Z.Y., XIAO, X.D., JI, X., DIMITROV, D.S.",X-RAY DIFFRACTION,NONE
7WPD,N,,SARS-COV-2 OMICRON VARIANT S TRIMER COMPLEXED WITH ONE JMB2002 FAB,VIRAL PROTEIN,"SARS-COV-2, OMICRON, S, TRIMER, FAB, ANTIBODY, VIRAL PROTEIN",STRUCTURES OF THE OMICRON SPIKE TRIMER WITH ACE2 AND AN ANTI-OMICRON ANTIBODY.,,,Z,,,,,VIRAL PROTEIN,03/16/22,SARS-COV-2 OMICRON VARIANT S TRIMER COMPLEXED WITH ONE JMB2002 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS; LAMA GLAMA,LAMA GLAMA,,,"YIN, W., XU, Y., XU, P., CAO, X., WU, C., GU, C., HE, X., WANG, X., HUANG, S., YUAN, Q., WU, K., HU, W., HUANG, Z., LIU, J., WANG, Z., JIA, F., XIA, K., LIU, P., WANG, X., SONG, B., ZHENG, J., JIANG, H., CHENG, X., JIANG, Y., DENG, S.J., XU, H.E.",ELECTRON MICROSCOPY,NONE
7M6E,N,"SPIKE GLYCOPROTEIN, BG10-19 FAB HEAVY CHAIN, BG10-19 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19",VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, COVID-19, ANTIBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING DOMAIN, SPIKE GLYCOPROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",B CELL GENOMICS BEHIND CROSS-NEUTRALIZATION OF SARS-COV-2 VARIANTS AND SARS-COV.,,,D,C,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/ANTIVIRAL PROTEIN,05/05/21,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7EJZ,N,,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-S477N OF COVID-19,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZATION ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD- OF COVID-19,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/13/22,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-S477N OF COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, H., WANG, B., ZHAO, T.N., SU, X.D.",X-RAY DIFFRACTION,NONE
7XXL,N,,RBD IN COMPLEX WITH FAB14,IMMUNE SYSTEM/VIRAL PROTEIN,"COMPLEX, RBD, FAB, PROTEIN BINDING, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",ENGINEERING SARS-COV-2 COCKTAIL ANTIBODIES INTO A BISPECIFIC FORMAT IMPROVES NEUTRALIZING POTENCY AND BREADTH.,,,A,C,B,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,09/14/22,RBD IN COMPLEX WITH FAB14,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIN, J.Q., TAN, Y.J.E., WU, B., LESCAR, J.",ELECTRON MICROSCOPY,NONE
6C6Y,N,"JC57-14 HEAVY CHAIN, JC57-14 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE IN COMPLEX WITH MERS RECEPTOR BINDING DOMAIN,IMMUNE SYSTEM,"ANTIBODY, NEUTRALIZING, VACCINE, IMMUNE SYSTEM",IMPORTANCE OF NEUTRALIZING MONOCLONAL ANTIBODIES TARGETING MULTIPLE ANTIGENIC SITES ON THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS SPIKE GLYCOPROTEIN TO AVOID NEUTRALIZATION ESCAPE.,,,A,B,S,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,01/19/18,CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE IN COMPLEX WITH MERS RECEPTOR BINDING DOMAIN,MACACA MULATTA; BETACORONAVIRUS ENGLAND 1,MACACA MULATTA,MACACA MULATTA,BETACORONAVIRUS ENGLAND 1,"JOYCE, M.G., MASCOLA, J.R., GRAHAM, B.S., KWONG, P.D.",X-RAY DIFFRACTION,NONE
4UBD,,"1968 H3 HA1, 1968 H3 HA2, HEAVY CHAIN, LIGHT CHAIN",CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA,VIRAL PROTEIN/IMMUNE SYSTEM,"HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A POTENT BROAD-SPECTRUM PROTECTIVE HUMAN MONOCLONAL ANTIBODY CROSSLINKING TWO HAEMAGGLUTININ MONOMERS OF INFLUENZA A VIRUS.,,,S,T,R | U,PROTEIN | PROTEIN,HEMAGGLUTININ HA2 CHAIN | HEMAGGLUTININ HA1 CHAIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/24/15,CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA,INFLUENZA A VIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,INFLUENZA A VIRUS | INFLUENZA A VIRUS,"SHORE, D.A., YANG, H., CHO, M., DONIS, R.O., STEVENS, J.",X-RAY DIFFRACTION,NONE
7B3O,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH STE90-C11 FAB,ANTIVIRAL PROTEIN,"NEUTRALIZING ANTIBODIES, SARS-COV-2, RBD, ANTIVIRAL PROTEIN",A SARS-COV-2 NEUTRALIZING ANTIBODY SELECTED FROM COVID-19 PATIENTS BINDS TO THE ACE2-RBD INTERFACE AND IS TOLERANT TO MOST KNOWN RBD MUTATIONS.,,,H,L,E,PROTEIN,SURFACE GLYCOPROTEIN,ANTIVIRAL PROTEIN,12/01/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH STE90-C11 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KLUENEMANN, T., VAN DEN HEUVEL, J.",X-RAY DIFFRACTION,NONE
7K90,N,"SPIKE GLYCOPROTEIN, C144 FAB HEAVY CHAIN, C144 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,M,N,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., ESSWEIN, S.R., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7ZF5,N,,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-12 AND BETA-54 FABS,VIRAL PROTEIN,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, OMI-12, BETA-54, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,D,F,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-12 AND BETA-54 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
5U65,N,VHH-5,CAMEL NANOBODY VHH-5,IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, HIV-1, NANOBODY VHH, IMMUNE SYSTEM",SELECTION OF NANOBODIES WITH BROAD NEUTRALIZING POTENTIAL AGAINST PRIMARY HIV-1 STRAINS USING SOLUBLE SUBTYPE C GP140 ENVELOPE TRIMERS.,,,B,,,,,IMMUNE SYSTEM,12/07/16,CAMEL NANOBODY VHH-5,CAMELUS DROMEDARIUS,CAMELUS DROMEDARIUS,,,"STANFIELD, R.L., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7ND9,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-253H55L FAB,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN, IMMUNE SYSTEM",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-253H55L FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7PS7,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-40 FAB,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 (ALPHA) VARIANT, B.1.351 (BETA) VARIANT, P.1 (GAMMA) VARIANT, B.1.617.2 (DELTA) VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,A,B,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-40 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7WS4,N,,ULTRAPOTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,I,H,C | A | B,PROTEIN | PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,ULTRAPOTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7WHZ,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH THREE HUMAN NEUTRALIZING ANTIBODIES,VIRAL PROTEIN,"SARS-COV-2, OMICRON, SPIKE PROTEIN, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN","THREE SARS-COV-2 ANTIBODIES PROVIDE BROAD AND SYNERGISTIC NEUTRALIZATION AGAINST VARIANTS OF CONCERN, INCLUDING OMICRON.",,,B,D,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/22/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH THREE HUMAN NEUTRALIZING ANTIBODIES,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, Q., LI, S., SUN, H., ZHENG, Z., WANG, S.",ELECTRON MICROSCOPY,NONE
7MJH,N,"SPIKE GLYCOPROTEIN, VH AB8",CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO VH AB8,VIRAL PROTEIN,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VH AB8, NEUTRALIZING ANTIBODY",CRYO-ELECTRON MICROSCOPY STRUCTURES OF THE N501Y SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH ACE2 AND 2 POTENT NEUTRALIZING ANTIBODIES.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/12/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO VH AB8,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SRIVASTAVA, S.S., BEREZUK, A.M., DEMERS, J.P., SAVILLE, J.W., LEOPOLD, K., LI, W., DIMITROV, D.S., TUTTLE, K.S., ZHOU, S., CHITTORI, S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
3ZKN,,"BETA-SECRETASE 2 (E.C.3.4.23.45), FAB HEAVY CHAIN, FAB LIGHT CHAIN",BACE2 FAB INHIBITOR COMPLEX,IMMUNE SYSTEM/HYDROLASE,"IMMUNE SYSTEM-HYDROLASE COMPLEX, FAB COMPLEX","MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USING SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS, FYNOMERS, AND XAPERONES",,,H,L,A,PROTEIN,BETA-SECRETASE 2,IMMUNE SYSTEM/HYDROLASE,01/23/13,BACE2 FAB INHIBITOR COMPLEX,HOMO SAPIENS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,HOMO SAPIENS,"BANNER, D.W., KUGLSTATTER, A., BENZ, J., STIHLE, M., RUF, A.",X-RAY DIFFRACTION,NONE
7F7H,N,,SARS-COV-2 S PROTEIN RBD IN COMPLEX WITH A8-1 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, SARS-COV-2, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",HIGH THROUGHPUT ISOLATION OF POTENT NEUTRALIZING ANTIBODIES FROM CONVALESCENT COVID-19 PATIENTS.,,,A,B,E,PROTEIN,SPIKE GLYCOPROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/15/22,SARS-COV-2 S PROTEIN RBD IN COMPLEX WITH A8-1 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DOU, Y., WANG, X., WANG, K., LIU, P., LU, B.",X-RAY DIFFRACTION,NONE
7KFX,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF HUMAN ANTIBODY C1A-C2 FAB, LIGHT CHAIN OF HUMAN ANTIBODY C1A-C2 FAB",STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-C2 FAB),IMMUNE SYSTEM/VIRAL PROTEIN,"COVID-19, SARS-COV-2, NEUTRALIZING ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MOLECULAR BASIS FOR A GERMLINE-BIASED NEUTRALIZING ANTIBODY RESPONSE TO SARS-COV-2.,,,H,L,A,PROTEIN,SURFACE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,10/15/20,STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-C2 FAB),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PAN, J., ABRAHAM, J., CLARK, L., CLARK, S.",X-RAY DIFFRACTION,NONE
7K8O,N,"C002 FAB HEAVY CHAIN, C002 FAB LIGHT CHAIN","CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002",IMMUNE SYSTEM,"HUMAN NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR BINDING DOMAIN, COVID-19, IMMUNE SYSTEM",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,H,L,,,,IMMUNE SYSTEM,09/27/20,"CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110",HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"JETTE, C.A., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
7WED,N,,SARS-COV-2 OMICRON VARIANT SPIKE RBD IN COMPLEX WITH FAB XGV347,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/13/22,SARS-COV-2 OMICRON VARIANT SPIKE RBD IN COMPLEX WITH FAB XGV347,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
4C2I,,"ENVELOPE PROTEIN, POLYPROTEIN, HEAVY CHAIN FAB FRAGMENT OF ANTIBODY 1F4, LIGHT CHAIN FAB FRAGMENT OF ANTIBODY 1F4",CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH FAB FRAGMENTS OF HUMAN ANTIBODY 1F4,VIRUS,"VIRUS, E PROTEINS, NEUTRALIZATION",A POTENT ANTI-DENGUE HUMAN ANTIBODY PREFERENTIALLY RECOGNIZES THE CONFORMATION OF E PROTEIN MONOMERS ASSEMBLED ON THE VIRUS SURFACE.,,"CA ATOMS ONLY, CHAIN A, C, E, B, D, F, H, M, L, N",H,L,C,PROTEIN,ENVELOPE PROTEIN,VIRUS,08/18/13,CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH FAB FRAGMENTS OF HUMAN ANTIBODY 1F4,HOMO SAPIENS; DENGUE VIRUS 1,HOMO SAPIENS,HOMO SAPIENS,DENGUE VIRUS 1,"FIBRIANSAH, G., TAN, J.L., DE ALWIS, R., SMITH, S.A., NG, T.-S., KOSTYUCHENKO, V.A., IBARRA, K.D., HARRIS, E., DE SILVA, A., CROWE JUNIOR, J.E., LOK, S.-M.",ELECTRON MICROSCOPY,NONE
7FAU,N,,STRUCTURE DETERMINATION OF THE NB1B11-RBD COMPLEX,STRUCTURAL PROTEIN,"SARS-COV-2, RBD, NANOBODY, STRUCTURAL PROTEIN",STRUCTURAL BASIS OF NANOBODIES NEUTRALIZING SARS-COV-2 VARIANTS.,,,B,,A,PROTEIN,SPIKE PROTEIN S1,STRUCTURAL PROTEIN,06/01/22,STRUCTURE DETERMINATION OF THE NB1B11-RBD COMPLEX,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELIDAE,CAMELIDAE,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SHI, Z.Z., LI, X.X., WANG, L., SUN, Z.C., ZHANG, H.W., CHEN, X.C., CUI, Q.Q., QIAO, H.R., LAN, Z.Y., ZHANG, X.",X-RAY DIFFRACTION,NONE
7CHC,N,"BD-629 FAB H, IGK@ PROTEIN, SPIKE GLYCOPROTEIN, BD-368-2 FAB H, BD-368-2 FAB L",CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB,PROTEIN BINDING/IMMUNE SYSTEM,"COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX",STRUCTURALLY RESOLVED SARS-COV-2 ANTIBODY SHOWS HIGH EFFICACY IN SEVERELY INFECTED HAMSTERS AND PROVIDES A POTENT COCKTAIL PAIRING STRATEGY.,,,H,L,R,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING/IMMUNE SYSTEM,07/05/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.Y.",X-RAY DIFFRACTION,NONE
7K8R,N,"C135 FAB LIGHT CHAIN, C135 FAB HEAVY CHAIN","CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135",IMMUNE SYSTEM,"HUMAN NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR BINDING DOMAIN, COVID-19, IMMUNE SYSTEM",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,H,L,,,,IMMUNE SYSTEM,09/27/20,"CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135",HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"JETTE, C.A., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
7EYA,N,,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-804 FAB,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURES OF SARS-COV-2 B.1.351 NEUTRALIZING ANTIBODIES PROVIDE INSIGHTS INTO COCKTAIL DESIGN AGAINST CONCERNING VARIANTS.,,,H,L,R,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,09/08/21,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-804 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.",ELECTRON MICROSCOPY,NONE
7NX7,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY EVASION BY THE P.1 STRAIN OF SARS-COV-2.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/07/21,CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7DEU,N,"SPIKE GLYCOPROTEIN, ANTIBODY SCFV",CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV,VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, RBD, ANTIBODY, VIRAL PROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",STRUCTURAL BASIS FOR SARS-COV-2 NEUTRALIZING ANTIBODIES WITH NOVEL BINDING EPITOPES.,,,B,B,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,03/31/21,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, Z., ZHANG, G., LI, X., RAO, Z., GUO, Y.",X-RAY DIFFRACTION,NONE
7E3K,N,,ULTRAPOTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS,VIRAL PROTEIN,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS.,,,F,G,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,09/15/21,ULTRAPOTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., LI, T., LIU, F., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
4F2M,,"MONOCLONAL ANTIBODY 1AF10, HEAVY CHAIN, MONOCLONAL ANTIBODY 1AF10, LIGHT CHAIN, SPIKE PROTEIN",CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10,VIRAL PROTEIN/IMMUNE SYSTEM,"BETA-BARREL, IMMUNOGLOBULIN, VIRUS ENTRY, VIRUS NEUTRALIZATION, CELLULAR RECEPTOR, AMINOPEPTIDASE N, GLYCOSYLATION, VIRUS MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASES OF CORONAVIRUS ATTACHMENT TO HOST AMINOPEPTIDASE N AND ITS INHIBITION BY NEUTRALIZING ANTIBODIES.,,,C,D,F,PROTEIN,SPIKE PROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/08/12,CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10,TGEV VIRULENT PURDUE; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,TGEV VIRULENT PURDUE,"REGUERA, J., SANTIAGO, C., MUDGAL, G., ORDONO, D., ENJUANES, L., CASASNOVAS, J.M.",X-RAY DIFFRACTION,NONE
7STR,N,,CRYSTAL STRUCTURE OF HUMAN FAB S24-1063 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS CORONAVIRUS 2, NUCLEOCAPSID PROTEIN, HUMAN ANTIBODY FAB, COVID-19, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYSTAL STRUCTURE OF HUMAN FAB S24-1063 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,,,H,L,C,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/10/22,CRYSTAL STRUCTURE OF HUMAN FAB S24-1063 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KIM, Y., MALTSEVA, N., TESAR, C., JEDRZEJCZAK, R., DUGAN, H., STAMPER, C., WILSON, P., JOACHIMIAK, A., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",X-RAY DIFFRACTION,NONE
7P40,N,,P5C3 IS A POTENT FAB NEUTRALIZER,VIRAL PROTEIN,"SPIKE, ANTIBODY, VIRAL PROTEIN",A HIGHLY POTENT ANTIBODY EFFECTIVE AGAINST SARS-COV-2 VARIANTS OF CONCERN.,,,F,B,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,10/13/21,P5C3 IS A POTENT FAB NEUTRALIZER,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PEREZ, L.",ELECTRON MICROSCOPY,NONE
7WP0,N,,CRYO-EM STRUCTURE OF SARS-COV-2 DELTA S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, DELTA VARIANT, SPIKE, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",IMMUNE ESCAPE BY SARS-COV-2 OMICRON VARIANT AND STRUCTURAL BASIS OF ITS EFFECTIVE NEUTRALIZATION BY A BROAD NEUTRALIZING HUMAN ANTIBODY VACW-209.,,,H,L,F,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,07/20/22,CRYO-EM STRUCTURE OF SARS-COV-2 DELTA S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, Q., SUN, H., JU, B., ZHANG, Z., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
7F5G,N,,"THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL4 (SA4)",VIRAL PROTEIN,"NANOBODY, RBD, NEUTRALIZING ANTIBODY, RECEPTOR-BINDING DOMAIN, SARS-COV-2, VIRAL PROTEIN","ISOLATION, CHARACTERIZATION, AND STRUCTURE-BASED ENGINEERING OF A NEUTRALIZING NANOBODY AGAINST SARS-COV-2.",,,B,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/25/22,"THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL4 (SA4)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T., LAI, Y., ZHOU, Y., TAN, J., LI, D.",X-RAY DIFFRACTION,NONE
7URS,N,,CRYSTAL STRUCTURE OF SARS-COV-2 S DELTA VARIANT RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB CRYSTAL FORM 2,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 S RBD FAB COMPLEX, SARS-COV-2 S RECEPTOR-BINDING DOMAIN ANTIBODY FAB COMPLEX, COVID-19 SPIKE PROTEIN ANTIBODY FAB COMPLEX, DELTA VARIANT, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYSTAL STRUCTURE OF SARS-COV-2 S DELTA VARIANT RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB CRYSTAL FORM 2,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,CRYSTAL STRUCTURE OF SARS-COV-2 S DELTA VARIANT RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB CRYSTAL FORM 2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TOLBERT, W.D., PAZGIER, M.",X-RAY DIFFRACTION,NONE
7KM5,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RBD COMPLEXED WITH NANOSOTA-1,VIRAL PROTEIN/IMMUNE SYSTEM,"RBD, NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE DEVELOPMENT OF NANOSOTA - 1 AS ANTI-SARS-COV-2 NANOBODY DRUG CANDIDATES.,,,D,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,CRYSTAL STRUCTURE OF SARS-COV-2 RBD COMPLEXED WITH NANOSOTA-1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YE, G., SHI, K., AIHARA, H., LI, F.",X-RAY DIFFRACTION,NONE
7A25,N,"SPIKE GLYCOPROTEIN, SYBODY 23",CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23),VIRAL PROTEIN,"SARS-COV-2, COMPLEX, NANOBODY, SPIKE, VIRAL PROTEIN","SELECTION, BIOPHYSICAL AND STRUCTURAL ANALYSIS OF SYNTHETIC NANOBODIES THAT EFFECTIVELY NEUTRALIZE SARS-COV-2.",,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/16/20,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALLBERG, B.M., DAS, H.",ELECTRON MICROSCOPY,NONE
7V5K,N,,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 0722 (STATE 1),PROTEIN BINDING,"MERS SPIKE ANTIBODY, PROTEIN BINDING",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 0722 (STATE 1),,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,08/24/22,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 0722 (STATE 1),HOMO SAPIENS; HUMAN BETACORONAVIRUS 2C EMC/2012,HOMO SAPIENS,HOMO SAPIENS,HUMAN BETACORONAVIRUS 2C EMC/2012,"WANG, X., ZHAO, J., WANG, Z., ZENG, J., ZHANG, S., WANG, Y.",ELECTRON MICROSCOPY,NONE
7N9B,N,,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS WITH NB21,VIRAL PROTEIN/IMMUNE SYSTEM,"COVS NB21 NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING DIVERSE AND CONSERVED EPITOPES,,,F,,C | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS WITH NB21,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, D., ZHANG, C., SHI, Y.",ELECTRON MICROSCOPY,NONE
7JWB,N,"AUTONOMOUS HUMAN HEAVY CHAIN VARIABLE DOMAIN, SPIKE GLYCOPROTEIN",SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER,VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, VH, SARS, COV2, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",BI-PARATOPIC AND MULTIVALENT VH DOMAINS BLOCK ACE2 BINDING AND NEUTRALIZE SARS-COV-2.,,,D,,A | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/25/20,SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,QCRG STRUCTURAL BIOLOGY CONSORTIUM,ELECTRON MICROSCOPY,NONE
6WS6,N,"S309 ANTIGEN-BINDING (FAB) HEAVY CHAIN, S309 ANTIGEN-BINDING (FAB) LIGHT CHAIN",STRUCTURAL AND FUNCTIONAL ANALYSIS OF A POTENT SARBECOVIRUS NEUTRALIZING ANTIBODY,IMMUNE SYSTEM,"FUSION PROTEIN, NEUTRALIZING ANTIBODY, SARBECOVIRUS, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, IMMUNE SYSTEM",CROSS-NEUTRALIZATION OF SARS-COV-2 BY A HUMAN MONOCLONAL SARS-COV ANTIBODY.,,,E,F,,,,IMMUNE SYSTEM,05/27/20,STRUCTURAL AND FUNCTIONAL ANALYSIS OF A POTENT SARBECOVIRUS NEUTRALIZING ANTIBODY,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"PINTO, D., PARK, Y.J., BELTRAMELLO, M., WALLS, A.C., TORTORICI, M.A., BIANCHI, S., JACONI, S., CULAP, K., ZATTA, F., MARCO, A.D., PETER, A., GUARINO, B., SPREAFICO, R., CAMERONI, E., CASE, J.B., CHEN, R.E., HAVENAR-DAUGHTON, C., SNELL, G., TELENTI, A., VIRGIN, H.W., LANZAVECCHIA, A., DIAMOND, M.S., FINK, K., VEESLER, D., CORTI, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7WD7,N,,SARS-COV-2 BETA SPIKE IN COMPLEX WITH THREE S5D2 FABS,VIRAL PROTEIN,"CORONAVIRUS, BETA VARIANT, B.1.351 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MAPPING CROSS-VARIANT NEUTRALIZING SITES ON THE SARS-COV-2 SPIKE PROTEIN.,,,A,B,A,PROTEIN,HEAVY CHAIN OF S5D2 FAB,VIRAL PROTEIN,02/02/22,SARS-COV-2 BETA SPIKE IN COMPLEX WITH THREE S5D2 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y.F., CONG, Y.",ELECTRON MICROSCOPY,NONE
7JV2,N,"S2H13 FAB HEAVY CHAIN, S2H13 FAB LIGHT CHAIN, SARS-COV-2 SPIKE GLYCOPROTEIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING MOTIF AND FAB VARIABLE DOMAINS),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,H,L,A,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/20/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING MOTIF AND FAB VARIABLE DOMAINS),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., TORTORICI, M.A., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",ELECTRON MICROSCOPY,NONE
7MFV,N,,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY (SB16),IMMUNE SYSTEM,"SARS-COV-2, SPIKE PROTEIN, RBD, ANTIBODY, NANOBODY, SYBODY, VIRAL PROTEIN, EPITOPE, NEUTRALIZATION, IMMUNE SYSTEM",STRUCTURES OF SYNTHETIC NANOBODY-SARS-COV-2 RECEPTOR-BINDING DOMAIN COMPLEXES REVEAL DISTINCT SITES OF INTERACTION.,,,B,,,,,IMMUNE SYSTEM,06/02/21,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY,SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,,"JIANG, J., AHMAD, J., NATARAJAN, K., BOYD, L.F., MARGULIES, D.H.",X-RAY DIFFRACTION,NONE
4NUJ,,"PGT152 LIGHT CHAIN, PGT152 HEAVY CHAIN",CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT152,IMMUNE SYSTEM,"IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE","STRUCTURAL DELINEATION OF A QUATERNARY, CLEAVAGE-DEPENDENT EPITOPE AT THE GP41-GP120 INTERFACE ON INTACT HIV-1 ENV TRIMERS.",,,B,A,,,,IMMUNE SYSTEM,12/03/13,CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT152,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"BLATTNER, C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7L5B,N,"SPIKE GLYCOPROTEIN, 2-15 HEAVY CHAIN, 2-15 LIGHT CHAIN",CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-15 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD).,VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE PROTEIN S1, RECEPTOR BINDING PROTEIN SARS COV-2, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MODULAR BASIS FOR POTENT SARS-COV-2 NEUTRALIZATION BY A PREVALENT VH1-2-DERIVED ANTIBODY CLASS.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,02/10/21,CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-15 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD).,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"REDDEM, E.R., SHAPIRO, L.",X-RAY DIFFRACTION,NONE
7MFU,N,,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY (SB14+SB68) COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN, RBD, ANTIBODY, NANOBODY, SYBODY, COMPLEX, NEUTRALIZATION, VIRAL PROTEIN, EPITOPE",STRUCTURES OF SYNTHETIC NANOBODY-SARS-COV-2 RECEPTOR-BINDING DOMAIN COMPLEXES REVEAL DISTINCT SITES OF INTERACTION.,,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/02/21,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JIANG, J., AHMAD, J., NATARAJAN, K., BOYD, L.F., MARGULIES, D.H.",X-RAY DIFFRACTION,NONE
7SOD,N,,SARS-COV-2 S NTD B.1.617.1 KAPPA VARIANT S2L20 LOCAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"KAPPA, SPIKE, ANTIBODY, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MOLECULAR BASIS OF IMMUNE EVASION BY THE DELTA AND KAPPA SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/17/21,SARS-COV-2 S NTD B.1.617.1 KAPPA VARIANT S2L20 LOCAL REFINEMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
6XC7,N,"SPIKE PROTEIN S1, CR3022 HEAVY CHAIN, CR3022 LIGHT CHAIN, CC12.3 HEAVY CHAIN, CC12.3 LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY, SARS-COV-2, CORONAVIRUS, SPIKE, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",STRUCTURAL BASIS OF A SHARED ANTIBODY RESPONSE TO SARS-COV-2.,,,C,D,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,06/08/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., LIU, H., WU, N.C., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7SOB,N,,SARS-COV-2 S B.1.617.1 KAPPA VARIANT + S309 + S2L20 GLOBAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"KAPPA, SPIKE, ANTIBODY, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MOLECULAR BASIS OF IMMUNE EVASION BY THE DELTA AND KAPPA SARS-COV-2 VARIANTS.,,,G,I,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/17/21,SARS-COV-2 S B.1.617.1 KAPPA VARIANT + S309 + S2L20 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7E88,N,GLUTAMINE--FRUCTOSE-6-PHOSPHATE AMINOTRANSFERASE [ISOMERIZING] (E.C.2.6.1.16),CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-515 FAB,"VIRAL PROTEIN,IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM",HUMORAL IMMUNE RESPONSE TO CIRCULATING SARS-COV-2 VARIANTS ELICITED BY INACTIVATED AND RBD-SUBUNIT VACCINES.,,,G,H,I,PROTEIN,SPIKE PROTEIN S1,"VIRAL PROTEIN,IMMUNE SYSTEM",06/09/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-515 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GAO, C., WEI, Y., XIAO, J.",X-RAY DIFFRACTION,NONE
7WRL,N,,LOCAL STRUCTURE OF BD55-1239 FAB AND SARS-COV2 OMICRON RBD COMPLEX,VIRAL PROTEIN,"SARS-COV2 OMICRON, VIRAL PROTEIN","BA.2.12.1, BA.4 AND BA.5 ESCAPE ANTIBODIES ELICITED BY OMICRON INFECTION.",,,A,B,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/22/22,LOCAL STRUCTURE OF BD55-1239 FAB AND SARS-COV2 OMICRON RBD COMPLEX,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,"ZHANG, Z.Z., XIAO, J.J.",ELECTRON MICROSCOPY,NONE
7URQ,N,,CRYSTAL STRUCTURE OF SARS-COV-2 S DELTA VARIANT RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB CRYSTAL FORM 1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 S RBD FAB COMPLEX, SARS-COV-2 S RECEPTOR-BINDING DOMAIN ANTIBODY FAB COMPLEX, COVID-19 SPIKE PROTEIN ANTIBODY FAB COMPLEX, DELTA VARIANT, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYSTAL STRUCTURE OF SARS-COV-2 S DELTA VARIANT RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB CRYSTAL FORM 1,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,CRYSTAL STRUCTURE OF SARS-COV-2 S DELTA VARIANT RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB CRYSTAL FORM 1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TOLBERT, W.D., PAZGIER, M.",X-RAY DIFFRACTION,NONE
7JXE,N,"S309 ANTIGEN-BINDING (FAB) HEAVY CHAIN, S309 ANTIGEN-BINDING (FAB) LIGHT CHAIN",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,IMMUNE SYSTEM,"FUSION PROTEIN, NEUTRALIZING ANTIBODY, SARBECOVIRUS, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, IMMUNE SYSTEM",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,H,L,,,,IMMUNE SYSTEM,08/27/20,MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"TORTORICI, M.A., PARK, Y.J., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",X-RAY DIFFRACTION,NONE
7CM4,N,"SPIKE GLYCOPROTEIN, IGG HEAVY CHAIN, IGG LIGHT CHAIN",CRYSTAL STRUCTURE OF COVID-19 VIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH A NEUTRALIZING ANTIBODY CT-P59,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RECEPTOR BINDING DOMAIN, RBD, IGG, FAB, VIRAL PROTEIN",A THERAPEUTIC NEUTRALIZING ANTIBODY TARGETING RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE PROTEIN.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/24/20,CRYSTAL STRUCTURE OF COVID-19 VIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH A NEUTRALIZING ANTIBODY CT-P59,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KIM, Y.G., JEONG, J.H., BAE, J.S., LEE, J.H.",X-RAY DIFFRACTION,NONE
7TCQ,N,,CRYSTAL STRUCTURE OF SARS-COV-2 NEUTRALIZING ANTIBODY WS6 IN COMPLEX WITH SPIKE S2 PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",VACCINE-ELICITED MURINE ANTIBODY WS6 NEUTRALIZES DIVERSE BETA-CORONAVIRUSES BY RECOGNIZING A HELICAL STEM SUPERSITE OF VULNERABILITY.,,,A,B,D,PEPTIDE,PEGYLATED SPIKE S2 PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/22,CRYSTAL STRUCTURE OF SARS-COV-2 NEUTRALIZING ANTIBODY WS6 IN COMPLEX WITH SPIKE S2 PEPTIDE,MUS MUSCULUS; SYNTHETIC CONSTRUCT,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., KWONG, P.D.",X-RAY DIFFRACTION,NONE
5DHY,,"ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, HEAVY CHAIN, ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, LIGHT CHAIN, PROTEIN REV",HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,IMMUNE SYSTEM,"HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM",THE STRUCTURE OF HIV-1 REV FILAMENTS SUGGESTS A BILATERAL MODEL FOR REV-RRE ASSEMBLY.,,,H,L,M,PROTEIN,PROTEIN REV,IMMUNE SYSTEM,08/31/15,HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"DIMATTIA, M.A., WATTS, N.R., WINGFIELD, P.T., GRIMES, J.M., STUART, D.I., STEVEN, A.C.",X-RAY DIFFRACTION,NONE
7RBV,N,,SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRUS, NEUTRALIZING ANTIBODY, VACCINE, PLASMABLAST, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","STRUCTURE OF A VACCINE-INDUCED, GERMLINE-ENCODED HUMAN ANTIBODY DEFINES A NEUTRALIZING EPITOPE ON THE SARS-COV-2 SPIKE N-TERMINAL DOMAIN.",,,H,L,B | C,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ALTOMARE, C.G., BAJIC, G.",ELECTRON MICROSCOPY,NONE
7S5P,N,,CRYSTAL STRUCTURE OF SARS-COV-2 B.1.351 VARIANT RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CS23,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, FAB, VOC, BETA, B.1.351, SPIKE, RBD, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 BETA VARIANT INFECTION ELICITS POTENT LINEAGE-SPECIFIC AND CROSS-REACTIVE ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/09/22,CRYSTAL STRUCTURE OF SARS-COV-2 B.1.351 VARIANT RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CS23,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7CAN,N,,STRUCTURE OF SYBODY MR17-K99Y IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD),PROTEIN BINDING,"CORONAVIRUS, COVID-19, NANOBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING PROTEIN, SARS-COV-2, S PROTEIN, SYNTHETIC ANTIBODY, VHH., PROTEIN BINDING",A SYNTHETIC NANOBODY TARGETING RBD PROTECTS HAMSTERS FROM SARS-COV-2 INFECTION.,,,A,,B,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,06/09/20,STRUCTURE OF SYBODY MR17-K99Y IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD),SYNTHETIC CONSTRUCT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T., YAO, H., CAI, H., QIN, W., LI, D.",X-RAY DIFFRACTION,NONE
7LKA,N,"COV107-23 HEAVY CHAIN, COV107-23 LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RBD-TARGETING ANTIBODY COV107-23,IMMUNE SYSTEM,"CORONAVIRUS, COVID-19, SARS-COV-2, ANTIBODY, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM",SEQUENCE SIGNATURES OF TWO IGHV3-53/3-66 PUBLIC CLONOTYPES TO SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,C,D,,,,IMMUNE SYSTEM,02/10/21,CRYSTAL STRUCTURE OF SARS-COV-2 RBD-TARGETING ANTIBODY COV107-23,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"YUAN, M., ZHU, X., WILSON, I.A., WU, N.C.",X-RAY DIFFRACTION,NONE
7E9Q,N,,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(1 OUT RBD, STATE3)","VIRAL PROTEIN,IMMUNE SYSTEM","VIRAL PROTEIN, IMMUNE SYSTEM",A POTENT HUMAN MONOCLONAL ANTIBODY WITH PAN-NEUTRALIZING ACTIVITIES DIRECTLY DISLOCATES S TRIMER OF SARS-COV-2 THROUGH BINDING BOTH UP AND DOWN FORMS OF RBD,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN,IMMUNE SYSTEM",03/09/22,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(1 OUT RBD, STATE3)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.F., ZHU, Y.Q.",ELECTRON MICROSCOPY,NONE
5W9O,N,"SPIKE GLYCOPROTEIN, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,H,I,G,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7WM0,N,,CRYO-EM STRUCTURE OF THE OMICRON RBD IN COMPLEX WITH 35B5 FAB( LOCAL REFINEMENT OF THE RBD AND 35B5 FAB),"VIRAL PROTEIN,IMMUNE SYSTEM","IMMUNE SYSTEM, VIRAL PROTEIN",35B5 ANTIBODY POTENTLY NEUTRALIZES SARS-COV-2 OMICRON BY DISRUPTING THE N-GLYCAN SWITCH VIA A CONSERVED SPIKE EPITOPE,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN,IMMUNE SYSTEM",08/17/22,CRYO-EM STRUCTURE OF THE OMICRON RBD IN COMPLEX WITH 35B5 FAB( LOCAL REFINEMENT OF THE RBD AND 35B5 FAB),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHU, Y.",ELECTRON MICROSCOPY,NONE
7D03,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-2G7,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-2G7,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7CWO,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF P17 FAB, LIGHT CHAIN OF P17 FAB",SARS-COV-2 SPIKE PROTEIN RBD AND P17 FAB COMPLEX,VIRAL PROTEIN,"COMPLEX, FAB, SARS-COV-2 SPIKE PROTEIN, VIRAL PROTEIN",RATIONAL DEVELOPMENT OF A HUMAN ANTIBODY COCKTAIL THAT DEPLOYS MULTIPLE FUNCTIONS TO CONFER PAN-SARS-COVS PROTECTION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/29/20,SARS-COV-2 SPIKE PROTEIN RBD AND P17 FAB COMPLEX,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, N.",ELECTRON MICROSCOPY,NONE
7KKK,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, SYNTHETIC NANOBODY NB6",SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY NB6,VIRAL PROTEIN/IMMUNE SYSTEM,"COMPLEX, NANOBODY, VHH, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ULTRAPOTENT SYNTHETIC NANOBODY NEUTRALIZES SARS-COV-2 BY STABILIZING INACTIVE SPIKE.,,,B,,A,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/27/20,SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY NB6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SCHOOF, M.S., FAUST, B.F., SAUNDERS, R.A., SANGWAN, S., REZELJ, V., HOPPE, N., BOONE, M., BILLESBOELLE, C.B., PUCHADES, C., AZUMAYA, C.M., KRATOCHVIL, H.T., ZIMANYI, M., DESPHANDE, I., LIANG, J., DICKINSON, S., NGUYEN, H.C., CHIO, C.M., MERZ, G.E., THOMPSON, M.C., DIWANJI, D., SCHAEFER, K., ANAND, A.A., DOBZINSKI, N., ZHA, B.S., SIMONEAU, C.R., LEON, K., WHITE, K.M., CHIO, U.S., GUPTA, M., JIN, M., LI, F., LIU, Y., ZHANG, K., BULKLEY, D., SUN, M., SMITH, A.M., RIZO, A.N., MOSS, F., BRILOT, A.F., POURMAL, S., TRENKER, R., POSPIECH, T., GUPTA, S., BARSI-RHYNE, B., BELYY, V., BARILE-HILL, A.W., NOCK, S., LIU, Y., KROGAN, N.J., RALSTON, C.Y., SWANEY, D.L., GARCIA-SASTRE, A., OTT, M., VIGNUZZI, M., WALTER, P., MANGLIK, A., QCRG STRUCTURAL BIOLOGY CONSORTIUM",ELECTRON MICROSCOPY,NONE
7Z0X,N,,THSC20.HVTR26 FAB BOUND TO SARS-COV-2 RECEPTOR BINDING DOMAIN,ANTIVIRAL PROTEIN,"NEUTRALIZING ANTIBODY, SARS-COV-2, SPIKE, RBD, ANTIVIRAL PROTEIN, IMMUNOLOGY",A COMBINATION OF POTENTLY NEUTRALIZING MONOCLONAL ANTIBODIES ISOLATED FROM AN INDIAN CONVALESCENT DONOR PROTECTS AGAINST THE SARS-COV-2 DELTA VARIANT.,,,H,L,R,PROTEIN,SURFACE GLYCOPROTEIN,ANTIVIRAL PROTEIN,04/13/22,THSC20.HVTR26 FAB BOUND TO SARS-COV-2 RECEPTOR BINDING DOMAIN,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WIBMER, C.K.",X-RAY DIFFRACTION,NONE
7U0A,N,,CRYSTAL STRUCTURE OF C77G12 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE, COVID-19, FUSION PEPTIDE, FAB, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ACE2-BINDING EXPOSES THE SARS-COV-2 FUSION PEPTIDE TO BROADLY NEUTRALIZING CORONAVIRUS ANTIBODIES.,,,H,L,A,PEPTIDE,SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/22,CRYSTAL STRUCTURE OF C77G12 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,MAMMAL ENVIRONMENTAL SAMPLE; SYNTHETIC CONSTRUCT,MAMMAL ENVIRONMENTAL SAMPLE,MAMMAL ENVIRONMENTAL SAMPLE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M.A., VEESLER, D.",X-RAY DIFFRACTION,NONE
7K45,N,"S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (HEAVY CHAIN), S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LIGHT CHAIN), SPIKE GLYCOPROTEIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ULTRAPOTENT HUMAN ANTIBODIES PROTECT AGAINST SARS-COV-2 CHALLENGE VIA MULTIPLE MECHANISMS.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/14/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M.A., VEESLER, D.",ELECTRON MICROSCOPY,NONE
7MY2,N,,CRYOEM STRUCTURE OF NEUTRALIZING NANOBODY NB30 IN COMPLEX WITH SARS-COV2 SPIKE,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV2, NANOBODY, NEUTRALIZING, SPIKE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",NANOBODIES FROM CAMELID MICE AND LLAMAS NEUTRALIZE SARS-COV-2 VARIANTS.,,,D,,C,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,06/16/21,CRYOEM STRUCTURE OF NEUTRALIZING NANOBODY NB30 IN COMPLEX WITH SARS-COV2 SPIKE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, K., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7WI0,N,,SARS-COV-2 OMICRON VARIANT SPIKE IN COMPLEX WITH THREE HUMAN NEUTRALIZING ANTIBODIES,VIRAL PROTEIN,"SARS-COV-2, OMICRON, SPIKE PROTEIN, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN","THREE SARS-COV-2 ANTIBODIES PROVIDE BROAD AND SYNERGISTIC NEUTRALIZATION AGAINST VARIANTS OF CONCERN, INCLUDING OMICRON.",,,C,E,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/22/22,SARS-COV-2 OMICRON VARIANT SPIKE IN COMPLEX WITH THREE HUMAN NEUTRALIZING ANTIBODIES,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"ZHENG, Q., LI, S., SUN, H., ZHENG, Z., WANG, S.",ELECTRON MICROSCOPY,NONE
7DD2,N,"SPIKE GLYCOPROTEIN, THE HEAVY CHAIN OF 3C1 FAB, THE LIGHT CHAIN OF 3C1 FAB","S-3C1-F2 STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, THE TWO UP RBD BIND WITH A 3C1 FAB.",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,A,B,C,PROTEIN,SARS-COV2-S PROTEIN,VIRAL PROTEIN,10/27/20,"S-3C1-F2 STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, THE TWO UP RBD BIND WITH A 3C1 FAB.",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., LIU, C.X.",ELECTRON MICROSCOPY,NONE
8DAD,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH AZ090 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, COMPLEX, SARS-COV-2, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH AZ090 FAB,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH AZ090 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZONG, S., WANG, Z.",ELECTRON MICROSCOPY,NONE
7LSS,N,,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-7,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR ACCOMMODATION OF EMERGING B.1.351 AND B.1.1.7 VARIANTS BY TWO POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/17/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-7,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"RAPP, M., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7WHK,N,,"THE STATE 3 COMPLEX STRUCTURE OF OMICRON SPIKE WITH BN03 (2-UP RBD, 5 NANOBODIES)",VIRAL PROTEIN,"OMICRON, SPIKE, NANOBODY, VIRAL PROTEIN",BROAD NEUTRALIZATION OF SARS-COV-2 VARIANTS BY AN INHALABLE BISPECIFIC SINGLE-DOMAIN ANTIBODY.,,,E,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/11/22,"THE STATE 3 COMPLEX STRUCTURE OF OMICRON SPIKE WITH BN03 (2-UP RBD, 5 NANOBODIES)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7TTX,N,,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH SARBECOVIRUS BAT RATG13 RECEPTOR-BINDING DOMAIN,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARBECOVIRUS, RATG13 RBD, VIRAL PROTEIN, SPIKE GLYCOPROTEIN, RECEPTOR BINDING PROTEIN, NEUTRALIZING ANTIBODY, POTENT, 10-40, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ANTIBODY CLASS WITH A COMMON CDRH3 MOTIF BROADLY NEUTRALIZES SARBECOVIRUSES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH SARBECOVIRUS BAT RAGT13 RECEPTOR-BINDING DOMAIN,BAT CORONAVIRUS RATG13; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,BAT CORONAVIRUS RATG13,"REDDEM, E.R., SHAPIRO, L.",X-RAY DIFFRACTION,NONE
7P77,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODY#15 AND SYBODY#68 IN A 3UP CONFORMATION,VIRAL PROTEIN,"SARS-COV-2 SPIKE PROTEIN SYBODY, VIRAL PROTEIN",BIPARATOPIC SYBODIES NEUTRALIZE SARS-COV-2 VARIANTS OF CONCERN AND MITIGATE DRUG RESISTANCE.,,,H,,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/04/21,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODY#15 AND SYBODY#68 IN A 3UP CONFORMATION,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WALTER, J.D., HUTTER, C.A.J., GARAEVA, A.A., SCHERER, M., ZIMMERMANN, I., WYSS, M., RHEINBERGER, J., RUEDIN, Y., EARP, J.C., EGLOFF, P., SORGENFREI, M., HUERLIMANN, L.M., GONDA, I., MEIER, G., REMM, S., THAVARASAH, S., ZIMMER, G., SLOTBOOM, D.J., PAULINO, C., PLATTET, P., SEEGER, M.A.",ELECTRON MICROSCOPY,NONE
7VFA,N,,THE COMPLEX OF SARS-COV2 3CL AND NB1A2,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, 3CL, NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN EXTENDED CONFORMATION OF SARS-COV-2 MAIN PROTEASE REVEALS ALLOSTERIC TARGETS.,,,D,,E,PROTEIN,3C-LIKE PROTEINASE,VIRAL PROTEIN/IMMUNE SYSTEM,03/30/22,THE COMPLEX OF SARS-COV2 3CL AND NB1A2,CAMELUS BACTRIANUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,CAMELUS BACTRIANUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, Z.C., WANG, L., GENG, Y.",X-RAY DIFFRACTION,NONE
4QNP,,"NEURAMINIDASE (E.C.3.2.1.18), NEUTRALIZING ANTIBODY, LIGHT CHAIN, NEUTRALIZING ANTIBODY, HEAVY CHAIN",CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY,HYDROLASE/IMMUNE SYSTEM,"INFLUENZA, NEURAMINIDASE, ANTIBODY, NEUTRALIZING ANTIBODY, HYDROLASE-IMMUNE SYSTEM COMPLEX",STRUCTURAL CHARACTERIZATION OF A PROTECTIVE EPITOPE SPANNING A(H1N1)PDM09 INFLUENZA VIRUS NEURAMINIDASE MONOMERS.,,,H,L,B,PROTEIN,NEURAMINIDASE,HYDROLASE/IMMUNE SYSTEM,02/11/15,CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY,INFLUENZA A VIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,INFLUENZA A VIRUS,"WAN, H.Q., YANG, H., SHORE, D.A., GARTEN, R.J., COUZENS, L., GAO, J., JIANG, L.L., CARNEY, P.J., VILLANUEVA, J., STEVENS, J., EICHELBERGER, M.C.",X-RAY DIFFRACTION,NONE
5WDU,N,"ENVELOPE GLYCOPROTEIN GP160, BNAB NIH45-46 SCFV HEAVY CHAIN, BNAB NIH45-46 SCFV LIGHT CHAIN, BNAB PGT122 FAB LIGHT CHAIN, BNAB PGT122 FAB HEAVY CHAIN, BNAB 35O55 FAB HEAVY CHAIN, BNAB 35O22 FAB LIGHT CHAIN","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV",IMMUNE SYSTEM,"HIV-1 ENV, BROADLY NEUTRALIZING ANTIBODIES, VIRAL GLYCOPROTEIN, IMMUNE SYSTEM",IMPROVING THE IMMUNOGENICITY OF NATIVE-LIKE HIV-1 ENVELOPE TRIMERS BY HYPERSTABILIZATION.,,,D,E,G,PROTEIN,ENVELOPE GLYCOPROTEIN GP160,IMMUNE SYSTEM,07/06/17,"HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV",HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"JULIEN, J.-P., TORRENTS DE LA PENA, A., SANDERS, R.W., WILSON, I.A.",X-RAY DIFFRACTION,NONE
8CYD,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-45,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,E,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-45,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7Q0G,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-49 AND FI-3A FABS,VIRAL PROTEIN,"SARS-COV-2 ALPHA VARIANT, BETA VARIANT, GAMMA VARIANT, DELTA VARIANT, B.1.1.7, B.1.351, P.1, B.1.617.2, ANTIBODY, RBD, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,12/22/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-49 AND FI-3A FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
6ZCZ,N,,CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN TERNARY COMPLEX WITH EY6A FAB AND A NANOBODY.,VIRAL PROTEIN,"EY6A, RBD, SPIKE GLYCOPROTEIN, SARS-COV-2, HUMAN NEUTRALIZING ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM",STRUCTURAL BASIS FOR THE NEUTRALIZATION OF SARS-COV-2 BY AN ANTIBODY FROM A CONVALESCENT PATIENT.,,,F,,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/12/20,CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN TERNARY COMPLEX WITH EY6A FAB AND A NANOBODY.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA; HOMO SAPIENS,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., FRY, E.E., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
6VLR,N,"ENVELOPE GLYCOPROTEIN GP120, BG505 SOSIPV5.2 GP41, PGT122 FAB HEAVY CHAIN, PGT122 FAB LIGHT CHAIN, RM20E1 FAB HEAVY CHAIN, RM20E1 FAB KAPPA CHAIN",BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV, ANTIBODY, FAB, VACCINE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MAPPING THE IMMUNOGENIC LANDSCAPE OF NEAR-NATIVE HIV-1 ENVELOPE TRIMERS IN NON-HUMAN PRIMATES.,,,D,K,H,PROTEIN,ENVELOPE GLYCOPROTEIN GP120,VIRAL PROTEIN/IMMUNE SYSTEM,01/24/20,BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS; MACACA MULATTA,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"COTTRELL, C.A., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7ZFB,N,,"SARS-COV-2 OMICRON RBD IN COMPLEX WITH NANOBODY C1, OMI-18 AND OMI-31 FABS",VIRAL PROTEIN,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, OMI-18, OMI-31, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,N,,F,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,"SARS-COV-2 OMICRON RBD IN COMPLEX WITH NANOBODY C1, OMI-18 AND OMI-31 FABS",LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7ZF6,N,,OMI-12 FAB,IMMUNE SYSTEM,"SARS-COV-2, OMICRON, RBD, ANTIBODY, FAB, OMI-12, IMMUNE SYSTEM",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,H,L,,,,IMMUNE SYSTEM,06/01/22,OMI-12 FAB,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7CAI,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF H014 FAB, HEAVY CHAIN OF H014 FAB",SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB,VIRAL PROTEIN,"SARS-COV-2 SPIKE GLYCOPROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR NEUTRALIZATION OF SARS-COV-2 AND SARS-COV BY A POTENT THERAPEUTIC ANTIBODY.,,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/08/20,SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHE, L., CAO, L., DENG, Y., SUN, Y., WANG, N., XIE, L., WANG, Y., RAO, Z., QIN, C., WANG, X.",ELECTRON MICROSCOPY,NONE
6ZHD,N,"SPIKE GLYCOPROTEIN,FIBRITIN, NANOBODY H11-H4",H11-H4 BOUND TO SPIKE,ANTIVIRAL PROTEIN,"SARS-COV-2, NANOBODY, LLAMA, NEUTRALISATION, SPIKE, ANTIVIRAL PROTEIN",H11-H4 BOUND TO SPIKE,,,D,,A,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",ANTIVIRAL PROTEIN,06/22/20,H11-H4 BOUND TO SPIKE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ENTEROBACTERIA PHAGE T4; LAMA GLAMA,LAMA GLAMA,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ENTEROBACTERIA PHAGE T4 ","CLARE, D.K., NAISMITH, J.H., WECKENER, M., VOGIRALA, V.K.",ELECTRON MICROSCOPY,NONE
7BEP,N,"SPIKE GLYCOPROTEIN, COVOX-384 HEAVY CHAIN, COVOX-384 LIGHT CHAIN, S309 HEAVY CHAIN, S309 LIGHT CHAIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,D,F,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7SO9,N,,SARS-COV-2 S B.1.617.2 DELTA VARIANT + S2M11 + S2L20 GLOBAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"DELTA, SPIKE, ANTIBODY, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MOLECULAR BASIS OF IMMUNE EVASION BY THE DELTA AND KAPPA SARS-COV-2 VARIANTS.,,,H,G,F,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/17/21,SARS-COV-2 S B.1.617.2 DELTA VARIANT + S2M11 + S2L20 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7JW0,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, S304 FAB LIGHT CHAIN, S304 FAB HEAVY CHAIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,G,F,E,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WALLS, A.C., PARK, Y.J., TORTORICI, M.A., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",ELECTRON MICROSCOPY,NONE
6J11,N,"SPIKE GLYCOPROTEIN, VH OF 7D10, VL OF 7D10",MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX,VIRAL PROTEIN,"MERS-COV, ANTIBODY, VIRAL PROTEIN",STRUCTURAL DEFINITION OF A NEUTRALIZATION EPITOPE ON THE N-TERMINAL DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN.,,,F,G,B,PROTEIN,N-TERMINAL DOMAIN OF SPIKE GLYCOPROTEIN,VIRAL PROTEIN,12/27/18,MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"ZHOU, H., ZHANG, S., ZHANG, S., TANG, W., WANG, X.",X-RAY DIFFRACTION,NONE
5VZR,N,"G4 ANTIBODY HEAVY CHAIN, G4 ANTIBODY LIGHT CHAIN",CRYSTAL STRUCTURE OF MERS-COV NEUTRALIZING ANTIBODY G4 FAB,IMMUNE SYSTEM,"IMMUNE SYSTEM, ANTIBODY, NEUTRALIZING",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,A,B,,,,IMMUNE SYSTEM,05/29/17,CRYSTAL STRUCTURE OF MERS-COV NEUTRALIZING ANTIBODY G4 FAB,MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,,"WANG, N., WRAPP, D., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
7CAH,N,"LIGHT CHAIN OF H014 FAB, HEAVY CHAIN OF H014 FAB, SPIKE GLYCOPROTEIN",THE INTERFACE OF H014 FAB BINDS TO SARS-COV-2 S,VIRAL PROTEIN,"NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR NEUTRALIZATION OF SARS-COV-2 AND SARS-COV BY A POTENT THERAPEUTIC ANTIBODY.,,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/08/20,THE INTERFACE OF H014 FAB BINDS TO SARS-COV-2 S,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHE, L., CAO, L., DENG, Y., SUN, Y., WANG, N., XIE, L., RAO, Z., WANG, Y., QIN, C., WANG, X.",ELECTRON MICROSCOPY,NONE
8CY6,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-65,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-65,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7VNB,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113,VIRAL PROTEIN,"SARS-COV-2, NANOBODY, VIRAL PROTEIN",A NON-ACE2 COMPETING HUMAN SINGLE-DOMAIN ANTIBODY CONFERS BROAD NEUTRALIZATION AGAINST SARS-COV-2 AND CIRCULATING VARIANTS.,,,A,,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,11/24/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, Z., WANG, Y., KONG, Y., JIN, Y., WU, Y., YING, T.",X-RAY DIFFRACTION,NONE
7JX3,N,"LIGHT CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S309, HEAVY CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S309, LIGHT CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S2H14, HEAVY CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S2H14, LIGHT CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S304, HEAVY CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S304, SPIKE GLYCOPROTEIN",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,C,D,R,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/26/20,MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SNELL, G., CZUDNOCHOWSKI, N., ROSEN, L.E., NIX, J.C., CORTI, D., VEESLER, D., PARK, Y.J., WALLS, A.C., TORTORICI, M.A., CAMERONI, E., PINTO, D., BELTRAMELLO, M.",X-RAY DIFFRACTION,NONE
7C01,N,"SPIKE PROTEIN S1, CB6 HEAVY CHAIN, CB6 LIGHT CHAIN",MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD,VIRAL PROTEIN,"SARS-COV-2, RBD, NEUTRALIZING ANTIBODIES, MOLECULAR BASIS, VIRAL PROTEIN",A HUMAN NEUTRALIZING ANTIBODY TARGETS THE RECEPTOR-BINDING SITE OF SARS-COV-2.,,,H,L,A,PROTEIN,SARS-COV-2 SPIKE PROTEIN S1,VIRAL PROTEIN,05/27/20,MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SHI, R., QI, J., WANG, Q., GAO, F.G., YAN, J.",X-RAY DIFFRACTION,NONE
7N3F,N,,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C080,IMMUNE SYSTEM,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,H,L,,,,IMMUNE SYSTEM,08/04/21,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C080,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"FLYAK, A.I., BJORKMAN, P.J., BARNES, C.O.",X-RAY DIFFRACTION,NONE
7N3G,N,,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C098,IMMUNE SYSTEM,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,H,L,,,,IMMUNE SYSTEM,08/04/21,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C098,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"FLYAK, A.I., BJORKMAN, P.J., BARNES, C.O.",X-RAY DIFFRACTION,NONE
6PXG,N,"G2 FAB HEAVY CHAIN, G2 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF MERS-COV NEUTRALIZING ANTIBODY G2 FAB,IMMUNE SYSTEM,"IMMUNE SYSTEM, ANTIBODY, FUSION GLYCOPROTEIN",STRUCTURAL DEFINITION OF A NEUTRALIZATION-SENSITIVE EPITOPE ON THE MERS-COV S1-NTD.,,,C,D,,,,IMMUNE SYSTEM,07/26/19,CRYSTAL STRUCTURE OF MERS-COV NEUTRALIZING ANTIBODY G2 FAB,MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,,"WANG, N., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
7WDF,N,,SARS-COV-2 BETA SPIKE IN COMPLEX WITH TWO S3H3 FABS,VIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, BETA VARIANT, B.1.351 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MAPPING CROSS-VARIANT NEUTRALIZING SITES ON THE SARS-COV-2 SPIKE PROTEIN.,,,D,E,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,02/02/22,SARS-COV-2 BETA SPIKE IN COMPLEX WITH TWO S3H3 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y.F., CONG, Y.",ELECTRON MICROSCOPY,NONE
7AKJ,N,"SPIKE GLYCOPROTEIN, 47D11 NEUTRALIZING ANTIBODY HEAVY CHAIN, 47D11 NEUTRALIZING ANTIBODY LIGHT CHAIN",STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,"SARS-COV, SPIKE, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURAL INSIGHTS INTO THE CROSS-NEUTRALIZATION OF SARS-COV AND SARS-COV-2 BY THE HUMAN MONOCLONAL ANTIBODY 47D11.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/19/21,STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT,SARS CORONAVIRUS WH20; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SARS CORONAVIRUS WH20,"FEDRY, J., HURDISS, D.L., WANG, C., LI, W., OBAL, G., DRULYTE, I., HOWES, S.C., VAN KUPPEVELD, F.J.M., FOERSTER, F., BOSCH, B.J.",ELECTRON MICROSCOPY,NONE
7PRY,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND BETA-6 FABS,VIRAL PROTEIN,"SARS-COV-2 ALPHA VARIANT, BETA VARIANT, GAMMA VARIANT, DELTA VARIANT, B.1.1.7, B.1.351, P.1, B.1.617.2, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,C,D,I,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND BETA-6 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7CHS,N,,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P22A-1D1 WITH RBD,VIRAL PROTEIN,"SPIKE, RECEPTOR BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN",POTENT AND PROTECTIVE IGHV3-53/3-66 PUBLIC ANTIBODIES AND THEIR SHARED ESCAPE MUTANT ON THE SPIKE OF SARS-COV-2.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/19/21,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P22A-1D1 WITH RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHANG, L., GE, J., WANG, R., ZHANG, Q.",X-RAY DIFFRACTION,NONE
7RBY,N,,CRYSTAL STRUCTURE OF NANOBODY NB112 AND SARS-COV-2 RBD,VIRAL PROTEIN,"SARS-COV-2, NANOBODY, RBD-SPECIFIC, BROAD NEUTRALIZATION, VIRAL PROTEIN","NEBULIZED DELIVERY OF A BROADLY NEUTRALIZING SARS-COV-2 RBD-SPECIFIC NANOBODY PREVENTS CLINICAL, VIROLOGICAL, AND PATHOLOGICAL DISEASE IN A SYRIAN HAMSTER MODEL OF COVID-19.",,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,03/23/22,CRYSTAL STRUCTURE OF NANOBODY NB112 AND SARS-COV-2 RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CHEN, Y., TOLBERT, W., PAZGIER, M.",X-RAY DIFFRACTION,NONE
7K8M,N,"C102 FAB HEAVY CHAIN, C102 FAB LIGHT CHAIN, SPIKE GLYCOPROTEIN","STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102",VIRAL PROTEIN/IMMUNE SYSTEM,"HUMAN NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR BINDING DOMAIN, COVID-19, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,A,B,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JETTE, C.A., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
7ND4,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN, IMMUNE SYSTEM",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
5W9I,N,"SPIKE GLYCOPROTEIN, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,C,D,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7MZF,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 37,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 37,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., CHAN, L.J., DIETRICH, M.H., TAN, L.L., THAM, W.H.",X-RAY DIFFRACTION,NONE
7A29,N,"SPIKE GLYCOPROTEIN, NEUTRALISING SYBODY (SB23)",CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION,VIRAL PROTEIN,"SARS-COV-2, COMPLEX, NANOBODY, SPIKE, VIRAL PROTEIN","SELECTION, BIOPHYSICAL AND STRUCTURAL ANALYSIS OF SYNTHETIC NANOBODIES THAT EFFECTIVELY NEUTRALIZE SARS-COV-2.",,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/16/20,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALLBERG, B.M., DAS, H.",ELECTRON MICROSCOPY,NONE
7ZFE,N,,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-32 FAB AND NANOBODY C1,VIRAL PROTEIN,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, OMI-32, VIRALPROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,J,K,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-32 FAB AND NANOBODY C1,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7CH5,N,"BD-629 FAB H, BD-629 FAB L, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB,PROTEIN BINDING/IMMUNE SYSTEM,"COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX",STRUCTURALLY RESOLVED SARS-COV-2 ANTIBODY SHOWS HIGH EFFICACY IN SEVERELY INFECTED HAMSTERS AND PROVIDES A POTENT COCKTAIL PAIRING STRATEGY.,,,H,L,R,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING/IMMUNE SYSTEM,07/05/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.Y.",X-RAY DIFFRACTION,NONE
7LAB,N,,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052,"VIRAL PROTEIN, IMMUNE SYSTEM","RBD ANTIBODY, DH1052, SARS, COVID-19, SARS-COV-2 2P S ECTODOMAIN, VIRAL PROTEIN, IMMUNE SYSTEM",IN VITRO AND IN VIVO FUNCTIONS OF SARS-COV-2 INFECTION-ENHANCING AND NEUTRALIZING ANTIBODIES.,,,Y,X,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/10/21,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MANNE, K., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7F6Y,N,,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-E484K OF COVID-19,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZATION ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-E484K OF COVID-19,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/29/22,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-E484K OF COVID-19,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, H., WANG, B., ZHAO, T.N., SU, X.D.",X-RAY DIFFRACTION,NONE
7SC1,N,,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, R40-1G8",VIRAL PROTEIN/IMMUNE SYSTEM,"IMMUNE SYSTEM, NEUTRALIZING ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",DISCOVERY OF ULTRAPOTENT BROADLY NEUTRALIZING ANTIBODIES FROM SARS-COV-2 ELITE NEUTRALIZERS.,,,P,Q,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/02/22,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, R40-1G8",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FAN, C., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
6QU9,N,"FAB 4B12 HEAVY CHAIN, FAB 4B12 LIGHT CHAIN",FAB FRAGMENT OF AN ANTIBODY THAT INHIBITS POLYMERISATION OF ALPHA-1-ANTITRYPSIN,PROTEIN BINDING,"ALPHA-1 ANTITRYPSIN, Z VARIANT, POLYMERS, PROTEIN AGGREGATION, MONOCLONAL ANTIBODY, FAB FRAGMENT, COPD, PROTEASE INHIBITOR, GLYCOPROTEIN, DEFICIENCY, PROTEIN BINDING",THE STRUCTURAL BASIS FOR Z ALPHA 1 -ANTITRYPSIN POLYMERIZATION IN THE LIVER.,,,A,B,,,,PROTEIN BINDING,02/26/19,FAB FRAGMENT OF AN ANTIBODY THAT INHIBITS POLYMERISATION OF ALPHA-1-ANTITRYPSIN,MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,,"JAGGER, A.M., HEYER-CHAUHAN, N., LOMAS, D.A., IRVING, J.A.",X-RAY DIFFRACTION,NONE
7Q9P,N,,BETA-06 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,E,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,BETA-06 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7KLW,N,,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY (SB45+SB68) COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN, RBD, ANTIBODY, NANOBODY, SYBODY, COMPLEX, NEUTRALIZATION, VIRAL PROTEIN, EPITOPE",STRUCTURES OF SYNTHETIC NANOBODY-SARS-COV-2 RECEPTOR-BINDING DOMAIN COMPLEXES REVEAL DISTINCT SITES OF INTERACTION.,,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,11/01/20,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JIANG, J., AHMAD, J., NATARAJAN, K., BOYD, L.F., MARGULIES, D.H.",X-RAY DIFFRACTION,NONE
7QF0,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE HUMAN ANTIBODY CV2.2325,VIRAL PROTEIN,"NEUTRALIZATION, ANTIBODY, CORONAVIRUS, VIRAL PROTEIN","POTENT ANTIBODIES AGAINST SARS-COV-2 
ISOLATED FROM A PATIENT",,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/18/22,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE HUMAN ANTIBODY CV2.2325,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FERNANDEZ, I., PEDERZOLI, R., REY, F.A.",X-RAY DIFFRACTION,NONE
7L3N,N,"SPIKE GLYCOPROTEIN, LY-COV555 FAB HEAVY CHAIN, LY-COV555 FAB LIGHT CHAIN",SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555,VIRAL PROTEIN/IMMUNE SYSTEM,"GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","LY-COV555, A RAPIDLY ISOLATED POTENT NEUTRALIZING ANTIBODY, PROVIDES PROTECTION IN A NON-HUMAN PRIMATE MODEL OF SARS-COV-2 INFECTION.",,,D,E,B | C,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/03/21,SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GOLDSMITH, J.A., MCLELLAN, J.S.",ELECTRON MICROSCOPY,NONE
7JMO,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-04,IMMUNE SYSTEM,"SARS-COV-2, COVID-19, RBD, ANTIBODY, SARS, SPIKE, IMMUNE SYSTEM",AN ALTERNATIVE BINDING MODE OF IGHV3-53 ANTIBODIES TO THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM,08/02/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-04,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WU, N.C., YUAN, M., LIU, H., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7ZFC,N,,"SARS-COV-2 BETA RBD IN COMPLEX WITH NANOBODY C1, OMI-18 AND OMI-31 FABS",VIRAL PROTEIN,"SARS-COV-2, BETA, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, OMI-18, OMI-31, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,"SARS-COV-2 BETA RBD IN COMPLEX WITH NANOBODY C1, OMI-18 AND OMI-31 FABS",HOMO SAPIENS; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7KQB,N,"SPIKE GLYCOPROTEIN, FAB 5A6 HEAVY CHAIN, FAB 5A6 LIGHT CHAIN",SARS-COV-2 SPIKE GLYCOPROTEIN:FAB 5A6 COMPLEX I,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL INSIGHT INTO SARS-COV-2 NEUTRALIZING ANTIBODIES AND MODULATION OF SYNCYTIA.,,,K,J,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/26/21,SARS-COV-2 SPIKE GLYCOPROTEIN:FAB 5A6 COMPLEX I,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ASARNOW, D., CHARLES, C., CHENG, Y.",ELECTRON MICROSCOPY,NONE
7OAQ,N,,NANOBODY H3 AND C1 BOUND TO RBD WITH KENT MUTATION,ANTIVIRAL PROTEIN,"RBD, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",A POTENT SARS-COV-2 NEUTRALISING NANOBODY SHOWS THERAPEUTIC EFFICACY IN THE SYRIAN GOLDEN HAMSTER MODEL OF COVID-19.,,,A,,E,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,01/08/09,NANOBODY H3 AND C1 BOUND TO RBD WITH KENT MUTATION,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,,,,"NAISMITH, J.H., MIKOLAJEK, H.",X-RAY DIFFRACTION,NONE
7MM0,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY B1-182.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, RECEPTOR-BINDING DOMAIN, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",ULTRAPOTENT ANTIBODIES AGAINST DIVERSE AND HIGHLY TRANSMISSIBLE SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,07/28/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY B1-182.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., TSYBOVSKY, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7P7A,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODY#68 IN A 2UP/1FLEXIBLE CONFORMATION,VIRAL PROTEIN,"SARS-COV-2 SPIKE PROTEIN SYBODY, VIRAL PROTEIN",BIPARATOPIC SYBODIES NEUTRALIZE SARS-COV-2 VARIANTS OF CONCERN AND MITIGATE DRUG RESISTANCE.,,,A,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/04/21,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODY#68 IN A 2UP/1FLEXIBLE CONFORMATION,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WALTER, J.D., HUTTER, C.A.J., GARAEVA, A.A., SCHERER, M., ZIMMERMANN, I., WYSS, M., RHEINBERGER, J., RUEDIN, Y., EARP, J.C., EGLOFF, P., SORGENFREI, M., HUERLIMANN, L.M., GONDA, I., MEIER, G., REMM, S., THAVARASAH, S., ZIMMER, G., SLOTBOOM, D.J., PAULINO, C., PLATTET, P., SEEGER, M.A.",ELECTRON MICROSCOPY,NONE
7MZG,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 42,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 42,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., CHAN, L.J., DIETRICH, M.H., TAN, L.L., THAM, W.H.",X-RAY DIFFRACTION,NONE
7U2E,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY ADI-55688,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, SPIKE, RBD, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A BROAD AND POTENT NEUTRALIZATION EPITOPE IN SARS-RELATED CORONAVIRUSES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY ADI-55688,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7WWM,N,,S PROTEIN OF DELTA VARIANT IN COMPLEX WITH ZWC6,VIRAL PROTEIN,"SARS-COV-2, VIRAL PROTEIN",BROADLY NEUTRALIZING ANTIBODIES AGAINST OMICRON-INCLUDED SARS-COV-2 VARIANTS INDUCED BY VACCINATION.,,,I,M,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/01/22,S PROTEIN OF DELTA VARIANT IN COMPLEX WITH ZWC6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, Y.Y., ZHANG, Y.Y., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
5JSA,N,"BROADLY NEUTRALIZING ANTIBODY PGT128 HEAVY CHAIN, BROADLY NEUTRALIZING ANTIBODY PGT128 LIGHT CHAIN, GP120, GP41, BROADLY NEUTRALIZING ANTIBODY 8ANC195 HEAVY CHAIN, BROADLY NEUTRALIZING ANTIBODY 8ANC195 LIGHT CHAIN",UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10-RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",UNCLEAVED PREFUSION-OPTIMIZED GP140 TRIMERS DERIVED FROM ANALYSIS OF HIV-1 ENVELOPE METASTABILITY.,,,E,F,C | D,PROTEIN | PROTEIN,GP120 | GP41,VIRAL PROTEIN/IMMUNE SYSTEM,07/13/16,UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10-RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128,HOMO SAPIENS; HUMAN IMMUNODEFICIENCY VIRUS 1,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1 | HUMAN IMMUNODEFICIENCY VIRUS 1,"KONG, L., WILSON, I.A.",X-RAY DIFFRACTION,NONE
4BFB,,"BETA-SECRETASE 2 (E.C.3.4.23.45), XA4813",BACE2 XAPERONE COMPLEX,HYDROLASE/IMMUNE SYSTEM,"HYDROLASE-IMMUNE SYSTEM COMPLEX, NANOBODY","MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USING SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS, FYNOMERS, AND XAPERONES",,,E,,B,PROTEIN,BETA-SECRETASE 2,HYDROLASE/IMMUNE SYSTEM,03/18/13,BACE2 XAPERONE COMPLEX,HOMO SAPIENS; LAMA GLAMA,LAMA GLAMA,,HOMO SAPIENS,"BANNER, D.W., KUGLSTATTER, A., BENZ, J., STIHLE, M., RUF, A.",X-RAY DIFFRACTION,NONE
7MSQ,N,,COMPLEX BETWEEN THE FAB ARM OF AB-3467 AND THE SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD),VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2 RECEPTOR BINDING DOMAIN AB-3467, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",IMMUNIZATIONS WITH DIVERSE SARBECOVIRUS RECEPTOR-BINDING DOMAINS ELICIT SARS-COV-2 NEUTRALIZING ANTIBODIES AGAINST A CONSERVED SITE OF VULNERABILITY.,,,D,E,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,01/19/22,COMPLEX BETWEEN THE FAB ARM OF AB-3467 AND THE SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LANGLEY, D.B., CHRIST, D.",X-RAY DIFFRACTION,NONE
7JVB,N,"SPIKE GLYCOPROTEIN, NANOBODY NB20",CRYSTAL STRUCTURE OF THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD) WITH NANOBODY NB20,VIRAL PROTEIN,"SARS-COV-2, COVID-19, NANOBODY, SPIKE PROTEIN, RECEPTOR-BINDING DOMAIN, VIRAL PROTEIN",VERSATILE AND MULTIVALENT NANOBODIES EFFICIENTLY NEUTRALIZE SARS-COV-2.,,,C,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/20/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD) WITH NANOBODY NB20,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XIANG, Y., XIAO, Z., LIU, H., SANG, Z., SCHNEIDMAN-DUHOVNY, D., ZHANG, C., SHI, Y.",X-RAY DIFFRACTION,NONE
7WP5,N,,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, OMICRON VARIANT, SPIKE, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",IMMUNE ESCAPE BY SARS-COV-2 OMICRON VARIANT AND STRUCTURAL BASIS OF ITS EFFECTIVE NEUTRALIZATION BY A BROAD NEUTRALIZING HUMAN ANTIBODY VACW-209.,,,H,L,F,PROTEIN,SPIKEPROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, Q., SUN, H., JU, B., ZHANG, Z., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
7XIC,N,,S-ECD (OMICRON) IN COMPLEX WITH STS165,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL AND FUNCTIONAL ANALYSIS OF AN INTER-SPIKE BIVALENT NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 VARIANTS.,,,K,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/15/22,S-ECD (OMICRON) IN COMPLEX WITH STS165,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Y.N., SHEN, Y.P., ZHANG, Y.Y., YAN, R.H.",ELECTRON MICROSCOPY,NONE
7OAO,N,,NANOBODY C5 BOUND TO RBD,ANTIVIRAL PROTEIN,"RBD, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",A POTENT SARS-COV-2 NEUTRALISING NANOBODY SHOWS THERAPEUTIC EFFICACY IN THE SYRIAN GOLDEN HAMSTER MODEL OF COVID-19.,,,F,,E,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,01/08/09,NANOBODY C5 BOUND TO RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,,,,"NAISMITH, J.H., MIKOLAJEK, H.",X-RAY DIFFRACTION,NONE
7LS9,N,,CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, FUSION PROTEIN, SPIKE GLYCOPROTEIN, COVID-19, RBD, RBD-DIRECTED ANTIBODY, 1-57, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR ACCOMMODATION OF EMERGING B.1.351 AND B.1.1.7 VARIANTS BY TWO POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/17/21,CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CERUTTI, G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7RAL,N,,SARS-COV-2 S BOUND TO S2X259 FAB (LOCAL REFINEMENT OF THE RBD/S2X259 VARIABLE DOMAINS),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, FAB S2X259, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",BROAD SARBECOVIRUS NEUTRALIZATION BY A HUMAN MONOCLONAL ANTIBODY.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,SARS-COV-2 S BOUND TO S2X259 FAB (LOCAL REFINEMENT OF THE RBD/S2X259 VARIABLE DOMAINS),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"VEESLER, D., TORTORICI, M.A., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7WO4,N,,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-15 (S-553-15 DIMER TRIMER ),VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT BY DISASSEMBLING THE SPIKE TRIMER.,,,D,E,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/20/22,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-15 (S-553-15 DIMER TRIMER ),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7FAT,N,,STRUCTURE DETERMINATION OF THE RBD-NB1A7,STRUCTURAL PROTEIN,"SARS-COV-2, RBD, NANOBODY, STRUCTURAL PROTEIN",STRUCTURAL BASIS OF NANOBODIES NEUTRALIZING SARS-COV-2 VARIANTS,,,B,,A,PROTEIN,SPIKE PROTEIN S1,STRUCTURAL PROTEIN,05/18/22,STRUCTURE DETERMINATION OF THE RBD-NB1A7,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELUS BACTRIANUS,CAMELUS BACTRIANUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GENG, Y., SHI, Z.Z., LI, X.Y., WANG, L., SUN, Z.C., ZHANG, H.W., CHEN, X.C.",X-RAY DIFFRACTION,NONE
7WE9,N,,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB XGV289,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,H,J,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB XGV289,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7MW3,N,,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH TWO RBDS DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 6,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","DEVELOPMENT, STRUCTURE AND FUNCTION OF POTENT MONOSPECIFIC AND BISPECIFIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE SARS-COV-2 AND ITS MUTANT VARIANT",,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/16/22,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH TWO RBDS DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 6,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HU, Y., XIONG, Y.",ELECTRON MICROSCOPY,NONE
7V23,N,,CRYOEM STRUCTURE OF DEL68-76/DEL679-688 PREFUSION-STABILIZED SPIKE IN COMPLEX WITH THE FAB OF N12-9,VIRAL PROTEIN,"ANTIBODY, VIRAL PROTEIN",CRYOEM STRUCTURE OF DEL68-76/DEL679-688 PREFUSION-STABILIZED SPIKE IN COMPLEX WITH THE FAB OF N12-9,,,S,T,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/10/22,CRYOEM STRUCTURE OF DEL68-76/DEL679-688 PREFUSION-STABILIZED SPIKE IN COMPLEX WITH THE FAB OF N12-9,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.",ELECTRON MICROSCOPY,NONE
7LOP,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR BINDING DOMAIN, CORONAVIRUS, COVID-19, ANTIBODY, FAB, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL AND FUNCTIONAL RAMIFICATIONS OF ANTIGENIC DRIFT IN RECENT SARS-COV-2 VARIANTS.,,,W,V,Z,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7KGK,N,,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY (SB16) COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, RBD, ANTIBODY, NANOBODY, SYBODY, VIRAL PROTEIN, EPITOPE, NEUTRALIZATION",STRUCTURES OF SYNTHETIC NANOBODY-SARS-COV-2 RECEPTOR-BINDING DOMAIN COMPLEXES REVEAL DISTINCT SITES OF INTERACTION.,,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/16/20,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JIANG, J., AHMAD, J., NATARAJAN, K., BOYD, L.F., MARGULIES, D.H.",X-RAY DIFFRACTION,NONE
7FH0,N,,CRYSTALLOGRAPHIC STRUCTURE OF TWO NEUTRALIZING NANOBODIES IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD),ANTIVIRAL PROTEIN,"SARS-COV-2, RBD, SPIKE, NANOBODIES, ANTIVIRAL PROTEIN",HETERO-BIVALENT NANOBODIES PROVIDE BROAD-SPECTRUM PROTECTION AGAINST SARS-COV-2 VARIANTS OF CONCERN INCLUDING OMICRON.,,,B,,A,PROTEIN,"SPIKE PROTEIN S1,SPIKE PROTEIN S1",ANTIVIRAL PROTEIN,08/03/22,CRYSTALLOGRAPHIC STRUCTURE OF TWO NEUTRALIZING NANOBODIES IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, P., JIN, J.",X-RAY DIFFRACTION,NONE
7VPY,N,,CRYSTAL STRUCTURE OF THE NEUTRALIZING NANOBODY P86 AGAINST SARS-COV-2,IMMUNE SYSTEM,"SARS-COV-2, IMMUNE SYSTEM",A PANEL OF NANOBODIES RECOGNIZING CONSERVED HIDDEN CLEFTS OF ALL SARS-COV-2 SPIKE VARIANTS INCLUDING OMICRON.,,,B,,,,,IMMUNE SYSTEM,07/20/22,CRYSTAL STRUCTURE OF THE NEUTRALIZING NANOBODY P86 AGAINST SARS-COV-2,VICUGNA PACOS,VICUGNA PACOS,,,"MAEDA, R., FUJITA, J., KONISHI, Y., KAZUMA, Y., YAMAZAKI, H., ANZAI, I., YAMAGUCHI, K., KASAI, K., NAGATA, K., YAMAOKA, Y., MIYAKAWA, K., RYO, A., SHIRAKAWA, K., MAKINO, F., MATSUURA, Y., INOUE, T., IMURA, A., NAMBA, K., TAKAORI-KONDO, A.",X-RAY DIFFRACTION,NONE
7WLZ,N,,"CRYO-EM STRUCTURE OF THE OMICRON S IN COMPLEX WITH 35B5 FAB(1 DOWN-, 1 UP- AND 1 INVISIBLE RBDS)","VIRAL PROTEIN,IMMUNE SYSTEM","VIRAL PROTEIN, IMMUNE SYSTEM",35B5 ANTIBODY POTENTLY NEUTRALIZES SARS-COV-2 OMICRON BY DISRUPTING THE N-GLYCAN SWITCH VIA A CONSERVED SPIKE EPITOPE.,,,P,O,B | A,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,"VIRAL PROTEIN,IMMUNE SYSTEM",05/25/22,"CRYO-EM STRUCTURE OF THE OMICRON S IN COMPLEX WITH 35B5 FAB(1 DOWN-, 1 UP- AND 1 INVISIBLE RBDS)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHU, Y.",ELECTRON MICROSCOPY,NONE
7KLG,N,,SARS-COV-2 RBD IN COMPLEX WITH FAB 15033,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",TETRAVALENT SARS-COV-2 NEUTRALIZING ANTIBODIES SHOW ENHANCED POTENCY AND RESISTANCE TO ESCAPE MUTATIONS.,,,I,M,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/10/21,SARS-COV-2 RBD IN COMPLEX WITH FAB 15033,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Z., RINI, J.M.",X-RAY DIFFRACTION,NONE
7KN6,N,"SPIKE PROTEIN S1, VHH V, CC12.3 FAB HEAVY CHAIN, CC12.3 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NANOBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, NANOBODY-ANTIGEN COMPLEX, SINGLE-DOMAIN ANTIBODY, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURE-GUIDED MULTIVALENT NANOBODIES BLOCK SARS-COV-2 INFECTION AND SUPPRESS MUTATIONAL ESCAPE.,,,C,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,11/04/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS; HOMO SAPIENS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., YUAN, M., ZHU, X., WU, N.C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7YE9,N,,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 3 R1-32 FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 SPIKE(6P)IN COMPLEX WITH 3 R1-32 FABS,,,N,O,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 3 R1-32 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, B., GAO, X., LI, Z., CHEN, X., HE, J., CHEN, L., XIONG, X.",ELECTRON MICROSCOPY,NONE
7SWO,N,,C98C7 FAB IN COMPLEX WITH SARS-COV-2 SPIKE 6P (RBD LOCAL RECONSTRUCTION),VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRUS, IMMUNITY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",FAB IN COMPLEX WITH SARS-COV-2 SPIKE,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,C98C7 FAB IN COMPLEX WITH SARS-COV-2 SPIKE 6P (RBD LOCAL RECONSTRUCTION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WINDSOR, I.W., TONG, P., WESEMANN, D.R., HARRISON, S.C.",ELECTRON MICROSCOPY,NONE
7N9C,N,,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS WITH NB95,VIRAL PROTEIN/IMMUNE SYSTEM,"COVS NB21 NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING DIVERSE AND CONSERVED EPITOPES,,,E,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS WITH NB95,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, D., ZHANG, C., SHI, Y.",ELECTRON MICROSCOPY,NONE
7UAR,N,,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE NEUTRALIZING ANTIBODY FAB FRAGMENT, C1717",VIRAL PROTEIN,"SARS-COV-2, N-TERMINAL DOMAIN, NTD, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",ANALYSIS OF MEMORY B CELLS IDENTIFIES CONSERVED NEUTRALIZING EPITOPES ON THE N-TERMINAL DOMAIN OF VARIANT SARS-COV-2 SPIKE PROTEINS.,,,F,G,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/27/22,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE NEUTRALIZING ANTIBODY FAB FRAGMENT, C1717",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O.",ELECTRON MICROSCOPY,NONE
7K8S,N,"SPIKE GLYCOPROTEIN, C002 FAB HEAVY CHAIN, C002 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1)",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., MALYUTIN, A.G., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7A5R,N,"CR3022 FAB HEAVY CHAIN, CR3022 FAB LIGHT CHAIN, SPIKE GLYCOPROTEIN",COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT),VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",ANTIBODY-MEDIATED DISRUPTION OF THE SARS-COV-2 SPIKE GLYCOPROTEIN.,,,I,M,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/21/20,COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WROBEL, A.G., BENTON, D.J., ROSENTHAL, P.B., GAMBLIN, S.J.",ELECTRON MICROSCOPY,NONE
7ORB,N,,CRYSTAL STRUCTURE OF THE L452R MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-75 AND COVOX-253 FABS,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, B.1.617 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",REDUCED NEUTRALIZATION OF SARS-COV-2 B.1.617 BY VACCINE AND CONVALESCENT SERUM.,,,E,F,X,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,07/07/21,CRYSTAL STRUCTURE OF THE L452R MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-75 AND COVOX-253 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7ZF3,N,,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-3 AND EY6A FABS,VIRAL PROTEIN,"SARS-COV-2, OMICRON, RBD, ANTIBODY, FAB, OMI-3, EY6A, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-3 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
6XC2,N,"SPIKE PROTEIN S1, CC12.1 LIGHT CHAIN, CC12.1 HEAVY CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY, SARS-COV-2, CORONAVIRUS, SPIKE, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",STRUCTURAL BASIS OF A SHARED ANTIBODY RESPONSE TO SARS-COV-2.,,,X,Y,Z,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,06/08/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., LIU, H., WU, N.C., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
6Z2M,N,"SPIKE GLYCOPROTEIN, ANTIBODY CR3022, ANTIBODY LIGHT CHAIN, NANOBODY","H11-D4, SARS-COV-2 RBD, CR3022 TERNARY COMPLEX",VIRAL PROTEIN,"ANTIBODY, NANOBODY COMPLEX, RBD, VIRAL PROTEIN",STRUCTURAL CHARACTERISATION OF A NANOBODY DERIVED FROM A NAIVE LIBRARY THAT NEUTRALISES SARS-COV-2,,,B,C,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/03/20,"H11-D4, SARS-COV-2 RBD, CR3022 TERNARY COMPLEX",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS; LAMA GLAMA,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NAISMITH, J.H., REN, J., ZHOU, D., ZHAO, Y., STUART, D.I.",X-RAY DIFFRACTION,NONE
7TP3,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY K288.2,IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, NEUTRALIZING ANTIBODY, FAB, COVID-19, CORONAVIRUS, RECEPTOR-BINDING DOMAIN, RBD, IMMUNE SYSTEM",BROADLY NEUTRALIZING ANTIBODIES TO SARS-RELATED VIRUSES CAN BE READILY INDUCED IN RHESUS MACAQUES.,,,H,L,Z,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM,02/23/22,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY K288.2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7LRT,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR-BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ULTRAPOTENT ANTIBODIES AGAINST DIVERSE AND HIGHLY TRANSMISSIBLE SARS-COV-2 VARIANTS.,,,F,G,B,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/14/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., TSYBOVSKY, T.",ELECTRON MICROSCOPY,NONE
7WOA,N,,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-60 (1-UP TRIMER),VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT BY DISASSEMBLING THE SPIKE TRIMER.,,,F,G,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/20/22,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-60 (1-UP TRIMER),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7SD5,N,,CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR BINDING DOMAIN,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, VIRAL PROTEIN, SPIKE GLYCOPROTEIN, RECEPTOR BINDING PROTEIN, RBD, NEUTRALIZING ANTIBODY, 10-40, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ANTIBODY CLASS WITH A COMMON CDRH3 MOTIF BROADLY NEUTRALIZES SARBECOVIRUSES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR BINDING DOMAIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"REDDEM, E.R., CASNER, R.G., SHAPIRO, L.",X-RAY DIFFRACTION,NONE
7FAE,N,,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P36-5D2(STATE2),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A POTENT AND PROTECTIVE HUMAN NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/22/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P36-5D2(STATE2),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, L., WANG, X., SHAN, S., ZHANG, S.",ELECTRON MICROSCOPY,NONE
5W9H,N,"MERS S, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,H,I,G,PROTEIN,MERS S,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
6PXH,N,"MERS-COV S1-NTD, G2 HEAVY CHAIN, G2 LIGHT CHAIN",CRYSTAL STRUCTURE OF MERS-COV S1-NTD BOUND WITH G2 FAB,IMMUNE SYSTEM/VIRAL PROTEIN,"IMMUNE SYSTEM, ANTIBODY, FUSION GLYCOPROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",STRUCTURAL DEFINITION OF A NEUTRALIZATION-SENSITIVE EPITOPE ON THE MERS-COV S1-NTD.,,,C,D,A,PROTEIN,MERS-COV S1-NTD,IMMUNE SYSTEM/VIRAL PROTEIN,07/26/19,CRYSTAL STRUCTURE OF MERS-COV S1-NTD BOUND WITH G2 FAB,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"WANG, N., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
6XKP,N,"SPIKE PROTEIN S1, CV07-270 HEAVY CHAIN, CV07-270 LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A THERAPEUTIC NON-SELF-REACTIVE SARS-COV-2 ANTIBODY PROTECTS FROM LUNG PATHOLOGY IN A COVID-19 HAMSTER MODEL.,,,M,N,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/26/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., YUAN, M., ZHU, X., WU, N.C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
6YZ5,N,"SPIKE GLYCOPROTEIN, NANOBODY H11-D4",H11-D4 COMPLEX WITH SARS-COV-2 RBD,VIRAL PROTEIN,"NANOBODY, COMPLEX, SARS-COV-2, VIRAL PROTEIN",H11-D4 COMPLEX WITH SARS-COV-2 RBD,,,F,,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/03/20,H11-D4 COMPLEX WITH SARS-COV-2 RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NAISMITH, J.H., HUO, J., MIKOLAJEK, H., WARD, P., DUMOUX, M., OWENS, R.J., LE BAS, A.",X-RAY DIFFRACTION,NONE
7WUE,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE MONOCLONAL ANTIBODY M31A7,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, RECEPTOR BINDING DOMAIN, M31A7, MONOCLONAL ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",VACCINATION WITH SARS-COV-2 SPIKE PROTEIN LACKING GLYCAN SHIELDS ELICITS ENHANCED PROTECTIVE RESPONSES IN ANIMAL MODELS.,,,C,D,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/16/22,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE MONOCLONAL ANTIBODY M31A7,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MOHAPATRA, A.",X-RAY DIFFRACTION,NONE
7CZT,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,I,M,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
6ZLR,N,"SPIKE GLYCOPROTEIN, CR3022 FAB HEAVY CHAIN, CR3022 FAB LIGHT CHAIN",SOAKING COMPETENT CRYSTAL FORM OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD):CR3022 COMPLEX.,VIRAL PROTEIN,"SARS-COV-2, VIRAL PROTEIN COMPLEX, ANTIBODY, VIRAL PROTEIN",A NEW CRYSTAL FORM OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN: CR3022 COMPLEX-AN IDEAL TARGET FOR IN-CRYSTAL FRAGMENT SCREENING OF THE ACE2 BINDING SITE SURFACE.,,,B,C,A,PROTEIN,UNKNOWN,VIRAL PROTEIN,01/08/09,SOAKING COMPETENT CRYSTAL FORM OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD):CR3022 COMPLEX.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,,,,"DE NICOLA, G.F., NICHOLS, C.E.",X-RAY DIFFRACTION,NONE
7JXD,N,"S309 ANTIGEN-BINDING (FAB) HEAVY CHAIN, S309 ANTIGEN-BINDING (FAB) LIGHT CHAIN",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,IMMUNE SYSTEM,"FUSION PROTEIN, NEUTRALIZING ANTIBODY, SARBECOVIRUS, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, IMMUNE SYSTEM",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,A,B,,,,IMMUNE SYSTEM,08/27/20,MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"PARK, Y.J., TORTORICI, M.A., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",X-RAY DIFFRACTION,NONE
7MZK,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129 AND FAB PDI 96,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129 AND FAB PDI 96,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., DIETRICH, M.H., TAN, L.L., CHAN, L.J., THAM, W.H.",X-RAY DIFFRACTION,NONE
8DLZ,N,,CRYO-EM STRUCTURE OF SARS-COV-2 D614G SPIKE PROTEIN IN COMPLEX WITH VH AB6,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VH AB6",SARS-COV-2 VARIANTS OF CONCERN: SPIKE PROTEIN MUTATIONAL ANALYSIS AND EPITOPE FOR BROAD NEUTRALIZATION.,,,H,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,01/08/09,CRYO-EM STRUCTURE OF SARS-COV-2 D614G SPIKE PROTEIN IN COMPLEX WITH VH AB6,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SAVILLE, J.W., SRIVASTAVA, S.S., BEREZUK, A.M., ZHOU, S., TUTTLE, K.S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7Z1A,N,,NANOBODY H11 AND F2 BOUND TO RBD,ANTIVIRAL PROTEIN,"SPIKE, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",STRUCTURE OF NANOBODY H11 AND F2 BOUND TO RBD,,,E,,C,PROTEIN,SPIKE PROTEIN S1,ANTIVIRAL PROTEIN,03/23/22,NANOBODY H11 AND F2 BOUND TO RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MIKOLAJEK, H., NAISMITH, J.H.",X-RAY DIFFRACTION,NONE
7Z6V,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 NANOBODY COMPLEX,ANTIVIRAL PROTEIN,"COMPLEX, SPIKE GLYCOPROTEIN, NANOBODY H11, ANTIVIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 NANOBODY COMPLEX,,,Y,,B,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",ANTIVIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 NANOBODY COMPLEX,ESCHERICHIA VIRUS T4; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ESCHERICHIA VIRUS T4 ","WECKENER, M., NAISMITH, J.H., VOGIRALA, V.K.",ELECTRON MICROSCOPY,NONE
7M7W,N,,ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 RBD ANTIBODIES THAT MAXIMIZE BREADTH AND RESISTANCE TO ESCAPE.,,,C,D,S,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/05/21,ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SNELL, G., CZUDNOCHOWSKI, N., CROLL, T.I., NIX, J.C., CORTI, D., CAMERONI, E., PINTO, D., BELTRAMELLO, M.",X-RAY DIFFRACTION,NONE
7MZI,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., TAN, L.L., DIETRICH, M.H., CHAN, L.J., THAM, W.H.",X-RAY DIFFRACTION,NONE
7F6Z,N,,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-501Y.V2 OF COVID-19,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZATION ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-501Y.V2 OF COVID-19,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/29/22,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-501Y.V2 OF COVID-19,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, H., WANG, B., ZHAO, T.N., SU, X.D.",X-RAY DIFFRACTION,NONE
7WLY,N,,CRYO-EM STRUCTURE OF THE OMICRON S IN COMPLEX WITH 35B5 FAB(1 DOWN- AND 2 UP RBDS),"VIRAL PROTEIN,IMMUNE SYSTEM","VIRAL PROTEIN, IMMUNE SYSTEM",35B5 ANTIBODY POTENTLY NEUTRALIZES SARS-COV-2 OMICRON BY DISRUPTING THE N-GLYCAN SWITCH VIA A CONSERVED SPIKE EPITOPE.,,,P,O,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN,IMMUNE SYSTEM",05/25/22,CRYO-EM STRUCTURE OF THE OMICRON S IN COMPLEX WITH 35B5 FAB(1 DOWN- AND 2 UP RBDS),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHU, Y.",ELECTRON MICROSCOPY,NONE
7WOB,N,,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-60 (2-UP TRIMER),VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT BY DISASSEMBLING THE SPIKE TRIMER.,,,D,B,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/20/22,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-60 (2-UP TRIMER),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7M3I,N,,"STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB",IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, COVID-19, ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",ISOLATION AND CHARACTERIZATION OF CROSS-NEUTRALIZING CORONAVIRUS ANTIBODIES FROM COVID-19+ SUBJECTS.,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,05/12/21,"STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HURLBURT, N.K., PANCERA, M.",X-RAY DIFFRACTION,NONE
7R4Q,N,,THE SARS-COV-2 SPIKE IN COMPLEX WITH THE 1.29 NEUTRALIZING NANOBODY,VIRAL PROTEIN,"CORONAVIRUS, COVID-19, SARS-COV-2, SPIKE, NANOBODIES, NEUTRALIZATION, VIRAL PROTEIN",NANOBODIES PROTECTING FROM LETHAL SARS-COV-2 INFECTION TARGET RECEPTOR BINDING EPITOPES PRESERVED IN VIRUS VARIANTS OTHER THAN OMICRON.,,,E,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/08/22,THE SARS-COV-2 SPIKE IN COMPLEX WITH THE 1.29 NEUTRALIZING NANOBODY,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELUS DROMEDARIUS,CAMELUS DROMEDARIUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CASASNOVAS, J.M., MELERO, R., ARRANZ, R., FERNANDEZ, L.A.",ELECTRON MICROSCOPY,NONE
6W7Y,N,"CR3022 HEAVY CHAIN, CR3022 LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV AND SARS-COV-2 REACTIVE HUMAN ANTIBODY CR3022,IMMUNE SYSTEM,"CORONAVIRUS, RECEPTOR-BINDING DOMAIN, COVID-19, VACCINE TARGET, ANTIBODY, CRYPTIC EPITOPE, VIRAL PROTEIN, IMMUNE SYSTEM",STRUCTURE AND ANTIGENICITY OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN,,,A,B,,,,IMMUNE SYSTEM,03/19/20,CRYSTAL STRUCTURE OF SARS-COV AND SARS-COV-2 REACTIVE HUMAN ANTIBODY CR3022,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"CHEN, W.H., JOYCE, M.G.",X-RAY DIFFRACTION,NONE
7MZL,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 210,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 210,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., CHAN, L.J., DIETRICH, M.H., TAN, L.L., THAM, W.H.",X-RAY DIFFRACTION,NONE
7CYV,N,,"CRYSTAL STRUCTURE OF FD20, A NEUTRALIZING SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD)",VIRAL PROTEIN,"CORONAVIRUS, COVID-19, NCOV-2019, NEUTRALIZING ANTIBODY, RECEPTOR-BINDING DOMAIN, SARS-COV-2, SCFV, SINGLE-CHAIN VARIABLE FRAGMENT, SPIKE, VIRAL PROTEIN",UNCOVERING A CONSERVED VULNERABILITY SITE IN SARS-COV-2 BY A HUMAN ANTIBODY.,,,H,H,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,09/15/21,"CRYSTAL STRUCTURE OF FD20, A NEUTRALIZING SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD)",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Y., LI, T., LAI, Y., CAI, H., YAO, H., LI, D.",X-RAY DIFFRACTION,NONE
7NDB,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-253H165L FAB,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN, IMMUNE SYSTEM",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-253H165L FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7E9N,N,,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(1 DOWN RBD, STATE1)","VIRAL PROTEIN,IMMUNE SYSTEM","VIRAL PROTEIN, IMMUNE SYSTEM",A POTENT HUMAN MONOCLONAL ANTIBODY WITH PAN-NEUTRALIZING ACTIVITIES DIRECTLY DISLOCATES S TRIMER OF SARS-COV-2 THROUGH BINDING BOTH UP AND DOWN FORMS OF RBD,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN,IMMUNE SYSTEM",04/06/22,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(1 DOWN RBD, STATE1)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.F., ZHU, Y.Q.",ELECTRON MICROSCOPY,NONE
7B27,N,"SURFACE GLYCOPROTEIN, NEUTRALIZING NANOBODY NM1230",RBD DOMAIN SARS-COV2 IN COMPLEX WITH NEUTRALIZING NANOBODY NM1230,VIRAL PROTEIN,"SARS-COV2, RECEPTOR BINDING DOMAIN, COMPLEX STRUCTURE, NEUTRALIZING NANOBODY, VIRAL PROTEIN",NEUTROBODYPLEX-MONITORING SARS-COV-2 NEUTRALIZING IMMUNE RESPONSES USING NANOBODIES.,,,C,,A,PROTEIN,UNKNOWN,VIRAL PROTEIN,01/08/09,RBD DOMAIN SARS-COV2 IN COMPLEX WITH NEUTRALIZING NANOBODY NM1230,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,,,,"OSTERTAG, E., ZOCHER, G., STEHLE, T.",X-RAY DIFFRACTION,NONE
8CYC,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-34,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,F,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-34,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
8DLR,N,,CRYO-EM STRUCTURE OF SARS-COV-2 GAMMA (P.1) SPIKE PROTEIN IN COMPLEX WITH FAB 4-8 (FOCUSED REFINEMENT OF NTD AND 4-8),VIRAL PROTEIN,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, GAMMA, P.1, 4-8",SARS-COV-2 VARIANTS OF CONCERN: SPIKE PROTEIN MUTATIONAL ANALYSIS AND EPITOPE FOR BROAD NEUTRALIZATION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/31/22,CRYO-EM STRUCTURE OF SARS-COV-2 GAMMA (P.1) SPIKE PROTEIN IN COMPLEX WITH FAB 4-8 (FOCUSED REFINEMENT OF NTD AND 4-8),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SAVILLE, J.W., SRIVASTAVA, S.S., BEREZUK, A.M., ZHOU, S., TUTTLE, K.S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7N9T,N,,CRYOEM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NB17,ANTIVIRAL PROTEIN/VIRAL PROTEIN,"SARS-COV-2 SPIKE RECEPTOR BINDING DOMAIN NANOBODY, ANTIVIRAL PROTEIN, ANTIVIRAL PROTEIN-VIRAL PROTEIN COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING DIVERSE AND CONSERVED EPITOPES,,,D,,C,PROTEIN,SPIKE GLYCOPROTEIN,ANTIVIRAL PROTEIN/VIRAL PROTEIN,08/11/21,CRYOEM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NB17,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7U0P,N,,SARS-COV2 S PROTEIN STRUCTURE IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY 002-S21F2,VIRAL PROTEIN,"SARS-COV2 6P SPIKE PROTEIN, IMMUNE COMPLEX, VIRAL PROTEIN",SARS-COV2 S PROTEIN STRUCTURE IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY 002-S21F2,,,D,I,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,01/08/09,SARS-COV2 S PROTEIN STRUCTURE IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY 002-S21F2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PATEL, A., ORTLUND, E.",ELECTRON MICROSCOPY,NONE
7DZX,N,"SPIKE GLYCOPROTEIN, EPIDIDYMIS LUMINAL PROTEIN 214, FAB LIGHT CHAIN OF ENHANCING ANTIBODY",SPIKE PROTEIN FROM SARS-COV2 WITH FAB FRAGMENT OF ENHANCING ANTIBODY 8D2,VIRAL PROTEIN,"SARS-COV2, SPIKE PROTEIN, FAB, ENHANCING ANTIBODY, VIRAL PROTEIN",AN INFECTIVITY-ENHANCING SITE ON THE SARS-COV-2 SPIKE PROTEIN TARGETED BY ANTIBODIES.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/02/21,SPIKE PROTEIN FROM SARS-COV2 WITH FAB FRAGMENT OF ENHANCING ANTIBODY 8D2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, Y., SOH, W.T., LI, S., KISHIKAWA, J., HIROSE, M., KATO, T., STANDLEY, D., OKADA, M., ARASE, H.",ELECTRON MICROSCOPY / HOMOLOGY MODEL,NONE
7WK9,N,,SARS-COV-2 OMICRON OPEN STATE SPIKE PROTEIN IN COMPLEX WITH S3H3 FAB,VIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, OMICRON VARIANT, B.1.1.529 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MOLECULAR BASIS OF RECEPTOR BINDING AND ANTIBODY NEUTRALIZATION OF OMICRON.,,,A,B,B,PROTEIN,LIGHT CHAIN OF S3H3 FAB,VIRAL PROTEIN,02/02/22,SARS-COV-2 OMICRON OPEN STATE SPIKE PROTEIN IN COMPLEX WITH S3H3 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HONG, Q., CONG, Y.",ELECTRON MICROSCOPY,NONE
7SWP,N,,G32Q4 FAB IN COMPLEX WITH SARS-COV-2 SPIKE 6P (RBD LOCAL RECONSTRUCTION),VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRUS, IMMUNITY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",DIMER OF HEPTAMER CLASS 2,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,G32Q4 FAB IN COMPLEX WITH SARS-COV-2 SPIKE 6P (RBD LOCAL RECONSTRUCTION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WINDSOR, I.W., TONG, P., WESEMANN, D.R., HARRISON, S.C.",ELECTRON MICROSCOPY,NONE
7X08,N,,S PROTEIN OF SARS-COV-2 IN COMPLEX WITH 2G1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",BROAD ULTRA-POTENT NEUTRALIZATION OF SARS-COV-2 VARIANTS BY MONOCLONAL ANTIBODIES SPECIFIC TO THE TIP OF RBD.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/09/22,S PROTEIN OF SARS-COV-2 IN COMPLEX WITH 2G1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"GUO, Y.Y., ZHANG, Y.Y., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7UPL,N,,SARS-COV2 OMICRON VARIENT S PROTEIN STRUCTURE IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY 002-S21F2,VIRAL PROTEIN,"SARS-COV2, 6P, SPIKE PROTEIN, IMMUNE COMPLEX, VIRAL PROTEIN",SARS-COV2 OMICRON VARIANT S PROTEIN STRUCTURE IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY 002-S21F2,,,F,I,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/10/22,SARS-COV2 OMICRON VARIENT S PROTEIN STRUCTURE IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY 002-S21F2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PATEL, A., ORTLUND, E.",ELECTRON MICROSCOPY,NONE
4ZPV,,"D12 FAB HEAVY CHAIN, D12 FAB LIGHT CHAIN, SPIKE GLYCOPROTEIN",STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2),VIRAL PROTEIN/IMMUNE SYSTEM,"VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",EVALUATION OF CANDIDATE VACCINE APPROACHES FOR MERS-COV.,,,H,L,R,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/08/15,STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2),HUMAN CORONAVIRUS EMC (ISOLATE UNITED KINGDOM/H123990006/2012); MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,HUMAN CORONAVIRUS EMC (ISOLATE UNITEDKINGDOM/H123990006/2012) ,"JOYCE, M.G., MASCOLA, J.R., GRAHAM, B.S., KWONG, P.D.",X-RAY DIFFRACTION,NONE
7WCZ,N,,SARS-COV-2 BETA SPIKE IN COMPLEX WITH ONE S5D2 FAB,VIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, BETA VARIANT, B.1.351 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MAPPING CROSS-VARIANT NEUTRALIZING SITES ON THE SARS-COV-2 SPIKE PROTEIN.,,,A,B,A,PROTEIN,HEAVY CHAIN OF S5D2 FAB,VIRAL PROTEIN,02/02/22,SARS-COV-2 BETA SPIKE IN COMPLEX WITH ONE S5D2 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y.F., CONG, Y.",ELECTRON MICROSCOPY,NONE
7PS2,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-29 AND BETA-53 FABS,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 (ALPHA) VARIANT, B.1.351 (BETA) VARIANT, P.1 (GAMMA) VARIANT, B.1.617.2 (DELTA) VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,G,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-29 AND BETA-53 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7MEJ,N,,CRYOEM STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH NANOBODIES NB21 AND NB36,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 RECEPTOR BINDING DOMAIN NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING DIVERSE AND CONSERVED EPITOPES,,,A,,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/11/21,CRYOEM STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH NANOBODIES NB21 AND NB36,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.J.",ELECTRON MICROSCOPY,NONE
5GMQ,N,"SPIKE PROTEIN S1, MCA1 HEAVY CHAIN, MCA1 LIGHT CHAIN",STRUCTURE OF MERS-COV RBD IN COMPLEX WITH A FULLY HUMAN ANTIBODY MCA1,VIRAL PROTEIN/IMMUNE SYSTEM,VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX,HUMAN NEUTRALIZING MONOCLONAL ANTIBODY INHIBITION OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS REPLICATION IN THE COMMON MARMOSET.,,,B,C,A,PROTEIN,S PROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/15/16,STRUCTURE OF MERS-COV RBD IN COMPLEX WITH A FULLY HUMAN ANTIBODY MCA1,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS,"CHEN, C., WANG, J.M., ZOU, T.T., GAO, X.P., CUI, S., JIN, Q.",X-RAY DIFFRACTION,NONE
7BEH,N,"SPIKE GLYCOPROTEIN, COVOX-316 HEAVY CHAIN, COVOX-316 LIGHT CHAIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7CZS,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,I,M,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
5W9M,N,"SPIKE GLYCOPROTEIN, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,B,C,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7JMW,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CROSS-NEUTRALIZATION OF A SARS-COV-2 ANTIBODY TO A FUNCTIONALLY CONSERVED SITE IS MEDIATED BY AVIDITY.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/20,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., YUAN, M., ZHU, X., WU, N.C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7QTJ,N,,SARS-COV-2 S OMICRON SPIKE B.1.1.529 - RBD UP - 1-P2G3 AND 1-P5C3 FABS (LOCAL),VIRAL PROTEIN,"SARS-COV-2 S OMICRON SPIKE B.1.1.529, VIRAL PROTEIN",PATIENT-DERIVED MONOCLONAL ANTIBODY NEUTRALIZES SARS-COV-2 OMICRON VARIANTS AND CONFERS FULL PROTECTION IN MONKEYS.,,,F,E,A,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,08/03/22,SARS-COV-2 S OMICRON SPIKE B.1.1.529 - RBD UP - 1-P2G3 AND 1-P5C3 FABS (LOCAL),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NI, D., LAU, K., TURELLI, P., FENWICK, C., PEREZ, L., POJER, F., STAHLBERG, H., PANTALEO, G., TRONO, D.",ELECTRON MICROSCOPY,NONE
7M6G,N,"SPIKE GLYCOPROTEIN, BG7-15 FAB HEAVY CHAIN, BG7-15 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15",VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, COVID-19, ANTIBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING DOMAIN, SPIKE GLYCOPROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",B CELL GENOMICS BEHIND CROSS-NEUTRALIZATION OF SARS-COV-2 VARIANTS AND SARS-COV.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/ANTIVIRAL PROTEIN,05/05/21,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7WK0,N,,LOCAL REFINE OF OMICRON SPIKE BITRIMER WITH 6M6 ANTIBODY,VIRAL PROTEIN,"OMICRON, SPIKE, ANTIBODY, VIRAL PROTEIN",A BROADLY NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 OMICRON VARIANT INFECTION EXHIBITING A NOVEL TRIMER DIMER CONFORMATION IN SPIKE PROTEIN BINDING.,,,D,E,F,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,07/13/22,LOCAL REFINE OF OMICRON SPIKE BITRIMER WITH 6M6 ANTIBODY,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7JMX,N,,CRYSTAL STRUCTURE OF A SARS-COV-2 CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB,IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM",CROSS-NEUTRALIZATION OF A SARS-COV-2 ANTIBODY TO A FUNCTIONALLY CONSERVED SITE IS MEDIATED BY AVIDITY.,,,H,L,,,,IMMUNE SYSTEM,08/03/20,CRYSTAL STRUCTURE OF A SARS-COV-2 CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"LIU, H., YUAN, M., ZHU, X., WU, N.C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7EY0,N,,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-813 FAB AND BD-744 FAB,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURES OF SARS-COV-2 B.1.351 NEUTRALIZING ANTIBODIES PROVIDE INSIGHTS INTO COCKTAIL DESIGN AGAINST CONCERNING VARIANTS.,,,A,B,R,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,01/08/09,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-813 FAB AND BD-744 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.",ELECTRON MICROSCOPY,NONE
7TCC,N,,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON SPIKE IN COMPLEX WITH ANTIBODIES A19-46.1 AND B1-182.1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON SPIKE,,,D,E,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/30/22,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON SPIKE IN COMPLEX WITH ANTIBODIES A19-46.1 AND B1-182.1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7NX6,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY EVASION BY THE P.1 STRAIN OF SARS-COV-2.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/07/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7M52,N,"SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE, B6 ANTIGEN-BINDING (FAB) FRAGMENT HEAVY CHAIN, B6 ANTIGEN-BINDING (FAB) FRAGMENT LIGHT CHAIN",B6 FAB FRAGMENT BOUND TO THE HKU4 SPIKE STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM","BROADLY NEUTRALIZING ANTIBODY, STRUCTURAL GENOMICS, SSGCID, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, ANTIVIRAL PROTEIN, IMMUNE SYSTEM, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE",STRUCTURAL BASIS FOR BROAD CORONAVIRUS NEUTRALIZATION.,,,H,L,A,PEPTIDE,SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM",05/26/21,B6 FAB FRAGMENT BOUND TO THE HKU4 SPIKE STEM HELIX PEPTIDE,MUS MUSCULUS; SYNTHETIC CONSTRUCT,MUS MUSCULUS,MUS MUSCULUS,BAT CORONAVIRUS HKU4,"SAUER, M.M., PARK, Y.J., VEESLER, D., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",X-RAY DIFFRACTION,NONE
7ZRC,N,,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE,STRUCTURAL PROTEIN,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM COMPLEX, STRUCTURAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,H,L,C,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",STRUCTURAL PROTEIN,06/01/22,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ENTEROBACTERIA PHAGE T4; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ENTEROBACTERIA PHAGE T4 ","DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7RU5,N,,CC6.30 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (NON-UNIFORM REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, SARS-COV-2, STABILIZING MUTATIONS, NEUTRALIZING ANTIBODY, RBD, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ENGINEERING SARS-COV-2 NEUTRALIZING ANTIBODIES FOR INCREASED POTENCY AND REDUCED VIRAL ESCAPE PATHWAYS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,CC6.30 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (NON-UNIFORM REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZOROWSKI, G., TURNER, H.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7S5R,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES CV07-287 AND COVA1-16,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, FAB, SPIKE, RBD, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 BETA VARIANT INFECTION ELICITS POTENT LINEAGE-SPECIFIC AND CROSS-REACTIVE ANTIBODIES.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/09/22,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES CV07-287 AND COVA1-16,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7KKZ,N,,CRYSTAL STRUCTURE OF MOUSE ANTI-HIV POTENT NEUTRALIZING ANTIBODY M4H2K1,ANTIVIRAL PROTEIN,"HIV-1, ENV, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, ANTIVIRAL PROTEIN",NEUTRALIZING ANTIBODIES INDUCED BY FIRST-GENERATION GP41-STABILIZED HIV-1 ENVELOPE TRIMERS AND NANOPARTICLES.,,,H,L,,,,ANTIVIRAL PROTEIN,07/07/21,CRYSTAL STRUCTURE OF MOUSE ANTI-HIV POTENT NEUTRALIZING ANTIBODY M4H2K1,MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,,"KUMAR, S., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7XOD,N,,SARS-COV-2 OMICRON BA.2 VARIANT SPIKE TRIMER WITH THREE JMB2002 FAB BOUND,VIRAL PROTEIN/IMMUNE SYSTEM,VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX,STRUCTURAL AND BIOCHEMICAL MECHANISM FOR INCREASED INFECTIVITY AND IMMUNE EVASION OF OMICRON BA.2 VARIANT COMPARED TO BA.1 AND THEIR POSSIBLE MOUSE ORIGINS.,,,X,Y,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/15/22,SARS-COV-2 OMICRON BA.2 VARIANT SPIKE TRIMER WITH THREE JMB2002 FAB BOUND,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS; LAMA GLAMA,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, Y., WU, C., LIU, H., YIN, W., XU, H.E.",ELECTRON MICROSCOPY,NONE
7MXP,N,,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE,VIRAL PROTEIN/IMMUNE SYSTEM,"NETURALSING ANTIBODY, FUSION PROTEIN, SPIKE GLYCOPROTEIN, NRD, NTD-DIRECTED ANTIBODY, LP5, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/25/22,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"REDDEM, E.R., CASNER, R.G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7KZA,N,"FAB FRAGMENT HEAVY CHAIN OF ANTI-COV2-RBD ANTIBODY VARIANT CR3022-B6, FAB FRAGMENT LIGHT CHAIN OF ANTI-COV2-RBD ANTIBODY VARIANT CR3022-B6",POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES,IMMUNE SYSTEM,"COVID19, SARS-COV2, ANTIBODY, ANTIVIRAL PROTEIN, IMMUNE SYSTEM",POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1 ANTIBODIES.,,,H,L,,,,IMMUNE SYSTEM,02/24/21,POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"LANGLEY, D.B., CHRIST, D.",X-RAY DIFFRACTION,NONE
7V6N,N,,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 111 STATE1,PROTEIN BINDING,"MERS SPIKE ANTIBODY, PROTEIN BINDING",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 111 STATE1,,,I,H,C,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,09/14/22,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 111 STATE1,HOMO SAPIENS; HUMAN BETACORONAVIRUS 2C EMC/2012,HOMO SAPIENS,HOMO SAPIENS,HUMAN BETACORONAVIRUS 2C EMC/2012,"WANG, X., ZHAO, J., WANG, Z., ZENG, J., ZHANG, S., WANG, Y.",ELECTRON MICROSCOPY,NONE
7KS9,N,SPIKE GLYCOPROTEIN,CRYO-EM STRUCTURE OF PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH 910-30 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, FUSION PROTEIN, SPIKE GLYCOPROTEIN, COVID-19, RBD, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",PAIRED HEAVY AND LIGHT CHAIN SIGNATURES CONTRIBUTE TO POTENT SARS-COV-2 NEUTRALIZATION IN PUBLIC ANTIBODY RESPONSES.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/10/21,CRYO-EM STRUCTURE OF PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH 910-30 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CERUTTI, G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
6VL8,N,"6-3 FAB HEAVY CHAIN, 6-3 FAB LIGHT CHAIN",ANTI-PEG ANTIBODY 6-3 FAB FRAGMENT IN COMPLEX WITH PEG,IMMUNE SYSTEM,"ANTIBODY, FAB, PEG, ANTI-PEG, POLYMER, ANTI-DRUG, IMMUNE SYSTEM",STRUCTURE OF AN ANTI-PEG ANTIBODY REVEALS AN OPEN RING THAT CAPTURES HIGHLY FLEXIBLE PEG POLYMERS,,,E,F,E,HAPTEN,"2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL",IMMUNE SYSTEM,01/23/20,ANTI-PEG ANTIBODY 6-3 FAB FRAGMENT IN COMPLEX WITH PEG,MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,"NICELY, N.I., HUCKABY, J.T., LAI, S.K., JACOBS, T.M.",X-RAY DIFFRACTION,NONE
7N9A,N,,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS RBD WITH NB21,VIRAL PROTEIN/IMMUNE SYSTEM,"COVS NB21 NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES,,,A,,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS RBD WITH NB21,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, D., ZHANG, C., SHI, Y.",ELECTRON MICROSCOPY,NONE
3BGF,,"SPIKE PROTEIN S1, F26G19 FAB",X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIGEN-ANTIBODY COMPLEX, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, VIRULENCE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL INSIGHTS INTO IMMUNE RECOGNITION OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS S PROTEIN RECEPTOR BINDING DOMAIN.,,,H,L,S,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,11/26/07,X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB,SARS CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SARS CORONAVIRUS,"PAK, J.E., RINI, J.M.",X-RAY DIFFRACTION,19324051
7WD0,N,,SARS-COV-2 BETA SPIKE IN COMPLEX WITH TWO S5D2 FABS,VIRAL PROTEIN,"CORONAVIRUS, BETA VARIANT, B.1.351 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MAPPING CROSS-VARIANT NEUTRALIZING SITES ON THE SARS-COV-2 SPIKE PROTEIN.,,,C,D,B,PROTEIN,LIGHT CHAIN OF S5D2 FAB,VIRAL PROTEIN,02/02/22,SARS-COV-2 BETA SPIKE IN COMPLEX WITH TWO S5D2 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y.F., CONG, Y.",ELECTRON MICROSCOPY,NONE
7LX5,N,"SPIKE GLYCOPROTEIN, WNB 2, WNB 10",THE SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN BOUND TO NEUTRALIZING NANOBODIES WNB 2 AND WNB 10,VIRAL PROTEIN,"SARS-COV-2, NANOBODY COCKTAIL, CORONAVIRUS SPIKE, NEUTRALIZING NANOBODY, VIRAL PROTEIN",NANOBODY COCKTAILS POTENTLY NEUTRALIZE SARS-COV-2 D614G N501Y VARIANT AND PROTECT MICE.,,,C,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/05/21,THE SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN BOUND TO NEUTRALIZING NANOBODIES WNB 2 AND WNB 10,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., GLUKHOVA, A., THAM, W.-H.",ELECTRON MICROSCOPY,NONE
7E8F,N,"SPIKE GLYCOPROTEIN, N9 H, N9 L, 368-2 H, 368-2 L, 604 H, 604 L, SPIKE PROTEIN S1",SARS-COV-2 NTD IN COMPLEX WITH N9 FAB,VIRAL PROTEIN,"SARS-COV-2, COMPLEX, ANTIBODY, VIRAL PROTEIN",HUMORAL IMMUNE RESPONSE TO CIRCULATING SARS-COV-2 VARIANTS ELICITED BY INACTIVATED AND RBD-SUBUNIT VACCINES.,,,C,B,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/09/21,SARS-COV-2 NTD IN COMPLEX WITH N9 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J., ZHANG, Z.",ELECTRON MICROSCOPY,NONE
7N3I,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C098,IMMUNE SYSTEM/VIRAL PROTEIN,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,H,L,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,08/04/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C098,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FLYAK, A.I., BJORKMAN, P.J., BARNES, C.O.",X-RAY DIFFRACTION,NONE
7ENF,N,,CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH FAB30,VIRAL PROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",A POTENT HUMAN MONOCLONAL ANTIBODY WITH PAN-NEUTRALIZING ACTIVITIES DIRECTLY DISLOCATES S TRIMER OF SARS-COV-2 THROUGH BINDING BOTH UP AND DOWN FORMS OF RBD,,,P,O,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/06/22,CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH FAB30,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.F., ZHU, Y.Q.",ELECTRON MICROSCOPY,NONE
6VL9,N,"6-3 FAB HEAVY CHAIN, 6-3 FAB LIGHT CHAIN",ANTI-PEG ANTIBODY 6-3 FAB FRAGMENT IN COMPLEX WITH PEG,IMMUNE SYSTEM,"ANTIBODY, FAB, PEG, ANTI-PEG, POLYMER, ANTI-DRUG, IMMUNE SYSTEM",STRUCTURE OF AN ANTI-PEG ANTIBODY REVEALS AN OPEN RING THAT CAPTURES HIGHLY FLEXIBLE PEG POLYMERS,,,A,B,,,,IMMUNE SYSTEM,01/23/20,ANTI-PEG ANTIBODY 6-3 FAB FRAGMENT IN COMPLEX WITH PEG,MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,,"NICELY, N.I., HUCKABY, J.T., LAI, S.K., JACOBS, T.M.",X-RAY DIFFRACTION,NONE
7M7B,N,"SPIKE GLYCOPROTEIN, ANTIBODY FAB 3D11 HEAVY CHAIN, ANTIBODY FAB 3D11 LIGHT CHAIN",SARS-COV-2 SPIKE:FAB 3D11 COMPLEX FOCUSED REFINEMENT,VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN",STRUCTURAL INSIGHT INTO SARS-COV-2 NEUTRALIZING ANTIBODIES AND MODULATION OF SYNCYTIA.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/26/21,SARS-COV-2 SPIKE:FAB 3D11 COMPLEX FOCUSED REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ASARNOW, D., CHENG, Y.",ELECTRON MICROSCOPY,NONE
7LQ7,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV503 AND COVA1-16,IMMUNE SYSTEM,"ANTIBODY, CORONAVIRUS, FAB, SPIKE, COVID-19, RBD, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM",BISPECIFIC ANTIBODIES TARGETING DISTINCT REGIONS OF THE SPIKE PROTEIN POTENTLY NEUTRALIZE SARS-COV-2 VARIANTS OF CONCERN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM,09/15/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV503 AND COVA1-16,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7WPE,N,,SARS-COV-2 OMICRON VARIANT S TRIMER COMPLEXED WITH TWO JMB2002 FAB,VIRAL PROTEIN,"SARS-COV-2, OMICRON, S, TRIMER, ANTIBODY, VIRAL PROTEIN",STRUCTURES OF THE OMICRON SPIKE TRIMER WITH ACE2 AND AN ANTI-OMICRON ANTIBODY.,,,X,Y,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/23/22,SARS-COV-2 OMICRON VARIANT S TRIMER COMPLEXED WITH TWO JMB2002 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS; LAMA GLAMA,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YIN, W., XU, Y., XU, P., CAO, X., WU, C., GU, C., HE, X., WANG, X., HUANG, S., YUAN, Q., WU, K., HU, W., HUANG, Z., LIU, J., WANG, Z., JIA, F., XIA, K., LIU, P., WANG, X., SONG, B., ZHENG, J., JIANG, H., CHENG, X., JIANG, Y., DENG, S.J., XU, H.E.",ELECTRON MICROSCOPY,NONE
7K8W,N,"SPIKE GLYCOPROTEIN, C119 FAB LIGHT CHAIN, C119 FAB HEAVY CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,N,S,G,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SHARAF, N.G., BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7DJZ,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW01 FAB,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, ANTIBODY, ADE, VIRUS, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",ANTIBODY-DEPENDENT ENHANCEMENT (ADE) OF SARS-COV-2 PSEUDOVIRAL INFECTION REQUIRES FC GAMMA RIIB AND VIRUS-ANTIBODY COMPLEX WITH BIVALENT INTERACTION.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,06/09/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW01 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, J., JIAO, S., WANG, R., ZHANG, J., ZHANG, M., WANG, M.",X-RAY DIFFRACTION,NONE
7T3M,N,,"SARS-COV-2 S (SPIKE GLYCOPROTEIN) D614G WITH THREE (3) RBDS UP, BOUND TO ANTIBODY 2-7 SCFV, COMPOSITE MAP",VIRAL PROTEIN/IMMUNE SYSTEM,"VIRUS, CORONAVIRUS, SARS COV-2, SARS-COV-2, SPIKE, 2-7, D614G, RBD, 3 RBDS UP, THREE RBDS UP, SCFV, COMPLEX, PHAGE DISPLAY, VIRAL PROTEIN, LOCAL REFINEMENT, FOCUSED REFINEMENT, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","SARS COV-2 S (SPIKE GLYCOPROTEIN) D614G WITH THREE (3) RBDS UP, BOUND TO ANTIBODY 2-7 SCFV",,,I,K,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,"SARS-COV-2 S (SPIKE GLYCOPROTEIN) D614G WITH THREE (3) RBDS UP, BOUND TO ANTIBODY 2-7 SCFV, COMPOSITE MAP",ESCHERICHIA COLI; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BYRNE, P.O., MCLELLAN, J.S.",ELECTRON MICROSCOPY,NONE
8DLW,N,,CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH FAB S2M11,VIRAL PROTEIN,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, EPSILON, B.1.429, S2M11",SARS-COV-2 VARIANTS OF CONCERN: SPIKE PROTEIN MUTATIONAL ANALYSIS AND EPITOPE FOR BROAD NEUTRALIZATION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/31/22,CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH FAB S2M11,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SAVILLE, J.W., SRIVASTAVA, S.S., BEREZUK, A.M., ZHOU, S., TUTTLE, K.S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7WON,N,,CRYO-EM STRUCTURE OF SARS-COV-2 S2P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",IMMUNE ESCAPE BY SARS-COV-2 OMICRON VARIANT AND STRUCTURAL BASIS OF ITS EFFECTIVE NEUTRALIZATION BY A BROAD NEUTRALIZING HUMAN ANTIBODY VACW-209.,,,H,L,F,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 S2P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, Q., SUN, H., JU, B., ZHANG, Z., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
7MZN,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 231,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 231,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., TAN, L.L., DIETRICH, M.H., CHAN, L.J., THAM, W.H.",X-RAY DIFFRACTION,NONE
7Q0I,N,,CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-43,VIRAL PROTEIN,"SARS-COV-2 ALPHA VARIANT, BETA VARIANT, GAMMA VARIANT, DELTA VARIANT, B.1.1.7, B.1.351, P.1, B.1.617.2, ANTIBODY, N-TERMINAL DOMAIN, NTD, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,12/22/21,CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-43,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
6XEY,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, 2-4 HEAVY CHAIN, 2-4 LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-4,VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, GLYCOPROTEIN, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING ANTIBODIES AGAINST MULTIPLE EPITOPES ON SARS-COV-2 SPIKE.,,,F,G,B,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/14/20,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-4,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"RAPP, M., SHAPIRO, L., HO, D.D.",ELECTRON MICROSCOPY,NONE
7DK5,N,"THE HEAVY CHAIN OF 3C1 FAB THAT BINDS WITH THE UP RBD, SPIKE GLYCOPROTEIN, THE LIGHT CHAIN OF 3C1 FAB","S-2H2-F1 STRUCTURE, ONE RBD IS UP AND TWO RBDS ARE DOWN, ONLY UP RBD BINDS WITH A 2H2 FAB",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,A,B,A,PROTEIN,THE HEAVY CHAIN OF 2H2 FAB,VIRAL PROTEIN,11/23/20,"S-2H2-F1 STRUCTURE, ONE RBD IS UP AND TWO RBDS ARE DOWN, ONLY UP RBD BINDS WITH A 2H2 FAB",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., WANG, Y.F.",ELECTRON MICROSCOPY,NONE
7RKV,N,,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C118 (STATE 1),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, BROADLY NEUTRALIZING, CORONAVIRUS, ANTIBODY, VIRUS, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",BROAD CROSS-REACTIVITY ACROSS SARBECOVIRUSES EXHIBITED BY A SUBSET OF COVID-19 DONOR-DERIVED NEUTRALIZING ANTIBODIES.,,,D,H,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/22/21,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C118 (STATE 1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., JETTE, C.A., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
5U64,N,VHH-28,CAMEL NANOBODY VHH-28,IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, CAMEL VHH NANOBODY, HIV-1, IMMUNE SYSTEM",SELECTION OF NANOBODIES WITH BROAD NEUTRALIZING POTENTIAL AGAINST PRIMARY HIV-1 STRAINS USING SOLUBLE SUBTYPE C GP140 ENVELOPE TRIMERS.,,,B,,,,,IMMUNE SYSTEM,12/07/16,CAMEL NANOBODY VHH-28,CAMELUS DROMEDARIUS,CAMELUS DROMEDARIUS,,,"STANFIELD, R.L., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7TCA,N,,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON SPIKE IN COMPLEX WITH ANTIBODY A19-46.1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON SPIKE,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/30/22,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON SPIKE IN COMPLEX WITH ANTIBODY A19-46.1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7WS7,N,,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,K,J,,,,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7PNM,N,,HUMAN CORONAVIRUS OC43 SPIKE GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH THE 46C12 ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,"CORONAVIRUS, GLYCOPROTEIN, ANTIBODY, SPIKE, VIRAL PROTEIN",NEUTRALIZING EPITOPES ON THE HUMAN CORONAVIRUS OC43 SPIKE TRIMER,,,I,E,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/20/22,HUMAN CORONAVIRUS OC43 SPIKE GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH THE 46C12 ANTIBODY FAB FRAGMENT,HUMAN CORONAVIRUS OC43; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN CORONAVIRUS OC43,"HURDISS, D.L.",ELECTRON MICROSCOPY,NONE
7FG3,N,,"MAJOR CRYO-EM STRUCTURE OF S PROTEIN TRIMER OF SARS-COV2 WITH K-874, COMPOSITE MAP",PROTEIN BINDING,"ANTIBODY, PROTEIN BINDING",NASAL DELIVERY OF SINGLE-DOMAIN ANTIBODY IMPROVES SYMPTOMS OF SARS-COV-2 INFECTION IN AN ANIMAL MODEL.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,09/29/21,"MAJOR CRYO-EM STRUCTURE OF S PROTEIN TRIMER OF SARS-COV2 WITH K-874, COMPOSITE MAP",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SONG, C., KATAYAMA, K., MURATA, K.",ELECTRON MICROSCOPY,NONE
7D4G,N,,A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN AGAINST SARS-COV-2,VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN AGAINST SARS-COV-2.,,,N,G,B,PROTEIN,SPIKE GLYCOPROTEIN S1,VIRAL PROTEIN,04/07/21,A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN AGAINST SARS-COV-2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CAO, L., WANG, X.",ELECTRON MICROSCOPY,NONE
7R8L,N,,STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODY C099 AND CR3022,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR BINDING DOMAIN, RBD, NEUTRALIZING ANTIBODY, COVID-19, SPIKE, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,C,D,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODY C099 AND CR3022,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
7WS5,N,,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,I,H,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7CZU,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,K,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7K4N,N,"SPIKE GLYCOPROTEIN, S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (HEAVY CHAIN), S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LIGHT CHAIN)",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ULTRAPOTENT HUMAN ANTIBODIES PROTECT AGAINST SARS-COV-2 CHALLENGE VIA MULTIPLE MECHANISMS.,,,C,D,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/15/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
8DZI,N,,STRUCTURE OF SARS-COV-2 OMICRON BA.1.1.529 SPIKE TRIMER WITH ONE RBD DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY MB.02,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 OMICRON SPIKE, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",FUNCTION AND CRYO-EM STRUCTURES OF BROADLY POTENT BISPECIFIC ANTIBODIES AGAINST MULTIPLE SARS-COV-2 OMICRON SUBLINEAGES.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/31/22,STRUCTURE OF SARS-COV-2 OMICRON BA.1.1.529 SPIKE TRIMER WITH ONE RBD DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY MB.02,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HU, Y., XIONG, Y.",ELECTRON MICROSCOPY,NONE
8CXN,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-57,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,E,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-57,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7L2D,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, 1-87 HEAVY CHAIN, 1-87 LIGHT CHAIN",CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 1-87 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, SARS-COV-2, FUSION PROTEIN, SPIKE GLYCOPROTEIN, VIRAL PROTEIN, NTD, NTD-DIRECTED ANTIBODY, 1-87, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES DIRECTED AGAINST SPIKE N-TERMINAL DOMAIN TARGET A SINGLE SUPERSITE.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/24/21,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 1-87 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CERUTTI, G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7LM8,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1-16 FABS ISOLATED FROM COVID-19 PATIENTS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SARS-COV, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, SARS, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, CROSS-NEUTRALIZATION, SYNERGY, VIRAL PROTEIN",A COMBINATION OF CROSS-NEUTRALIZING ANTIBODIES SYNERGIZES TO PREVENT SARS-COV-2 AND SARS-COV PSEUDOVIRUS INFECTION.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/31/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1-16 FABS ISOLATED FROM COVID-19 PATIENTS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7MW2,N,,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH ALL RBDS DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 6,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","DEVELOPMENT, STRUCTURE AND FUNCTION OF POTENT MONOSPECIFIC AND BISPECIFIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE SARS-COV-2 AND ITS MUTANT VARIANT",,,F,G,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/16/22,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH ALL RBDS DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HU, Y., XIONG, Y.",ELECTRON MICROSCOPY,NONE
7NAB,N,,CRYSTAL STRUCTURE OF HUMAN NEUTRALIZING MAB CV3-25 BINDING TO SARS-COV-2 S MPER PEPTIDE 1140-1165,VIRAL PROTEIN/IMMUNE SYSTEM,"HUMAN NEUTRALIZING MAB, MPER-TARGETING, SARS-COV-2, SPIKE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS AND MODE OF ACTION FOR TWO BROADLY NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 EMERGING VARIANTS OF CONCERN.,,,A,B,D,PEPTIDE,SPIKE PROTEIN S2,VIRAL PROTEIN/IMMUNE SYSTEM,12/08/21,CRYSTAL STRUCTURE OF HUMAN NEUTRALIZING MAB CV3-25 BINDING TO SARS-COV-2 S MPER PEPTIDE 1140-1165,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CHEN, Y., TOLBERT, W.D., PAZGIER, M.",X-RAY DIFFRACTION,NONE
7LXZ,N,"SPIKE GLYCOPROTEIN, S2M11 FAB LIGHT CHAIN VARIABLE REGION, S2M11 FAB HEAVY CHAIN VARIABLE REGION, S2L28 FAB HEAVY CHAIN VARIABLE REGION, S2L28 FAB LIGHT CHAIN VARIABLE REGION",SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",N-TERMINAL DOMAIN ANTIGENIC MAPPING REVEALS A SITE OF VULNERABILITY FOR SARS-COV-2.,,,H,J,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7MJJ,N,"SPIKE GLYCOPROTEIN, FAB AB1 HEAVY CHAIN, FAB AB1 LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO FAB AB1 (CLASS 1),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, FAB AB1, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYO-ELECTRON MICROSCOPY STRUCTURES OF THE N501Y SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH ACE2 AND 2 POTENT NEUTRALIZING ANTIBODIES.,,,F,G,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/12/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO FAB AB1 (CLASS 1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SRIVASTAVA, S.S., BEREZUK, A.M., DEMERS, J.P., SAVILLE, J.W., LEOPOLD, K., LI, W., DIMITROV, D.S., TUTTLE, K.S., ZHOU, S., CHITTORI, S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
6XKQ,N,"SPIKE PROTEIN S1, CV07-250 HEAVY CHAIN, CV07-250 LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-250,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A THERAPEUTIC NON-SELF-REACTIVE SARS-COV-2 ANTIBODY PROTECTS FROM LUNG PATHOLOGY IN A COVID-19 HAMSTER MODEL.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/26/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-250,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., LIU, H., ZHU, X., WU, N.C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7M51,N,"SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE, B6 ANTIGEN-BINDING (FAB) FRAGMENT HEAVY CHAIN, B6 ANTIGEN-BINDING (FAB) FRAGMENT LIGHT CHAIN",B6 FAB FRAGMENT BOUND TO THE OC43 SPIKE STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM","BROADLY NEUTRALIZING ANTIBODY, STRUCTURAL GENOMICS, SSGCID, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, ANTIVIRAL PROTEIN, IMMUNE SYSTEM",STRUCTURAL BASIS FOR BROAD CORONAVIRUS NEUTRALIZATION.,,,H,L,A,PEPTIDE,SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM",05/26/21,B6 FAB FRAGMENT BOUND TO THE OC43 SPIKE STEM HELIX PEPTIDE,MUS MUSCULUS; SYNTHETIC CONSTRUCT,MUS MUSCULUS,MUS MUSCULUS,HUMAN CORONAVIRUS OC43,"SAUER, M.M., PARK, Y.J., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7DCX,N,"THE HEAVY CHAIN OF 3C1 FAB THAT BINDS WITH THE UP RBD, SPIKE GLYCOPROTEIN, THE LIGHT CHAIN OF 3C1 FAB","S-3C1-F3A STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, EACH RBD BINDS WITH A 3C1 FAB.",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,B,G,D,PROTEIN,SARS-COV2 S PROTEIN,VIRAL PROTEIN,10/27/20,"S-3C1-F3A STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, EACH RBD BINDS WITH A 3C1 FAB.",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., LIU, C.X.",ELECTRON MICROSCOPY,NONE
6VO3,N,"ENVELOPE GLYCOPROTEIN GP120, ENVELOPE GLYCOPROTEIN GP41, PGV04 HEAVY CHAIN, PGV04 LIGHT CHAIN",AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB,IMMUNE SYSTEM,"HIV, ENV, ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM",NEUTRALIZING ANTIBODY RESPONSES INDUCED BY HIV-1 ENVELOPE GLYCOPROTEIN SOSIP TRIMERS DERIVED FROM ELITE NEUTRALIZERS.,,,I,K,D,PROTEIN,AMC009 SOSIP.V4.2 ENVELOPE GLYCOPROTEIN GP120,IMMUNE SYSTEM,01/29/20,AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB,HOMO SAPIENS; HUMAN IMMUNODEFICIENCY VIRUS 1,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"COTTRELL, C.A., DE VAL, N., WARD, A.B.",ELECTRON MICROSCOPY,NONE
6PK8,N,SCFV-M204 ANTIBODY,ANTIBODY SCFV-M204 DIMERIC STATE,IMMUNE SYSTEM,"ANTI-TAU-OLIGOMER SCFV ANTIBODY, IMMUNE SYSTEM",CRYSTAL STRUCTURE OF A CONFORMATIONAL ANTIBODY THAT BINDS TAU OLIGOMERS AND INHIBITS PATHOLOGICAL SEEDING BY EXTRACTS FROM DONORS WITH ALZHEIMER'S DISEASE.,,,D,D,,,,IMMUNE SYSTEM,06/28/19,ANTIBODY SCFV-M204 DIMERIC STATE,ORYCTOLAGUS CUNICULUS,ORYCTOLAGUS CUNICULUS,,,"ABSKHARON, R., SAWAYA, M.R., SEIDLER, P.M., CASCIO, D., EISENBERG, D.S.",X-RAY DIFFRACTION,NONE
7OAN,N,,NANOBODY C5 BOUND TO SPIKE,ANTIVIRAL PROTEIN,"SPIKE, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",A POTENT SARS-COV-2 NEUTRALISING NANOBODY SHOWS THERAPEUTIC EFFICACY IN THE SYRIAN GOLDEN HAMSTER MODEL OF COVID-19.,,,F,,A,PROTEIN,SPIKE GLYCOPROTEIN,ANTIVIRAL PROTEIN,08/11/21,NANOBODY C5 BOUND TO SPIKE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NAISMITH, J.H., WECKENER, M.",ELECTRON MICROSCOPY,NONE
7OLZ,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD WITH NEUTRALIZING-VHHS RE5D06 AND RE9F06,VIRAL PROTEIN,"COVID19, NEUTRALIZING VHH, VIRAL PROTEIN","NEUTRALIZATION OF SARS-COV-2 BY HIGHLY POTENT, HYPERTHERMOSTABLE, AND MUTATION-TOLERANT NANOBODIES.",,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,08/11/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD WITH NEUTRALIZING-VHHS RE5D06 AND RE9F06,VICUGNA PACOS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"AKSU, M., GUTTLER, T., GORLICH, D.",X-RAY DIFFRACTION,NONE
8DLX,N,,CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH VH AB6,VIRAL PROTEIN,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, EPSILON, B.1.429, VH AB6",SARS-COV-2 VARIANTS OF CONCERN: SPIKE PROTEIN MUTATIONAL ANALYSIS AND EPITOPE FOR BROAD NEUTRALIZATION.,,,H,,C | A,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,01/08/09,CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH VH AB6,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SAVILLE, J.W., SRIVASTAVA, S.S., BEREZUK, A.M., ZHOU, S., TUTTLE, K.S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7BYR,N,"SPIKE GLYCOPROTEIN, AB23-FAB-HEAVY CHAIN, AB23-FAB-LIGHT CHAIN",BD23-FAB IN COMPLEX WITH THE S ECTODOMAIN TRIMER,VIRAL PROTEIN,"SARS-COV-2, ANTIGEN, RBD, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 IDENTIFIED BY HIGH-THROUGHPUT SINGLE-CELL SEQUENCING OF CONVALESCENT PATIENTS' B CELLS.,,,H,L,B,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/10/20,BD23-FAB IN COMPLEX WITH THE S ECTODOMAIN TRIMER,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, Q., WANG, G., XIAO, J.",ELECTRON MICROSCOPY,NONE
7K8T,N,"SPIKE GLYCOPROTEIN, C002 FAB HEAVY CHAIN, C002 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2)",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,O,P,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MALYUTIN, A.G., BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7KML,N,,"CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",TETRAVALENT SARS-COV-2 NEUTRALIZING ANTIBODIES SHOW ENHANCED POTENCY AND RESISTANCE TO ESCAPE MUTATIONS.,,,J,N,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/10/21,"CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Z., RINI, J.M.",ELECTRON MICROSCOPY,NONE
7M8J,N,"SPIKE PROTEIN S1, CM25 FAB - HEAVY CHAIN, CM25 FAB - LIGHT CHAIN",SARS-COV-2 S-NTD + FAB CM25,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, CM25, NTD, FAB, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","PREVALENT, PROTECTIVE, AND CONVERGENT IGG RECOGNITION OF SARS-COV-2 NON-RBD SPIKE EPITOPES.",,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/19/21,SARS-COV-2 S-NTD + FAB CM25,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JOHNSON, N.V., MCLELLAN, J.S.",ELECTRON MICROSCOPY,NONE
7TB8,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODIES B1-182.1 AND A19-61.1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","TO BE PUBLISHED
PREPRINT IN BIORXIV
HTTPS://WWW.BIORXIV.ORG/CONTENT/10.1101/2021.12.27.474307V1",,,J,K,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/30/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODIES B1-182.1 AND A19-61.1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., TSYBOVSKY, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7L2F,N,,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, FUSION PROTEIN, SPIKE GLYCOPROTEIN, COVID-19, NTD, NTD-DIRECTED ANTIBODY, 5-24, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES DIRECTED AGAINST SPIKE N-TERMINAL DOMAIN TARGET A SINGLE SUPERSITE.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/24/21,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CERUTTI, G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7F3Q,N,,SARS-COV-2 RBD IN COMPLEX WITH A5-10 FAB AND A34-2 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RBD, FAB, COCKTAIL, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",HIGH THROUGHPUT ISOLATION OF POTENT NEUTRALIZING ANTIBODIES FROM CONVALESCENT COVID-19 PATIENTS,,,C,B,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/22/22,SARS-COV-2 RBD IN COMPLEX WITH A5-10 FAB AND A34-2 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DOU, Y., WANG, X., LIU, P., LU, B., WANG, K.",ELECTRON MICROSCOPY,NONE
7K8U,N,"SPIKE GLYCOPROTEIN, C104 FAB HEAVY CHAIN, C104 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C104",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,H,L,A | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., MALYUTIN, A.G., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7N8I,N,,SARS-COV-2 S (B.1.429 / EPSILON VARIANT) + S2M11 + S2L20 (LOCAL REFINEMENT OF THE NTD/S2L20),VIRAL PROTEIN/IMMUNE SYSTEM,"CORONAVIRUS, ANTIBODY, CALIFORNIA, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 IMMUNE EVASION BY THE B.1.427/B.1.429 VARIANT OF CONCERN.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/14/21,SARS-COV-2 S (B.1.429 / EPSILON VARIANT) + S2M11 + S2L20 (LOCAL REFINEMENT OF THE NTD/S2L20),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), VEESLER, D.",ELECTRON MICROSCOPY,NONE
7Z1B,N,,NANOBODY H11-A10 AND F2 BOUND TO RBD,ANTIVIRAL PROTEIN,"SPIKE, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",STRUCTURE OF NANOBODY A10 AND F2 BOUND TO RBD,,,F,,A,PROTEIN,SPIKE PROTEIN S1,ANTIVIRAL PROTEIN,03/23/22,NANOBODY H11-A10 AND F2 BOUND TO RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MIKOLAJEK, H., NAISMITH, J.H.",X-RAY DIFFRACTION,NONE
7DET,N,"SPIKE GLYCOPROTEIN, ANTIBODY SCFV",CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV,VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, RBD, ANTIBODY, VIRAL PROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",STRUCTURAL BASIS FOR SARS-COV-2 NEUTRALIZING ANTIBODIES WITH NOVEL BINDING EPITOPES.,,,D,D,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,03/31/21,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y., ZHANG, G., LI, X., RAO, Z., GUO, Y.",X-RAY DIFFRACTION,NONE
7SBU,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A HIGHLY POTENT ANTIBODY J08 FAB,IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, NEUTRALIZING ANTIBODY, RECEPTOR BINDING DOMAIN",STRUCTURAL INSIGHTS OF A HIGHLY POTENT PAN-NEUTRALIZING SARS-COV-2 HUMAN MONOCLONAL ANTIBODY.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM,05/11/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A HIGHLY POTENT ANTIBODY J08 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7BEK,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 2),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 2),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7MJK,N,"SPIKE GLYCOPROTEIN, FAB AB1 HEAVY CHAIN, FAB AB1 LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO FAB AB1 (CLASS 2),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, FAB AB1, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYO-ELECTRON MICROSCOPY STRUCTURES OF THE N501Y SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH ACE2 AND 2 POTENT NEUTRALIZING ANTIBODIES.,,,H,I,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/12/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO FAB AB1 (CLASS 2),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SRIVASTAVA, S.S., BEREZUK, A.M., DEMERS, J.P., SAVILLE, J.W., LEOPOLD, K., LI, W., DIMITROV, D.S., TUTTLE, K.S., ZHOU, S., CHITTORI, S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7WEF,N,,SARS-COV-2 OMICRON VARIANT SPIKE RBD IN COMPLEX WITH FAB XGV289,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,C,L,E,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE RBD IN COMPLEX WITH FAB XGV289,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7Q9K,N,,BETA-32 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,BETA-32 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7YDY,N,,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 1 R1-32 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 SPIKE(6P)IN COMPLEX WITH 1 R1-32 FAB,,,H,L,A | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 1 R1-32 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, B., GAO, X., LI, Z., CHEN, X., HE, J., CHEN, L., XIONG, X.",ELECTRON MICROSCOPY,NONE
7WEA,N,,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH TWO XGV347 BINDING TO ONE CLOSE STATE RBD AND ONE OPEN STATE RBD,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,H,L,A | C,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH TWO XGV347 BINDING TO ONE CLOSE STATE RBD AND ONE OPEN STATE RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7EJ4,N,"SPIKE GLYCOPROTEIN, RBD-CHAB-25, HEAVY CHAIN, RBD-CHAB-25, LIGHT CHAIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY RBD-CHAB-25,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY RBD-CHAB-25,,,J,N,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY RBD-CHAB-25,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, T.J., YU, P.Y., WU, H.C., HSU, S.T.D.",ELECTRON MICROSCOPY,NONE
7T01,N,,SARS-COV-2 S-RBD + FAB 54042-4,VIRAL PROTEIN,"SARS-COV-2, 54042-4, RBD, FAB, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM, VIRAL PROTEIN",POTENT NEUTRALIZATION OF SARS-COV-2 VARIANTS OF CONCERN BY AN ANTIBODY WITH AN UNCOMMON GENETIC SIGNATURE AND STRUCTURAL MODE OF SPIKE RECOGNITION.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,04/13/22,SARS-COV-2 S-RBD + FAB 54042-4,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JOHNSON, N.V., MCLELLAN, J.S.",ELECTRON MICROSCOPY,NONE
7V2A,N,,SARS-COV-2 SPIKE TRIMER IN COMPLEX WITH XG014 FAB,VIRAL PROTEIN,"A NEUTRALIZING ANTIBODY BOUND WITH THE S PROTEIN OF SARS-COV-2, VIRAL PROTEIN",AN ULTRAPOTENT PAN-BETA-CORONAVIRUS LINEAGE B ( BETA-COV-B) NEUTRALIZING ANTIBODY LOCKS THE RECEPTOR-BINDING DOMAIN IN CLOSED CONFORMATION BY TARGETING ITS CONSERVED EPITOPE.,,,G,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,10/20/21,SARS-COV-2 SPIKE TRIMER IN COMPLEX WITH XG014 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, K., WANG, X., PAN, L.",ELECTRON MICROSCOPY,NONE
6WAQ,N,"NANOBODY SARS VHH-72, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE SARS-COV-1 RBD BOUND BY THE CROSS-REACTIVE SINGLE-DOMAIN ANTIBODY SARS VHH-72,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-1, VHH, NANOBODY, RBD, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR POTENT NEUTRALIZATION OF BETACORONAVIRUSES BY SINGLE-DOMAIN CAMELID ANTIBODIES.,,,C,,D,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/25/20,CRYSTAL STRUCTURE OF THE SARS-COV-1 RBD BOUND BY THE CROSS-REACTIVE SINGLE-DOMAIN ANTIBODY SARS VHH-72,LAMA GLAMA; HUMAN SARS CORONAVIRUS,LAMA GLAMA,,HUMAN SARS CORONAVIRUS,"WRAPP, D., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
7CYH,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF HB27, HEAVY CHAIN OF HB27",BINDING INTERFACE OF SARS-COV-2 RBD AND ITS NEUTRALIZING ANTIBODY HB27,VIRAL PROTEIN,"SARS-COV-2, SPIKE TRIMER, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",BINDING INTERFACE OF SARS-COV-2 RBD AND ITS NEUTRALIZING ANTIBODY HB27,,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/09/21,BINDING INTERFACE OF SARS-COV-2 RBD AND ITS NEUTRALIZING ANTIBODY HB27,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHU, L.",ELECTRON MICROSCOPY,NONE
7SOE,N,,SARS-COV-2 S B.1.617.1 KAPPA VARIANT + S2X303 GLOBAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"KAPPA, SPIKE, ANTIBODY, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MOLECULAR BASIS OF IMMUNE EVASION BY THE DELTA AND KAPPA SARS-COV-2 VARIANTS.,,,E,D,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,01/08/09,SARS-COV-2 S B.1.617.1 KAPPA VARIANT + S2X303 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7WP1,N,,CRYO-EM STRUCTURE OF SARS-COV-2 MU S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, MU VARIANT, SPIKE, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",IMMUNE ESCAPE BY SARS-COV-2 OMICRON VARIANT AND STRUCTURAL BASIS OF ITS EFFECTIVE NEUTRALIZATION BY A BROAD NEUTRALIZING HUMAN ANTIBODY VACW-209.,,,H,L,F,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 MU S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, Q., SUN, H., JU, B., ZHANG, Z., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
7X1M,N,,"THE COMPLEX STRUCTURE OF OMICRON BA.1 RBD WITH BD604, S309,AND S304",VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","THE COMPLEX STRUCTURE OF OMICRON BA.1 RBD WITH BD604, S309,AND S304",,,C,D,M,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,07/06/22,"THE COMPLEX STRUCTURE OF OMICRON BA.1 RBD WITH BD604, S309,AND S304",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, M., XIE, Y.F., QI, J.X.",ELECTRON MICROSCOPY,NONE
7TM0,N,,SARS-COV-2 S B.1.1.529 OMICRON VARIANT + S309 + S2L20 GLOBAL REFINEMENT,VIRUS,"OMICRON, SARS-COV-2, COVID, B.1.529, ANTIBODY, FAB, S309, SOTROVIMAB, S2L20, VIRUS, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID",STRUCTURAL BASIS OF SARS-COV-2 OMICRON IMMUNE EVASION AND RECEPTOR ENGAGEMENT.,,,E,D,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS,02/02/22,SARS-COV-2 S B.1.1.529 OMICRON VARIANT + S309 + S2L20 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7CZZ,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,I,M,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7MF1,N,"SPIKE PROTEIN S1, 47D1 FAB HEAVY CHAIN, 47D1 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 47D1,IMMUNE SYSTEM/VIRAL PROTEIN,"COVID-19, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",DIVERSE IMMUNOGLOBULIN GENE USAGE AND CONVERGENT EPITOPE TARGETING IN NEUTRALIZING ANTIBODY RESPONSES TO SARS-COV-2.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,05/12/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 47D1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7C2L,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8,MEMBRANE PROTEIN/IMMUNE SYSTEM,"ACE2-B0AT1 COMPLEX, MEMBRANE PROTEIN, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX",A NEUTRALIZING HUMAN ANTIBODY BINDS TO THE N-TERMINAL DOMAIN OF THE SPIKE PROTEIN OF SARS-COV-2.,,,J,N,C,PROTEIN,SPIKE GLYCOPROTEIN,MEMBRANE PROTEIN/IMMUNE SYSTEM,05/08/20,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., GUO, Y.Y., LI, Y.N., XIA, L., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7PS1,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-27 FAB,VIRAL PROTEIN,"SARS-COV-2 ALPHA VARIANT, BETA VARIANT, GAMMA VARIANT, DELTA VARIANT, B.1.1.7, B.1.351, P.1, B.1.617.2, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,A,B,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-27 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7NDC,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN, IMMUNE SYSTEM",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7CZY,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,K,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
6YM0,N,"SARS-COV-2 RBD, HEAVY CHAIN, LIGHT CHAIN",CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH CR3022 FAB (CRYSTAL FORM 1),VIRAL PROTEIN,"SARS-COV-2, RECEPTOR BINDING DOMAIN (RBD), CR3022, VAGABOND, VIRAL PROTEIN",NEUTRALIZATION OF SARS-COV-2 BY DESTRUCTION OF THE PREFUSION SPIKE.,,,H,L,E,PROTEIN,RBD,VIRAL PROTEIN,04/07/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH CR3022 FAB (CRYSTAL FORM 1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUO, J., ZHAO, Y., REN, J., ZHOU, D., GINN, H.M., FRY, E.E., OWENS, R., STUART, D.I.",X-RAY DIFFRACTION,NONE
7NTC,N,"SPIKE GLYCOPROTEIN, P008_056 FAB HEAVY CHAIN, P008_056 FAB LIGHT CHAIN",TRIMERIC SARS-COV-2 SPIKE ECTODOMAIN BOUND TO P008_056 FAB,VIRAL PROTEIN,"SARS-COV-2, SPIKE, BILIVERDIN, COVID19, ANTIBODY, FAB, EPITOPE, NTD, VIRAL PROTEIN",SARS-COV-2 CAN RECRUIT A HEME METABOLITE TO EVADE ANTIBODY IMMUNITY.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/28/21,TRIMERIC SARS-COV-2 SPIKE ECTODOMAIN BOUND TO P008_056 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ROSA, A., PYE, V.E., NANS, A., CHEREPANOV, P.",ELECTRON MICROSCOPY,NONE
7EZV,N,,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-812 FAB AND BD-836 FAB,VIRAL PROTEIN,"COMPLEX ANTIBODY SARS-COV-2, VIRAL PROTEIN",STRUCTURES OF SARS-COV-2 B.1.351 NEUTRALIZING ANTIBODIES PROVIDE INSIGHTS INTO COCKTAIL DESIGN AGAINST CONCERNING VARIANTS.,,,M,N,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,09/08/21,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-812 FAB AND BD-836 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, P.L.",ELECTRON MICROSCOPY,NONE
4XAK,,MERS-COV RECEPTOR-BINDING DOMAIN,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD,IMMUNE SYSTEM,"MERS-COV RBD, ANTIBODY M336, NEUTRALIZATION, IMMUNE SYSTEM",JUNCTIONAL AND ALLELE-SPECIFIC RESIDUES ARE CRITICAL FOR MERS-COV NEUTRALIZATION BY AN EXCEPTIONALLY POTENT GERMLINE-LIKE ANTIBODY.,,,D,E,B,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,12/15/14,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD,HUMAN CORONAVIRUS EMC; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN CORONAVIRUS EMC,"ZHOU, T., DIMTROV, D.S., YING, T.",X-RAY DIFFRACTION,NONE
7TAT,N,,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2K146 NEUTRALIZING ANTIBODY FAB FRAGMENT (TWO RECEPTOR-BINDING DOMAINS OPEN),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, INHIBITOR, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY-MEDIATED BROAD SARBECOVIRUS NEUTRALIZATION THROUGH ACE2 MOLECULAR MIMICRY.,,,D,E,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,01/12/22,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2K146 NEUTRALIZING ANTIBODY FAB FRAGMENT (TWO RECEPTOR-BINDING DOMAINS OPEN),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), VEESLER, D.",ELECTRON MICROSCOPY,NONE
5JMR,N,CAMELID VHH FRAGMENT,X-RAY STRUCTURE OF THE FURIN INHIBITORY ANTIBODY NB14,IMMUNE SYSTEM,"CAMELID, ANTIBODY, INHIBITOR, FURIN, IMMUNE SYSTEM",THE STRUCTURE OF A FURIN-ANTIBODY COMPLEX EXPLAINS NON-COMPETITIVE INHIBITION BY STERIC EXCLUSION OF SUBSTRATE CONFORMERS.,,,B,,,,,IMMUNE SYSTEM,04/29/16,X-RAY STRUCTURE OF AN CAMELID VHH FRAGMENT,CAMELUS DROMEDARIUS,CAMELUS DROMEDARIUS,,,"DAHMS, S.O., THAN, M.E.",X-RAY DIFFRACTION,NONE
4NUG,,"PGT151 LIGHT CHAIN, PGT151 HEAVY CHAIN",CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT151,IMMUNE SYSTEM,"IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE","STRUCTURAL DELINEATION OF A QUATERNARY, CLEAVAGE-DEPENDENT EPITOPE AT THE GP41-GP120 INTERFACE ON INTACT HIV-1 ENV TRIMERS.",,,H,L,,,,IMMUNE SYSTEM,12/03/13,CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT151,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"BLATTNER, C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7E7X,N,"SPIKE PROTEIN S1, N11 FAB HEAVY CHAIN, N11 FAB LIGHT CHAIN",SARS-COV-2 SPIKE PROTEIN N TERMINAL DOMAIN IN COMPLEX WITH N11 FAB,VIRAL PROTEIN,"SARS-COV-2, SPIKE, NTD, ANTIBODY, VIRAL PROTEIN",HUMORAL IMMUNE RESPONSE TO CIRCULATING SARS-COV-2 VARIANTS ELICITED BY INACTIVATED AND RBD-SUBUNIT VACCINES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/09/21,SARS-COV-2 SPIKE PROTEIN N TERMINAL DOMAIN IN COMPLEX WITH N11 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, Z., SHUO, D., XIAO, J.",X-RAY DIFFRACTION,NONE
7PS0,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-24 FABS,VIRAL PROTEIN,"SARS-COV-2 ALPHA VARIANT, BETA VARIANT, GAMMA VARIANT, DELTA VARIANT, B.1.1.7, B.1.351, P.1, B.1.617.2, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-24 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7ZFD,N,,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-25 FAB,VIRAL PROTEIN,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, OMI-25, VIRALPROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,A,B,F,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-25 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
3ZKX,,"BETA-SECRETASE 2 (E.C.3.4.23.45), XA4813, XA4815",TERNARY BACE2 XAPERONE COMPLEX,HYDROLASE,HYDROLASE,"MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USING SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS, FYNOMERS, AND XAPERONES",,,C,,A,PROTEIN,BETA-SECRETASE 2,HYDROLASE,01/25/13,TERNARY BACE2 XAPERONE COMPLEX,HOMO SAPIENS; LAMA GLAMA,LAMA GLAMA,,HOMO SAPIENS,"KUGLSTATTER, A., BANNER, D.W., BENZ, J., BERTSCHINGER, J., BURGER, D., CUPPULERI, S., DEBULPAEP, M., GAST, A., GRABULOVSKI, D., GSELL, B., HILPERT, H., HUBER, W., KUSZNIR, E., LAEREMANS, T., MATILE, H., RUFER, A., SCHLATTER, D., STEYEART, J., STIHLE, M., THOMA, R., WEBER, M., RUF, A.",X-RAY DIFFRACTION,NONE
7DK4,N,"THE HEAVY CHAIN OF 3C1 FAB THAT BINDS WITH THE UP RBD, SPIKE GLYCOPROTEIN, THE LIGHT CHAIN OF 3C1 FAB","S-2H2-F3A STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, EACH RBD BINDS WITH A 2H2 FAB.",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,A,B,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,12/02/20,"S-2H2-F3A STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, EACH RBD BINDS WITH A 2H2 FAB.",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., WANG, Y.F.",ELECTRON MICROSCOPY,NONE
7SKZ,N,,CRYSTAL STRUCTURE OF VN01H1 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE, COVID-19, FUSION PEPTIDE, FAB, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID",ACE2-BINDING EXPOSES THE SARS-COV-2 FUSION PEPTIDE TO BROADLY NEUTRALIZING CORONAVIRUS ANTIBODIES.,,,H,L,A,PEPTIDE,PRO-SER-LYS-ARG-SER-PHE-ILE-GLU-ASP-LEU-LEU-PHE-ASN,VIRAL PROTEIN/IMMUNE SYSTEM,07/20/22,CRYSTAL STRUCTURE OF VN01H1 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,MAMMAL ENVIRONMENTAL SAMPLE; SYNTHETIC CONSTRUCT,MAMMAL ENVIRONMENTAL SAMPLE,MAMMAL ENVIRONMENTAL SAMPLE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M.A., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7WS2,N,,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,E,D,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7YAD,N,,CRYO-EM STRUCTURE OF S309-RBD-RBD-S309 IN THE S309-BOUND OMICRON SPIKE PROTEIN (LOCAL REFINEMENT),IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, OMICRON, SPIKE PROTEIN, S309 ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",OMICRON SARS-COV-2 MUTATIONS STABILIZE SPIKE UP-RBD CONFORMATION AND LEAD TO A NON-RBM-BINDING MONOCLONAL ANTIBODY ESCAPE.,,,C,D,E,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,08/31/22,CRYO-EM STRUCTURE OF S309-RBD-RBD-S309 IN THE S309-BOUND OMICRON SPIKE PROTEIN (LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAO, Z.N., XIE, Y.F., QI, J.X., GAO, F.",ELECTRON MICROSCOPY,NONE
7B17,N,"SPIKE GLYCOPROTEIN, NEUTRALISING NANOBODY E BOUND TO SPIKE PROTEIN FROM SARS-2, NEUTRALISING ANTIBODY V BOUND TO SARS-2",SARS-COV-SPIKE RBD BOUND TO TWO NEUTRALISING NANOBODIES.,VIRAL PROTEIN,"SPIKE GLYCOPROTEIN, SARS-COV-2, NANOBODY, VIRAL PROTEIN",STRUCTURE-GUIDED MULTIVALENT NANOBODIES BLOCK SARS-COV-2 INFECTION AND SUPPRESS MUTATIONAL ESCAPE.,,,B,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,02/10/21,SARS-COV-SPIKE RBD BOUND TO TWO NEUTRALISING NANOBODIES,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS; LAMA GLAMA,"VICUGNA PACOS, LAMA GLAMA",,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALLBERG, B.M., DAS, H.",ELECTRON MICROSCOPY,NONE
7B18,N,"SPIKE GLYCOPROTEIN, NANOBODY AGAINST SARS-COV-2 VHH E, NANOBODY AGAINST SPIKE GLYCOPROTEIN VHH V",SARS-COV-SPIKE BOUND TO TWO NEUTRALISING NANOBODIES,VIRAL PROTEIN,"SPIKE GLYCOPROTEIN, SARS-COV-2, NANOBODY, VIRAL PROTEIN",STRUCTURE-GUIDED MULTIVALENT NANOBODIES BLOCK SARS-COV-2 INFECTION AND SUPPRESS MUTATIONAL ESCAPE.,,,H,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/28/21,SARS-COV-SPIKE BOUND TO TWO NEUTRALISING NANOBODIES,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA; VICUGNA PACOS,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALLBERG, B.M., DAS, H.",ELECTRON MICROSCOPY,NONE
7K9H,N,,"SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NEUTRALIZING ANTIBODY, ACE2-COMPETITIVE, RECEPTOR-BINDING DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID",STRUCTURAL MECHANISM OF SARS-COV-2 NEUTRALIZATION BY TWO MURINE ANTIBODIES TARGETING THE RBD.,,,H,L,B | A,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/29/21,"SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ERRICO, J.M., FREMONT, D.H., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",ELECTRON MICROSCOPY,NONE
7MDW,N,,CRYOEM STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH NANOBODIES NB21 AND NB105,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 RECEPTOR BINDING DOMAIN NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING DIVERSE AND CONSERVED EPITOPES,,,A,,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/11/21,CRYOEM STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH NANOBODIES NB21 AND NB105,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.J.",ELECTRON MICROSCOPY,NONE
6C6Z,N,"SPIKE PROTEIN, CDC2-C2 HEAVY CHAIN, CDC2-C2 LIGHT CHAIN",CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD,IMMUNE SYSTEM,"IMMUNE SYSTEM, ANTIBODY, FUSION GLYCOPROTEIN, VIRUS, ANTIVIRAL PROTEIN",IMPORTANCE OF NEUTRALIZING MONOCLONAL ANTIBODIES TARGETING MULTIPLE ANTIGENIC SITES ON THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS SPIKE GLYCOPROTEIN TO AVOID NEUTRALIZATION ESCAPE.,,,H,L,B,PROTEIN,SPIKE PROTEIN,IMMUNE SYSTEM,01/19/18,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"WANG, N., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
7WP2,N,,CRYO-EM STRUCTURE OF SARS-COV-2 C.1.2 S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, C.1.2 VARIANT, SPIKE, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",IMMUNE ESCAPE BY SARS-COV-2 OMICRON VARIANT AND STRUCTURAL BASIS OF ITS EFFECTIVE NEUTRALIZATION BY A BROAD NEUTRALIZING HUMAN ANTIBODY VACW-209.,,,H,L,F,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,07/20/22,CRYO-EM STRUCTURE OF SARS-COV-2 C.1.2 S6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY VACW-209 (LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, Q., SUN, H., JU, B., ZHANG, Z., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
3ZKS,,"BETA-SECRETASE 2 (E.C.3.4.23.45), XA4813",BACE2 XAPERONE COMPLEX WITH INHIBITOR,HYDROLASE/IMMUNE SYSTEM,"HYDROLASE-IMMUNE SYSTEM COMPLEX, INHIBITOR, NANOBODY","MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USING SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS, FYNOMERS, AND XAPERONES",,,D,,A,PROTEIN,BETA-SECRETASE 2,HYDROLASE/IMMUNE SYSTEM,01/24/13,BACE2 XAPERONE COMPLEX WITH INHIBITOR,HOMO SAPIENS; LAMA GLAMA,LAMA GLAMA,,HOMO SAPIENS,"BANNER, D.W., KUGLSTATTER, A., BENZ, J., STIHLE, M., RUF, A.",X-RAY DIFFRACTION,NONE
7TBF,N,,LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODIES B1-182.1 AND A19-61.1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODIES,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/30/22,LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODIES B1-182.1 AND A19-61.1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., TSYBOVSKY, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7RXD,N,,CRYOEM STRUCTURE OF RBD DOMAIN OF COVID-19 IN COMPLEX WITH LEGOBODY,STRUCTURAL PROTEIN,"RBD, MALTOSE-BINDING PROTEIN, FAB, NANOBODY, STRUCTURAL PROTEIN",CRYO-EM STRUCTURE DETERMINATION OF SMALL PROTEINS BY NANOBODY-BINDING SCAFFOLDS (LEGOBODIES).,,,H,L,B,PROTEIN,"MALTODEXTRIN-BINDING PROTEIN,IMMUNOGLOBULIN G-BINDINGPROTEIN A,IMMUNOGLOBULIN G-BINDING PROTEIN G ",STRUCTURAL PROTEIN,10/06/21,CRYOEM STRUCTURE OF RBD DOMAIN OF COVID-19 IN COMPLEX WITH LEGOBODY,ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS SP.; MUS MUSCULUS; VICUGNA PACOS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,MUS MUSCULUS,MUS MUSCULUS,"ESCHERICHIA COLI, STAPHYLOCOCCUS AUREUS,STREPTOCOCCUS SP. ","WU, X.D., RAPOPORT, T.A.",ELECTRON MICROSCOPY,NONE
7TLY,N,,SARS-COV-2 S B.1.1.529 OMICRON VARIANT (RBD + S309 LOCAL REFINEMENT),VIRUS/IMMUNE SYSTEM,"OMICRON, RECEPTOR-BINDING DOMAIN, SARS-COV-2, COVID, B.1.529, RBD, ANTIBODY, FAB, S309, SOTROVIMAB, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRUS-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS OF SARS-COV-2 OMICRON IMMUNE EVASION AND RECEPTOR ENGAGEMENT.,,,A,B,I,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS/IMMUNE SYSTEM,02/02/22,SARS-COV-2 S B.1.1.529 OMICRON VARIANT (RBD + S309 LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
6ZDG,N,,ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB,VIRAL PROTEIN,"EY6A, RBD, SPIKE GLYCOPROTEIN, SARS-COV-2, HUMAN NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR THE NEUTRALIZATION OF SARS-COV-2 BY AN ANTIBODY FROM A CONVALESCENT PATIENT.,,,B,C,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/14/20,ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHOU, D., ZHAO, Y., FRY, E.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7S0E,N,,STRUCTURE OF THE SARS-COV-2 S1 SUBUNIT IN COMPLEX WITH ANTIBODY N-612-004,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, COVID-19, SPIKE GLYCOPROTEIN, MRNA DISPLAY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",RAPID IDENTIFICATION OF NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 VARIANTS BY MRNA DISPLAY.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/06/21,STRUCTURE OF THE SARS-COV-2 S1 SUBUNIT IN COMPLEX WITH ANTIBODY N-612-004,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
5W9J,N,"SPIKE GLYCOPROTEIN, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,B,C,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7NDA,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-253H55L FAB,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,C | A,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-253H55L FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7CHB,N,"BD-236 FAB HEAVY CHAIN, BD-236 FAB LIGHT CHAIN, SARS-COV-2 RECEPTOR BINDING DOMAIN",CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RBD, MAB, ANTIVIRAL PROTEIN, ANTIVIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURALLY RESOLVED SARS-COV-2 ANTIBODY SHOWS HIGH EFFICACY IN SEVERELY INFECTED HAMSTERS AND PROVIDES A POTENT COCKTAIL PAIRING STRATEGY.,,,H,L,R,PROTEIN,SARS-COV-2 RECEPTOR BINDING DOMAIN,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,07/05/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JUNYU, X., QINYU, Z.",X-RAY DIFFRACTION,NONE
8DF5,N,,SARS-COV-2 BETA RBD IN COMPLEX WITH HUMAN ACE2 AND S304 FAB AND S309 FAB,VIRAL PROTEIN/HYDROLASE/IMMUNE SYSTEM,"RBD, SARS-COV-2, COVID, S309, BETA, B.1.351, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN, VIRAL PROTEIN-HYDROLASE-IMMUNE SYSTEM COMPLEX",SHIFTING MUTATIONAL CONSTRAINTS IN THE SARS-COV-2 RECEPTOR-BINDING DOMAIN DURING VIRAL EVOLUTION.,,,M,N,S,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/HYDROLASE/IMMUNE SYSTEM,08/03/22,SARS-COV-2 BETA RBD IN COMPLEX WITH HUMAN ACE2 AND S304 FAB AND S309 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",X-RAY DIFFRACTION,NONE
7L2E,N,,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, FUSION PROTEIN, SPIKE GLYCOPROTEIN, COVID-19, NTD, NTD-DIRECTED ANTIBODY, 4-18, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES DIRECTED AGAINST SPIKE N-TERMINAL DOMAIN TARGET A SINGLE SUPERSITE.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/24/21,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CERUTTI, G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7WJY,N,,OMICRON SPIKE TRIMER WITH 6M6 ANTIBODY,VIRAL PROTEIN,"OMICRON, SPIKE, ANTIBODY, VIRAL PROTEIN",A BROADLY NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 OMICRON VARIANT INFECTION EXHIBITING A NOVEL TRIMER DIMER CONFORMATION IN SPIKE PROTEIN BINDING.,,,E,F,D,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/13/22,OMICRON SPIKE TRIMER WITH 6M6 ANTIBODY,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7OR9,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND COVOX-278 FABS,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, B.1.617 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",REDUCED NEUTRALIZATION OF SARS-COV-2 B.1.617 BY VACCINE AND CONVALESCENT SERUM.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,07/07/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND COVOX-278 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7M55,N,"SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE, B6 ANTIGEN BINDING FRAGMENT (FAB) HEAVY CHAIN, B6 ANTIGEN BINDING FRAGMENT (FAB) LIGHT CHAIN",B6 FAB FRAGMENT BOUND TO THE MERS-COV SPIKE STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM","BROADLY NEUTRALIZING ANTIBODY, STRUCTURAL GENOMICS, SSGCID, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, ANTIVIRAL PROTEIN, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, IMMUNE SYSTEM",STRUCTURAL BASIS FOR BROAD CORONAVIRUS NEUTRALIZATION.,,,H,L,A,PEPTIDE,SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM",05/26/21,B6 FAB FRAGMENT BOUND TO THE MERS-COV SPIKE STEM HELIX PEPTIDE,MUS MUSCULUS; SYNTHETIC CONSTRUCT,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"SAUER, M.M., PARK, Y.J., VEESLER, D., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID), SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7NY5,N,,STRUCTURE OF SARS-COV-2 SPIKE WITH P5C3 FAB,VIRAL PROTEIN,"SARS-COV-2 SPIKE, FAB, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN",STRUCTURE OF SARS-COV-2 SPIKE WITH P5C3 FAB,,,C,D,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/30/22,STRUCTURE OF SARS-COV-2 SPIKE WITH P5C3 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PEREZ, L.",ELECTRON MICROSCOPY,NONE
7BWJ,N,"SARS-COV-2 RECEPTOR BINDING DOMAIN, ANTIBODY LIGHT CHAIN, ANTIBODY HEAVY CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY WITH RBD,VIRAL PROTEIN,"SPIKE, RECEPTOR BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN",HUMAN NEUTRALIZING ANTIBODIES ELICITED BY SARS-COV-2 INFECTION.,,,H,L,E,PROTEIN,SARS-COV-2 RECEPTOR BINDING DOMAIN,VIRAL PROTEIN,06/03/20,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY WITH RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., GE, J.",X-RAY DIFFRACTION,NONE
7DK6,N,"THE HEAVY CHAIN OF 3C1 FAB THAT BINDS WITH THE UP RBD, SPIKE GLYCOPROTEIN, THE LIGHT CHAIN OF 3C1 FAB","S-2H2-F2 STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, EACH UP RBD BINDS WITH A 2H2 FAB.",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,A,B,A,PROTEIN,THE HEAVY CHAIN OF 2H2 FAB,VIRAL PROTEIN,11/23/20,"S-2H2-F2 STRUCTURE, TWO RBDS ARE UP AND ONE RBD IS DOWN, EACH UP RBD BINDS WITH A 2H2 FAB.",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., WANG, Y.F.",ELECTRON MICROSCOPY,NONE
8DLS,N,,CRYO-EM STRUCTURE OF SARS-COV-2 GAMMA (P.1) SPIKE PROTEIN IN COMPLEX WITH FAB 4A8 (FOCUSED REFINEMENT OF NTD AND 4A8),VIRAL PROTEIN,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, GAMMA, P.1, 4A8",SARS-COV-2 VARIANTS OF CONCERN: SPIKE PROTEIN MUTATIONAL ANALYSIS AND EPITOPE FOR BROAD NEUTRALIZATION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/31/22,CRYO-EM STRUCTURE OF SARS-COV-2 GAMMA (P.1) SPIKE PROTEIN IN COMPLEX WITH FAB 4A8 (FOCUSED REFINEMENT OF NTD AND 4A8),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SAVILLE, J.W., SRIVASTAVA, S.S., BEREZUK, A.M., ZHOU, S., TUTTLE, K.S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7KMH,N,,LY-COV488 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY NEUTRALIZING SARS-COV-2, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX","THE NEUTRALIZING ANTIBODY, LY-COV555, PROTECTS AGAINST SARS-COV-2 INFECTION IN NONHUMAN PRIMATES.",,,A,B,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,11/02/20,LY-COV488 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HENDLE, J., PUSTILNIK, A., SAUDER, J.M., BOYLES, J.S., DICKINSON, C.D., COLEMAN, K.A.",X-RAY DIFFRACTION,NONE
7D00,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,J,N,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7V5J,N,,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 0722(STATE 2),PROTEIN BINDING,PROTEIN BINDING,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 0722(STATE 2),,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,09/21/22,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 0722(STATE 2),HOMO SAPIENS; HUMAN BETACORONAVIRUS 2C EMC/2012,HOMO SAPIENS,HOMO SAPIENS,HUMAN BETACORONAVIRUS 2C EMC/2012,"WANG, X., ZHAO, J., WANG, Z., ZENG, J., ZHANG, S., WANG, Y.",ELECTRON MICROSCOPY,NONE
5N0A,N,"ENVELOPE GLYCOPROTEIN E, BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 HEAVY CHAIN, BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11",CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11,IMMUNE SYSTEM/VIRAL PROTEIN,"IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, DENGUE VIRUS, ENVELOPE FUSION PROTEIN, BROADLY NEUTRALIZING ANTIBODY",COVALENTLY LINKED DENGUE VIRUS ENVELOPE GLYCOPROTEIN DIMERS REDUCE EXPOSURE OF THE IMMUNODOMINANT FUSION LOOP EPITOPE.,,,H,L,A,PROTEIN,ENVELOPE GLYCOPROTEIN E,IMMUNE SYSTEM/VIRAL PROTEIN,02/02/17,CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11,HOMO SAPIENS; DENGUE VIRUS 2,HOMO SAPIENS,HOMO SAPIENS,DENGUE VIRUS 2,"VANEY, M.C., ROUVINSKI, A., GUARDADO-CALVO, P., SHARMA, A., REY, F.A.",X-RAY DIFFRACTION,NONE
7CZP,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,J,N,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7WKA,N,,SARS-COV-2 OMICRON CLOSED STATE SPIKE PROTEIN IN COMPLEX WITH S3H3 FAB,VIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, OMICRON VARIANT, B.1.1.529 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MOLECULAR BASIS OF RECEPTOR BINDING AND ANTIBODY NEUTRALIZATION OF OMICRON.,,,C,D,C,PROTEIN,HEAVY CHAIN OF S3H3 FAB,VIRAL PROTEIN,01/26/22,SARS-COV-2 OMICRON CLOSED STATE SPIKE PROTEIN IN COMPLEX WITH S3H3 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HONG, Q., CONG, Y.",ELECTRON MICROSCOPY,NONE
7Q0A,N,,SARS-COV-2 SPIKE ECTODOMAIN WITH FAB FI3A,VIRAL PROTEIN,"SARS-COV2, SPIKE, ECTODOMAIN, FAB, ANTIBODY, TRIMER, VIRUS, VIRAL PROTEIN",STRUCTURES AND THERAPEUTIC POTENTIAL OF ANTI-RBD HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2.,,,Y,Z,B,PROTEIN,"SPIKE GLYCOPROTEIN,SPIKE ECTODOMAIN,SPIKE PROTEIN S2'",VIRAL PROTEIN,02/23/22,SARS-COV-2 SPIKE ECTODOMAIN WITH FAB FI3A,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; BAT CORONAVIRUS RP3/2004; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, BAT CORONAVIRUS RP3/2004 ","DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
4R8W,,"HEMAGGLUTININ, HEAVY CHAIN OF NEUTRALIZING ANTIBODY CT149, LIGHT CHAIN OF NEUTRALIZING ANTIBODY CT149",CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A NEUTRALIZING ANTIBODY CT149,IMMUNE SYSTEM,"INFLUENZA A VIRUS, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM",A POTENT BROAD-SPECTRUM PROTECTIVE HUMAN MONOCLONAL ANTIBODY CROSSLINKING TWO HAEMAGGLUTININ MONOMERS OF INFLUENZA A VIRUS,,,H,L,B | A,PROTEIN | PROTEIN,HEMAGGLUTININ | HEMAGGLUTININ,IMMUNE SYSTEM,09/03/14,CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A NEUTRALIZING ANTIBODY CT149,INFLUENZA A VIRUS (A/ANHUI/1-BALF_RG45/2013(H7N9)); HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,INFLUENZA A VIRUS (A/ANHUI/1-BALF_RG45/2013(H7N9))  | INFLUENZA A VIRUS (A/ANHUI/1-BALF_RG45/2013(H7N9)) ,"WU, Y., SHI, Y., QI, J., GAO, G.F.",X-RAY DIFFRACTION,TBD
7FCP,N,,CRYSTALLOGRAPHIC STRUCTURE OF TWO NEUTRALIZING ANTIBODIES IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD),ANTIVIRAL PROTEIN,"SARS-COV-2, RBD, NEUTRALIZING ANTIBODIES, ANTIVIRAL PROTEIN",ULTRAPOTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 WITH A HIGH DEGREE OF MUTATION RESISTANCE.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,ANTIVIRAL PROTEIN,06/15/22,CRYSTALLOGRAPHIC STRUCTURE OF TWO NEUTRALIZING ANTIBODIES IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, P., JIN, T.",X-RAY DIFFRACTION,NONE
7K43,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, S2M11 FAB FRAGMENT (HEAVY CHAIN), S2M11 FAB FRAGMENT (LIGHT CHAIN)",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ULTRAPOTENT HUMAN ANTIBODIES PROTECT AGAINST SARS-COV-2 CHALLENGE VIA MULTIPLE MECHANISMS.,,,C,D,B,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/14/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M.A., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7KMK,N,,"CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",TETRAVALENT SARS-COV-2 NEUTRALIZING ANTIBODIES SHOW ENHANCED POTENCY AND RESISTANCE TO ESCAPE MUTATIONS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/10/21,"CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Z., RINI, J.M.",ELECTRON MICROSCOPY,NONE
7CWT,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF HB27, HEAVY CHAIN OF HB27, HEAVY CHAIN OF FC05, LIGHT CHAIN OF FC05",SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH HB27 AND FC05 FAB COCKTAIL,VIRAL PROTEIN,VIRAL PROTEIN,STRUCTURE-BASED DEVELOPMENT OF HUMAN ANTIBODY COCKTAILS AGAINST SARS-COV-2.,,,I,J,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/21,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH HB27 AND FC05 FAB COCKTAIL,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CUI, Z., WANG, X.",ELECTRON MICROSCOPY,NONE
7SUE,N,,CRYSTAL STRUCTURE OF HUMAN FAB S24-188 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,VIRAL PROTEIN,"SARS CORONAVIRUS 2, NUCLEOCAPSID PROTEIN, HUMAN ANTIBODY FAB, COVID-19, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, VIRAL PROTEIN",CRYSTAL STRUCTURE OF HUMAN FAB S24-188 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,,,F,E,J,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN,08/10/22,CRYSTAL STRUCTURE OF HUMAN FAB S24-188 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KIM, Y., MALTSEVA, N., TESAR, C., JEDRZEJCZAK, R., DUGAN, H., STAMPER, C., WILSON, P., JOACHIMIAK, A., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",X-RAY DIFFRACTION,NONE
7WPF,N,,SARS-COV-2 OMICRON VARIANT S TRIMER COMPLEXED WITH THREE JMB2002 FAB,VIRAL PROTEIN,"ANTIBODY, VIRAL PROTEIN",STRUCTURES OF THE OMICRON SPIKE TRIMER WITH ACE2 AND AN ANTI-OMICRON ANTIBODY.,,,T,,,,,VIRAL PROTEIN,03/16/22,SARS-COV-2 OMICRON VARIANT S TRIMER COMPLEXED WITH THREE JMB2002 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS; LAMA GLAMA,LAMA GLAMA,,,"YIN, W., XU, Y., XU, P., CAO, X., WU, C., GU, C., HE, X., WANG, X., HUANG, S., YUAN, Q., WU, K., HU, W., HUANG, Z., LIU, J., WANG, Z., JIA, F., XIA, K., LIU, P., WANG, X., SONG, B., ZHENG, J., JIANG, H., CHENG, X., JIANG, Y., DENG, S.J., XU, H.E.",ELECTRON MICROSCOPY,NONE
7DX4,N,,THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX,VIRAL PROTEIN,"SARS-COV-2, SPIKE, NEUTRALIZING ANTIBODY, HACE2, RBD, VIRAL PROTEIN",A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN AGAINST SARS-COV-2.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,04/21/21,THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CAO, L., WANG, X.",ELECTRON MICROSCOPY,NONE
7DK7,N,"THE HEAVY CHAIN OF 3C1 FAB THAT BINDS WITH THE UP RBD, SPIKE GLYCOPROTEIN, THE LIGHT CHAIN OF 3C1 FAB","S-2H2-F3B STRUCTURE, THREE RBDS ARE UP AND EACH RBD BINDS WITH A 2H2 FAB.",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,E,F,C,PROTEIN,SARS-COV-2 S PROTEIN,VIRAL PROTEIN,11/23/20,"S-2H2-F3B STRUCTURE, THREE RBDS ARE UP AND EACH RBD BINDS WITH A 2H2 FAB.",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., WANG, Y.F.",ELECTRON MICROSCOPY,NONE
7N4I,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2057.,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, SARS-COV-2, WRAIR-2057, RECEPTOR BINDING DOMAIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",LOW-DOSE IN VIVO PROTECTION AND NEUTRALIZATION ACROSS SARS-COV-2 VARIANTS BY MONOCLONAL ANTIBODY COMBINATIONS.,,,H,L,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,10/06/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2057.,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SANKHALA, R.S., JOYCE, M.G.",X-RAY DIFFRACTION,NONE
7PS4,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-38,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 (ALPHA) VARIANT, B.1.351 (BETA) VARIANT, P.1 (GAMMA) VARIANT, B.1.617.2 (DELTA) VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,B,C,A,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-38,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7RU8,N,,CC6.30 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (RBD/FV LOCAL REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, SARS-COV-2, STABILIZING MUTATIONS, NEUTRALIZING ANTIBODY, RBD, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ENGINEERING SARS-COV-2 NEUTRALIZING ANTIBODIES FOR INCREASED POTENCY AND REDUCED VIRAL ESCAPE PATHWAYS.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,CC6.30 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (RBD/FV LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZOROWSKI, G., TURNER, H.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
6NIJ,N,"PGT145 FAB HEAVY CHAIN, PGT145 FAB LIGHT CHAIN, AMC011 GLYCOPROTEIN 120, AMC011 GLYCOPROTEIN 41",PGT145 FAB IN COMPLEX WITH FULL LENGTH AMC011 HIV-1 ENV,IMMUNE SYSTEM,"HIV-1, ANTIBODY, GLYCOPROTEIN, IMMUNE SYSTEM",SIMILARITIES AND DIFFERENCES BETWEEN NATIVE HIV-1 ENVELOPE GLYCOPROTEIN TRIMERS AND STABILIZED SOLUBLE TRIMER MIMETICS.,,,H,L,E | A | C,PROTEIN | PROTEIN | PROTEIN,AMC011 GLYCOPROTEIN 120 | AMC011 GLYCOPROTEIN 120 | AMC011 GLYCOPROTEIN 120,IMMUNE SYSTEM,12/29/18,PGT145 FAB IN COMPLEX WITH FULL LENGTH AMC011 HIV-1 ENV,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS | HOMO SAPIENS | HOMO SAPIENS,"COTTRELL, C.A., TORRENTS DE LA PENA, A., RANTALAINEN, K., TORRES, J.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7CZQ,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,J,N,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7E7E,N,,THE CO-CRYSTAL STRUCTURE OF ACE2 WITH FAB,ANTIVIRAL PROTEIN,"ACE2 FAB, ANTIVIRAL PROTEIN",A BROADLY NEUTRALIZING HUMANIZED ACE2-TARGETING ANTIBODY AGAINST SARS-COV-2 VARIANTS.,,,C,D,B,PROTEIN,PROCESSED ANGIOTENSIN-CONVERTING ENZYME 2,ANTIVIRAL PROTEIN,07/14/21,THE CO-CRYSTAL STRUCTURE OF ACE2 WITH FAB,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"XIAO, J.Y., ZHANG, Y.",X-RAY DIFFRACTION,NONE
7NX9,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY EVASION BY THE P.1 STRAIN OF SARS-COV-2.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/07/21,CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7QTK,N,,SARS-COV-2 S OMICRON SPIKE B.1.1.529 - RBD DOWN - 1-P2G3 FAB (LOCAL),VIRAL PROTEIN,"SARS-COV-2 S OMICRON SPIKE B.1.1.529, VIRAL PROTEIN",PATIENT-DERIVED MONOCLONAL ANTIBODY NEUTRALIZES SARS-COV-2 OMICRON VARIANTS AND CONFERS FULL PROTECTION IN MONKEYS.,,,B,C,D,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,08/03/22,SARS-COV-2 S OMICRON SPIKE B.1.1.529 - RBD DOWN - 1-P2G3 FAB (LOCAL),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NI, D., LAU, K., TURELLI, P., FENWICK, C., PEREZ, L., POJER, F., STAHLBERG, H., PANTALEO, G., TRONO, D.",ELECTRON MICROSCOPY,NONE
7ND5,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN, IMMUNE SYSTEM",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7M42,N,,COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES REGN10985 AND REGN10989,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RBD, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE MONOCLONAL ANTIBODY COMBINATION REGEN-COV PROTECTS AGAINST SARS-COV-2 MUTATIONAL ESCAPE IN PRECLINICAL AND HUMAN STUDIES.,,,D,C,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,07/28/21,COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES REGN10985 AND REGN10989,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, Y., ROMERO HERNANDEZ, A., SAOTOME, K., FRANKLIN, M.C.",ELECTRON MICROSCOPY,NONE
6NB8,N,THE ANTIGEN-BINDING (FAB) FRAGMENT,CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT,IMMUNE SYSTEM,"FAB, CORONAVIRUS, SARS, GLYCOPROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, IMMUNE SYSTEM",UNEXPECTED RECEPTOR FUNCTIONAL MIMICRY ELUCIDATES ACTIVATION OF CORONAVIRUS FUSION.,,,H,L,,,,IMMUNE SYSTEM,12/06/18,CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"WALLS, A.J., XIONG, X., PARK, Y.J., TORTORICI, M.A., SNIJDER, J., QUISPE, J., CAMERONI, E., GOPAL, R., DAI, M., LANZAVECCHIA, A., ZAMBON, M., REY, F.A., CORTI, D., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7MKL,N,,SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB SARS2-38 (THREE DOWN CONFORMATION),VIRAL PROTEIN/IMMUNE SYSTEM,"GLYCOPROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID",A POTENTLY NEUTRALIZING SARS-COV-2 ANTIBODY INHIBITS VARIANTS OF CONCERN BY UTILIZING UNIQUE BINDING RESIDUES IN A HIGHLY CONSERVED EPITOPE.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/12/21,SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB SARS2-38 (THREE DOWN CONFORMATION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ADAMS, L.J., FREMONT, D.H.",ELECTRON MICROSCOPY,NONE
7ZFA,N,,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-6 AND COVOX-150 FABS,VIRAL PROTEIN,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, OMI-6, COVOX-150, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,M,N,D,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/29/22,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-6 AND COVOX-150 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
6WPT,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, S309 NEUTRALIZING ANTIBODY HEAVY CHAIN, S309 NEUTRALIZING ANTIBODY LIGHT CHAIN",STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT (OPEN STATE),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SARS-COV, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODY, SARBECOVIRUS, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CROSS-NEUTRALIZATION OF SARS-COV-2 BY A HUMAN MONOCLONAL SARS-COV ANTIBODY.,,,H,L,C,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/27/20,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT (OPEN STATE),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PINTO, D., PARK, Y.J., BELTRAMELLO, M., WALLS, A.C., TORTORICI, M.A., BIANCHI, S., JACONI, S., CULAP, K., ZATTA, F., DE MARCO, A., PETER, A., GUARINO, B., SPREAFICO, R., CAMERONI, E., CASE, J.B., CHEN, R.E., HAVENAR-DAUGHTON, C., SNELL, G., VIRGIN, H.W., LANZAVECCHIA, A., DIAMOND, M.S., FINK, K., VEESLER, D., CORTI, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7RU3,N,,CC6.33 IGG IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (NON-UNIFORM REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, SARS-COV-2, STABILIZING MUTATIONS, NEUTRALIZING ANTIBODY, RBD, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ENGINEERING SARS-COV-2 NEUTRALIZING ANTIBODIES FOR INCREASED POTENCY AND REDUCED VIRAL ESCAPE PATHWAYS.,,,E,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,CC6.33 IGG IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (NON-UNIFORM REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZOROWSKI, G., TURNER, H.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
8D6Z,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE STEM FUSION PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY COV91-27,IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, FUSION PEPTIDE, NEUTRALIZING ANTIBODY, COVID-19, IMMUNE SYSTEM",BROADLY NEUTRALIZING ANTIBODIES TARGET THE CORONAVIRUS FUSION PEPTIDE.,,,C,D,K,PEPTIDE,SPIKE PROTEIN S2 FUSION PEPTIDE,IMMUNE SYSTEM,07/27/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE STEM FUSION PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY COV91-27,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LEE, C.C.D., LIN, T.H., YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7L7D,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH HUMAN MONOCLONAL ANTIBODY AZD8895,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN, HUMAN MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",GENETIC AND STRUCTURAL BASIS FOR SARS-COV-2 VARIANT NEUTRALIZATION BY A TWO-ANTIBODY COCKTAIL.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/01/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH HUMAN MONOCLONAL ANTIBODY AZD8895,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DONG, J., CROWE, J.E.",X-RAY DIFFRACTION,NONE
7VNC,N,,"STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113 (UDD-STATE, STATE 1)",VIRAL PROTEIN,"SARS-COV-2, NANOBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN",A NON-ACE2 COMPETING HUMAN SINGLE-DOMAIN ANTIBODY CONFERS BROAD NEUTRALIZATION AGAINST SARS-COV-2 AND CIRCULATING VARIANTS.,,,V,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,11/24/21,"STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113 (UDD-STATE, STATE 1)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, Z., WANG, Y., KONG, Y., JIN, Y., WU, Y., YING, T.",ELECTRON MICROSCOPY,NONE
7RBU,N,,SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRUS, NEUTRALIZING ANTIBODY, VACCINE, PLASMABLAST, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","STRUCTURE OF A VACCINE-INDUCED, GERMLINE-ENCODED HUMAN ANTIBODY DEFINES A NEUTRALIZING EPITOPE ON THE SARS-COV-2 SPIKE N-TERMINAL DOMAIN.",,,H,L,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ALTOMARE, C.G., BAJIC, G.",ELECTRON MICROSCOPY,NONE
7VGS,N,,SARS-COV-2 M PROTEIN DIMER (SHORT FORM) IN COMPLEX WITH YN7717_9 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, M PROTEIN, VIRAL STRUCTURAL PROTEIN, VIRUS ASSEMBLY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 M PROTEIN DIMER (SHORT FORM) IN COMPLEX WITH YN7717_9 FAB,,,D,C,A,PROTEIN,MEMBRANE PROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/22,SARS-COV-2 M PROTEIN DIMER (SHORT FORM) IN COMPLEX WITH YN7717_9 FAB,MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, Z., OHTO, U., SHIMIZU, T.",ELECTRON MICROSCOPY,NONE
7WRZ,N,,LOCAL RESOLUTION OF BD55-5840 FAB AND SARS-COV2 OMICRON RBD,VIRAL PROTEIN,"SARS-COV2 OMICRON RBD, VIRAL PROTEIN","BA.2.12.1, BA.4 AND BA.5 ESCAPE ANTIBODIES ELICITED BY OMICRON INFECTION.",,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/22/22,LOCAL RESOLUTION OF BD55-5840 FAB AND SARS-COV2 OMICRON RBD,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,"ZHANG, Z.Z., XIAO, J.J.",ELECTRON MICROSCOPY,NONE
7Q0H,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-50 AND BETA-54,VIRAL PROTEIN,"SARS-COV-2 ALPHA VARIANT, BETA VARIANT, GAMMA VARIANT, DELTA VARIANT, B.1.1.7, B.1.351, P.1, B.1.617.2, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,12/22/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-50 AND BETA-54,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7CDJ,N,,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1A3 WITH RBD,VIRAL PROTEIN,"SPIKE, RECEPTOR BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN",ANTIBODY NEUTRALIZATION OF SARS-COV-2 THROUGH ACE2 RECEPTOR MIMICRY.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/19/20,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1A3 WITH RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHANG, L., GE, J., WANG, R.",X-RAY DIFFRACTION,NONE
7B0B,N,,FAB HBNC3T1P1_C6 BOUND TO SARS-COV-2 RBD,ANTIVIRAL PROTEIN,"SARS-COV-2, NEUTRALIZING MONOCLONAL ANTIBODY, RECEPTOR-BINDING MOTIF, RECEPTOR-BINDING DOMAIN, ANTIVIRAL PROTEIN",FAB HBNC3T1P1_C6 BOUND TO SARS-COV-2 RBD,,,H,L,F,PROTEIN,SURFACE GLYCOPROTEIN,ANTIVIRAL PROTEIN,12/01/21,FAB HBNC3T1P1_C6 BOUND TO SARS-COV-2 RBD,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BORENSTEIN-KATZ, A., DISKIN, R.",X-RAY DIFFRACTION,NONE
7S0C,N,,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY N-612-017,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, COVID-19, SPIKE GLYCOPROTEIN, MRNA DISPLAY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",RAPID IDENTIFICATION OF NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 VARIANTS BY MRNA DISPLAY.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/06/21,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY N-612-017,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7TTM,N,,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH SARBECOVIRUS BAT SHC014 RECEPTOR-BINDING DOMAIN,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARBECOVIRUS, SCH014 RBD, VIRAL PROTEIN, SPIKE GLYCOPROTEIN, RECEPTOR BINDING PROTEIN, NEUTRALIZING ANTIBODY, POTENT, 10-40, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ANTIBODY CLASS WITH A COMMON CDRH3 MOTIF BROADLY NEUTRALIZES SARBECOVIRUSES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH SARBECOVIRUS BAT SHC014 RECEPTOR-BINDING DOMAIN,BAT SARS-LIKE CORONAVIRUS RSSHC014; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,BAT SARS-LIKE CORONAVIRUS RSSHC014,"REDDEM, E.R., SHAPIRO, L.",X-RAY DIFFRACTION,NONE
7R98,N,,STRUCTURE OF THE SARS-COV-2 N PROTEIN RNA-BINDING DOMAIN BOUND TO SINGLE-DOMAIN ANTIBODY B6,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NANOBODY, NUCLEOCAPSID, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, RNA BINDING PROTEIN",STRUCTURAL BASIS FOR SARS-COV-2 NUCLEOCAPSID PROTEIN RECOGNITION BY SINGLE-DOMAIN ANTIBODIES.,,,E,,B,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/07/21,STRUCTURE OF THE SARS-COV-2 N PROTEIN RNA-BINDING DOMAIN BOUND TO SINGLE-DOMAIN ANTIBODY B6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CORBETT, K.D., YE, Q.",X-RAY DIFFRACTION,NONE
5W9N,N,"MERS S, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,E,F,D,PROTEIN,MERS S,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7RW2,N,,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-7 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, FUSION PROTEIN, SPIKE GLYCOPROTEIN, COVID-19, N-TERMINAL DOMAIN, NTD, 5-7, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",NEUTRALIZING ANTIBODY 5-7 DEFINES A DISTINCT SITE OF VULNERABILITY IN SARS-COV-2 SPIKE N-TERMINAL DOMAIN.,,,G,J,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/01/21,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-7 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CERUTTI, G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7U0D,N,,LOCAL REFINEMENT OF CRYO-EM STRUCTURE OF THE INTERFACE OF THE OMICRON RBD IN COMPLEX WITH ANTIBODIES B-182.1 AND A19-46.1,VRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, SARS-COV-2, OMICRON, B.1.1.529, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM, VRAL PROTEIN-IMMUNE SYSTEM COMPLEX",OMICRON RBD IN COMPLEX WITH ANTIBODIES,,,O,P,B,PROTEIN,SURFACE GLYCOPROTEIN,VRAL PROTEIN/IMMUNE SYSTEM,03/30/22,LOCAL REFINEMENT OF CRYO-EM STRUCTURE OF THE INTERFACE OF THE OMICRON RBD IN COMPLEX WITH ANTIBODIES B-182.1 AND A19-46.1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7LQV,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, NEUTRALIZING ANTIBODY 4-8 FAB",CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, COVID19, SARS-COV2, PREFUSION, NEUTRALIZING, NTD, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES DIRECTED AGAINST SPIKE N-TERMINAL DOMAIN TARGET A SINGLE SUPERSITE,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/24/21,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GORMAN, J., RAPP, M., KWONG, P.D., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7ND7,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7E3L,N,,ULTRAPOTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS,VIRAL PROTEIN,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS.,,,D,E,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,09/15/21,ULTRAPOTENT SARS-COV-2 NEUTRALIZING ANTIBODIES WITH PROTECTIVE EFFICACY AGAINST NEWLY EMERGED MUTATIONAL VARIANTS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., LI, T., LIU, F., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7WOC,N,,LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-60,VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT BY DISASSEMBLING THE SPIKE TRIMER.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,07/20/22,"S-MAB60 NRAB1 LOCAL-REFINED MAP"""" INTO """"LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-60",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7ME7,N,,CRYOEM STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH NANOBODIES NB17 AND NB105,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 RECEPTOR BINDING DOMAIN NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING DIVERSE AND CONSERVED EPITOPES,,,B,,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/11/21,CRYOEM STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH NANOBODIES NB17 AND NB105,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.J.",ELECTRON MICROSCOPY,NONE
7VGR,N,,SARS-COV-2 M PROTEIN DIMER (LONG FORM) IN COMPLEX WITH YN7756_1 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, M PROTEIN, VIRAL STRUCTURAL PROTEIN, VIRUS ASSEMBLY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 M PROTEIN DIMER (LONG FORM) IN COMPLEX WITH YN7756_1 FAB,,,D,C,A,PROTEIN,MEMBRANE PROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/22,SARS-COV-2 M PROTEIN DIMER (LONG FORM) IN COMPLEX WITH YN7756_1 FAB,MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, Z., OHTO, U., SHIMIZU, T.",ELECTRON MICROSCOPY,NONE
7BEL,N,"SPIKE GLYCOPROTEIN, COVOX-45 HEAVY CHAIN, COVOX-88 HEAVY CHAIN, COVOX-88 LIGHT CHAIN, COVOX-45 LIGHT CHAIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,C,D,X,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7Q9F,N,,BETA-50 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,J,K,C,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/15/21,BETA-50 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7EPX,N,,S PROTEIN OF SARS-COV-2 IN COMPLEX WITH GW01,VIRAL PROTEIN,"S PROTEIN, SARS-COV-2, VIRAL PROTEIN",NOVEL SARBECOVIRUS BISPECIFIC NEUTRALIZING ANTIBODIES WITH EXCEPTIONAL BREADTH AND POTENCY AGAINST CURRENTLY CIRCULATING SARS-COV-2 VARIANTS AND SARBECOVIRUSES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/18/22,S PROTEIN OF SARS-COV-2 IN COMPLEX WITH GW01,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SHEN, Y.P., ZHANG, Y.Y., YAN, R.H., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7MKM,N,,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB SARS2-38 (LOCAL REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"GLYCOPROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID",A POTENTLY NEUTRALIZING SARS-COV-2 ANTIBODY INHIBITS VARIANTS OF CONCERN BY UTILIZING UNIQUE BINDING RESIDUES IN A HIGHLY CONSERVED EPITOPE.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/12/21,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB SARS2-38 (LOCAL REFINEMENT),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ADAMS, L.J., FREMONT, D.H., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",ELECTRON MICROSCOPY,NONE
7F5H,N,,"THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL28 (SC4)",VIRAL PROTEIN,"NANOBODY, RBD, NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR-BINDING DOMAIN, RECEPTOR-BINDING MOTIF, RBM DISTORTION, VIRAL PROTEIN",DISCOVERY OF NANOBODIES AGAINST SARS-COV-2 AND AN UNCOMMON NEUTRALIZING MECHANISM,,,D,,B,PROTEIN,SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD),VIRAL PROTEIN,06/29/22,"THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL28 (SC4)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LUO, Z.P., LI, T., LAI, Y., ZHOU, Y., TAN, J., LI, D.",X-RAY DIFFRACTION,NONE
4HBC,,"ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - HEAVY CHAIN, ANTIGEN BINDING FRAGMENT, IMMUNOGLOBULIN IGG - LIGHT CHAIN",CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS,IMMUNE SYSTEM,"FAB, RABBIT, CONFORMATION-SPECIFIC, AMYLOID, IMMUNE SYSTEM",CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS.,,,H,L,,,,IMMUNE SYSTEM,09/27/12,CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS,ORYCTOLAGUS CUNICULUS,ORYCTOLAGUS CUNICULUS,ORYCTOLAGUS CUNICULUS,,"ARAI, H.",X-RAY DIFFRACTION,NONE
7B14,N,"SPIKE GLYCOPROTEIN, NANOBODY AGAINST SARS-COV-2",NANOBODY E BOUND TO SPIKE-RBD IN A LOCALIZED RECONSTRUCTION,VIRAL PROTEIN,"SPIKE GLYCOPROTEIN, SARS-COV-2, NANOBODY, VIRAL PROTEIN",STRUCTURE-GUIDED MULTIVALENT NANOBODIES BLOCK SARS-COV-2 INFECTION AND SUPPRESS MUTATIONAL ESCAPE.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/28/21,NANOBODY E BOUND TO SPIKE-RBD IN A LOCALIZED RECONSTRUCTION.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELUS BACTRIANUS,CAMELUS BACTRIANUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALLBERG, B.M., DAS, H.",ELECTRON MICROSCOPY,NONE
7F62,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY CHAB-25 (FOCUSED REFINEMENT OF S-RBD AND CHAB-25 REGION),VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURE-GUIDED ANTIBODY COCKTAIL FOR PREVENTION AND TREATMENT OF COVID-19.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/04/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY CHAB-25 (FOCUSED REFINEMENT OF S-RBD AND CHAB-25 REGION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, T.J., YU, P.Y., WU, H.C., HSU, S.T.D.",ELECTRON MICROSCOPY,NONE
7TE1,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH AB17,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY-ANTIGEN COMPLEX, SARS-COV-2, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",RATIONALLY DESIGNED IMMUNOGENS ENABLE IMMUNE FOCUSING FOLLOWING SARS-COV-2 SPIKE IMPRINTING.,,,H,L,D,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,03/30/22,SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH AB17,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"HAUSER, B.M., SCHMIDT, A.G.",X-RAY DIFFRACTION,NONE
7N8H,N,,SARS-COV-2 S (B.1.429 / EPSILON VARIANT) + S2M11 + S2L20 GLOBAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"CORONAVIRUS, ANTIBODY, CALIFORNIA, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 IMMUNE EVASION BY THE B.1.427/B.1.429 VARIANT OF CONCERN.,,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/14/21,SARS-COV-2 S (B.1.429 / EPSILON VARIANT) + S2M11 + S2L20 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7THE,N,,STRUCTURE OF RBD DIRECTED ANTIBODY DH1042 IN COMPLEX WITH SARS-COV-2 SPIKE: LOCAL REFINEMENT OF RBD-FAB INTERFACE,VIRAL PROTEIN/IMMUNE SYSTEM,"RBD, FAB, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL DIVERSITY OF THE SARS-COV-2 OMICRON SPIKE.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,02/16/22,STRUCTURE OF RBD DIRECTED ANTIBODY DH1042 IN COMPLEX WITH SARS-COV-2 SPIKE: LOCAL REFINEMENT OF RBD-FAB INTERFACE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MAY, A.J., MANNE, K., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
6PZ8,N,"S PROTEIN, G2 HEAVY CHAIN, G2 LIGHT CHAIN",MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2,VIRAL PROTEIN/IMMUNE SYSTEM,"MERS-COV, CORONAVIRUS, DPP4, RECEPTOR-BINDING, MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL DEFINITION OF A NEUTRALIZATION-SENSITIVE EPITOPE ON THE MERS-COV S1-NTD.,,,C,G,J,PROTEIN,S PROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/31/19,MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"BOWMAN, C.A., PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7L06,N,"2G12 HEAVY CHAIN, 2G12 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12,VIRAL PROTEIN/IMMUNE SYSTEM,"FAB-DIMERIZED, GLYCAN-REACTIVE, ANTIBODIES, SARS, COVID19, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, SARS-COV-2 2P S ECTODOMAIN",FAB-DIMERIZED GLYCAN-REACTIVE ANTIBODIES ARE A STRUCTURAL CATEGORY OF NATURAL ANTIBODIES.,,,H,L,U,CARBOHYDRATE,ALPHA-D-MANNOSE,VIRAL PROTEIN/IMMUNE SYSTEM,12/11/20,CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"MANNE, K., HENDERSON, R., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7D6I,N,,A NEUTRALIZING MAB TARGETING RECEPTOR-BINDING-DOMAIN OF SARS-COV-2,"ANTIVIRAL PROTEIN,IMMUNE SYSTEM","NETRALIZING ANTIBODY, ANTIVIRAL PROTEIN, IMMUNE SYSTEM",A NEUTRALIZING MAB TARGETING RECEPTOR-BINDING-DOMAIN OF SARS-COV-2,,,B,C,A,PROTEIN,SARS-COV-2 RECEPTOR BINDING DOMAIN,"ANTIVIRAL PROTEIN,IMMUNE SYSTEM",10/13/21,A NEUTRALIZING MAB TARGETING RECEPTOR-BINDING-DOMAIN OF SARS-COV-2,SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"SHI, R., QI, J.X., GAO, G.F., YAN, J.H.",X-RAY DIFFRACTION,NONE
7OAP,N,,NANOBODY H3 AND C1 BOUND TO RBD,ANTIVIRAL PROTEIN,"RBD, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",A POTENT SARS-COV-2 NEUTRALISING NANOBODY SHOWS THERAPEUTIC EFFICACY IN THE SYRIAN GOLDEN HAMSTER MODEL OF COVID-19.,,,A,,E,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,01/08/09,NANOBODY H3 AND C1 BOUND TO RBD,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,,,,"NAISMITH, J.H., MIKOLAJEK, H.",X-RAY DIFFRACTION,NONE
7WD9,N,,SARS-COV-2 BETA SPIKE IN COMPLEX WITH THREE S3H3 FABS,VIRAL PROTEIN,"CORONAVIRUS, BETA VARIANT, B.1.351 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MAPPING CROSS-VARIANT NEUTRALIZING SITES ON THE SARS-COV-2 SPIKE PROTEIN.,,,E,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,02/02/22,SARS-COV-2 BETA SPIKE IN COMPLEX WITH THREE S3H3 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y.F., CONG, Y.",ELECTRON MICROSCOPY,NONE
7X7E,N,,SARS-COV-2 RBD AND NB22,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 RBD, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 RBD AND NB22,,,B,,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/20/22,SARS-COV-2 RBD AND NB22,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA,LAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y., YE, S.",X-RAY DIFFRACTION,NONE
7SI2,N,,CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY 10-28 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR BINDING DOMAIN (RBD),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, VIRAL PROTEIN, SPIKE GLYCOPROTEIN, RECEPTOR BINDING PROTEIN, RBD, NEUTRALIZING ANTIBODY, 10-28, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ANTIBODY CLASS WITH A COMMON CDRH3 MOTIF BROADLY NEUTRALIZES SARBECOVIRUSES.,,,G,F,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY 10-28 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR BINDING DOMAIN (RBD),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"REDDEM, E.R., SHAPIRO, L.",X-RAY DIFFRACTION,NONE
7Z9Q,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 NANOBODY COMPLEX,ANTIVIRAL PROTEIN,"COMPLEX, SPIKE GLYCOPROTEIN, NANOBODY H11-A10, ANTIVIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 NANOBODY COMPLEX,,,F,,B,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",ANTIVIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 NANOBODY COMPLEX,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; TEQUATROVIRUS T4,LAMA GLAMA,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, TEQUATROVIRUS T4 ","WECKENER, M., NAISMITH, J.H.",ELECTRON MICROSCOPY,NONE
7ND6,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7KFW,N,,STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB),IMMUNE SYSTEM/VIRAL PROTEIN,"COVID-19, SARS-COV-2, NEUTRALIZING ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MOLECULAR BASIS FOR A GERMLINE-BIASED NEUTRALIZING ANTIBODY RESPONSE TO SARS-COV-2.,,,C,D,B,PROTEIN,SURFACE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,10/15/20,STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PAN, J., ABRAHAM, J., CLARK, L., CLARK, S.",X-RAY DIFFRACTION,NONE
7DK0,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW05 FAB,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, ANTIBODY, ADE, VIRUS, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",ANTIBODY-DEPENDENT ENHANCEMENT (ADE) OF SARS-COV-2 PSEUDOVIRAL INFECTION REQUIRES FC GAMMA RIIB AND VIRUS-ANTIBODY COMPLEX WITH BIVALENT INTERACTION.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,06/09/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW05 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, J., JIAO, S., WANG, R., ZHANG, J., ZHANG, M., WANG, M.",X-RAY DIFFRACTION,NONE
7WPV,N,,FAB14 - A SARS-COV2 RBD NEUTRALISING ANTIBODY,PROTEIN BINDING,"SARS-COV2 RBD NEUTRALISING ANTIBODY, PROTEIN BINDING",ENGINEERING SARS-COV-2 COCKTAIL ANTIBODIES INTO A BISPECIFIC FORMAT IMPROVES NEUTRALIZING POTENCY AND BREADTH.,,,H,L,,,,PROTEIN BINDING,03/30/22,FAB14 - A SARS-COV2 RBD NEUTRALISING ANTIBODY,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"LIN, J.Q., EL SAHILI, A., LESCAR, J.",X-RAY DIFFRACTION,NONE
7WR8,N,,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.1.529) IN COMPLEX WITH BD55-3152 FAB,VIRAL PROTEIN,"ANTIBODY, COMPLEX, S6P, VIRAL PROTEIN","BA.2.12.1, BA.4 AND BA.5 ESCAPE ANTIBODIES ELICITED BY OMICRON INFECTION.",,,A,B,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/22/22,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.1.529) IN COMPLEX WITH BD55-3152 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.Y.",ELECTRON MICROSCOPY,NONE
7KMG,N,,LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY NEUTRALIZING SARS-COV-2, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX","THE NEUTRALIZING ANTIBODY, LY-COV555, PROTECTS AGAINST SARS-COV-2 INFECTION IN NONHUMAN PRIMATES.",,,A,B,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,01/27/21,LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HENDLE, J., PUSTILNIK, A., SAUDER, J.M., COLEMAN, K.A., BOYLES, J.S., DICKINSON, C.D.",X-RAY DIFFRACTION,NONE
6XCM,N,"SPIKE GLYCOPROTEIN, C105 FAB HEAVY CHAIN, C105 FAB LIGHT CHAIN",STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL NEUTRALIZING ANTIBODY, FABS, NSEMPEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF HUMAN ANTIBODIES BOUND TO SARS-COV-2 SPIKE REVEAL COMMON EPITOPES AND RECURRENT FEATURES OF ANTIBODIES.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/08/20,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7N5H,N,,CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 2-36 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, VIRAL SPIKE, TRIMER, GLYCOPROTEIN, NEUTRALIZING ANTIBODY FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","A MONOCLONAL ANTIBODY THAT NEUTRALIZES SARS-COV-2 VARIANTS, SARS-COV, AND OTHER SARBECOVIRUSES.",,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/03/21,CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 2-36 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CASNER, R.G., CERUTTI, G., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7MZJ,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129 AND FAB PDI 93,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,F,E,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129 AND FAB PDI 93,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., DIETRICH, M.H., TAN, L.L., CHAN, L.J., THAM, W.H.",X-RAY DIFFRACTION,NONE
8CY9,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-23,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,F,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-23,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7ZR9,N,,OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN,STRUCTURAL PROTEIN,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, STRUCTURAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,F,G,B,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",STRUCTURAL PROTEIN,06/01/22,OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ENTEROBACTERIA PHAGE T4; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ENTEROBACTERIA PHAGE T4 ","DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7LY2,N,"SPIKE GLYCOPROTEIN, S2M11 FAB LIGHT CHAIN VARIABLE REGION, S2M11 FAB HEAVY CHAIN VARIABLE REGION, S2M28 FAB HEAVY CHAIN VARIABLE REGION, S2M28 FAB LIGHT CHAIN VARIABLE REGION",SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",N-TERMINAL DOMAIN ANTIGENIC MAPPING REVEALS A SITE OF VULNERABILITY FOR SARS-COV-2.,,,N,O,J,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7N3D,N,,CRYSTAL STRUCTURE OF HUMAN FAB S24-1564 IN THE COMPLEX WITH THE N-TERMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,VIRAL PROTEIN,"SARS CORONAVIRUS 2, NUCLEOCAPSID PROTEIN, HUMAN ANTIBODY FAB, COVID-19, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, VIRAL PROTEIN",CRYSTAL STRUCTURE OF HUMAN FAB S24-1564 IN THE COMPLEX WITH THE N-TERMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,,,H,L,C,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN,07/07/21,CRYSTAL STRUCTURE OF HUMAN FAB S24-1564 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KIM, Y., MALTSEVA, N., TESAR, C., JEDRZEJCZAK, R., DUGAN, H., STAMPER, C., WILSON, P., JOACHIMIAK, A., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",X-RAY DIFFRACTION,NONE
7KKL,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, SYNTHETIC NANOBODY MNB6",SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6,VIRAL PROTEIN/IMMUNE SYSTEM,"COMPLEX, NANOBODY, VHH, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ULTRAPOTENT SYNTHETIC NANOBODY NEUTRALIZES SARS-COV-2 BY STABILIZING INACTIVE SPIKE.,,,E,,C,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/27/20,SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SCHOOF, M.S., FAUST, B.F., SAUNDERS, R.A., SANGWAN, S., REZELJ, V., HOPPE, N., BOONE, M., BILLESBOELLE, C.B., PUCHADES, C., AZUMAYA, C.M., KRATOCHVIL, H.T., ZIMANYI, M., DESPHANDE, I., LIANG, J., DICKINSON, S., NGUYEN, H.C., CHIO, C.M., MERZ, G.E., THOMPSON, M.C., DIWANJI, D., SCHAEFER, K., ANAND, A.A., DOBZINSKI, N., ZHA, B.S., SIMONEAU, C.R., LEON, K., WHITE, K.M., CHIO, U.S., GUPTA, M., JIN, M., LI, F., LIU, Y., ZHANG, K., BULKLEY, D., SUN, M., SMITH, A.M., RIZO, A.N., MOSS, F., BRILOT, A.F., POURMAL, S., TRENKER, R., POSPIECH, T., GUPTA, S., BARSI-RHYNE, B., BELYY, V., BARILE-HILL, A.W., NOCK, S., LIU, Y., KROGAN, N.J., RALSTON, C.Y., SWANEY, D.L., GARCIA-SASTRE, A., OTT, M., VIGNUZZI, M., WALTER, P., MANGLIK, A., QCRG STRUCTURAL BIOLOGY CONSORTIUM",ELECTRON MICROSCOPY,NONE
7YEG,N,,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 3 R1-32 FABS AND 3 ACE2,VIRAL PROTEIN/IMMUNE SYSTEM,"ACE2, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 SPIKE(6P)IN COMPLEX WITH 3 R1-32 FABS AND 3 ACE2,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 3 R1-32 FABS AND 3 ACE2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, B., GAO, X., LI, Z., CHEN, X., HE, J., CHEN, L., XIONG, X.",ELECTRON MICROSCOPY,NONE
7CWM,N,"SPIKE GLYCOPROTEIN, P17 HEAVY CHAIN, P17 LIGHT CHAIN",COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE,VIRAL PROTEIN,"COMPLEX, FAB, SARS-COV-2 SPIKE, VIRAL PROTEIN",RATIONAL DEVELOPMENT OF A HUMAN ANTIBODY COCKTAIL THAT DEPLOYS MULTIPLE FUNCTIONS TO CONFER PAN-SARS-COVS PROTECTION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/29/20,COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, N., WANG, X.",ELECTRON MICROSCOPY,NONE
7CHH,N,"SPIKE GLYCOPROTEIN, BD-368-2 FAB HEAVY CHAIN, BD-368-2 FAB LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE, NEUTRALIZING ANTIBODY, ANTIVIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURALLY RESOLVED SARS-COV-2 ANTIBODY SHOWS HIGH EFFICACY IN SEVERELY INFECTED HAMSTERS AND PROVIDES A POTENT COCKTAIL PAIRING STRATEGY.,,,J,K,C,PROTEIN,SPIKE GLYCOPROTEIN,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,07/05/20,CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XIAO, J., ZHU, Q., WANG, G.",ELECTRON MICROSCOPY,NONE
7FJC,N,,CRYSTAL STRUCTURE OF SARS-COV-2 BETA RBD COMPLEXED WITH P36-5D2 FAB,VIRAL PROTEIN,"SARS-COV-2 VARIANT OF CONCERN, BETA, RBD, NEUTRALIZATION ANTIBODY, VIRAL PROTEIN",CRYSTAL STRUCTURE OF SARS-COV-2 BETA RBD COMPLEXED WITH P36-5D2 FAB,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,08/10/22,CRYSTAL STRUCTURE OF SARS-COV-2 BETA RBD COMPLEXED WITH P36-5D2 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, L.Q., WANG, X.Q., SHAN, S.S., LAN, J.",X-RAY DIFFRACTION,NONE
7VQ0,N,,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN (2-UP RBD) BOUND TO NEUTRALIZING NANOBODIES P86,VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, NANOBODY, VHH, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A PANEL OF NANOBODIES RECOGNIZING CONSERVED HIDDEN CLEFTS OF ALL SARS-COV-2 SPIKE VARIANTS INCLUDING OMICRON.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/20/22,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN (2-UP RBD) BOUND TO NEUTRALIZING NANOBODIES P86,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MAEDA, R., FUJITA, J., KONISHI, Y., KAZUMA, Y., YAMAZAKI, H., ANZAI, I., YAMAGUCHI, K., KASAI, K., NAGATA, K., YAMAOKA, Y., MIYAKAWA, K., RYO, A., SHIRAKAWA, K., MAKINO, F., MATSUURA, Y., INOUE, T., IMURA, A., NAMBA, K., TAKAORI-KONDO, A.",ELECTRON MICROSCOPY,NONE
7PS5,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-47 FAB,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 (ALPHA) VARIANT, B.1.351 (BETA) VARIANT, P.1 (GAMMA) VARIANT, B.1.617.2 (DELTA) VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-47 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7E7Y,N,"BD-623 FAB H, BD-623 FAB L, SPIKE PROTEIN S1",CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-623 FAB,VIRAL PROTEIN,"SPIKE RBD ANTIBODY, VIRAL PROTEIN",HUMORAL IMMUNE RESPONSE TO CIRCULATING SARS-COV-2 VARIANTS ELICITED BY INACTIVATED AND RBD-SUBUNIT VACCINES.,,,C,D,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/09/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-623 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WEI, Y., XIAO, J.",X-RAY DIFFRACTION,NONE
6NB4,N,"SPIKE GLYCOPROTEIN, LCA60 HEAVY CHAIN, LCA60 LIGHT CHAIN",MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2),VIRUS,"CORONAVIRUS SPIKE GLYCOPROTEIN, MERS-COV, SARS-COV, HUMAN NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRUS",UNEXPECTED RECEPTOR FUNCTIONAL MIMICRY ELUCIDATES ACTIVATION OF CORONAVIRUS FUSION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS,12/06/18,MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2),MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS,"WALLS, A.C., XIONG, X., PARK, Y.J., TORTORICI, M.A., SNIJDER, S., QUISPE, J., CAMERONI, E., GOPAL, R., MIAN, D., LANZAVECCHIA, A., ZAMBON, M., REY, F.A., CORTI, D., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7QF1,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE HUMAN ANTIBODY CV2.6264,VIRAL PROTEIN,"NEUTRALIZATION, ANTIBODY, CORONAVIRUS, VIRAL PROTEIN","POTENT ANTIBODIES AGAINST SARS-COV-2 
ISOLATED FROM A PATIENT",,,C,B,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/18/22,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE HUMAN ANTIBODY CV2.6264,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FERNANDEZ, I., PEDERZOLI, R., REY, F.A.",X-RAY DIFFRACTION,NONE
8D36,N,,CRYSTAL STRUCTURE OF SARS-COV-2 FUSION PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY COV44-62,IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, FUSION PEPTIDE, NEUTRALIZING ANTIBODY, COVID-19, IMMUNE SYSTEM",BROADLY NEUTRALIZING ANTIBODIES TARGET THE CORONAVIRUS FUSION PEPTIDE.,,,H,L,F,PEPTIDE,SPIKE PROTEIN S2 FUSION PEPTIDE,IMMUNE SYSTEM,07/27/22,CRYSTAL STRUCTURE OF SARS-COV-2 FUSION PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY COV44-62,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., LEE, C.C.D., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7CWS,N,"HEAVY CHAIN OF FC05 FAB, LIGHT CHAIN OF FC05 FAB, LIGHT CHAIN OF H014 FAB, HEAVY CHAIN OF H014 FAB, SPIKE GLYCOPROTEIN",SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL,VIRAL PROTEIN,VIRAL PROTEIN,STRUCTURE-BASED DEVELOPMENT OF HUMAN ANTIBODY COCKTAILS AGAINST SARS-COV-2.,,,P,M,R,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/31/20,SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, L., WANG, X.",ELECTRON MICROSCOPY,NONE
7U2D,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY ADG20,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, SPIKE, RBD, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A BROAD AND POTENT NEUTRALIZATION EPITOPE IN SARS-RELATED CORONAVIRUSES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY ADG20,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7C8V,N,,STRUCTURE OF SYBODY SR4 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD),PROTEIN BINDING,"CORONAVIRUS, COVID-19, NANOBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING PROTEIN, SARS-COV-2, S PROTEIN, SYNTHETIC ANTIBODY, VHH., PROTEIN BINDING",A SYNTHETIC NANOBODY TARGETING RBD PROTECTS HAMSTERS FROM SARS-COV-2 INFECTION.,,,A,,B,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,06/03/20,STRUCTURE OF SYBODY SR4 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD),SYNTHETIC CONSTRUCT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T., YAO, H., CAI, H., QIN, W., LI, D.",X-RAY DIFFRACTION,NONE
8CY7,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-34,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-34,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7RAQ,N,,CRYSTAL STRUCTURE OF CV3-25 FAB BOUND TO SARS-COV-2 SPIKE STEM HELIX PEPTIDE,IMMUNE SYSTEM,"ANTIBODY, FAB, SARS-COV-2, IMMUNE SYSTEM",STRUCTURAL DEFINITION OF A PAN-SARBECOVIRUS NEUTRALIZING EPITOPE ON THE SPIKE S2 SUBUNIT.,,,H,L,P,PEPTIDE,SPIKE STEM HELIX PEPTIDE,IMMUNE SYSTEM,04/13/22,CRYSTAL STRUCTURE OF CV3-25 FAB BOUND TO SARS-COV-2 SPIKE STEM HELIX PEPTIDE,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HURLBURT, N.K., PANCERA, M.",X-RAY DIFFRACTION,NONE
7RSO,N,,AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV, ENV, ANTIBODY, BNAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE GLYCAN HOLE AREA OF HIV-1 ENVELOPE TRIMERS CONTRIBUTES PROMINENTLY TO THE INDUCTION OF AUTOLOGOUS NEUTRALIZATION.,,,I,K,D,PROTEIN,AMC016 GP120,VIRAL PROTEIN/IMMUNE SYSTEM,09/15/21,AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"BADER, D.L.V., COTTRELL, C.A., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7CYP,N,,COMPLEX OF SARS-COV-2 SPIKE TRIMER WITH ITS NEUTRALIZING ANTIBODY HB27,VIRAL PROTEIN,"SARS-COV-2 SPIKE, NEUTRALIZING ANTIBODY, COMPLEX, VIRAL PROTEIN",DOUBLE LOCK OF A POTENT HUMAN THERAPEUTIC MONOCLONAL ANTIBODY AGAINST SARS-COV-2.,,,E,D,A,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/09/21,COMPLEX OF SARS-COV-2 SPIKE TRIMER WITH ITS NEUTRALIZING ANTIBODY HB27,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHU, L.",ELECTRON MICROSCOPY,NONE
7K8Y,N,"SPIKE GLYCOPROTEIN, C121 FAB HEAVY CHAIN, C121 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2)",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,G,I,B | D,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ABERNATHY, M.E., BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
5A1Z,,"ENVELOPE PROTEIN, MEMBRANE GLYCOPROTEIN, ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN, ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN",CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94-07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C,VIRUS,"VIRUS, DENGUE VIRUS, HUMAN ANTIBODY, CRYO-EM, NEUTRALIZATION",CRYO-EM STRUCTURE OF AN ANTIBODY THAT NEUTRALIZES DENGUE VIRUS TYPE 2 BY LOCKING E PROTEIN DIMERS.,,"CA ATOMS ONLY, CHAIN A, C, E, B, D, F, G, I, K, H, J, L AUTHOR G.FIBRIANSAH,K.D.IBARRA,T.S.NG,S.A.SMITH,J.L.TAN,X.N.LIM,J.S.G.OOI,",K,L,C,PROTEIN,ENVELOPE PROTEIN,,05/06/15,CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94-07  COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C,DENGUE VIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,DENGUE VIRUS 2,"FIBRIANSAH, G., IBARRA, K.D., NG, T.S., SMITH, S.A., TAN, J.L., LIM, X.N., OOI, J.S.G., KOSTYUCHENKO, V.A., WANG, J., DE SILVA, A.M., HARRIS, E., CROWE JR, J.E., LOK, S.M.",ELECTRON MICROSCOPY,NONE
7D0B,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF 207FAB, HEAVY CHAIN OF 207 FAB",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_1B,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_1B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., WANG, R.K., JU, B., YU, J.F., ZHANG, Y.Y., LIU, N., WANG, H.W., WANG, X.Q., ZHANG, L.Q., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
6W41,N,"CR3022 FAB HEAVY CHAIN, CR3022 FAB LIGHT CHAIN, SPIKE PROTEIN S1 RECEPTOR BINDING DOMAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY, VIRUS, COMPLEX, SARS-COV-2, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",A HIGHLY CONSERVED CRYPTIC EPITOPE IN THE RECEPTOR BINDING DOMAINS OF SARS-COV-2 AND SARS-COV.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN RECEPTOR BINDING DOMAIN,IMMUNE SYSTEM/VIRAL PROTEIN,03/09/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., WU, N.C., ZHU, X.Y., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7RR0,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 222,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, SARS-COV-2 RBD, COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 222,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., GLUKHOVA, A., BLACK, K.A., THAM, W.H.",ELECTRON MICROSCOPY,NONE
7WHJ,N,,"THE STATE 1 COMPLEX STRUCTURE OF OMICRON SPIKE WITH BN03 (1-UP RBD, 3 NANOBODIES)",VIRAL PROTEIN,"OMICRON, SPIKE, NANOBODY, VIRAL PROTEIN",BROAD NEUTRALIZATION OF SARS-COV-2 VARIANTS BY AN INHALABLE BISPECIFIC SINGLE-DOMAIN ANTIBODY.,,,E,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/11/22,"THE STATE 1 COMPLEX STRUCTURE OF OMICRON SPIKE WITH BN03 (1-UP RBD, 3 NANOBODIES)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7F7E,N,,SARS-COV-2 S PROTEIN RBD IN COMPLEX WITH A5-10 FAB,VIRAL PROTEIN,"ANTIBODY, SARS-COV-2, VIRUS, VIRAL PROTEIN",ETESEVIMAB IN COMBINATION WITH JS026 NEUTRALIZING SARS-COV-2 AND ITS VARIANTS.,,,C,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,02/02/22,SARS-COV-2 S PROTEIN RBD IN COMPLEX WITH A5-10 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DOU, Y., WANG, X., WANG, K., LIU, P., LU, B.",X-RAY DIFFRACTION,NONE
5DHV,,"ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, HEAVY CHAIN, ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, LIGHT CHAIN, PROTEIN REV",HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,IMMUNE SYSTEM,"HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM",THE STRUCTURE OF HIV-1 REV FILAMENTS SUGGESTS A BILATERAL MODEL FOR REV-RRE ASSEMBLY.,,,H,L,M,PROTEIN,PROTEIN REV,IMMUNE SYSTEM,08/31/15,HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"DIMATTIA, M.A., WATTS, N.R., WINGFIELD, P.T., GRIMES, J.M., STUART, D.I., STEVEN, A.C.",X-RAY DIFFRACTION,NONE
7CAC,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF H014 FAB, HEAVY CHAIN OF H014 FAB",SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB.,VIRAL PROTEIN,"SARS-COV-2, SPIKE, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN",STRUCTURAL BASIS FOR NEUTRALIZATION OF SARS-COV-2 AND SARS-COV BY A POTENT THERAPEUTIC ANTIBODY.,,,E,D,B | A,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,02/24/21,SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHE, L., CAO, L., DENG, Y., SUN, Y., WANG, N., XIE, L., WANG, Y., RAO, Z., QIN, C., WANG, X.",ELECTRON MICROSCOPY,NONE
7FJN,N,,CRYO-EM STRUCTURE OF SOUTH AFRICAN (B.1.351) SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH TWO T6 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",RBD TRIMER MRNA VACCINE ELICITS BROAD AND PROTECTIVE IMMUNE RESPONSES AGAINST SARS-COV-2 VARIANTS.,,,I,J,A,PROTEIN,"SPIKE GLYCOPROTEIN,ENVELOPE GLYCOPROTEIN",VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,CRYO-EM STRUCTURE OF SOUTH AFRICAN (B.1.351) SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH TWO T6 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, HUMAN IMMUNODEFICIENCY VIRUS 1 ","WANG, X., ZHANG, L., ZHANG, S., LIANG, Q.",ELECTRON MICROSCOPY,NONE
7WO7,N,,LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-15,VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT BY DISASSEMBLING THE SPIKE TRIMER.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,07/20/22,LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-15,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7TOW,N,,ANTIBODY DH1058 FAB FRAGMENT BOUND TO SARS-COV-2 FUSION PEPTIDE,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",STRUCTURAL DIVERSITY OF THE SARS-COV-2 OMICRON SPIKE.,,,H,L,E,PEPTIDE,SPIKE PROTEIN S2,IMMUNE SYSTEM/VIRAL PROTEIN,02/16/22,ANTIBODY DH1058 FAB FRAGMENT BOUND TO SARS-COV-2 FUSION PEPTIDE,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GOBEIL, S., ACHARYA, P.",X-RAY DIFFRACTION,NONE
7MJI,N,"SPIKE GLYCOPROTEIN, VH AB8",CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO VH AB8 (FOCUSED REFINEMENT OF RBD AND VH AB8),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VH AB8, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYO-ELECTRON MICROSCOPY STRUCTURES OF THE N501Y SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH ACE2 AND 2 POTENT NEUTRALIZING ANTIBODIES.,,,E,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/12/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO VH AB8 (FOCUSED REFINEMENT OF RBD AND VH AB8),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SRIVASTAVA, S.S., BEREZUK, A.M., DEMERS, J.P., SAVILLE, J.W., LEOPOLD, K., LI, W., DIMITROV, D.S., TUTTLE, K.S., ZHOU, S., CHITTORI, S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7ND3,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHAO, Y., REN, J., STUART, D.",ELECTRON MICROSCOPY,NONE
7WPH,N,,SARS-COV2 RBD BOUND TO FAB06,PROTEIN BINDING,"SARS-COV2 RBD, ANTIBODY, PROTEIN BINDING",ENGINEERING SARS-COV-2 COCKTAIL ANTIBODIES INTO A BISPECIFIC FORMAT IMPROVES NEUTRALIZING POTENCY AND BREADTH.,,,E,D,A,PROTEIN,SPIKE PROTEIN S1,PROTEIN BINDING,03/30/22,SARS-COV2 RBD BOUND TO FAB06,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIN, J.Q., EL SAHILI, A., LESCAR, J.",X-RAY DIFFRACTION,NONE
7WEE,N,,SARS-COV-2 OMICRON VARIANT SPIKE RBD IN COMPLEX WITH FAB XGV265,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE RBD IN COMPLEX WITH FAB XGV265,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
4ZPT,,"D12 FAB HEAVY CHAIN, D12 FAB LIGHT CHAIN, SPIKE GLYCOPROTEIN",STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1),VIRAL PROTEIN/IMMUNE SYSTEM,"VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",EVALUATION OF CANDIDATE VACCINE APPROACHES FOR MERS-COV,,,H,L,S,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/08/15,STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1),HUMAN CORONAVIRUS EMC (ISOLATE UNITED KINGDOM/H123990006/2012); MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,HUMAN CORONAVIRUS EMC (ISOLATE UNITEDKINGDOM/H123990006/2012) ,"JOYCE, M.G., MASCOLA, J.R., GRAHAM, B.S., KWONG, P.D.",X-RAY DIFFRACTION,TBD
7V24,N,,LOCAL CRYOEM STRUCTURE OF DEL68-76/DEL679-688 PREFUSION-STABILIZED SPIKE IN COMPLEX WITH THE FAB OF N12-9,VIRAL PROTEIN,"SPIKE, ANTIBODY, VIRAL PROTEIN",LOCAL CRYOEM STRUCTURE OF DEL68-76/DEL679-688 PREFUSION-STABILIZED SPIKE IN COMPLEX WITH THE FAB OF N12-9,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/10/22,LOCAL CRYOEM STRUCTURE OF DEL68-76/DEL679-688 PREFUSION-STABILIZED SPIKE IN COMPLEX WITH THE FAB OF N12-9,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.",ELECTRON MICROSCOPY,NONE
7PQY,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH FI-3A FAB,VIRAL PROTEIN,"SARS-COV-2 ANTIBODY, RECEPTOR-BINDING-DOMAIN, RBD, SPIKE, NEUTRALISATION, FI-3A, FD-11A, FD-5D, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",STRUCTURES AND THERAPEUTIC POTENTIAL OF ANTI-RBD HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,02/02/22,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH FI-3A FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7KN3,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN COMPLEXED WITH A PRE-PANDEMIC ANTIBODY S-B8 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PHAGE DISPLAY, PRE-PANDEMIC",NEUTRALIZING ANTIBODIES TO SARS-COV-2 SELECTED FROM A HUMAN ANTIBODY LIBRARY CONSTRUCTED DECADES AGO.,,,M,N,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/22/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN COMPLEXED WITH A PRE-PANDEMIC ANTIBODY S-B8 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7U09,N,,CRYSTAL STRUCTURE OF C13B8 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE, COVID-19, FUSION PEPTIDE, FAB, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ACE2-BINDING EXPOSES THE SARS-COV-2 FUSION PEPTIDE TO BROADLY NEUTRALIZING CORONAVIRUS ANTIBODIES.,,,H,L,A,PEPTIDE,SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/22,CRYSTAL STRUCTURE OF C13B8 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,MAMMAL ENVIRONMENTAL SAMPLE; SYNTHETIC CONSTRUCT,MAMMAL ENVIRONMENTAL SAMPLE,MAMMAL ENVIRONMENTAL SAMPLE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M.A., VEESLER, D.",X-RAY DIFFRACTION,NONE
7KXK,N,,"SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-""UP""-1-""DOWN"" CONFORMATION",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN",TETRAVALENT SARS-COV-2 NEUTRALIZING ANTIBODIES SHOW ENHANCED POTENCY AND RESISTANCE TO ESCAPE MUTATIONS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/04/20,"SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-""""UP""""-1-""""DOWN"""" CONFORMATION",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Z., RINI, J.",ELECTRON MICROSCOPY,NONE
7ZF8,N,,SARS-COV-2 OMICRON BA.2 RBD IN COMPLEX WITH COVOX-150 FAB,VIRAL PROTEIN,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, COVOX-150, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,SARS-COV-2 OMICRON BA.2 RBD IN COMPLEX WITH COVOX-150 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7E5Y,N,,MOLECULAR BASIS FOR NEUTRALIZING ANTIBODY 2B11 TARGETING SARS-COV-2 RBD,VIRAL PROTEIN,"COMPLEX, ANTIBODY, VIRAL PROTEIN",SCREENING OF POTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 USING CONVALESCENT PATIENTS-DERIVED PHAGE-DISPLAY LIBRARIES.,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/23/21,MOLECULAR BASIS FOR NEUTRALIZING ANTIBODY 2B11 TARGETING SARS-COV-2 RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WU, H., YU, F., WANG, Q.S., ZHOU, H., WANG, W.W., ZHAO, T., PAN, Y.B., YANG, X.M.",X-RAY DIFFRACTION,NONE
7UAP,N,,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE NEUTRALIZING ANTIBODY FAB FRAGMENT, C1520",VIRAL PROTEIN,"SARS-COV-2, N-TERMINAL DOMAIN, NTD, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",ANALYSIS OF MEMORY B CELLS IDENTIFIES CONSERVED NEUTRALIZING EPITOPES ON THE N-TERMINAL DOMAIN OF VARIANT SARS-COV-2 SPIKE PROTEINS.,,,M,N,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/27/22,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE NEUTRALIZING ANTIBODY FAB FRAGMENT, C1520",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O.",ELECTRON MICROSCOPY,NONE
7AKD,N,"SPIKE GLYCOPROTEIN, 47D11 NEUTRALIZING ANTIBODY HEAVY CHAIN, 47D11 NEUTRALIZING ANTIBODY LIGHT CHAIN",STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,"SARS-COV-2, SPIKE, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURAL INSIGHTS INTO THE CROSS-NEUTRALIZATION OF SARS-COV AND SARS-COV-2 BY THE HUMAN MONOCLONAL ANTIBODY 47D11.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/19/21,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FEDRY, J., HURDISS, D.L., WANG, C., LI, W., OBAL, G., DRULYTE, I., HOWES, S.C., VAN KUPPEVELD, F.J.M., FOERSTER, F., BOSCH, B.J.",ELECTRON MICROSCOPY,NONE
7NP1,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODY ION-360,VIRAL PROTEIN,"ANTIBODY IMMUNE SYSTEM, VIRAL PROTEIN",CROSS-REACTIVE SARS-COV-2 NEUTRALIZING ANTIBODIES FROM DEEP MINING OF EARLY PATIENT RESPONSES.,,,I,M,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,11/17/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODY ION-360,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALL, G., COWAN, R., CARR, M.",X-RAY DIFFRACTION,NONE
7CWL,N,"SPIKE GLYCOPROTEIN, FAB P17 HEAVY CHAIN, FAB P17 LIGHT CHAIN",SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE,VIRAL PROTEIN,"COMPLEX, FAB, SARS-COV-2 SPIKE PROTEIN, VIRAL PROTEIN",RATIONAL DEVELOPMENT OF A HUMAN ANTIBODY COCKTAIL THAT DEPLOYS MULTIPLE FUNCTIONS TO CONFER PAN-SARS-COVS PROTECTION.,,,I,K,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/29/20,SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, N.",ELECTRON MICROSCOPY,NONE
2DD8,,"IGG HEAVY CHAIN, IGG LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY,,,H,L,S,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,01/24/06,CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY,HOMO SAPIENS; SARS CORONAVIRUS,HOMO SAPIENS,HOMO SAPIENS,SARS CORONAVIRUS,"PRABAKARAN, P., GAN, J.H., FENG, Y., ZHU, Z.Y., XIAO, X.D., JI, X., DIMITROV, D.S.",X-RAY DIFFRACTION,16597622
6PIL,N,SCFV-M204 ANTIBODY,ANTIBODY SCFV-M204 MONOMERIC STATE,IMMUNE SYSTEM,"ANTI-TAU-OLIGOMER SCFV ANTIBODY, IMMUNE SYSTEM",CRYSTAL STRUCTURE OF A CONFORMATIONAL ANTIBODY THAT BINDS TAU OLIGOMERS AND INHIBITS PATHOLOGICAL SEEDING BY EXTRACTS FROM DONORS WITH ALZHEIMER'S DISEASE.,,,A,A,,,,IMMUNE SYSTEM,06/26/19,ANTIBODY SCFV-M204 MONOMERIC STATE,ORYCTOLAGUS CUNICULUS,ORYCTOLAGUS CUNICULUS,,,"ABSKHARON, R., SAWAYA, M.R., SEIDLER, P.M., CASCIO, D., EISENBERG, D.S.",X-RAY DIFFRACTION,NONE
7LRS,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR-BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ULTRAPOTENT ANTIBODIES AGAINST DIVERSE AND HIGHLY TRANSMISSIBLE SARS-COV-2 VARIANTS.,,,D,E,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/14/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., TSYBOVSKY, Y.",ELECTRON MICROSCOPY,NONE
7F46,N,,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB (STATE1, LOCAL REFINEMENT OF THE RBD, NTD AND 35B5 FAB)",VIRAL PROTEIN,"IMMUNE SYSTEM, VIRAL PROTEIN",A POTENT HUMAN MONOCLONAL ANTIBODY WITH PAN-NEUTRALIZING ACTIVITIES DIRECTLY DISLOCATES S TRIMER OF SARS-COV-2 THROUGH BINDING BOTH UP AND DOWN FORMS OF RBD,,,H,L,B | C,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/23/22,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB (STATE1, LOCAL REFINEMENT OF THE RBD, NTD AND 35B5 FAB)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.F., ZHU, Y.Q.",ELECTRON MICROSCOPY,NONE
8CYB,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7CWU,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF P17 FAB, LIGHT CHAIN OF P17 FAB, HEAVY CHAIN OF FC05 FAB, LIGHT CHAIN OF FC05 FAB",SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL,VIRAL PROTEIN,VIRAL PROTEIN,STRUCTURE-BASED DEVELOPMENT OF HUMAN ANTIBODY COCKTAILS AGAINST SARS-COV-2.,,,N,G,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/31/20,SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, N.",ELECTRON MICROSCOPY,NONE
7RKS,N,,"STRUCTURE OF THE SARS-COV RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C118",VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, SURFACE PROTEIN, FAB, CORONAVIRUS, FUSION PROTEIN, BINDING DOMAIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",BROAD CROSS-REACTIVITY ACROSS SARBECOVIRUSES EXHIBITED BY A SUBSET OF COVID-19 DONOR-DERIVED NEUTRALIZING ANTIBODIES.,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/22/21,"STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C118",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"JETTE, C.A., BJORKMAN, P.J., BARNES, C.O.",X-RAY DIFFRACTION,NONE
7EH5,N,,"CRYO-EM STRUCTURE OF SARS-COV-2 S-D614G VARIANT IN COMPLEX WITH NEUTRALIZING ANTIBODIES, RBD-CHAB15 AND RBD-CHAB45",VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, VIRAL PROTEIN, NEUTRALIZING ANTIBODY",EFFECT OF SARS-COV-2 B.1.1.7 MUTATIONS ON SPIKE PROTEIN STRUCTURE AND FUNCTION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,09/01/21,"CRYO-EM STRUCTURE OF SARS-COV-2 S-D614G VARIANT IN COMPLEX WITH NEUTRALIZING ANTIBODIES, RBD-CHAB15 AND RBD-CHAB45",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, T.J., YU, P.Y., CHANG, Y.C., WU, H.C., HSU, S.T.D.",ELECTRON MICROSCOPY,NONE
7D2Z,N,,STRUCTURE OF SYBODY SR31 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD),PROTEIN BINDING,"CORONAVIRUS, COVID-19, NANOBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING PROTEIN, SARS-COV-2, S PROTEIN, SYNTHETIC ANTIBODY, VHH., PROTEIN BINDING",A HIGH-AFFINITY RBD-TARGETING NANOBODY IMPROVES FUSION PARTNER'S POTENCY AGAINST SARS-COV-2.,,,A,,B,PROTEIN,SPIKE PROTEIN S1,PROTEIN BINDING,02/17/21,STRUCTURE OF SYBODY SR31 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD),SYNTHETIC CONSTRUCT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T., CAI, H., YAO, H., QIN, W., LI, D.",X-RAY DIFFRACTION,NONE
7K8Z,N,"SPIKE GLYCOPROTEIN, C135 FAB LIGHT CHAIN, C135 FAB HEAVY CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,M,N,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7BNV,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODY ION-300,VIRAL PROTEIN,"ANTIBODY IMMUNE SYSTEM, VIRAL PROTEIN",CROSS-REACTIVE SARS-COV-2 NEUTRALIZING ANTIBODIES FROM DEEP MINING OF EARLY PATIENT RESPONSES.,,,H,L,A,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,11/17/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODY ION-300,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALL, G., COWAN, R., CARR, M.",X-RAY DIFFRACTION,NONE
6XC3,N,"CR3022 HEAVY CHAIN, CR3022 LIGHT CHAIN, CC12.1 LIGHT CHAIN, CC12.1 HEAVY CHAIN, SPIKE PROTEIN S1",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY, SARS-COV-2, CORONAVIRUS, SPIKE, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",STRUCTURAL BASIS OF A SHARED ANTIBODY RESPONSE TO SARS-COV-2.,,,H,L,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,06/08/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., LIU, H., WU, N.C., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
5YY5,N,"MERS-COV RBD, HEAVY CHAIN, LIGHT CHAIN",STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN,VIRAL PROTEIN,"MERS-COV, SPIKE GLYCORPTOTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN,,,H,L,A,PROTEIN,MERS-COV RBD,VIRAL PROTEIN,12/08/17,STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS,"ZHANG, S.Y., WANG, P.F., ZHOU, P.P., WANG, X.Q., ZHANG, L.Q.",X-RAY DIFFRACTION,NONE
7VMU,N,,CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY,IMMUNE SYSTEM,"SARS-COV-2 VARIANTS, COVID-19, NEUTRALIZING ANTIBODY, PHAGE DISPLAY LIBRARY, ANTIBODY ENGINEERING, IMMUNE SYSTEM",ANTIBODY ENGINEERING IMPROVES NEUTRALIZATION ACTIVITY AGAINST K417 SPIKE MUTANT VARIANTS OF SARS-COV-2,,,A,A,B,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM,11/03/21,CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, Y., WANG, W., JIAO, P., YANG, H., RAO, Z., CHENG, G.",X-RAY DIFFRACTION,NONE
7CHO,N,,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P5A-1D2 WITH RBD,VIRAL PROTEIN,"SPIKE, RECEPTOR BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN",POTENT AND PROTECTIVE IGHV3-53/3-66 PUBLIC ANTIBODIES AND THEIR SHARED ESCAPE MUTANT ON THE SPIKE OF SARS-COV-2.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/19/21,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P5A-1D2 WITH RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHANG, L., GE, J., WANG, R., ZHANG, Q.",X-RAY DIFFRACTION,NONE
7TAS,N,,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2K146 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND S2K146),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, INHIBITOR, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY-MEDIATED BROAD SARBECOVIRUS NEUTRALIZATION THROUGH ACE2 MOLECULAR MIMICRY.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,01/12/22,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2K146 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND S2K146),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7EAN,N,,IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 6D6,VIRAL PROTEIN,"SARS-COV-2, RECEPTOR BINDING DOMAIN, NEUTRALIZING ANTIBODY, IMMUNE COMPLEX, VIRAL PROTEIN",CROSS-NEUTRALIZING ANTIBODIES BIND A SARS-COV-2 CRYPTIC SITE AND RESIST CIRCULATING VARIANTS.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,03/31/21,IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 6D6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T.T., GU, Y., LI, S.W.",X-RAY DIFFRACTION,NONE
7E5S,N,,SARS-COV-2 S TRIMER WITH FOUR-ANTIBODY COCKTAIL COMPLEX,VIRAL PROTEIN/IMMUNE SYSTEM,"COMPLEX, ANTIBODY, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURE-BASED DEVELOPMENT OF THREE- AND FOUR-ANTIBODY COCKTAILS AGAINST SARS-COV-2 VIA MULTIPLE MECHANISMS.,,,U,Q,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/17/21,SARS-COV-2 S TRIMER WITH FOUR-ANTIBODY COCKTAIL COMPLEX,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, Y., WANG, L., WANG, N., FENG, R., WANG, X.",ELECTRON MICROSCOPY,NONE
6WPS,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, S309 NEUTRALIZING ANTIBODY HEAVY CHAIN, S309 NEUTRALIZING ANTIBODY LIGHT CHAIN",STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SARS-COV, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODY, SARBECOVIRUS, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CROSS-NEUTRALIZATION OF SARS-COV-2 BY A HUMAN MONOCLONAL SARS-COV ANTIBODY.,,,F,G,E,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/27/20,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PINTO, D., PARK, Y.J., BELTRAMELLO, M., WALLS, A.C., TORTORICI, M.A., BIANCHI, S., JACONI, S., CULAP, K., ZATTA, F., DE MARCO, A., PETER, A., GUARINO, B., SPREAFICO, R., CAMERONI, E., CASE, J.B., CHEN, R.E., HAVENAR-DAUGHTON, C., SNELL, G., VIRGIN, H.W., LANZAVECCHIA, A., DIAMOND, M.S., FINK, K., VEESLER, D., CORTI, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7YE5,N,,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 2 R1-32 FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"ACE2, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 2 R1-32 FABS,,,H,L,A | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 2 R1-32 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, B., GAO, X., LI, Z., CHEN, X., HE, J., CHEN, L., XIONG, X.",ELECTRON MICROSCOPY,NONE
7WBZ,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH FAB 2303,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CONFORMATIONAL FLEXIBILITY IN NEUTRALIZATION OF SARS-COV-2 BY NATURALLY ELICITED ANTI-SARS-COV-2 ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/31/22,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH FAB 2303,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XIANG, Y., MA, B.",X-RAY DIFFRACTION,NONE
3ZKQ,,"BETA-SECRETASE 2 (E.C.3.4.23.45), XA4813",BACE2 XAPERONE COMPLEX,HYDROLASE/IMMUNE SYSTEM,"HYDROLASE-IMMUNE SYSTEM COMPLEX, NANOBODY","MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USING SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS, FYNOMERS, AND XAPERONES",,,D,,A,PROTEIN,BETA-SECRETASE 2,HYDROLASE/IMMUNE SYSTEM,01/24/13,BACE2 XAPERONE COMPLEX,LAMA GLAMA; HOMO SAPIENS,LAMA GLAMA,,HOMO SAPIENS,"BANNER, D.W., KUGLSTATTER, A., BENZ, J., STIHLE, M., RUF, A.",X-RAY DIFFRACTION,TBD
6VN0,N,"ENVELOPE GLYCOPROTEIN GP160, BG505 SOSIPV5.2 GP41, RM19R KAPPA LIGHT CHAIN, RM19R HEAVY CHAIN",BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MAPPING THE IMMUNOGENIC LANDSCAPE OF NEAR-NATIVE HIV-1 ENVELOPE TRIMERS IN NON-HUMAN PRIMATES.,,,I,K,F | D,PROTEIN | PROTEIN,ENVELOPE GLYCOPROTEIN GP41 | ENVELOPE GLYCOPROTEIN GP160,VIRAL PROTEIN/IMMUNE SYSTEM,06/24/20,BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F,HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,HUMAN IMMUNODEFICIENCY VIRUS 1 | HUMAN IMMUNODEFICIENCY VIRUS 1,"COTTRELL, C.A., SHIN, M., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7KLC,N,,CRYSTAL STRUCTURE OF M4H2K1 FAB BOUND TO HIV-1 BG505 GP120 CORE AND TO 17B FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"MOUSE ANTIBODY, IMMUNE SYSTEM, ANTI-HIV1 NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",NEUTRALIZING ANTIBODIES INDUCED BY FIRST-GENERATION GP41-STABILIZED HIV-1 ENVELOPE TRIMERS AND NANOPARTICLES.,,,H,L,A,PROTEIN,"HIV-1 CLADE A BG505 GP120,HIV-1 CLADE A BG505 GP120",VIRAL PROTEIN/IMMUNE SYSTEM,07/07/21,CRYSTAL STRUCTURE OF M4H2K1 FAB BOUND TO HIV-1 BG505 GP120 CORE AND TO 17B FAB,MUS MUSCULUS; HOMO SAPIENS; HUMAN IMMUNODEFICIENCY VIRUS 1,MUS MUSCULUS,MUS MUSCULUS,HUMAN IMMUNODEFICIENCY VIRUS 1,"KUMAR, S., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7LQW,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, NEUTRALIZING ANTIBODY 2-17 FAB",CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 2-17 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, COVID19, SARS-COV2, PREFUSION, NEUTRALIZING, NTD, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT SARS-COV-2 NEUTRALIZING ANTIBODIES DIRECTED AGAINST SPIKE N-TERMINAL DOMAIN TARGET A SINGLE SUPERSITE.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/24/21,CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 2-17 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GORMAN, J., RAPP, M., KWONG, P.D., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7MW5,N,,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH ONE RBD DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 2,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","DEVELOPMENT, STRUCTURE AND FUNCTION OF POTENT MONOSPECIFIC AND BISPECIFIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE SARS-COV-2 AND ITS MUTANT VARIANT",,,F,G,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/16/22,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH ONE RBD DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HU, Y., XIONG, Y.",ELECTRON MICROSCOPY,NONE
7QEZ,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE ULTRAPOTENT ANTIBODY CV2.1169 AND CR3022,VIRAL PROTEIN,"NEUTRALIZATION, ANTIBODY, CORONAVIRUS, VIRAL PROTEIN","POTENT ANTIBODIES AGAINST SARS-COV-2 
ISOLATED FROM A PATIENT",,,E,F,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/18/22,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE ULTRAPOTENT ANTIBODY CV2.1169 AND CR3022,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FERNANDEZ, I., REY, F.A.",X-RAY DIFFRACTION,NONE
7RQ6,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NON-NEUTRALIZING NTD-DIRECTED CV3-13 FAB ISOLATED FROM CONVALESCENT INDIVIDUAL,VIRAL PROTEIN/IMMUNE SYSTEM,"HUMAN NON-NEUTRALIZING MAB, NTD-DIRECTED ANTIBODY, ADCC, NOVEL NTD EPITOPE, SARS-COV-2, SPIKE, N-TERMINAL DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A FC-ENHANCED NTD-BINDING NON-NEUTRALIZING ANTIBODY DELAYS VIRUS SPREAD AND SYNERGIZES WITH A NAB TO PROTECT MICE FROM LETHAL SARS-COV-2 INFECTION.,,,J,K,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/20/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NON-NEUTRALIZING NTD-DIRECTED CV3-13 FAB ISOLATED FROM CONVALESCENT INDIVIDUAL,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CHEN, Y., POZHARSKIY, E., TOLBERT, W.D., PAZGIER, M.",ELECTRON MICROSCOPY,NONE
7L0N,N,"LIGHT CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S309, HEAVY CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S309, LIGHT CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S2H14, HEAVY CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S2H14, LIGHT CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S304, HEAVY CHAIN OF FAB DOMAIN OF MONOCLONAL ANTIBODY S304, SPIKE GLYCOPROTEIN",CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY,VIRAL PROTEIN/HYDROLASE,"COVID-19, SARS-COV-2, VARIANT RBD, VIRAL PROTEIN-RECEPTOR COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-HYDROLASE COMPLEX",CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY.,,,M,N,S,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/HYDROLASE,02/17/21,CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SNELL, G., CZUDNOCHOWSKI, N., DILLEN, J., NIX, J.C., CROLL, T.I., CORTI, D.",X-RAY DIFFRACTION,NONE
5JMO,N,"FURIN (E.C.3.4.21.75), CAMELID VHH FRAGMENT, CMK-INHIBITOR",X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE INHIBITORY ANTIBODY NB14,HYDROLASE/ANTIBODY,"PROTEASE, CAMELID, ANTIBODY, COMPLEX, HYDROLASE-ANTIBODY COMPLEX, FURIN",THE STRUCTURE OF A FURIN-ANTIBODY COMPLEX EXPLAINS NON-COMPETITIVE INHIBITION BY STERIC EXCLUSION OF SUBSTRATE CONFORMERS.,,,C,,A,PROTEIN,FURIN,HYDROLASE/ANTIBODY,04/29/16,X-RAY STRUCTURE OF A PROTEASE-ANTIBODY COMPLEX,CAMELUS DROMEDARIUS; HOMO SAPIENS; SYNTHETIC CONSTRUCT,CAMELUS DROMEDARIUS,,HOMO SAPIENS,"DAHMS, S.O., THAN, M.E.",X-RAY DIFFRACTION,NONE
7BZ5,N,"SPIKE PROTEIN S1, HEAVY CHAIN OF B38, LIGHT CHAIN OF B38",STRUCTURE OF COVID-19 VIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH A NEUTRALIZING ANTIBODY,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19 ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A NONCOMPETING PAIR OF HUMAN NEUTRALIZING ANTIBODIES BLOCK COVID-19 VIRUS BINDING TO ITS RECEPTOR ACE2.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/13/20,STRUCTURE OF COVID-19 VIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH A NEUTRALIZING ANTIBODY,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WU, Y., QI, J., GAO, F.",X-RAY DIFFRACTION,NONE
7UPW,N,,THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,VIRAL PROTEIN,HUMANIZED ANTIBODY POTENTLY NEUTRALIZES ALL SARS-COV-2 VARIANTS BY A NOVEL MECHANISM,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/10/22,THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT,HOMO SAPIENS; MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"HOMO SAPIENS, MUS MUSCULUS","HOMO SAPIENS, MUS MUSCULUS",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"ZHANG, J., LUO, S., KREUTZBERGER, A., KIRCHHAUSEN, T., CHEN, B., HAYNES, B., ALT, F.",ELECTRON MICROSCOPY,NONE
7Z1E,N,,NANOBODY H11-H4 Q98R H100E BOUND TO RBD,ANTIVIRAL PROTEIN,"SPIKE, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",STRUCTURE OF NANOBODY H11-H4 Q98R H100E BOUND TO RBD,,,F,,E,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,01/08/09,NANOBODY H11-H4 Q98R H100E BOUND TO RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,,,,"MIKOLAJEK, H., NAISMITH, J.H.",X-RAY DIFFRACTION,NONE
7LDJ,N,"SPIKE GLYCOPROTEIN, NANOBODY 2",SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH WNB-2,VIRAL PROTEIN/IMMUNE SYSTEM,"NANOBODY, COMPLEX, SARS-COV-2, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH WNB-2,,,G,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/05/21,SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH WNB-2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., DIETRICH, M.H., TAN, L.L., ADAIR, A., THAM, W.H.",X-RAY DIFFRACTION,NONE
7TLZ,N,,SARS-COV-2 S NTD B.1.1.529 OMICRON VARIANT + S309 LOCAL REFINEMENT,VIRUS/IMMUNE SYSTEM,"OMICRON, RECEPTOR-BINDING DOMAIN, SARS-COV-2, COVID, B.1.529, NTD, ANTIBODY, FAB, S2L20, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRUS-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS OF SARS-COV-2 OMICRON IMMUNE EVASION AND RECEPTOR ENGAGEMENT.,,,B,A,J,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS/IMMUNE SYSTEM,02/02/22,SARS-COV-2 S NTD B.1.1.529 OMICRON VARIANT + S309 LOCAL REFINEMENT,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7T7B,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING ANTIBODY ADI-62113 FAB,IMMUNE SYSTEM/VIRAL PROTEIN,"CROSS-NEUTRALIZING ANTIBODY; YYDRXG; SARS-COV-2; ADI-62113; SARBECOVIRUS; PATTERN SEARCH; IGHD3-22, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",HUMAN ANTIBODIES TO SARS-COV-2 WITH A RECURRING YYDRXG MOTIF RETAIN BINDING AND NEUTRALIZATION TO VARIANTS OF CONCERN INCLUDING OMICRON.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,08/03/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING ANTIBODY ADI-62113 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7E5R,N,,SARS-COV-2 S TRIMER WITH THREE-ANTIBODY COCKTAIL COMPLEX,VIRAL PROTEIN/IMMUNE SYSTEM,"COMPLEX, ANTIBODY, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURE-BASED DEVELOPMENT OF THREE- AND FOUR-ANTIBODY COCKTAILS AGAINST SARS-COV-2 VIA MULTIPLE MECHANISMS.,,,L,H,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/13/21,SARS-COV-2 S TRIMER WITH THREE-ANTIBODY COCKTAIL COMPLEX,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, Y., WANG, L., WANG, N., FENG, R., WANG, X.",ELECTRON MICROSCOPY,NONE
5W9P,N,"SPIKE GLYCOPROTEIN, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,D,E,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7MW4,N,,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH ONE RBD DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 6,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","DEVELOPMENT, STRUCTURE AND FUNCTION OF POTENT MONOSPECIFIC AND BISPECIFIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE SARS-COV-2 AND ITS MUTANT VARIANT",,,F,G,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/16/22,STRUCTURE OF THE SARS-COV-2 SPIKE TRIMER WITH ONE RBD DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY CLONE 6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HU, Y., XIONG, Y.",ELECTRON MICROSCOPY,NONE
7NXA,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY EVASION BY THE P.1 STRAIN OF SARS-COV-2.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/07/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7N0H,N,,"CRYOEM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN (S-6P, 2-UP) IN COMPLEX WITH SYBODIES (SB45)",VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, S-6P (HEXAPRO), NANOBODY, SYBODY, SB45, NEUTRALIZATION, VIRAL PROTEIN",STRUCTURES OF SYNTHETIC NANOBODY-SARS-COV-2 RECEPTOR-BINDING DOMAIN COMPLEXES REVEAL DISTINCT SITES OF INTERACTION.,,,Z,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/02/21,"CRYOEM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN (S-6P, 2-UP) IN COMPLEX WITH SYBODIES (SB45)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JIANG, J., HUANG, R., MARGULIES, D.",ELECTRON MICROSCOPY,NONE
7Q9M,N,,BETA-53 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,E,F,B,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/15/21,BETA-53 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7C8W,N,,STRUCTURE OF SYBODY MR17 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD),PROTEIN BINDING,"CORONAVIRUS, COVID-19, NANOBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING PROTEIN, SARS-COV-2, S PROTEIN, SYNTHETIC ANTIBODY, VHH., PROTEIN BINDING",A SYNTHETIC NANOBODY TARGETING RBD PROTECTS HAMSTERS FROM SARS-COV-2 INFECTION.,,,A,,B,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,06/03/20,STRUCTURE OF SYBODY MR17 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD),SYNTHETIC CONSTRUCT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T., CAI, H., YAO, H., QIN, W., LI, D.",X-RAY DIFFRACTION,NONE
6YLA,N,"SARS-COV-2 RBD, HEAVY CHAIN, LIGHT CHAIN",CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH CR3022 FAB,VIRAL PROTEIN,"SARS-COV-2 SPIKE PROTEIN, RBD, CR3022, COMPLEX, VIRAL PROTEIN",NEUTRALIZATION OF SARS-COV-2 BY DESTRUCTION OF THE PREFUSION SPIKE.,,,H,L,E,PROTEIN,SARS-COV-2 RBD,VIRAL PROTEIN,04/06/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH CR3022 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUO, J., ZHAO, Y., REN, J., ZHOU, D., GINN, H.M., FRY, E.E., OWENS, R., STUART, D.I.",X-RAY DIFFRACTION,NONE
7R8N,N,,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C051,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR BINDING DOMAIN, RBD, NEUTRALIZING ANTIBODY, COVID-19, SPIKE, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,M,N,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C051,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
5JS9,N,"BROADLY NEUTRALIZING ANTIBODY PGT128 HEAVY CHAIN, BROADLY NEUTRALIZING ANTIBODY PGT128 LIGHT CHAIN, GP120, GP41, BROADLY NEUTRALIZING ANTIBODY 8ANC195 HEAVY CHAIN, BROADLY NEUTRALIZING ANTIBODY 8ANC195 LIGHT CHAIN",UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8-RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",UNCLEAVED PREFUSION-OPTIMIZED GP140 TRIMERS DERIVED FROM ANALYSIS OF HIV-1 ENVELOPE METASTABILITY.,,,E,F,C | D,PROTEIN | PROTEIN,GP120 | GP41,VIRAL PROTEIN/IMMUNE SYSTEM,07/13/16,UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8-RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128,HOMO SAPIENS; HUMAN IMMUNODEFICIENCY VIRUS 1,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1 | HUMAN IMMUNODEFICIENCY VIRUS 1,"KONG, L., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7KXJ,N,,"SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-""UP"", ASYMMETRIC",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN",TETRAVALENT SARS-COV-2 NEUTRALIZING ANTIBODIES SHOW ENHANCED POTENCY AND RESISTANCE TO ESCAPE MUTATIONS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/04/20,"SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-""""UP"""", ASYMMETRIC",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Z., RINI, J.",ELECTRON MICROSCOPY,NONE
7WD8,N,,SARS-COV-2 BETA SPIKE SD1 IN COMPLEX WITH S3H3 FAB,VIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, BETA VARIANT, B.1.351 LINEAGE, SPIKE PROTEIN, VIRAL PROTEIN",MAPPING CROSS-VARIANT NEUTRALIZING SITES ON THE SARS-COV-2 SPIKE PROTEIN.,,,E,F,B | A,PROTEIN | PEPTIDE,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,02/02/22,SARS-COV-2 BETA SPIKE SD1 IN COMPLEX WITH S3H3 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y.F., CONG, Y.",ELECTRON MICROSCOPY,NONE
7U0E,N,,CRYSTAL STRUCTURE OF C13C9 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE, COVID-19, FUSION PEPTIDE, FAB, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ACE2-BINDING EXPOSES THE SARS-COV-2 FUSION PEPTIDE TO BROADLY NEUTRALIZING CORONAVIRUS ANTIBODIES.,,,A,B,D,PEPTIDE,SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/22,CRYSTAL STRUCTURE OF C13C9 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,MAMMAL ENVIRONMENTAL SAMPLE; SYNTHETIC CONSTRUCT,MAMMAL ENVIRONMENTAL SAMPLE,MAMMAL ENVIRONMENTAL SAMPLE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M.A., VEESLER, D.",X-RAY DIFFRACTION,NONE
7NS6,N,,SARS-COV-2 SPIKE (DIMERS) IN COMPLEX WITH SIX FU2 NANOBODIES,VIRAL PROTEIN,"NANOBODY, SPIKE, COMPLEX, DIMER, VIRAL PROTEIN",A BISPECIFIC MONOMERIC NANOBODY INDUCES SPIKE TRIMER DIMERS AND NEUTRALIZES SARS-COV-2 IN VIVO.,,,H,,J,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",VIRAL PROTEIN,02/02/22,SARS-COV-2 SPIKE (DIMERS) IN COMPLEX WITH SIX FU2 NANOBODIES,VICUGNA PACOS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ENTEROBACTERIA PHAGE T4,VICUGNA PACOS,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ENTEROBACTERIA PHAGE T4 ","DAS, H., HALLBERG, B.M.",ELECTRON MICROSCOPY,NONE
7DZY,N,"SPIKE GLYCOPROTEIN, FAB HEAVY CHAIN OF ENHANCING ANTIBODY 2490, FAB LIGHT CHAIN OF ENHANCING ANTIBODY 2490",SPIKE PROTEIN FROM SARS-COV2 WITH FAB FRAGMENT OF ENHANCING ANTIBODY 2490,VIRAL PROTEIN,"SARS-COV2, SPIKE PROTEIN, FAB, ENHANCING ANTIBODY, VIRAL PROTEIN",AN INFECTIVITY-ENHANCING SITE ON THE SARS-COV-2 SPIKE PROTEIN TARGETED BY ANTIBODIES.,,,O,P,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/02/21,SPIKE PROTEIN FROM SARS-COV2 WITH FAB FRAGMENT OF ENHANCING ANTIBODY 2490,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, Y., SOH, W.T., LI, S., KISHIKAWA, J., HIROSE, M., KATO, T., STANDLEY, D., OKADA, M., ARASE, H.",ELECTRON MICROSCOPY / HOMOLOGY MODEL,NONE
7ON5,N,,CRYSTAL STRUCTURE OF THE SARS-COV-2 NEUTRALIZING NANOBODY RE5D06,IMMUNE SYSTEM,"NEUTRALIZING VHH, IMMUNE SYSTEM","NEUTRALIZATION OF SARS-COV-2 BY HIGHLY POTENT, HYPERTHERMOSTABLE, AND MUTATION-TOLERANT NANOBODIES.",,,A,,,,,IMMUNE SYSTEM,08/11/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 NEUTRALIZING NANOBODY RE5D06,VICUGNA PACOS,VICUGNA PACOS,,,"AKSU, M., GUTTLER, T., GORLICH, D.",X-RAY DIFFRACTION,NONE
7TP4,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY K398.22,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, NEUTRALIZING ANTIBODY, FAB, COVID-19, CORONAVIRUS, RECEPTOR-BINDING DOMAIN, RBD, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",BROADLY NEUTRALIZING ANTIBODIES TO SARS-RELATED VIRUSES CAN BE READILY INDUCED IN RHESUS MACAQUES.,,,H,L,Z,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,02/23/22,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY K398.22,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7K9I,N,,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB 2B04 (LOCAL REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"COMPLEX, NEUTRALIZING ANTIBODY, ACE2-COMPETITIVE, RECEPTOR-BINDING DOMAIN, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL MECHANISM OF SARS-COV-2 NEUTRALIZATION BY TWO MURINE ANTIBODIES TARGETING THE RBD.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/29/21,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB 2B04 (LOCAL REFINEMENT),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ERRICO, J.M., FREMONT, D.H., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",ELECTRON MICROSCOPY,NONE
7RSN,N,,AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV, ENV, ANTIBODY, BNAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE GLYCAN HOLE AREA OF HIV-1 ENVELOPE TRIMERS CONTRIBUTES PROMINENTLY TO THE INDUCTION OF AUTOLOGOUS NEUTRALIZATION.,,,H,L,A,PROTEIN,AMC018 GP120,VIRAL PROTEIN/IMMUNE SYSTEM,09/15/21,AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"COTTRELL, C.A., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7V27,N,,RBD/XG005 LOCAL REFINEMENT,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD DOMAIN, ANTIBODIES, INTERFACE REGION, VIRAL PROTEIN",RBD/XG005 LOCAL REFINEMENT,,,B,A,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,08/10/22,RBD/XG005 LOCAL REFINEMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., SUN, L., CHEN, Z.G.",ELECTRON MICROSCOPY,NONE
7KN7,N,"SPIKE PROTEIN S1, VHH W, CC12.3 FAB HEAVY CHAIN, CC12.3 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NANOBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, NANOBODY-ANTIGEN COMPLEX, SINGLE-DOMAIN ANTIBODY, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURE-GUIDED MULTIVALENT NANOBODIES BLOCK SARS-COV-2 INFECTION AND SUPPRESS MUTATIONAL ESCAPE.,,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,11/04/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS; HOMO SAPIENS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., YUAN, M., ZHU, X., WU, N.C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7KZC,N,"FAB HEAVY CHAIN OF M396-B10 ANTIBODY, FAB LIGHT CHAIN OF M396-B10 ANTIBODY",POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES,IMMUNE SYSTEM,"COVID19, SARS-COV2, ANTIBODY, IMMUNE SYSTEM",POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1 ANTIBODIES.,,,H,L,,,,IMMUNE SYSTEM,02/24/21,POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"LANGLEY, D.B., CHRIST, D.",X-RAY DIFFRACTION,NONE
7UPY,N,,ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,VIRAL PROTEIN,HUMANIZED ANTIBODY POTENTLY NEUTRALIZES ALL SARS-COV-2 VARIANTS BY A NOVEL MECHANISM,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/10/22,ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT,HOMO SAPIENS; MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"HOMO SAPIENS, MUS MUSCULUS","HOMO SAPIENS, MUS MUSCULUS",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"ZHANG, J., LUO, S., KREUTZBERGER, A., KIRCHHAUSEN, T., CHEN, B., HAYNES, B., ALT, F.",ELECTRON MICROSCOPY,NONE
7S0B,N,,STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODY N-612-056,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, SARS-COV-2, COVID-19, MRNA DISPLAY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",RAPID IDENTIFICATION OF NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 VARIANTS BY MRNA DISPLAY.,,,C,D,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,10/06/21,STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODY N-612-056,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TANAKA, S., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
6NB6,N,"SPIKE GLYCOPROTEIN, S230 HEAVY CHAIN, S230 LIGHT CHAIN",SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1),VIRUS,"CORONAVIRUS SPIKE GLYCOPROTEIN, MERS-COV, SARS-COV, HUMAN NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRUS",UNEXPECTED RECEPTOR FUNCTIONAL MIMICRY ELUCIDATES ACTIVATION OF CORONAVIRUS FUSION.,,,I,M,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS,12/06/18,SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1),SARS CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SARS CORONAVIRUS,"WALLS, A.C., XIONG, X., PARK, Y.J., TORTORICI, M.A., SNIJDER, S., QUISPE, J., CAMERONI, E., GOPAL, R., MIAN, D., LANZAVECCHIA, A., ZAMBON, M., REY, F.A., CORTI, D., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7W1S,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING NANOBODY NB-007,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A POTENT NEUTRALIZING NANOBODY TARGETING THE SPIKE RECEPTOR-BINDING DOMAIN OF SARS-COV-2 AND THE STRUCTURAL BASIS OF ITS INTIMATE BINDING.,,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/29/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING NANOBODY NB-007,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, J., LIN, S., SUN, H.L., LU, G.W.",X-RAY DIFFRACTION,NONE
7NEG,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, N501Y MUTATION, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",REDUCED NEUTRALIZATION OF SARS-COV-2 B.1.1.7 VARIANT BY CONVALESCENT AND VACCINE SERA.,,,H,L,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7X7O,N,,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING ANTIBODY UT28K,VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",NOVEL SUPER-NEUTRALIZING ANTIBODY UT28K IS CAPABLE OF PROTECTING AGAINST INFECTION FROM A WIDE VARIETY OF SARS-COV-2 VARIANTS.,,,H,L,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/25/22,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING ANTIBODY UT28K,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZAWA, T., TANI, H., ANRAKU, Y., KITA, S., IGARASHI, E., SAGA, Y., INASAKI, N., KAWASUJI, H., YAMADA, H., SASAKI, S., SOMEKAWA, M., SASAKI, J., HAYAKAWA, Y., YAMAMOTO, Y., MORINAGA, Y., KUROSAWA, N., ISOBE, M., FUKUHARA, H., MAENAKA, K., HASHIGUCHI, T., KISHI, H., KITAJIMA, I., SAITO, S., NIIMI, H.",X-RAY DIFFRACTION,NONE
7N0G,N,,"CRYOEM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN (S-6P, 1-UP) IN COMPLEX WITH SYBODIES (SB45)",VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, S-6P (HEXAPRO), NANOBODY, SYBODY, SB45, NEUTRALIZATION, VIRAL PROTEIN",STRUCTURES OF SYNTHETIC NANOBODY-SARS-COV-2 RECEPTOR-BINDING DOMAIN COMPLEXES REVEAL DISTINCT SITES OF INTERACTION.,,,Z,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/02/21,"CRYOEM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN (S-6P, 1-UP) IN COMPLEX WITH SYBODIES (SB45)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JIANG, J., HUANG, R., MARGULIES, D.",ELECTRON MICROSCOPY,NONE
7ZF4,N,,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-9 FAB AND NANOBODY F2,VIRAL PROTEIN,"SARS-COV-2, OMICRON, RBD, ANTIBODY, FAB, OMI-3, EY6A, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,F,,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/08/22,SARS-COV-2 OMICRON RBD IN COMPLEX WITH OMI-9 FAB AND NANOBODY F2,LAMA GLAMA; HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7Z1C,N,,NANOBODY H11-B5 AND H11-F2 BOUND TO RBD,ANTIVIRAL PROTEIN,"SPIKE, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",STRUCTURE OF NANOBODY B5 AND F2 BOUND TO RBD,,,D,,C,PROTEIN,SPIKE PROTEIN S1,ANTIVIRAL PROTEIN,03/23/22,NANOBODY H11-B5 AND H11-F2 BOUND TO RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MIKOLAJEK, H., NAISMITH, J.H.",X-RAY DIFFRACTION,NONE
8CYA,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-67,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,F,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-67,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7WE7,N,,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB XGV282,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,H,L,D,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB XGV282,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7M6F,N,"SPIKE GLYCOPROTEIN, BG1-22 FAB HEAVY CHAIN, BG1-22 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22",VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, COVID-19, ANTIBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING DOMAIN, SPIKE GLYCOPROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",B CELL GENOMICS BEHIND CROSS-NEUTRALIZATION OF SARS-COV-2 VARIANTS AND SARS-COV.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/ANTIVIRAL PROTEIN,05/05/21,"STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7V3L,N,,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 6516,PROTEIN BINDING,"MERS, SPIKE, ANTIBODY, PROTEIN BINDING",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 6516,,,H,I,C,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,08/17/22,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 6516,HOMO SAPIENS; HUMAN BETACORONAVIRUS 2C EMC/2012,HOMO SAPIENS,HOMO SAPIENS,HUMAN BETACORONAVIRUS 2C EMC/2012,"WANG, X., ZHAO, J., WANG, Z., WANG, Y., ZENG, J.",ELECTRON MICROSCOPY,NONE
7ZR8,N,,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (LOCAL REFINEMENT),STRUCTURAL PROTEIN,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM COMPLEX, STRUCTURAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,H,L,A,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",STRUCTURAL PROTEIN,06/01/22,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (LOCAL REFINEMENT),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ENTEROBACTERIA PHAGE T4; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ENTEROBACTERIA PHAGE T4 ","DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7WEC,N,,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN WITH THREE XGV347 FABS BINDING TO THREE CLOSED STATE RBDS,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,I,K,C,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN WITH THREE XGV347 FABS BINDING TO THREE CLOSED STATE RBDS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7Q6E,N,,"BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS-COV-2 VARIANTS",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,"BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS-COV-2 VARIANTS",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7CR5,N,"NUCLEOPROTEIN, MONOCLONAL ANTIBODY CHAIN H, MONOCLONAL ANTIBODY CHAIN L",COMPLEX STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY WITH SARS-COV-2 NUCLEOCAPSID PROTEIN NTD,VIRAL PROTEIN/IMMUNE SYSTEM,"HUMAN MONOCLONAL ANTIBODY, SARS-COV-2, NUCLEOCAPSID PROTEIN, COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A SARS-COV-2 ANTIBODY CURBS VIRAL NUCLEOCAPSID PROTEIN-INDUCED COMPLEMENT HYPERACTIVATION.,,,H,L,A,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/24/21,COMPLEX STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY WITH SARS-COV-2 NUCLEOCAPSID PROTEIN NTD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CHEN, S., KANG, S.",X-RAY DIFFRACTION,NONE
7WS1,N,,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
3J8D,,"GLYCOPROTEIN DIII, ANTIBODY E111 FAB FRAGMENT, ENVELOPE PROTEIN E",CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5,VIRUS/IMMUNE SYSTEM,"DENGUE VIRUS, DENV2 FAB E104, LOW PH, FUSION TRIMER, VIRUS-IMMUNE SYSTEM COMPLEX",STRUCTURE OF ACIDIC PH DENGUE VIRUS SHOWING THE FUSOGENIC GLYCOPROTEIN TRIMERS.,,,D,D,F,PROTEIN,GLYCOPROTEIN DIII,VIRUS/IMMUNE SYSTEM,10/13/14,CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5,DENGUE VIRUS 2 THAILAND/16681/84; UNIDENTIFIED,,UNIDENTIFIED,DENGUE VIRUS 2 THAILAND/16681/84,"ZHANG, X.Z., SHENG, J., AUSTIN, S.K., HOORNWEG, T., SMIT, J.M., KUHN, R.J., DIAMOND, M.S., ROSSMANN, M.G.",ELECTRON MICROSCOPY,NONE
7S0D,N,,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY N-612-014,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, COVID-19, SPIKE GLYCOPROTEIN, MRNA DISPLAY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",RAPID IDENTIFICATION OF NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 VARIANTS BY MRNA DISPLAY.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/06/21,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY N-612-014,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7D30,N,,STRUCTURE OF SYBODY MR17-SR31 FUSION IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD),PROTEIN BINDING,"CORONAVIRUS, COVID-19, NANOBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING PROTEIN, SARS-COV-2, S PROTEIN, SYNTHETIC ANTIBODY, VHH., PROTEIN BINDING",A HIGH-AFFINITY RBD-TARGETING NANOBODY IMPROVES FUSION PARTNER'S POTENCY AGAINST SARS-COV-2.,,,A,,B,PROTEIN,SPIKE PROTEIN S1,PROTEIN BINDING,02/17/21,STRUCTURE OF SYBODY MR17-SR31 FUSION IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD),SYNTHETIC CONSTRUCT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T., YAO, H., CAI, H., QIN, W., LI, D.",X-RAY DIFFRACTION,NONE
5DO2,,"S PROTEIN, 4C2 HEAVY CHAIN, 4C2 LIGHT CHAIN",COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY,VIRAL PROTEIN/IMMUNE SYSTEM,"RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE, 4C2 ANTIBODY, NEURALIZATION, RECEPTOR-BINDING BLOCKING., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A HUMANIZED NEUTRALIZING ANTIBODY AGAINST MERS-COV TARGETING THE RECEPTOR-BINDING DOMAIN OF THE SPIKE PROTEIN.,,,H,L,A,PROTEIN,S PROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/10/15,COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS,"LI, Y., WAN, Y., LIU, P., ZHAO, J., LU, G., QI, J., WANG, Q., LU, X., WU, Y., LIU, W., YUEN, K.Y., PERLMAN, S., GAO, G.F., YAN, J.",X-RAY DIFFRACTION,TBD
7E39,N,,SARS-COV-2 SPIKE IN COMPLEX WITH THE AB4 NEUTRALIZING ANTIBODY (STATE 3),VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, SARS-COV-2, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THREE EPITOPE-DISTINCT HUMAN ANTIBODIES FROM RENMAB MICE NEUTRALIZE SARS-COV-2 AND COOPERATIVELY MINIMIZE THE ESCAPE OF MUTANTS.,,,C,B,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/01/21,SARS-COV-2 SPIKE IN COMPLEX WITH THE AB4 NEUTRALIZING ANTIBODY (STATE 3),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, C.",ELECTRON MICROSCOPY,NONE
7MLX,N,,SARS-COV-2 PROGRAMMED -1 FRAMESHIFTING ELEMENT THREE STEM H-TYPE PSEUDOKNOT,RNA/IMMUNE SYSTEM,"H-TYPE PSEUDOKNOT, RNA, RNA-IMMUNE SYSTEM COMPLEX",THE SARS-COV-2 PROGRAMMED -1 RIBOSOMAL FRAMESHIFTING ELEMENT CRYSTAL STRUCTURE SOLVED TO 2.09 ANGSTROM USING CHAPERONE-ASSISTED RNA CRYSTALLOGRAPHY.,,,H,L,R,NUCLEIC-ACID,RNA (65-MER),RNA/IMMUNE SYSTEM,08/11/21,SARS-COV-2 PROGRAMMED -1 FRAMESHIFTING ELEMENT THREE STEM H-TYPE PSEUDOKNOT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ROMAN, C., LEWICKA, A.",X-RAY DIFFRACTION,NONE
6YOR,N,,STRUCTURE OF THE SARS-COV-2 SPIKE S1 PROTEIN IN COMPLEX WITH CR3022 FAB,VIRAL PROTEIN,"SARS-COV-2 SPIKE PROTEIN, RBD, CR3022, COMPLEX, VIRAL PROTEIN",NEUTRALIZATION OF SARS-COV-2 BY DESTRUCTION OF THE PREFUSION SPIKE.,,,B,C,A,PROTEIN,RBD,VIRAL PROTEIN,04/15/20,STRUCTURE OF THE SARS-COV-2 SPIKE S1 PROTEIN IN COMPLEX WITH CR3022 FAB,SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"HUO, J., ZHAO, Y., REN, J., ZHOU, D., DUYVESTEYN, H.M.E., CARRIQUE, L., MALINAUSKAS, T., RUZA, R.R., SHAH, P.N.M., FRY, E.E., OWENS, R., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7KN4,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN COMPLEXED WITH A PRE-PANDEMIC ANTIBODY S-E6 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PHAGE DISPLAY, PRE-PANDEMIC",NEUTRALIZING ANTIBODIES TO SARS-COV-2 SELECTED FROM A HUMAN ANTIBODY LIBRARY CONSTRUCTED DECADES AGO.,,,M,N,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/22/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN COMPLEXED WITH A PRE-PANDEMIC ANTIBODY S-E6 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7TC9,N,,LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODY A19-46.1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",TO BE PUBLISHED,,,H,L,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/30/22,LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODY A19-46.1,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"ZHOU, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7M6I,N,"SPIKE GLYCOPROTEIN, BG1-24 FAB LIGHT CHAIN, BG1-24 FAB HEAVY CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24",VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, COVID-19, ANTIBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING DOMAIN, SPIKE GLYCOPROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",B CELL GENOMICS BEHIND CROSS-NEUTRALIZATION OF SARS-COV-2 VARIANTS AND SARS-COV.,,,H,L,C | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/ANTIVIRAL PROTEIN,05/05/21,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7E8M,N,,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH MUTATED RBD,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE, RECEPTOR BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANALYSIS OF SARS-COV-2 VARIANT MUTATIONS REVEALS NEUTRALIZATION ESCAPE MECHANISMS AND THE ABILITY TO USE ACE2 RECEPTORS FROM ADDITIONAL SPECIES.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/26/21,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH MUTATED RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.Q., ZHANG, L.Q., GE, J.W., WANG, R.K., LAN, J.",X-RAY DIFFRACTION,NONE
7YDI,N,,"SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 3 R1-32 FABS AND 3 ACE2, FOCUSED REFINEMENT OF RBD REGION",VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SPIKE_GSAS_6P AND R1-32 FAB WITH 3TO1 RATIO,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,"SARS-COV-2 SPIKE (6P) IN COMPLEX WITH 3 R1-32 FABS AND 3 ACE2, FOCUSED REFINEMENT OF RBD REGION",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, B., GAO, X., LI, Z., CHEN, X., HE, J., CHEN, L., XIONG, X.",ELECTRON MICROSCOPY,NONE
7A5S,N,"CR3022 FAB HEAVY CHAIN, CR3022 FAB LIGHT CHAIN, SPIKE GLYCOPROTEIN,SURFACE GLYCOPROTEIN",COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT),VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",ANTIBODY-MEDIATED DISRUPTION OF THE SARS-COV-2 SPIKE GLYCOPROTEIN.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/21/20,COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WROBEL, A.G., BENTON, D.J., ROSENTHAL, P.B., GAMBLIN, S.J.",ELECTRON MICROSCOPY,NONE
7R4R,N,,THE SARS-COV-2 SPIKE IN COMPLEX WITH THE 1.10 NEUTRALIZING NANOBODY,VIRAL PROTEIN,"CORONAVIRUS, COVID-19, SARS-COV-2, SPIKE, NANOBODIES, NEUTRALIZATION, VIRAL PROTEIN",NANOBODIES PROTECTING FROM LETHAL SARS-COV-2 INFECTION TARGET RECEPTOR BINDING EPITOPES PRESERVED IN VIRUS VARIANTS OTHER THAN OMICRON.,,,D,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/08/22,THE SARS-COV-2 SPIKE IN COMPLEX WITH THE 1.10 NEUTRALIZING NANOBODY,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELUS DROMEDARIUS,CAMELUS DROMEDARIUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CASASNOVAS, J.M., MELERO, R., ARRANZ, R., FERNANDEZ, L.A.",ELECTRON MICROSCOPY,NONE
7PS6,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-44 AND BETA-54 FABS,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 (ALPHA) VARIANT, B.1.351 (BETA) VARIANT, P.1 (GAMMA) VARIANT, B.1.617.2 (DELTA) VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-44 AND BETA-54 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7WRO,N,,LOCAL STRUCTURE OF BD55-3372 AND DELTA SPIKE,VIRAL PROTEIN/IMMUNE SYSTEM,"COMPLEX, SARS-COV-2, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","BA.2.12.1, BA.4 AND BA.5 ESCAPE ANTIBODIES ELICITED BY OMICRON INFECTION.",,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/22/22,LOCAL STRUCTURE OF BD55-3372 AND DELTA SPIKE,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"LIU, P.L.",ELECTRON MICROSCOPY,NONE
7CH4,N,"BD-604 FAB H, BD-604 FAB L, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-604 FAB,PROTEIN BINDING/IMMUNE SYSTEM,"COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX",STRUCTURALLY RESOLVED SARS-COV-2 ANTIBODY SHOWS HIGH EFFICACY IN SEVERELY INFECTED HAMSTERS AND PROVIDES A POTENT COCKTAIL PAIRING STRATEGY.,,,H,L,R,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING/IMMUNE SYSTEM,07/05/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-604 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.Y.",X-RAY DIFFRACTION,NONE
7DPM,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, ANTIBODY, ADE, VIRUS, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX","CHARACTERIZATION OF MW06, A HUMAN MONOCLONAL ANTIBODY WITH CROSS-NEUTRALIZATION ACTIVITY AGAINST BOTH SARS-COV-2 AND SARS-COV.",,,A,B,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,02/17/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, J., JIAO, S., WANG, R., ZHANG, J., ZHANG, M., WANG, M.",X-RAY DIFFRACTION,NONE
7E3O,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY NCOV617,VIRAL PROTEIN,"SARS-COV-2, S-RBD, RBS-C, NATIVE HUMAN MONOCLONAL ANTIBODY, THERAPEUTIC ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS OF A HUMAN NEUTRALIZING ANTIBODY SPECIFIC TO THE SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN.,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,09/15/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY NCOV617,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CHEN, S.D., YANG, M.",X-RAY DIFFRACTION,NONE
7WRV,N,,THE INTERFACE OF JMB2002 FAB BINDS TO SARS-COV-2 OMICRON VARIANT S,VIRAL PROTEIN,"SARS-COV-2, OMICRON, FAB, VIRAL PROTEIN",STRUCTURES OF THE OMICRON SPIKE TRIMER WITH ACE2 AND AN ANTI-OMICRON ANTIBODY.,,,U,V,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/23/22,THE INTERFACE OF JMB2002 FAB BINDS TO SARS-COV-2 OMICRON VARIANT S,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YIN, W., XU, Y., XU, P., CAO, X., WU, C., GU, C., HE, X., WANG, X., HUANG, S., YUAN, Q., WU, K., HU, W., HUANG, Z., LIU, J., WANG, Z., JIA, F., XIA, K., LIU, P., WANG, X., SONG, B., ZHENG, J., JIANG, H., CHENG, X., JIANG, Y., DENG, S.J., XU, H.E.",ELECTRON MICROSCOPY,NONE
5DHX,,"ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, HEAVY CHAIN, ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, LIGHT CHAIN, PROTEIN REV",HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,IMMUNE SYSTEM,"HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM",THE STRUCTURE OF HIV-1 REV FILAMENTS SUGGESTS A BILATERAL MODEL FOR REV-RRE ASSEMBLY.,,,B,B,C,PROTEIN,PROTEIN REV,IMMUNE SYSTEM,08/31/15,HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,ORYCTOLAGUS CUNICULUS; HUMAN IMMUNODEFICIENCY VIRUS 1,ORYCTOLAGUS CUNICULUS,,HUMAN IMMUNODEFICIENCY VIRUS 1,"DIMATTIA, M.A., WATTS, N.R., WINGFIELD, P.T., GRIMES, J.M., STUART, D.I., STEVEN, A.C.",X-RAY DIFFRACTION,NONE
7ZBU,N,,CRYOEM STRUCTURE OF SARS-COV-2 SPIKE MONOMER IN COMPLEX WITH NEUTRALISING ANTIBODY P008_60,VIRAL PROTEIN,"COVID-19, SARS-COV-2, SPIKE, NEUTRALIZING ANTIBODY, IMMUNITY, VIRAL PROTEIN",A NEUTRALIZING EPITOPE ON THE SD1 DOMAIN OF SARS-COV-2 SPIKE TARGETED FOLLOWING INFECTION AND VACCINATION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/17/22,CRYOEM STRUCTURE OF SARS-COV-2 SPIKE MONOMER IN COMPLEX WITH NEUTRALISING ANTIBODY P008_60,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ROSA, A., PYE, V.E., CRONIN, N., CHEREPANOV, P.",ELECTRON MICROSCOPY,NONE
8DLY,N,,CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH VH AB6 (FOCUSED REFINEMENT OF NTD AND VH AB6),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, EPSILON, B.1.429, VH AB6",SARS-COV-2 VARIANTS OF CONCERN: SPIKE PROTEIN MUTATIONAL ANALYSIS AND EPITOPE FOR BROAD NEUTRALIZATION.,,,H,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/31/22,CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH VH AB6 (FOCUSED REFINEMENT OF NTD AND VH AB6),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SAVILLE, J.W., SRIVASTAVA, S.S., BEREZUK, A.M., ZHOU, S., TUTTLE, K.S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7OAU,N,,NANOBODY C5 BOUND TO KENT VARIANT RBD (N501Y),ANTIVIRAL PROTEIN,"RBD, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",A POTENT SARS-COV-2 NEUTRALISING NANOBODY SHOWS THERAPEUTIC EFFICACY IN THE SYRIAN GOLDEN HAMSTER MODEL OF COVID-19.,,,B,,A,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,01/08/09,NANOBODY C5 BOUND TO KENT VARIANT RBD (N501Y),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,,,,"NAISMITH, J.H., MIKOLAJEK, H.",X-RAY DIFFRACTION,NONE
7N0I,N,,STRUCTURE OF THE SARS-COV-2 N PROTEIN C-TERMINAL DOMAIN BOUND TO SINGLE-DOMAIN ANTIBODY E2,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NANOBODY, NUCLEOCAPSID, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR SARS-COV-2 NUCLEOCAPSID PROTEIN RECOGNITION BY SINGLE-DOMAIN ANTIBODIES.,,,I,,A | B,PROTEIN | PROTEIN,NUCLEOPROTEIN | NUCLEOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/09/21,STRUCTURE OF THE SARS-COV-2 N PROTEIN C-TERMINAL DOMAIN BOUND TO SINGLE-DOMAIN ANTIBODY E2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YE, Q., CORBETT, K.D.",X-RAY DIFFRACTION,NONE
4UIH,,"DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C E PROTEIN ECTODOMAIN (E.C.3.4.21.91, 3.6.1.15, 3.6.4.13, 2.1.1.56, 2.1.1.57, 2.7.7.48), ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -HEAVY CHAIN, ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -LIGHT CHAIN",CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.,VIRAL PROTEIN,"VIRAL PROTEIN, DENGUE VIRUS, DENGUE SEROTYPE 2, HUMAN ANTIBODY, CRYO-EM, NEUTRALIZATION",CRYO-EM STRUCTURE OF AN ANTIBODY THAT NEUTRALIZES DENGUE VIRUS TYPE 2 BY LOCKING E PROTEIN DIMERS.,,"CA ATOMS ONLY, CHAIN A, B, C, D, F, E, G",F,G,C,PROTEIN,DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C E PROTEINECTODOMAIN ,,03/30/15,CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C  COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB  MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.,DENGUE VIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,DENGUE VIRUS 2,"FIBRIANSAH, G., IBARRA, K.D., NG, T.-S., SMITH, S.A., TAN, J.L., LIM, X.N., OOI, J.S.G., KOSTYUCHENKO, V.A., WANG, J., DESILVA, A.M., HARRIS, E., CROWE, J.E., LOK, S.-M.",ELECTRON MICROSCOPY,NONE
5ZXV,N,"MERS-COV RBD, HEAVY CHAIN, LIGHT CHAIN",STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN,VIRAL PROTEIN,"ANTIBODY, VIRAL PROTEIN",STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN,,,C,D,B,PROTEIN,MERS-COV RBD,VIRAL PROTEIN,05/21/18,STRUCTURAL DEFINITION OF A UNIQUE NEUTRALIZATION EPITOPE ON THE RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE GLYCOPROTEIN,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS,"ZHANG, S., WANG, X.",X-RAY DIFFRACTION,TBD
7WOG,N,,SARS-COV-2 OMICRON S MONOMER COMPLEXED WITH 553-49,VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT BY DISASSEMBLING THE SPIKE TRIMER.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,07/20/22,SARS-COV-2 OMICRON S MONOMER COMPLEXED WITH 553-49,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7CHP,N,,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P5A-3C8 WITH RBD,VIRAL PROTEIN,"SPIKE, RECEPTOR BINDING DOMAIN, ANTIBODY, VIRAL PROTEIN",POTENT AND PROTECTIVE IGHV3-53/3-66 PUBLIC ANTIBODIES AND THEIR SHARED ESCAPE MUTANT ON THE SPIKE OF SARS-COV-2.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/19/21,CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P5A-3C8 WITH RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHANG, L., GE, J., WANG, R., ZHANG, Q.",X-RAY DIFFRACTION,NONE
7BEI,N,"COVOX-150 HEAVY CHAIN, COVOX-150 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7F12,N,,A SARS-COV-2 NEUTRALIZING ANTIBODY,VIRAL PROTEIN/ANTIVIRAL PROTEIN,"NEUTRALIZING ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX","A SARS-COV-2 NEUTRALIZING
ANTIBODY",,,B,B,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,06/15/22,A SARS-COV-2 NEUTRALIZING ANTIBODY,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, G., LI, X., GUO, Y., WANG, Y., YUAN, S.",X-RAY DIFFRACTION,NONE
6XE1,N,,"STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A POTENT NEUTRALIZING ANTIBODY, CV30 FAB",VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, COVID-19, IMMUNE SYSTEM, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR POTENT NEUTRALIZATION OF SARS-COV-2 AND ROLE OF ANTIBODY AFFINITY MATURATION.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/11/20,"STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A POTENT NEUTRALIZING ANTIBODY, CV30 FAB",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HURLBURT, N.K., PANCERA, M.",X-RAY DIFFRACTION,NONE
7XCP,N,,CRYO-EM STRUCTURE OF OMICRON RBD COMPLEXED WITH ACE2 AND 304 FAB,VIRAL PROTEIN,"SARS-COV-2, OMICRON, RECEPTOR BINDING DOMAIN, ACE2, FAB 304, VIRAL PROTEIN",OMICRON SARS-COV-2 MUTATIONS STABILIZE SPIKE UP-RBD CONFORMATION AND LEAD TO A NON-RBM-BINDING MONOCLONAL ANTIBODY ESCAPE,,,H,L,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,08/31/22,CRYO-EM STRUCTURE OF OMICRON RBD COMPLEXED WITH ACE2 AND 304 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAO, Z., QI, J., GAO, F.G.",ELECTRON MICROSCOPY,NONE
7P79,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODYB#15 IN A 1UP/1UP-OUT/1DOWN CONFORMATION.,VIRAL PROTEIN,"SARS-COV-2 SPIKE PROTEIN SYBODY, VIRAL PROTEIN",BIPARATOPIC SYBODIES NEUTRALIZE SARS-COV-2 VARIANTS OF CONCERN AND MITIGATE DRUG RESISTANCE.,,,D,,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/04/21,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH SYBODYB#15 IN A 1UP/1UP-OUT/1DOWN CONFORMATION.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WALTER, J.D., HUTTER, C.A.J., GARAEVA, A.A., SCHERER, M., ZIMMERMANN, I., WYSS, M., RHEINBERGER, J., RUEDIN, Y., EARP, J.C., EGLOFF, P., SORGENFREI, M., HUERLIMANN, L.M., GONDA, I., MEIER, G., REMM, S., THAVARASAH, S., ZIMMER, G., SLOTBOOM, D.J., PAULINO, C., PLATTET, P., SEEGER, M.A.",ELECTRON MICROSCOPY,NONE
7SOC,N,,SARS-COV-2 S RBD B.1.617.1 KAPPA VARIANT S309 LOCAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"KAPPA, SPIKE, ANTIBODY, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MOLECULAR BASIS OF IMMUNE EVASION BY THE DELTA AND KAPPA SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/17/21,SARS-COV-2 S RBD B.1.617.1 KAPPA VARIANT S309 LOCAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7WLC,N,,SARS-COV-2 OMICRON VARIANT SPIKE RBD IN COMPLEX WITH FAB XGV282,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/13/22,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB XGV265,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7JXC,N,"S309 ANTIGEN-BINDING (FAB) HEAVY CHAIN, S309 ANTIGEN-BINDING (FAB) LIGHT CHAIN",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,IMMUNE SYSTEM,"FUSION PROTEIN, NEUTRALIZING ANTIBODY, SARBECOVIRUS, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, IMMUNE SYSTEM",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,H,L,,,,IMMUNE SYSTEM,08/27/20,MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"PARK, Y.J., TORTORICI, M.A., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",X-RAY DIFFRACTION,NONE
7CJF,N,"ANTIBODY HEAVY CHAIN, ANTIBODY LIGHT CHAIN, SPIKE PROTEIN S1",CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB,VIRAL PROTEIN,"SARS-COV-2, RBD, ANTIBODY, VIRAL PROTEIN",A SARS-COV-2 NEUTRALIZING ANTIBODY WITH EXTENSIVE SPIKE BINDING COVERAGE AND MODIFIED FOR OPTIMAL THERAPEUTIC OUTCOMES.,,,A,B,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/10/20,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, Y., LI, X., ZHANG, G., FU, D., SCHWEIZER, L., ZHANG, H., RAO, Z.",X-RAY DIFFRACTION,NONE
6NB7,N,"SPIKE GLYCOPROTEIN, S230 HEAVY CHAIN, S230 LIGHT CHAIN",SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2),VIRUS,"CORONAVIRUS SPIKE GLYCOPROTEIN, MERS-COV, SARS-COV, HUMAN NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRUS",UNEXPECTED RECEPTOR FUNCTIONAL MIMICRY ELUCIDATES ACTIVATION OF CORONAVIRUS FUSION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS,12/06/18,SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2),SARS CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SARS CORONAVIRUS,"WALLS, A.C., XIONG, X., PARK, Y.J., TORTORICI, M.A., SNIJDER, S., QUISPE, J., CAMERONI, E., GOPAL, R., MIAN, D., LANZAVECCHIA, A., ZAMBON, M., REY, F.A., CORTI, D., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7DK2,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW07 FAB,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, ANTIBODY, ADE, VIRUS, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",ARCHITECTURAL VERSATILITY OF SPIKE NEUTRALIZATION BY A SARS-COV-2 ANTIBODY,,,D,E,F,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,12/08/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW07 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, J., JIAO, S., WANG, R., ZHANG, J., ZHANG, M., WANG, M., CHEN, S.",X-RAY DIFFRACTION,NONE
7KZB,N,"FAB HEAVY CHAIN OF CR3014-C8 ANTIBODY, FAB LIGHT CHAIN OF CR3014-C8 ANTIBODY, SPIKE GLYCOPROTEIN, FAB HEAVY CHAIN OF CR3022-B6 ANTIBODY, FAB LIGHT CHAIN OF CR3022-B6 ANTIBODY",POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID19, SARS-COV2, ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1 ANTIBODIES.,,,A,B,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/10/20,POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LANGLEY, D.B., CHRIST, D.",X-RAY DIFFRACTION,NONE
7FJS,N,,CRYSTAL STRUCTURE OF T6 FAB BOUND TO THESARS-COV-2 RBD OF B.1.351,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, RECEPTOR BINDING, COMPLEX, ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",RBD TRIMER MRNA VACCINE ELICITS BROAD AND PROTECTIVE IMMUNE RESPONSES AGAINST SARS-COV-2 VARIANTS.,,,C,A,B,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,04/27/22,CRYSTAL STRUCTURE OF T6 FAB BOUND TO THESARS-COV-2 RBD OF B.1.351,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHANG, L., ZHANG, S., LIANG, Q.",X-RAY DIFFRACTION,NONE
8DZH,N,,STRUCTURE OF SARS-COV-2 OMICRON BA.1.1.529 SPIKE TRIMER WITH TWO RBDS DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY MB.02,VIRAL PROTEIN/IMMUNE SYSTEM,"VIRAL PROTEIN, HUMAN ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",FUNCTION AND CRYO-EM STRUCTURES OF BROADLY POTENT BISPECIFIC ANTIBODIES AGAINST MULTIPLE SARS-COV-2 OMICRON SUBLINEAGES.,,,I,J,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/31/22,STRUCTURE OF SARS-COV-2 OMICRON BA.1.1.529 SPIKE TRIMER WITH TWO RBDS DOWN IN COMPLEX WITH THE FAB FRAGMENT OF HUMAN NEUTRALIZING ANTIBODY MB.02,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HU, Y., XIONG, Y.",ELECTRON MICROSCOPY,NONE
7FG2,N,,"MINOR CRYO-EM STRUCTURE OF S PROTEIN TRIMER OF SARS-COV2 WITH K-874A VHH, COMPOSITE MAP",PROTEIN BINDING,"ANTIBODY, PROTEIN BINDING",NASAL DELIVERY OF SINGLE-DOMAIN ANTIBODY IMPROVES SYMPTOMS OF SARS-COV-2 INFECTION IN AN ANIMAL MODEL.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,09/29/21,"MINOR CRYO-EM STRUCTURE OF S PROTEIN TRIMER OF SARS-COV2 WITH K-874A VHH, COMPOSITE MAP",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SONG, C., MURATA, K., KATAYAMA, K.",ELECTRON MICROSCOPY,NONE
7L02,N,"2G12 HEAVY CHAIN, 2G12 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12,VIRAL PROTEIN/IMMUNE SYSTEM,"FAB-DIMERIZED, GLYCAN-REACTIVE, ANTIBODIES, HIV, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",FAB-DIMERIZED GLYCAN-REACTIVE ANTIBODIES ARE A STRUCTURAL CATEGORY OF NATURAL ANTIBODIES.,,,M,K,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/10/20,CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MANNE, K., HENDERSON, R., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7W9F,N,,SARS-COV-2 DELTA S-RBD-8D3,VIRAL PROTEIN,"SARS-COV-2 DELTA VARIANT SPIKE PROTEIN, VIRAL PROTEIN",STRUCTURAL BASIS FOR SARS-COV-2 DELTA VARIANT RECOGNITION OF ACE2 RECEPTOR AND BROADLY NEUTRALIZING ANTIBODIES.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,01/12/22,SARS-COV-2 DELTA S-RBD-8D3,MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., LIU, C.X.",ELECTRON MICROSCOPY,NONE
7SG4,N,,STRUCTURE OF SARS-COV S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047,VIRAL PROTEIN,"SARS-COV SPIKE PROTEIN TRIMER, VIRAL PROTEIN",A BROADLY CROSS-REACTIVE ANTIBODY NEUTRALIZES AND PROTECTS AGAINST SARBECOVIRUS CHALLENGE IN MICE.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,11/10/21,STRUCTURE OF SARS-COV S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"GOBEIL, S., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7UPX,N,,THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS),VIRAL PROTEIN,VIRAL PROTEIN,HUMANIZED ANTIBODY POTENTLY NEUTRALIZES ALL SARS-COV-2 VARIANTS BY A NOVEL MECHANISM,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/10/22,THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS),HOMO SAPIENS; MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"HOMO SAPIENS, MUS MUSCULUS","HOMO SAPIENS, MUS MUSCULUS",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS,"ZHANG, J., LUO, S., KREUTZBERGER, A., KIRCHHAUSEN, T., CHEN, B., HAYNES, B., ALT, F.",ELECTRON MICROSCOPY,NONE
7BEO,N,"SPIKE GLYCOPROTEIN, COVOX-253H55L HEAVY CHAIN, COVOX-253H55L LIGHT CHAIN, COVOX-75 HEAVY CHAIN, COVOX-75 LIGHT CHAIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,R,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7TTY,N,,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH BAT WIV1 RECEPTOR-BINDING DOMAIN,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARBECOVIRUS, WIV1 RBD, VIRAL PROTEIN, SPIKE GLYCOPROTEIN, RECEPTOR BINDING PROTEIN, NEUTRALIZING ANTIBODY, POTENT, 10-40, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ANTIBODY CLASS WITH A COMMON CDRH3 MOTIF BROADLY NEUTRALIZES SARBECOVIRUSES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY 10-40 IN COMPLEX WITH BAT WIV1 RECEPTOR-BINDING DOMAIN,BAT SARS-LIKE CORONAVIRUS WIV1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,BAT SARS-LIKE CORONAVIRUS WIV1,"REDDEM, E.R., SHAPIRO, L.",X-RAY DIFFRACTION,NONE
7LXY,N,"SPIKE GLYCOPROTEIN, S2M11 FAB LIGHT CHAIN VARIABLE REGION, S2M11 FAB HEAVY CHAIN VARIABLE REGION, S2X333 FAB HEAVY CHAIN VARIABLE REGION, S2X333 FAB LIGHT CHAIN VARIABLE REGION",SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",N-TERMINAL DOMAIN ANTIGENIC MAPPING REVEALS A SITE OF VULNERABILITY FOR SARS-COV-2.,,,M,K,J,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7KLH,N,,SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",TETRAVALENT SARS-COV-2 NEUTRALIZING ANTIBODIES SHOW ENHANCED POTENCY AND RESISTANCE TO ESCAPE MUTATIONS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/10/21,SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, Z., RINI, J.M.",X-RAY DIFFRACTION,NONE
7KMD,N,,CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV, ENVELOPE, GLYCOPROTEIN, PREFUSION TRIMER, GLYCAN, HIV-1 GP120, HIV-1 GP41, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",NEUTRALIZING ANTIBODIES INDUCED BY FIRST-GENERATION GP41-STABILIZED HIV-1 ENVELOPE TRIMERS AND NANOPARTICLES.,,,H,L,G,PROTEIN,ENVELOPE GLYCOPROTEIN GP120,VIRAL PROTEIN/IMMUNE SYSTEM,07/07/21,CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22,HOMO SAPIENS; HUMAN IMMUNODEFICIENCY VIRUS 1,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"KUMAR, S., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7CHF,N,"BD-604 FAB HEAVY CHAIN, BD-604 FAB LIGHT CHAIN, SARS-COV-2 RECEPTOR BINDING DOMAIN, BD-368-2 FAB HEAVY CHAIN, BD-368-2 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,"MAB, ANTIVIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURALLY RESOLVED SARS-COV-2 ANTIBODY SHOWS HIGH EFFICACY IN SEVERELY INFECTED HAMSTERS AND PROVIDES A POTENT COCKTAIL PAIRING STRATEGY.,,,A,B,R,PROTEIN,SARS-COV-2 RECEPTOR BINDING DOMAIN,ANTIVIRAL PROTEIN/IMMUNE SYSTEM,07/05/20,CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XIAO, J., ZHU, Q.",X-RAY DIFFRACTION,NONE
7JVC,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, S2A4 FAB HEAVY CHAIN, S2A4 FAB LIGHT CHAIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,H,L,A,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/20/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., TORTORICI, M.A., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",ELECTRON MICROSCOPY,NONE
7R4I,N,,THE SARS-COV-2 SPIKE IN COMPLEX WITH THE 2.15 NEUTRALIZING NANOBODY,VIRAL PROTEIN,"CORONAVIRUS, COVID-19, SARS-COV-2, SPIKE, NANOBODIES, NEUTRALIZATION, VIRAL PROTEIN",NANOBODIES PROTECTING FROM LETHAL SARS-COV-2 INFECTION TARGET RECEPTOR BINDING EPITOPES PRESERVED IN VIRUS VARIANTS OTHER THAN OMICRON.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/08/22,THE SARS-COV-2 SPIKE IN COMPLEX WITH THE 2.15 NEUTRALIZING NANOBODY,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELUS DROMEDARIUS,CAMELUS DROMEDARIUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CASASNOVAS, J.M., MELERO, R., ARRANZ, R., FERNANDEZ, L.A.",ELECTRON MICROSCOPY,NONE
7WEB,N,,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN WITH TWO XGV347 BINDING TO TWO OPEN STATE RBDS,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,G,I,D,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN WITH TWO XGV347 BINDING TO TWO OPEN STATE RBDS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
6VOR,N,"RM20E1 FAB HEAVY CHAIN, RM20E1 FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF MACAQUE ANTI-HIV-1 ANTIBODY RM20E1,IMMUNE SYSTEM,"HIV, ANTIBODY, NON-HUMAN PRIMATES, IMMUNE SYSTEM",MAPPING THE IMMUNOGENIC LANDSCAPE OF NEAR-NATIVE HIV-1 ENVELOPE TRIMERS IN NON-HUMAN PRIMATES.,,,C,D,,,,IMMUNE SYSTEM,01/31/20,CRYSTAL STRUCTURE OF MACAQUE ANTI-HIV-1 ANTIBODY RM20E1,MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,,"YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7XH8,N,,THE STRUCTURE OF ZCB11 FAB AGAINST SARS-COV-2 OMICRON SPIKE,VIRAL PROTEIN/IMMUNE SYSTEM,"SARC-COV-2 OMICRON SPIKE, FAB, ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A BROADLY NEUTRALIZING ANTIBODY PROTECTS SYRIAN HAMSTERS AGAINST SARS-COV-2 OMICRON CHALLENGE.,,,B,C,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/29/22,THE STRUCTURE OF ZCB11 FAB AGAINST SARS-COV-2 OMICRON SPIKE,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HANG, L., DANG, S.",ELECTRON MICROSCOPY,NONE
7K8N,N,"C102 FAB HEAVY CHAIN, C102 FAB LIGHT CHAIN","CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102",IMMUNE SYSTEM,"HUMAN NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR BINDING DOMAIN, COVID-19, IMMUNE SYSTEM",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,A,B,,,,IMMUNE SYSTEM,09/27/20,"CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102",HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"JETTE, C.A., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
3ZKM,,"BETA-SECRETASE 2 (E.C.3.4.23.45), FAB HEAVY CHAIN, FAB LIGHT CHAIN",BACE2 FAB COMPLEX,HYDROLASE/IMMUNE SYSTEM,"HYDROLASE-IMMUNE SYSTEM COMPLEX, HYDROLASE, ASPARTYL PROTEASE-FAB COMPLEX","MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USING SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS, FYNOMERS, AND XAPERONES",,,H,L,A,PROTEIN,BETA-SECRETASE 2,HYDROLASE/IMMUNE SYSTEM,01/23/13,BACE2 FAB COMPLEX,HOMO SAPIENS; MUS MUSCULUS,HOMO SAPIENS,MUS MUSCULUS,HOMO SAPIENS,"BANNER, D.W., KUGLSTATTER, A., BENZ, J., STIHLE, M., RUF, A.",X-RAY DIFFRACTION,NONE
7LM9,N,,CRYSTAL STRUCTURE OF SARS-COV SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING ANTIBODY CV38-142 FAB ISOLATED FROM COVID-19 PATIENT,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV, ANTIBODY, SPIKE, CORONAVIRUS, SARS, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, CROSS-NEUTRALIZATION, VIRAL PROTEIN",A COMBINATION OF CROSS-NEUTRALIZING ANTIBODIES SYNERGIZES TO PREVENT SARS-COV-2 AND SARS-COV PSEUDOVIRUS INFECTION.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/31/21,CRYSTAL STRUCTURE OF SARS-COV SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING ANTIBODY CV38-142 FAB ISOLATED FROM COVID-19 PATIENT,SARS CORONAVIRUS MA15; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SARS CORONAVIRUS MA15,"LIU, H., YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7MMO,N,,LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY NEUTRALIZING SARS-COV-2, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",LY-COV1404 (BEBTELOVIMAB) POTENTLY NEUTRALIZES SARS-COV-2 VARIANTS.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,05/12/21,LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HENDLE, J., PUSTILNIK, A., SAUDER, J.M., COLEMAN, K.A., BOYLES, J.S., DICKINSON, C.D.",X-RAY DIFFRACTION,NONE
7JV6,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, S2H13 FAB HEAVY CHAIN, S2H13 FAB LIGHT CHAIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID",MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY.,,,F,G,E,PROTEIN,SARS-COV-2 SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/20/20,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., TORTORICI, M.A., WALLS, A.C., CZUDNOCHOWSKI, N., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID), SNELL, G., VEESLER, D.",ELECTRON MICROSCOPY,NONE
7S3N,N,,SARS-COV-2 S STEM HELIX PEPTIDE BOUND TO FAB22,VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, FUSION, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STABILIZED CORONAVIRUS SPIKE STEM ELICITS A BROADLY PROTECTIVE ANTIBODY.,,,H,L,A,PEPTIDE,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/27/21,SARS-COV-2 S STEM HELIX PEPTIDE BOUND TO FAB22,MUS MUSCULUS; SYNTHETIC CONSTRUCT,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GOLDSMITH, J.A., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
4ZS6,,"FAB LIGHT CHAIN, FAB HEAVY CHAIN, S PROTEIN",RECEPTOR BINDING DOMAIN AND FAB COMPLEX,IMMUNE SYSTEM,"COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM",STRUCTURAL BASIS FOR THE NEUTRALIZATION OF MERS-COV BY A HUMAN MONOCLONAL ANTIBODY MERS-27,,,C,D,B,PROTEIN,S PROTEIN,IMMUNE SYSTEM,05/13/15,RECEPTOR BINDING DOMAIN AND FAB COMPLEX,HOMO SAPIENS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS,"YU, X., WANG, X.",X-RAY DIFFRACTION,TBD
7S5Q,N,,CRYSTAL STRUCTURE OF SARS-COV-2 B.1.351 VARIANT RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES CS44 AND COVA1-16,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, FAB, VOC, BETA, B.1.351, SPIKE, RBD, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 BETA VARIANT INFECTION ELICITS POTENT LINEAGE-SPECIFIC AND CROSS-REACTIVE ANTIBODIES.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/09/22,CRYSTAL STRUCTURE OF SARS-COV-2 B.1.351 VARIANT RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES CS44 AND COVA1-16,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7KN5,N,"SPIKE PROTEIN S1, VHH E, VHH U",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NANOBODY, SPIKE, CORONAVIRUS, COVID-19, IMMUNE SYSTEM, NANOBODY-ANTIGEN COMPLEX, SINGLE-DOMAIN ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURE-GUIDED MULTIVALENT NANOBODIES BLOCK SARS-COV-2 INFECTION AND SUPPRESS MUTATIONAL ESCAPE.,,,C,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,11/04/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., YUAN, M., ZHU, X., WU, N.C., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7LCN,N,,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1,IMMUNE SYSTEM,"RBD ANTIBODY, DH1050.1, SARS, COVID-19, SARS-COV-2 2P S ECTODOMAIN, VIRAL PROTEIN, IMMUNE SYSTEM",IN VITRO AND IN VIVO FUNCTIONS OF SARS-COV-2 INFECTION-ENHANCING AND NEUTRALIZING ANTIBODIES.,,,B,D,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,01/11/21,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MANNE, K., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7Z86,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E NANOBODY COMPLEX IN 1UP2DOWN CONFORMATION,ANTIVIRAL PROTEIN,"COMPLEX, SPIKE GLYCOPROTEIN, NANOBODY H11-H4 Q98R H100E, ANTIVIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E NANOBODY COMPLEX IN 1UP2DOWN CONFORMATION,,,X,,A,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",ANTIVIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E NANOBODY COMPLEX IN 1UP2DOWN CONFORMATION,ESCHERICHIA VIRUS T4; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ESCHERICHIA VIRUS T4 ","WECKENER, M., NAISMITH, J.H.",ELECTRON MICROSCOPY,NONE
7E5O,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH ANTIBODY NT-193,VIRAL PROTEIN,"SPIKE, IGG, VIRAL PROTEIN",A SARS-COV-2 ANTIBODY BROADLY NEUTRALIZES SARS-RELATED CORONAVIRUSES AND VARIANTS BY COORDINATED RECOGNITION OF A VIRUS-VULNERABLE SITE.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,09/08/21,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH ANTIBODY NT-193,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KITA, S., ONODERA, T., ADACHI, Y., MORIAYMA, S., NOMURA, T., TADOKORO, T., ANRAKU, Y., YUMOTO, K., TIAN, C., FUKUHARA, H., SUZUKI, T., TONOUCHI, K., SASAKI, J., SUN, L., HASHIGUCHI, T., TAKAHASHI, Y., MAENAKA, K.",X-RAY DIFFRACTION,NONE
7M53,N,"SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE, B6 ANTIGEN-BINDING (FAB) FRAGMENT HEAVY CHAIN, B6 ANTIGEN-BINDING (FAB) FRAGMENT LIGHT CHAIN",B6 FAB FRAGMENT BOUND TO THE SARS-COV/SARS-COV-2 SPIKE STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM","BROADLY NEUTRALIZING ANTIBODY, STRUCTURAL GENOMICS, SSGCID, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, ANTIVIRAL PROTEIN, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, IMMUNE SYSTEM",STRUCTURAL BASIS FOR BROAD CORONAVIRUS NEUTRALIZATION.,,,H,L,A,PEPTIDE,SPIKE GLYCOPROTEIN STEM HELIX PEPTIDE,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM",05/26/21,B6 FAB FRAGMENT BOUND TO THE SARS-COV/-2 SPIKE STEM HELIX PEPTIDE,MUS MUSCULUS; SYNTHETIC CONSTRUCT,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SAUER, M.M., PARK, Y.J., VEESLER, D., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID), SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7XCK,N,,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON RBD IN COMPLEX WITH S309 FAB (LOCAL REFINEMENT),VIRAL PROTEIN,VIRAL PROTEIN,OMICRON SARS-COV-2 MUTATIONS STABILIZE SPIKE UP-RBD CONFORMATION AND LEAD TO A NON-RBM-BINDING MONOCLONAL ANTIBODY ESCAPE,,,A,B,M,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,08/31/22,CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON RBD IN COMPLEX WITH S309 FAB (LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GAO, G.F., QI, J.X., ZHAO, Z.N., XIE, Y.F., LIU, S.",ELECTRON MICROSCOPY,NONE
7E3C,N,,SARS-COV-2 SPIKE IN COMPLEX WITH THE AB1 NEUTRALIZING ANTIBODY (FOCUSED REFINEMENT ON FAB-RBD),VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, SARS-COV-2, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THREE EPITOPE-DISTINCT HUMAN ANTIBODIES FROM RENMAB MICE NEUTRALIZE SARS-COV-2 AND COOPERATIVELY MINIMIZE THE ESCAPE OF MUTANTS.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/01/21,SARS-COV-2 SPIKE IN COMPLEX WITH THE AB1 NEUTRALIZING ANTIBODY (FOCUSED REFINEMENT ON FAB-RBD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, C.",ELECTRON MICROSCOPY,NONE
7LK9,N,"COV107-23 HEAVY CHAIN, COVD21-C8 LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RBD-TARGETING ANTIBODY COV107-23 HC + COVD21-C8 LC,IMMUNE SYSTEM,"CORONAVIRUS, COVID-19, SARS-COV-2, ANTIBODY, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM",SEQUENCE SIGNATURES OF TWO IGHV3-53/3-66 PUBLIC CLONOTYPES TO SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,A,B,,,,IMMUNE SYSTEM,02/17/21,CRYSTAL STRUCTURE OF SARS-COV-2 RBD-TARGETING ANTIBODY COV107-23 HC + COVD21-C8 LC,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"YUAN, M., ZHU, X., WILSON, I.A., WU, N.C.",X-RAY DIFFRACTION,NONE
7KFY,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF HUMAN ANTIBODY C1A-F10 FAB, LIGHT CHAIN OF HUMAN ANTIBODY C1A-F10 FAB",STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-F10 FAB),IMMUNE SYSTEM/VIRAL PROTEIN,"COVID-19, SARS-COV-2, NEUTRALIZING ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MOLECULAR BASIS FOR A GERMLINE-BIASED NEUTRALIZING ANTIBODY RESPONSE TO SARS-COV-2.,,,H,L,A,PROTEIN,SURFACE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,10/15/20,STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-F10 FAB),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PAN, J., ABRAHAM, J., CLARK, L., CLARK, S.",X-RAY DIFFRACTION,NONE
6ZXN,N,"SPIKE GLYCOPROTEIN, NANOBODY TY1",CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING NANOBODIES (TY1),VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NEUTRALISING ANTIBODY, VIRAL PROTEIN",AN ALPACA NANOBODY NEUTRALIZES SARS-COV-2 BY BLOCKING RECEPTOR INTERACTION.,,,F,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/30/20,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING NANOBODIES (TY1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALLBERG, B.M., DAS, H.",ELECTRON MICROSCOPY,NONE
7Q9I,N,,BETA-43 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,E,F,B,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/15/21,BETA-43 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7ZF9,N,,SARS-COV-2 OMICRON BA.2 RBD IN COMPLEX WITH COVOX-150 FAB (P21),VIRAL PROTEIN,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, COVOX-150, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/01/22,SARS-COV-2 OMICRON BA.2 RBD IN COMPLEX WITH COVOX-150 FAB (P21),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7L57,N,"SPIKE GLYCOPROTEIN, FAB 2-15 VARIABLE DOMAIN HEAVY CHAIN, FAB 2-15 VARIABLE DOMAIN LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-15,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, GLYCOPROTEIN, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MODULAR BASIS FOR POTENT SARS-COV-2 NEUTRALIZATION BY A PREVALENT VH1-2-DERIVED ANTIBODY CLASS.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-15,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"RAPP, M., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7K8Q,N,"C121 FAB HEAVY CHAIN, C121 FAB LIGHT CHAIN","CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121",IMMUNE SYSTEM,"HUMAN NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR BINDING DOMAIN, COVID-19, IMMUNE SYSTEM",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,H,L,,,,IMMUNE SYSTEM,09/27/20,"CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110",HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"ABERNATHY, M.E., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
7E9P,N,,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(STATE2, LOCAL REFINEMENT OF THE RBD AND 35B5 FAB)","VIRAL PROTEIN, IMMUNE SYSTEM","IMMUNE SYSTEM, VIRAL PROTEIN",A POTENT HUMAN MONOCLONAL ANTIBODY WITH PAN-NEUTRALIZING ACTIVITIES DIRECTLY DISLOCATES S TRIMER OF SARS-COV-2 THROUGH BINDING BOTH UP AND DOWN FORMS OF RBD,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/23/22,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(STATE2, LOCAL REFINEMENT OF THE RBD AND 35B5 FAB)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.F., ZHU, Y.Q.",ELECTRON MICROSCOPY,NONE
7FCQ,N,,CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY P14-44 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD),ANTIVIRAL PROTEIN,"SARS-COV-2, RBD, NEUTRALIZING ANTIBODIES, ANTIVIRAL PROTEIN",ULTRAPOTENT NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 WITH A HIGH DEGREE OF MUTATION RESISTANCE.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,ANTIVIRAL PROTEIN,06/15/22,CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY P14-44 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHENG, P., JIN, T.",X-RAY DIFFRACTION,NONE
7RU4,N,,CC6.33 IGG IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (RBD/FV LOCAL REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, SARS-COV-2, STABILIZING MUTATIONS, NEUTRALIZING ANTIBODY, RBD, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ENGINEERING SARS-COV-2 NEUTRALIZING ANTIBODIES FOR INCREASED POTENCY AND REDUCED VIRAL ESCAPE PATHWAYS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/24/22,CC6.33 IGG IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (RBD/FV LOCAL REFINEMENT),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZOROWSKI, G., TURNER, H.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7X9E,N,,CRYSTAL STRUCTURE OF THE 76E1 FAB IN COMPLEX WITH A SARS-COV-2 SPIKE PEPTIDE,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, FAB, SPIKE, FUSION PEPTIDE, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",NEUTRALIZATION MECHANISM OF A HUMAN ANTIBODY WITH PAN-CORONAVIRUS REACTIVITY INCLUDING SARS-COV-2.,,,A,B,E,PEPTIDE,SPIKE PEPTIDE,IMMUNE SYSTEM/VIRAL PROTEIN,05/11/22,CRYSTAL STRUCTURE OF THE 76E1 FAB IN COMPLEX WITH A SARS-COV-2 SPIKE PEPTIDE,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CHEN, X., ZHANG, T., DING, J., SUN, X., SUN, B.",X-RAY DIFFRACTION,NONE
7K9Z,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52,IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR BINDING DOMAIN, NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM",MULTIVALENCY TRANSFORMS SARS-COV-2 ANTIBODIES INTO ULTRAPOTENT NEUTRALIZERS.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,09/29/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NEWTON, J.C., KUCHARSKA, I., RUJAS, E., CUI, H., JULIEN, J.P.",X-RAY DIFFRACTION,NONE
7S3M,N,,MERS-COV S STEM HELIX PEPTIDE BOUND TO FAB22,VIRAL PROTEIN/IMMUNE SYSTEM,"SPIKE, FUSION, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STABILIZED CORONAVIRUS SPIKE STEM ELICITS A BROADLY PROTECTIVE ANTIBODY.,,,H,L,A,PEPTIDE,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,10/27/21,MERS-COV S STEM HELIX PEPTIDE BOUND TO FAB22,MUS MUSCULUS; SYNTHETIC CONSTRUCT,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"GOLDSMITH, J.A., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
7SWN,N,,G32A4 FAB IN COMPLEX WITH SARS-COV-2 SPIKE 6P (RBD LOCAL RECONSTRUCTION),VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRUS, IMMUNITY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",FAB IN COMPLEX WITH SARS-COV-2 SPIKE,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/27/22,G32A4 FAB IN COMPLEX WITH SARS-COV-2 SPIKE 6P (RBD LOCAL RECONSTRUCTION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WINDSOR, I.W., TONG, P., WESEMANN, D.R., HARRISON, S.C.",ELECTRON MICROSCOPY,NONE
7OAY,N,,NANOBODY F2 BOUND TO RBD,ANTIVIRAL PROTEIN,"SPIKE, NANOBODY, HIGH AFFINITY, ANTIVIRAL PROTEIN",A POTENT SARS-COV-2 NEUTRALISING NANOBODY SHOWS THERAPEUTIC EFFICACY IN THE SYRIAN GOLDEN HAMSTER MODEL OF COVID-19.,,,L,,K,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,01/08/09,NANOBODY F2 BOUND TO RBD,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,,,,"NAISMITH, J.H., MIKOLAJEK, H.",X-RAY DIFFRACTION,NONE
7K9K,N,,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB 2H04 (LOCAL REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NEUTRALIZING ANTIBODY, RECEPTOR-BINDING DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID",STRUCTURAL MECHANISM OF SARS-COV-2 NEUTRALIZATION BY TWO MURINE ANTIBODIES TARGETING THE RBD.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/29/21,SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB 2H04 (LOCAL REFINEMENT),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ERRICO, J.M., FREMONT, D.H., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",ELECTRON MICROSCOPY,NONE
1WTL,,"WAT, A VARIABLE DOMAIN FROM IMMUNOGLOBULIN LIGHT-CHAIN (BENCE-JONES PROTEIN)",COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS,IMMUNOGLOBULIN,IMMUNOGLOBULIN,COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT-CHAIN DIMERS.,,,,B,,,,IMMUNOGLOBULIN,06/08/94,COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS,HOMO SAPIENS,,HOMO SAPIENS,,"HUANG, D.B., CHANG, C.H., SCHIFFER, M.",X-RAY DIFFRACTION,NONE
7LAA,N,,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1041,"VIRAL PROTEIN, IMMUNE SYSTEM","RBD ANTIBODY, DH1041, SARS, COVID-19, SARS-COV-2 2P S ECTODOMAIN, VIRAL PROTEIN, IMMUNE SYSTEM",IN VITRO AND IN VIVO FUNCTIONS OF SARS-COV-2 INFECTION-ENHANCING AND NEUTRALIZING ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN, IMMUNE SYSTEM",03/17/21,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1041,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MANNE, K., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7PR0,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH FD-5D FAB,VIRAL PROTEIN,"SARS-COV-2 ANTIBODY, RECEPTOR-BINDING-DOMAIN, RBD, SPIKE, NEUTRALISATION, FI-3A, FD-11A, FD-5D, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",STRUCTURES AND THERAPEUTIC POTENTIAL OF ANTI-RBD HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2.,,,C,B,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,02/02/22,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH FD-5D FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7PQZ,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH FI-3A AND FD-11A FABS,VIRAL PROTEIN,"SARS-COV-2 ANTIBODY, RECEPTOR-BINDING-DOMAIN, RBD, SPIKE, NEUTRALISATION, FI-3A, FD-11A, FD-5D, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",STRUCTURES AND THERAPEUTIC POTENTIAL OF ANTI-RBD HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2.,,,A,B,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,02/02/22,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH FI-3A AND FD-11A FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7PO5,N,,HUMAN CORONAVIRUS OC43 SPIKE GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH THE 47C9 ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,"CORONAVIRUS, GLYCOPROTEIN, ANTIBODY, SPIKE, VIRAL PROTEIN",NEUTRALIZING EPITOPES ON THE HUMAN CORONAVIRUS OC43 SPIKE TRIMER,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/20/22,HUMAN CORONAVIRUS OC43 SPIKE GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH THE 47C9 ANTIBODY FAB FRAGMENT,HOMO SAPIENS; HUMAN CORONAVIRUS OC43,HOMO SAPIENS,HOMO SAPIENS,HUMAN CORONAVIRUS OC43,"HURDISS, D.L.",ELECTRON MICROSCOPY,NONE
8CYJ,N,,"RBD OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH PAN-SARBECOVIRUS NANOBODIES 2-10, 2-67, 2-62 AND 1-25",VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,A,,R,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,"RBD OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH PAN-SARBECOVIRUS NANOBODIES 2-10, 2-67, 2-62 AND 1-25",LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
7LXX,N,"S2L28 FAB HEAVY CHAIN VARIABLE REGION, S2L28 FAB LIGHT CHAIN VARIABLE REGION, SPIKE GLYCOPROTEIN",SARS-COV-2 S/S2M11/S2L28 LOCAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",N-TERMINAL DOMAIN ANTIGENIC MAPPING REVEALS A SITE OF VULNERABILITY FOR SARS-COV-2.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,SARS-COV-2 S/S2M11/S2L28 LOCAL REFINEMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7E8C,N,"SPIKE GLYCOPROTEIN, 604 H, 604 L, N9 H, 368-2 L, 368-2 H, N9 L",SARS-COV-2 S-6P IN COMPLEX WITH 9 FABS,VIRAL PROTEIN,"ANTIBODY, COMPLEX, VIRAL PROTEIN",HUMORAL IMMUNE RESPONSE TO CIRCULATING SARS-COV-2 VARIANTS ELICITED BY INACTIVATED AND RBD-SUBUNIT VACCINES.,,,M,J,A,PROTEIN,368-2 H,VIRAL PROTEIN,06/09/21,SARS-COV-2 S-6P IN COMPLEX WITH 9 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J., ZHANG, Z.",ELECTRON MICROSCOPY,NONE
7WHI,N,,"THE STATE 2 COMPLEX STRUCTURE OF OMICRON SPIKE WITH BN03 (2-UP RBD, 4 NANOBODIES)",VIRAL PROTEIN,"OMICRON, SPIKE, NANOBODY, VIRAL PROTEIN",BROAD NEUTRALIZATION OF SARS-COV-2 VARIANTS BY AN INHALABLE BISPECIFIC SINGLE-DOMAIN ANTIBODY.,,,D,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/11/22,"THE STATE 2 COMPLEX STRUCTURE OF OMICRON SPIKE WITH BN03 (2-UP RBD, 4 NANOBODIES)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7KSG,N,"SARS-COV-2 SPIKE GLYCOPROTEIN, NANOBODY AGAINST SARS-COV-2 GLYCOPROTEIN",SARS-COV-2 SPIKE IN COMPLEX WITH NANOBODIES E,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURE-GUIDED MULTIVALENT NANOBODIES BLOCK SARS-COV-2 INFECTION AND SUPPRESS MUTATIONAL ESCAPE.,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,11/22/20,SARS-COV-2 SPIKE IN COMPLEX WITH NANOBODIES E,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELUS BACTRIANUS,CAMELUS BACTRIANUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HALLBERG, B.M., DAS, H.",ELECTRON MICROSCOPY,NONE
7MJL,N,"SPIKE GLYCOPROTEIN, FAB AB1 HEAVY CHAIN, FAB AB1 LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO FAB AB1 (FOCUSED REFINEMENT OF RBD AND FAB AB1),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, FAB AB1, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYO-ELECTRON MICROSCOPY STRUCTURES OF THE N501Y SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH ACE2 AND 2 POTENT NEUTRALIZING ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/12/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 N501Y MUTANT SPIKE PROTEIN ECTODOMAIN BOUND TO FAB AB1 (FOCUSED REFINEMENT OF RBD AND FAB AB1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SRIVASTAVA, S.S., BEREZUK, A.M., DEMERS, J.P., SAVILLE, J.W., LEOPOLD, K., LI, W., DIMITROV, D.S., TUTTLE, K.S., ZHOU, S., CHITTORI, S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
6VO1,N,"ENVELOPE GLYCOPROTEIN GP120, ENVELOPE GLYCOPROTEIN GP41, RM20J HEAVY CHAIN FAB, RM20J KAPPA LIGHT CHAIN",BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J,VIRAL PROTEIN,"HIV, RHESUS MACAQUE, ANTIBODY, FAB, VACCINE, VIRAL PROTEIN",MAPPING THE IMMUNOGENIC LANDSCAPE OF NEAR-NATIVE HIV-1 ENVELOPE TRIMERS IN NON-HUMAN PRIMATES.,,,G,J,C,PROTEIN,ENVELOPE GLYCOPROTEIN GP120,VIRAL PROTEIN,01/29/20,BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J,HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,HUMAN IMMUNODEFICIENCY VIRUS 1,"COTTRELL, C.A., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7EPB,N,"METABOTROPIC GLUTAMATE RECEPTOR 2, ANTI-RON NANOBODY",CRYO-EM STRUCTURE OF LY354740-BOUND MGLU2 HOMODIMER,MEMBRANE PROTEIN,"CRYO-EM STRUCTURE, MEMBRANE PROTEIN, GPCR",STRUCTURES OF HUMAN MGLU2 AND MGLU7 HOMO- AND HETERODIMERS.,,,C,,A,PROTEIN,METABOTROPIC GLUTAMATE RECEPTOR 2,MEMBRANE PROTEIN,06/23/21,CRYO-EM STRUCTURE OF LY354740-BOUND MGLU2 HOMODIMER,HOMO SAPIENS; LAMA GLAMA,LAMA GLAMA,,HOMO SAPIENS,"DU, J., WANG, D., FAN, H., TAI, L., LIN, S., HAN, S., SUN, F., WU, B., ZHAO, Q.",ELECTRON MICROSCOPY,NONE
7L58,N,"SPIKE GLYCOPROTEIN, FAB H4 VARIABLE DOMAIN HEAVY CHAIN, FAB H4 VARIABLE DOMAIN LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB H4,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, GLYCOPROTEIN, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MODULAR BASIS FOR POTENT SARS-COV-2 NEUTRALIZATION BY A PREVALENT VH1-2-DERIVED ANTIBODY CLASS.,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB H4,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"RAPP, M., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7R40,N,,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 87G7 ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,"CORONAVIRUS, SPIKE, ANTIBODY, COMPLEX, VIRAL PROTEIN",AN ACE2-BLOCKING ANTIBODY CONFERS BROAD NEUTRALIZATION AND PROTECTION AGAINST OMICRON AND OTHER SARS-COV-2 VARIANTS OF CONCERN.,,,D,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/20/22,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 87G7 ANTIBODY FAB FRAGMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HURDISS, D.L.",ELECTRON MICROSCOPY,NONE
7V61,N,,ACE2 -TARGETING MONOCLONAL ANTIBODY AS POTENT AND BROAD-SPECTRUM CORONAVIRUS BLOCKER,MEMBRANE PROTEIN,"ACE2-B0AT1 COMPLEX, MEMBRANE PROTEIN",ACE2-TARGETING MONOCLONAL ANTIBODY AS POTENT AND BROAD-SPECTRUM CORONAVIRUS BLOCKER.,,,I,M,D,PROTEIN,ANGIOTENSIN-CONVERTING ENZYME 2,MEMBRANE PROTEIN,06/22/22,ACE2 -TARGETING MONOCLONAL ANTIBODY AS POTENT AND BROAD-SPECTRUM CORONAVIRUS BLOCKER,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,HOMO SAPIENS,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7M6D,N,"BG4-25 FAB HEAVY CHAIN, BG4-25 FAB LIGHT CHAIN, SPIKE PROTEIN S1, CR3022 FAB HEAVY CHAIN, CR3022 FAB LIGHT CHAIN",STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022,VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, COVID-19, ANTIBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING DOMAIN, SPIKE GLYCOPROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",B CELL GENOMICS BEHIND CROSS-NEUTRALIZATION OF SARS-COV-2 VARIANTS AND SARS-COV.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,05/05/21,STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
7BEN,N,"SPIKE GLYCOPROTEIN, COVOX-253 HEAVY CHAIN, COVOX-253 LIGHT CHAIN, COVOX-75 HEAVY CHAIN, COVOX-75 LIGHT CHAIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,G,I,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7M71,N,"SPIKE GLYCOPROTEIN, FAB 5A6 HEAVY CHAIN, FAB 5A6 LIGHT CHAIN",SARS-COV-2 SPIKE:5A6 FAB COMPLEX I FOCUSED REFINEMENT,VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN",STRUCTURAL INSIGHT INTO SARS-COV-2 NEUTRALIZING ANTIBODIES AND MODULATION OF SYNCYTIA.,,,H,L,A | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/26/21,SARS-COV-2 SPIKE:5A6 FAB COMPLEX I FOCUSED REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ASARNOW, D., CHENG, Y.",ELECTRON MICROSCOPY,NONE
7F63,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY CHAB-45 (FOCUSED REFINEMENT OF S-RBD AND CHAB-45 REGION),VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURE-GUIDED ANTIBODY COCKTAIL FOR PREVENTION AND TREATMENT OF COVID-19.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/04/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY CHAB-45 (FOCUSED REFINEMENT OF S-RBD AND CHAB-45 REGION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, T.J., YU, P.Y., WU, H.C., HSU, S.T.D.",ELECTRON MICROSCOPY,NONE
8CXQ,N,,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-22,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NANOBODY, BROAD BINDING, VIRAL PROTEIN",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,F,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/06/22,SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-22,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUANG, W., TAYLOR, D.",ELECTRON MICROSCOPY,NONE
8DCC,N,,SARS-COV-2 RECEPTOR-BINDING DOMAIN SPEEDESIGN IMMUNOGEN 3 BOUND TO P2B-2F6 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"IMMUNOGEN, ANTIGEN, DESIGN, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",DESIGN OF THE SARS-COV-2 RBD VACCINE ANTIGEN IMPROVES NEUTRALIZING ANTIBODY RESPONSE.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,07/06/22,SARS-COV-2 RECEPTOR-BINDING DOMAIN SPEEDESIGN IMMUNOGEN 3 BOUND TO P2B-2F6 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DICKEY, T.D., TOLIA, N.H.",X-RAY DIFFRACTION,NONE
7ZR7,N,,OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN,STRUCTURAL PROTEIN,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM COMPLEX, STRUCTURAL PROTEIN",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,D,E,A,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",STRUCTURAL PROTEIN,06/01/22,OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; TEQUATROVIRUS T4; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, TEQUATROVIRUS T4 ","DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7UAQ,N,,"STRUCTURE OF THE SARS-COV-2 NTD IN COMPLEX WITH C1520, LOCAL REFINEMENT",VIRAL PROTEIN,"SARS-COV-2, N-TERMINAL DOMAIN, NTD, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",ANALYSIS OF MEMORY B CELLS IDENTIFIES CONSERVED NEUTRALIZING EPITOPES ON THE N-TERMINAL DOMAIN OF VARIANT SARS-COV-2 SPIKE PROTEINS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/27/22,"STRUCTURE OF THE SARS-COV-2 NTD IN COMPLEX WITH C1520, LOCAL REFINEMENT",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O.",ELECTRON MICROSCOPY,NONE
7E86,N,GLUTAMINE--FRUCTOSE-6-PHOSPHATE AMINOTRANSFERASE [ISOMERIZING] (E.C.2.6.1.16),CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-508 FAB,"VIRAL PROTEIN,IMMUNE SYSTEM","SARS-COV-2, ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM",HUMORAL IMMUNE RESPONSE TO CIRCULATING SARS-COV-2 VARIANTS ELICITED BY INACTIVATED AND RBD-SUBUNIT VACCINES.,,,A,B,C,PROTEIN,SPIKE PROTEIN S1,"VIRAL PROTEIN,IMMUNE SYSTEM",06/09/21,CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-508 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GAO, C., XIAO, J.",X-RAY DIFFRACTION,NONE
7WCD,N,,CRYO EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH TAU-2212 MABS IN CONFORMATION 4,VIRAL PROTEIN/IMMUNE SYSTEM,VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX,CONFORMATIONAL FLEXIBILITY IN NEUTRALIZATION OF SARS-COV-2 BY NATURALLY ELICITED ANTI-SARS-COV-2 ANTIBODIES.,,,E,F,H,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/10/22,CRYO EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH TAU-2212 MABS IN CONFORMATION 4,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XIANG, Y., MA, B., LI, R.",ELECTRON MICROSCOPY,NONE
7WS3,N,,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,I,H,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7PHG,N,,MAP OF P5C3RBD INTERFACE,VIRAL PROTEIN,"RBD, ANTIBODY, VIRAL PROTEIN",A HIGHLY POTENT ANTIBODY EFFECTIVE AGAINST SARS-COV-2 VARIANTS OF CONCERN.,,,H,L,A,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,10/13/21,MAP OF P5C3RBD INTERFACE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PEREZ, L.",ELECTRON MICROSCOPY,NONE
7S6K,N,,J08 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT2 S PROTEIN (CONFORMATION 2),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, SARS, COV-2, VIRAL GLYCOPROTEIN, SPIKE, STABILIZING MUTATIONS, CORONAVIRUS, ULTRAPOTENT ANTIBODY, NEUTRALIZING ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL INSIGHTS OF A HIGHLY POTENT PAN-NEUTRALIZING SARS-COV-2 HUMAN MONOCLONAL ANTIBODY.,,,F,G,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/11/22,J08 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT2 S PROTEIN (CONFORMATION 2),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZOROWSKI, G., TORRES, J.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
8DT3,N,,CRYO-EM STRUCTURE OF SPIKE BINDING TO FAB OF NEUTRALIZING ANTIBODY (LOCALLY REFINED),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, ANTIBODY, NEUTRALIZING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ANTIBODY THAT NEUTRALIZES SARS-COV-1 AND SARS-COV-2 BY BINDING TO A CONSERVED SPIKE EPITOPE OUTSIDE THE RECEPTOR BINDING MOTIF.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/22,CRYO-EM STRUCTURE OF SPIKE BINDING TO FAB OF NEUTRALIZING ANTIBODY (LOCALLY REFINED),MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, P.C., FANG, Y., BAI, X.C., CHEN, Z.J.",ELECTRON MICROSCOPY,NONE
6VOS,N,"RM20J FAB HEAVY CHAIN, RM20J FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF MACAQUE ANTI-HIV-1 ANTIBODY RM20J,IMMUNE SYSTEM,"HIV, ANTIBODY, NON-HUMAN PRIMATES, IMMUNE SYSTEM",MAPPING THE IMMUNOGENIC LANDSCAPE OF NEAR-NATIVE HIV-1 ENVELOPE TRIMERS IN NON-HUMAN PRIMATES.,,,H,L,,,,IMMUNE SYSTEM,01/31/20,CRYSTAL STRUCTURE OF MACAQUE ANTI-HIV-1 ANTIBODY RM20J,MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,,"YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7TPR,N,,CAMEL NANOBODIES 7A3 AND 8A2 BROADLY NEUTRALIZE SARS-COV-2 VARIANTS,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZATION, NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CAMEL NANOBODIES BROADLY NEUTRALIZE SARS-COV-2 VARIANTS,,,H,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/20/22,CAMEL NANOBODIES 7A3 AND 8A2 BROADLY NEUTRALIZE SARS-COV-2 VARIANTS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CAMELUS DROMEDARIUS,CAMELUS DROMEDARIUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BUTAY, K.J., ZHU, J., DANDEY, V.P., HONG, J., KWON, H.J., CHEN, C.Z., DUAN, Z., LI, D., REN, H., LIANG, T., MARTIN, N., ESPOSITO, D., ORTEGA-RODRIGUEZ, U., XU, M., XIE, H., HO, M., CACHAU, R., BORGNIA, M.J.",ELECTRON MICROSCOPY,NONE
6NB3,N,"SPIKE GLYCOPROTEIN, LCA60 LIGHT CHAIN, LCA60 HEAVY CHAIN",MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1),VIRUS,"CORONAVIRUS SPIKE GLYCOPROTEIN, MERS-COV, SARS-COV, HUMAN NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRUS",UNEXPECTED RECEPTOR FUNCTIONAL MIMICRY ELUCIDATES ACTIVATION OF CORONAVIRUS FUSION.,,,D,E,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS,12/06/18,MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1),MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"WALLS, A.C., XIONG, X., PARK, Y.J., TORTORICI, M.A., SNIJDER, S., QUISPE, J., CAMERONI, E., GOPAL, R., MIAN, D., LANZAVECCHIA, A., ZAMBON, M., REY, F.A., CORTI, D., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7KFV,N,,STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB),IMMUNE SYSTEM/VIRAL PROTEIN,"COVID-19, SARS-COV-2, NEUTRALIZING ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",MOLECULAR BASIS FOR A GERMLINE-BIASED NEUTRALIZING ANTIBODY RESPONSE TO SARS-COV-2.,,,F,G,E,PROTEIN,SURFACE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,10/15/20,STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PAN, J., ABRAHAM, J., CLARK, L., CLARK, S.",X-RAY DIFFRACTION,NONE
7D0D,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF FAB, HEAVY CHAIN OF FAB",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_2B,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_2B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., WANG, R.K., JU, B., YU, J.F., ZHANG, Y.Y., LIU, N., WANG, H.W., WANG, X.Q., ZHANG, L.Q., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7D0C,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF FAB207, HEAVY CHAIN OF FAB207",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,G,F,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., WANG, R.K., YU, J.F., ZHANG, Y.Y., LIU, N., WANG, H.W., WANG, X.Q., ZHANG, L.Q., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7VNE,N,,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113.1 (UUU-STATE),VIRAL PROTEIN,"SARS-COV-2, NANOBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN",A NON-ACE2 COMPETING HUMAN SINGLE-DOMAIN ANTIBODY CONFERS BROAD NEUTRALIZATION AGAINST SARS-COV-2 AND CIRCULATING VARIANTS.,,,W,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,11/24/21,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A HUMAN SINGLE DOMAIN ANTIBODY N3113.1 (UUU-STATE),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, Z., WANG, Y., KONG, Y., JIN, Y., WU, Y., YING, T.",ELECTRON MICROSCOPY,NONE
4BEL,,"BETA-SECRETASE 2 (E.C.3.4.23.45), XA4813",BACE2 XAPERONE COMPLEX,HYDROLASE/IMMUNE SYSTEM,"HYDROLASE-IMMUNE SYSTEM COMPLEX, NANOBODY","MAPPING THE CONFORMATIONAL SPACE ACCESSIBLE TO BACE2 USING SURFACE MUTANTS AND CO-CRYSTALS WITH FAB-FRAGMENTS, FYNOMERS, AND XAPERONES",,,D,,A,PROTEIN,BETA-SECRETASE 2,HYDROLASE/IMMUNE SYSTEM,03/11/13,BACE2 XAPERONE COMPLEX,HOMO SAPIENS; LAMA GLAMA,LAMA GLAMA,,HOMO SAPIENS,"BANNER, D.W., KUGLSTATTER, A., BENZ, J., STIHLE, M., RUF, A.",X-RAY DIFFRACTION,NONE
7SOF,N,,SARS-COV-2 S NTD B.1.617.1 KAPPA VARIANT S2X303 LOCAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"KAPPA, SPIKE, ANTIBODY, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MOLECULAR BASIS OF IMMUNE EVASION BY THE DELTA AND KAPPA SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,01/08/09,SARS-COV-2 S NTD B.1.617.1 KAPPA VARIANT S2X303 LOCAL REFINEMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7X6A,N,,SARS-COV-2 BA.2 VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB BD55-5840,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","BA.2.12.1, BA.4 AND BA.5 ESCAPE ANTIBODIES ELICITED BY OMICRON INFECTION.",,,G,J,D,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/13/22,SARS-COV-2 BA.2 VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB BD55-5840,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7R6X,N,,"SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX WITH S2E12 FAB, S309 FAB, AND S304 FAB",VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 RBD ANTIBODIES THAT MAXIMIZE BREADTH AND RESISTANCE TO ESCAPE.,,,A,B,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,07/21/21,"SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX WITH S2E12 FAB, S309 FAB, AND S304 FAB",HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SNELL, G., CZUDNOCHOWSKI, N., CROLL, T.I., NIX, J.C., CORTI, D., CAMERONI, E., PINTO, D., BELTRAMELLO, M.",X-RAY DIFFRACTION,NONE
7N3C,N,,CRYSTAL STRUCTURE OF HUMAN FAB S24-202 IN THE COMPLEX WITH THE N-TERMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,VIRAL PROTEIN,"SARS CORONAVIRUS 2, NUCLEOCAPSID PROTEIN, HUMAN ANTIBODY FAB, COVID-19, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, VIRAL PROTEIN",CRYSTAL STRUCTURE OF HUMAN FAB S24-202 IN THE COMPLEX WITH THE N-TERMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,,,H,L,C,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN,07/07/21,CRYSTAL STRUCTURE OF HUMAN FAB S24-202 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KIM, Y., MALTSEVA, N., TESAR, C., JEDRZEJCZAK, R., DUGAN, H., STAMPER, C., WILSON, P., JOACHIMIAK, A., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",X-RAY DIFFRACTION,NONE
7E23,N,"SPIKE PROTEIN S1, CA521 HEAVY CHAIN, CA521 LIGHT CHAIN",SARS-COV-2 SPIKE IN COMPLEX WITH THE CA521 NEUTRALIZING ANTIBODY FAB (FOCUSED REFINEMENT ON FAB-RBD),VIRAL PROTEIN,"SPIKE, SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURE AND FUNCTION ANALYSIS OF A POTENT HUMAN NEUTRALIZING ANTIBODY CA521 FALA AGAINST SARS-COV-2.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,05/05/21,SARS-COV-2 SPIKE IN COMPLEX WITH THE CA521 NEUTRALIZING ANTIBODY FAB (FOCUSED REFINEMENT ON FAB-RBD),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, C., SONG, D., DOU, C.",ELECTRON MICROSCOPY,NONE
8DAO,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE STEM FUSION PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY COV44-79,IMMUNE SYSTEM,"SARS-COV-2, CORONAVIRUS, ANTIBODY, FUSION PEPTIDE, NEUTRALIZING ANTIBODY, COVID-19, IMMUNE SYSTEM",BROADLY NEUTRALIZING ANTIBODIES TARGET THE CORONAVIRUS FUSION PEPTIDE.,,,C,D,I,PEPTIDE,SPIKE PROTEIN S2 FUSION PEPTIDE,IMMUNE SYSTEM,07/27/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE STEM FUSION PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY COV44-79,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIN, T.H., LEE, C.C.D., YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7MZM,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 215,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 215,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., DIETRICH, M.H., TAN, L.L., CHAN, L.J., THAM, W.H.",X-RAY DIFFRACTION,NONE
7LXW,N,"S2X333 FAB LIGHT CHAIN VARIABLE REGION, S2X333 FAB HEAVY CHAIN VARIABLE REGION, SPIKE GLYCOPROTEIN",SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRAL PROTEIN, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",N-TERMINAL DOMAIN ANTIGENIC MAPPING REVEALS A SITE OF VULNERABILITY FOR SARS-COV-2.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
5N09,N,,CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11,IMMUNE SYSTEM/VIRAL PROTEIN,"IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY, FAB FRAGMENT",COVALENTLY LINKED DENGUE VIRUS ENVELOPE GLYCOPROTEIN DIMERS REDUCE EXPOSURE OF THE IMMUNODOMINANT FUSION LOOP EPITOPE.,,,I,M,B,PROTEIN,ENVELOPE GLYCOPROTEIN E,IMMUNE SYSTEM/VIRAL PROTEIN,02/02/17,CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11,HOMO SAPIENS; DENGUE VIRUS 2,HOMO SAPIENS,HOMO SAPIENS,DENGUE VIRUS 2,"DUQUERROY, S., ROUVINSKI, A., GUARDADO-CALVO, P., VANEY, M.-C., SHARMA, A., REY, F.",X-RAY DIFFRACTION,NONE
6NB5,N,THE ANTIGEN-BINDING (FAB) FRAGMENT,CRYSTAL STRUCTURE OF ANTI- MERS-COV HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT,IMMUNE SYSTEM,"FAB, CORONAVIRUS, MERS-COV, GLYCOPROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, IMMUNE SYSTEM",UNEXPECTED RECEPTOR FUNCTIONAL MIMICRY ELUCIDATES ACTIVATION OF CORONAVIRUS FUSION.,,,I,M,,,,IMMUNE SYSTEM,12/06/18,CRYSTAL STRUCTURE OF ANTI- MERS-COV HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"WALLS, A.J., XIONG, X., PARK, Y.J., TORTORICI, M.A., SNIJDER, J., QUISPE, J., CAMERONI, E., GOPAL, R., DAI, M., LANZAVECCHIA, A., ZAMBON, M., REY, F.A., CORTI, D., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
8CWV,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING NANOBODY 2-31 AND A HUMAN ANTIBODY CC12.1 FAB,IMMUNE SYSTEM,"CROSS-NEUTRALIZING ANTIBODY; NANOBODY; SARS-COV-2; SARBECOVIRUS; IMMUNE SYSTEM; VHH; CC12.1, IMMUNE SYSTEM",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM,07/06/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING NANOBODY 2-31 AND A HUMAN ANTIBODY CC12.1 FAB,HOMO SAPIENS; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7LJR,N,SPIKE GLYCOPROTEIN,SARS-COV-2 SPIKE PROTEIN TRIMER BOUND TO DH1043 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE PROTEIN TRIMER, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE FUNCTIONS OF SARS-COV-2 NEUTRALIZING AND INFECTION-ENHANCING ANTIBODIES IN VITRO AND IN MICE AND NONHUMAN PRIMATES.,,,S,T,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/31/21,SARS-COV-2 SPIKE PROTEIN TRIMER BOUND TO DH1043 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GOBEIL, S., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7ZXU,N,,SARS-COV-2 OMICRON BA.4/5 RBD IN COMPLEX WITH BETA-27 FAB AND C1 NANOBODY,VIRAL PROTEIN,"SARS-COV-2, OMICRON BA.4, BA.5, RBD, ANTIBODY, FAB, BETA-27, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",ANTIBODY ESCAPE OF SARS-COV-2 OMICRON BA.4 AND BA.5 FROM VACCINE AND BA.1 SERUM.,,,A,,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,06/29/22,SARS-COV-2 OMICRON BA.4/5 RBD IN COMPLEX WITH BETA-27 FAB AND C1 NANOBODY,HOMO SAPIENS; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"HUO, J., ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7PS3,N,,CRYSTAL STRUCTURE OF ANTIBODY BETA-32 FAB,VIRAL PROTEIN,"SARS-COV-2 B.1.1.7 (ALPHA) VARIANT, B.1.351 (BETA) VARIANT, P.1 (GAMMA) VARIANT, B.1.617.2 (DELTA) VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,,,,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF ANTIBODY BETA-32 FAB,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7K8X,N,"SPIKE GLYCOPROTEIN, C121 FAB HEAVY CHAIN, C121 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1)",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,D,F,B | C,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ABERNATHY, M.E., BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7S6J,N,,J08 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT2 S PROTEIN (CONFORMATION 1),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, SARS, COV-2, VIRAL GLYCOPROTEIN, SPIKE, STABILIZING MUTATIONS, CORONAVIRUS, ULTRAPOTENT ANTIBODY, NEUTRALIZING ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL INSIGHTS OF A HIGHLY POTENT PAN-NEUTRALIZING SARS-COV-2 HUMAN MONOCLONAL ANTIBODY.,,,C,D,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/11/22,J08 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT2 S PROTEIN (CONFORMATION 1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZOROWSKI, G., TORRES, J.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7KKJ,N,SYNTHETIC NANOBODY MNB6,STRUCTURE OF ANTI-SARS-COV-2 SPIKE NANOBODY MNB6,IMMUNE SYSTEM,"COMPLEX, NANOBODY, VHH, IMMUNE SYSTEM",AN ULTRAPOTENT SYNTHETIC NANOBODY NEUTRALIZES SARS-COV-2 BY STABILIZING INACTIVE SPIKE.,,,A,,,,,IMMUNE SYSTEM,10/27/20,STRUCTURE OF ANTI-SARS-COV-2 SPIKE NANOBODY MNB6,SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,,"SCHOOF, M.S., FAUST, B.F., SAUNDERS, R.A., SANGWAN, S., REZELJ, V., HOPPE, N., BOONE, M., BILLESBOELLE, C.B., PUCHADES, C., AZUMAYA, C.M., KRATOCHVIL, H.T., ZIMANYI, M., DESPHANDE, I., LIANG, J., DICKINSON, S., NGUYEN, H.C., CHIO, C.M., MERZ, G.E., THOMPSON, M.C., DIWANJI, D., SCHAEFER, K., ANAND, A.A., DOBZINSKI, N., ZHA, B.S., SIMONEAU, C.R., LEON, K., WHITE, K.M., CHIO, U.S., GUPTA, M., JIN, M., LI, F., LIU, Y., ZHANG, K., BULKLEY, D., SUN, M., SMITH, A.M., RIZO, A.N., MOSS, F., BRILOT, A.F., POURMAL, S., TRENKER, R., POSPIECH, T., GUPTA, S., BARSI-RHYNE, B., BELYY, V., BARILE-HILL, A.W., NOCK, S., LIU, Y., KROGAN, N.J., RALSTON, C.Y., SWANEY, D.L., GARCIA-SASTRE, A., OTT, M., VIGNUZZI, M., WALTER, P., MANGLIK, A., QCRG STRUCTURAL BIOLOGY CONSORTIUM",X-RAY DIFFRACTION,NONE
7PNQ,N,,HUMAN CORONAVIRUS OC43 SPIKE GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH THE 43E6 ANTIBODY FAB FRAGMENT,VIRAL PROTEIN,"CORONAVIRUS, GLYCOPROTEIN, ANTIBODY, SPIKE, VIRAL PROTEIN",NEUTRALIZING EPITOPES ON THE HUMAN CORONAVIRUS OC43 SPIKE TRIMER,,,D,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/20/22,HUMAN CORONAVIRUS OC43 SPIKE GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH THE 43E6 ANTIBODY FAB FRAGMENT,HOMO SAPIENS; HUMAN CORONAVIRUS OC43,HOMO SAPIENS,HOMO SAPIENS,HUMAN CORONAVIRUS OC43,"HURDISS, D.L.",ELECTRON MICROSCOPY,NONE
7WS6,N,,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,I,H,C,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7DD8,N,"THE HEAVY CHAIN OF 3C1 FAB, THE LIGHT CHAIN OF 3C1 CHAIN, SPIKE GLYCOPROTEIN","S-3C1-F1 STRUCTURE, ONE RBD IS UP AND TWO RBDS ARE DOWN, THE UP RBD BINDS WITH A 3C1 FAB",VIRAL PROTEIN,VIRAL PROTEIN,DEVELOPMENT AND STRUCTURAL BASIS OF A TWO-MAB COCKTAIL FOR TREATING SARS-COV-2 INFECTIONS.,,,A,B,C | D,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN,10/28/20,"S-3C1-F1 STRUCTURE, ONE RBD IS UP AND TWO RBDS ARE DOWN, THE UP RBD BINDS WITH A 3C1 FAB",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., LIU, C.X.",ELECTRON MICROSCOPY,NONE
7EY4,N,,LOCAL CRYOEM OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-667,VIRAL PROTEIN,"COMPLEX ANTIBODY, VIRAL PROTEIN",STRUCTURES OF SARS-COV-2 B.1.351 NEUTRALIZING ANTIBODIES PROVIDE INSIGHTS INTO COCKTAIL DESIGN AGAINST CONCERNING VARIANTS.,,,H,L,R | N,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | NTD,VIRAL PROTEIN,01/08/09,LOCAL CRYOEM OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-667,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | HOMO SAPIENS,"LIU, P.L.",ELECTRON MICROSCOPY,NONE
7CZV,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,K,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7M6H,N,"SPIKE GLYCOPROTEIN, BG7-20 FAB HEAVY CHAIN, BG7-20 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20",VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, CORONAVIRUS, COVID-19, ANTIBODY, NEUTRALIZING ANTIBODY, RECEPTOR BINDING DOMAIN, SPIKE GLYCOPROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",B CELL GENOMICS BEHIND CROSS-NEUTRALIZATION OF SARS-COV-2 VARIANTS AND SARS-COV.,,,E,G,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/ANTIVIRAL PROTEIN,05/05/21,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7WO5,N,,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-15 (S-553-15 TRIMER),VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN",STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT BY DISASSEMBLING THE SPIKE TRIMER.,,,H,I,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/20/22,SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-15 (S-553-15 TRIMER),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7K8P,N,"C110 FAB HEAVY CHAIN, C110 FAB LIGHT CHAIN","CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110",IMMUNE SYSTEM,"HUMAN NEUTRALIZING ANTIBODY, SARS-COV-2, RECEPTOR BINDING DOMAIN, COVID-19, IMMUNE SYSTEM",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,H,L,,,,IMMUNE SYSTEM,09/27/20,"CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110",HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"DAM, K.A., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
6YZ7,N,"SPIKE GLYCOPROTEIN, ANTIBODY CR3022, ANTIBODY LIGHT CHAIN, NANOBODY","H11-D4, SARS-COV-2 RBD, CR3022 TERNARY COMPLEX",VIRAL PROTEIN,"ANTIBODY, NANOBODY COMPLEX, RBD, VIRAL PROTEIN",STRUCTURAL CHARACTERISATION OF A NANOBODY DERIVED FROM A NAIVE LIBRARY THAT NEUTRALISES SARS-COV-2,,,D,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,05/06/20,"H11-D4, SARS-COV-2 RBD, CR3022 TERNARY COMPLEX",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NAISMITH, J.H., REN, J., ZHOU, D., ZHAO, Y., STUART, D.I.",X-RAY DIFFRACTION,NONE
6WAR,N,"SPIKE PROTEIN, NANOBODY MERS VHH-55",CRYSTAL STRUCTURE OF THE MERS-COV RBD BOUND BY THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY MERS VHH-55,VIRAL PROTEIN/IMMUNE SYSTEM,"MERS-COV, NANOBODY, CORONAVIRUS, RBD, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR POTENT NEUTRALIZATION OF BETACORONAVIRUSES BY SINGLE-DOMAIN CAMELID ANTIBODIES.,,,D,,C,PROTEIN,SPIKE PROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/08/20,CRYSTAL STRUCTURE OF THE MERS-COV RBD BOUND BY THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY MERS VHH-55,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; LAMA GLAMA,LAMA GLAMA,,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"WRAPP, D., TORRES, G.M., MCLELLAN, J.S.",X-RAY DIFFRACTION,NONE
7VYR,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH THE D27 NEUTRALIZING ANTIBODY FAB FRAGMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COMPUTATIONAL DESIGN, NEUTRALIZING ANTIBODY, SARS-COV-2, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",COMPUTATIONAL DESIGN OF A NEUTRALIZING ANTIBODY WITH PICOMOLAR BINDING AFFINITY FOR ALL CONCERNING SARS-COV-2 VARIANTS.,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,03/02/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH THE D27 NEUTRALIZING ANTIBODY FAB FRAGMENT,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JEONG, B.-S., OH, B.-H.",X-RAY DIFFRACTION,NONE
5W9L,N,"SPIKE GLYCOPROTEIN, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,E,F,D,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7WS0,N,,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SPIKE GLYCOPROTEIN, VIRUS, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF OMICRON SPIKE COMPLEXES AND IMPLICATIONS FOR NEUTRALIZING ANTIBODY DEVELOPMENT.,,,G,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/01/22,STRUCTURES OF OMICRON SPIKE COMPLEXES ILLUMINATE BROAD-SPECTRUM NEUTRALIZING ANTIBODY DEVELOPMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, H., GAO, Y., JI, X., YANG, H.",ELECTRON MICROSCOPY,NONE
7LY0,N,"SPIKE GLYCOPROTEIN, S2M28 FAB LIGHT CHAIN VARIABLE REGION, S2M28 FAB HEAVY CHAIN VARIABLE REGION",SARS-COV-2 S/S2M11/S2M28 LOCAL REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, VIRAL PROTEIN, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",N-TERMINAL DOMAIN ANTIGENIC MAPPING REVEALS A SITE OF VULNERABILITY FOR SARS-COV-2.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,SARS-COV-2 S/S2M11/S2M28 LOCAL REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MCCALLUM, M., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7WUH,N,,SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, MONOCLONAL ANTIBODY, BROAD NEUTRALIZATION, M31A7, MONO-GLCNAC-DECORATED S VACCINE, MEMORY B CELLS, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",VACCINATION WITH SARS-COV-2 SPIKE PROTEIN LACKING GLYCAN SHIELDS ELICITS ENHANCED PROTECTIVE RESPONSES IN ANIMAL MODELS.,,,D,F,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/23/22,SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CHEN, X., WU, Y.-M.",ELECTRON MICROSCOPY,NONE
7X7U,N,,"CRYO-EM STRUCTURE OF SARS-COV-2 DELTA VARIANT SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 DELTA VARIANT, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","CRYO-EM STRUCTURE OF SARS-COV-2 DELTA VARIANT SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",,,C,D,G,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/17/22,"CRYO-EM STRUCTURE OF SARS-COV-2 DELTA VARIANT SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, H., LIU, L., ZHANG, T., ZHENG, Q., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
5W9K,N,"SPIKE GLYCOPROTEIN, G4 VH, G4 VL",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,VIRAL PROTEIN,"IMMUNOGEN, PEPLOMER, VIRAL SPIKE, MERS, MERS S PROTEIN, ANTIBODY, G4, VIRAL PROTEIN",IMMUNOGENICITY AND STRUCTURES OF A RATIONALLY DESIGNED PREFUSION MERS-COV SPIKE ANTIGEN.,,,H,I,G,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/17,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF NEUTRALIZING ANTIBODY G4,MIDDLE EAST RESPIRATORY SYNDROME-RELATED CORONAVIRUS; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,MIDDLE EAST RESPIRATORY SYNDROME-RELATEDCORONAVIRUS ,"PALLESEN, J., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7N9E,N,,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS WITH NB34,VIRAL PROTEIN/IMMUNE SYSTEM,"COVS NB34 NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING DIVERSE AND CONSERVED EPITOPES,,,D,,A | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,POTENT NEUTRALIZING NANOBODIES RESIST CONVERGENT CIRCULATING VARIANTS OF SARS-COV-2 BY TARGETING NOVEL AND CONSERVED EPITOPES-COVS WITH NB34,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, D., ZHANG, C., SHI, Y.",ELECTRON MICROSCOPY,NONE
6C6X,N,"JC57-14 HEAVY CHAIN, JC57-14 LIGHT CHAIN",CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.,IMMUNE SYSTEM,"ANTIBODY, NEUTRALIZING, VACCINE, IMMUNE SYSTEM",IMPORTANCE OF NEUTRALIZING MONOCLONAL ANTIBODIES TARGETING MULTIPLE ANTIGENIC SITES ON THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS SPIKE GLYCOPROTEIN TO AVOID NEUTRALIZATION ESCAPE.,,,E,F,,,,IMMUNE SYSTEM,01/19/18,CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.,MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,,"JOYCE, M.G., MASCOLA, J.R., GRAHAM, B.S., KWONG, P.D.",X-RAY DIFFRACTION,NONE
7EK0,N,,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-N501Y OF COVID-19,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZATION ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-N501Y OF COVID-19,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/13/22,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD-N501Y OF COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, H., WANG, B., ZHAO, T.N., SU, X.D.",X-RAY DIFFRACTION,NONE
7CAK,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF H014 FAB, HEAVY CHAIN OF H014 FAB",SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB,VIRAL PROTEIN,"NEUTRALIZING ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR NEUTRALIZATION OF SARS-COV-2 AND SARS-COV BY A POTENT THERAPEUTIC ANTIBODY.,,,I,H,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/08/20,SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHE, L., CAO, L., DENG, Y., SUN, Y., WANG, N., XIE, L., WANG, Y., RAO, Z., QIN, C., WANG, X.",ELECTRON MICROSCOPY,NONE
6WIX,N,"ENVELOPE GLYCOPROTEIN GP41, 35O22 SCFV HEAVY CHAIN, 35O22 SCFV LIGHT CHAIN, ENVELOPE GLYCOPROTEIN GP120, 3H109L FAB HEAVY CHAIN, 3H109L FAB LIGHT CHAIN",CRYSTAL STRUCTURE OF HIV-1 MI369 RNS-DS.SOSIP PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV-1 ENVELOPE PREFUSION TRIMER, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AUTOMATED DESIGN BY STRUCTURE-BASED STABILIZATION AND CONSENSUS REPAIR TO ACHIEVE PREFUSION-CLOSED ENVELOPE TRIMERS IN A WIDE VARIETY OF HIV STRAINS.,,,D,E,B,PROTEIN,ENVELOPE GLYCOPROTEIN GP41,VIRAL PROTEIN/IMMUNE SYSTEM,11/25/20,CRYSTAL STRUCTURE OF HIV-1 MI369 RNS-DS.SOSIP PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"LAI, Y.-T., OLIA, A., KWONG, P.D.",X-RAY DIFFRACTION,NONE
7ENG,N,,CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH FAB30 (LOCAL REFINEMENT OF THE RBD AND FAB30),VIRAL PROTEIN,"IMMUNE SYSTEM, VIRAL PROTEIN",A POTENT HUMAN MONOCLONAL ANTIBODY WITH PAN-NEUTRALIZING ACTIVITIES DIRECTLY DISLOCATES S TRIMER OF SARS-COV-2 THROUGH BINDING BOTH UP AND DOWN FORMS OF RBD,,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,04/06/22,CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH FAB30 (LOCAL REFINEMENT OF THE RBD AND FAB30),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.F., ZHU, Y.Q.",ELECTRON MICROSCOPY,NONE
7SL5,N,,CRYSTAL STRUCTURE OF VP12E7 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 SPIKE, COVID-19, FUSION PEPTIDE, FAB, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID",ACE2-BINDING EXPOSES THE SARS-COV-2 FUSION PEPTIDE TO BROADLY NEUTRALIZING CORONAVIRUS ANTIBODIES.,,,D,E,F,PEPTIDE,PRO-SER-LYS-ARG-SER-PHE-ILE-GLU-ASP-LEU-LEU-PHE-ASN,VIRAL PROTEIN/IMMUNE SYSTEM,07/20/22,CRYSTAL STRUCTURE OF VP12E7 FAB IN COMPLEX WITH SARS-COV-2 S FUSION PEPTIDE,MAMMAL ENVIRONMENTAL SAMPLE; SYNTHETIC CONSTRUCT,MAMMAL ENVIRONMENTAL SAMPLE,MAMMAL ENVIRONMENTAL SAMPLE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TORTORICI, M.A., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",X-RAY DIFFRACTION,NONE
7Q9G,N,,COVOX-222 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,A,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/15/21,COVOX-222 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7N3H,N,,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C099,IMMUNE SYSTEM,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,H,L,,,,IMMUNE SYSTEM,08/04/21,CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT C099,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"FLYAK, A.I., BJORKMAN, P.J., BARNES, C.O.",X-RAY DIFFRACTION,NONE
7N4L,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2125.,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, SARS-COV-2, WRAIR-2125, RECEPTOR BINDING DOMAIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",LOW-DOSE IN VIVO PROTECTION AND NEUTRALIZATION ACROSS SARS-COV-2 VARIANTS BY MONOCLONAL ANTIBODY COMBINATIONS.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,11/10/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2125.,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SANKHALA, R.S., JOYCE, M.G.",X-RAY DIFFRACTION,NONE
7N0R,N,,STRUCTURE OF THE SARS-COV-2 N PROTEIN RNA-BINDING DOMAIN BOUND TO SINGLE-DOMAIN ANTIBODY C2,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NANOBODY, NUCLEOCAPSID, VIRUS, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR SARS-COV-2 NUCLEOCAPSID PROTEIN RECOGNITION BY SINGLE-DOMAIN ANTIBODIES.,,,D,,B,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/02/21,STRUCTURE OF THE SARS-COV-2 N PROTEIN RNA-BINDING DOMAIN BOUND TO SINGLE-DOMAIN ANTIBODY C2,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YE, Q., CORBETT, K.D.",X-RAY DIFFRACTION,NONE
7NX8,N,"COVOX-158 HEAVY CHAIN, COVOX-158 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 B.1.1.7 VARIANT, B.1.351 VARIANT, P.1 VARIANT, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",ANTIBODY EVASION BY THE P.1 STRAIN OF SARS-COV-2.,,,H,L,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/07/21,CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7CZW,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7S4S,N,,CRYSTAL STRUCTURE OF SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 S RBD FAB COMPLEX, SARS-COV-2 S RECEPTOR-BINDING DOMAIN ANTIBODY FAB COMPLEX, COVID-19 SPIKE PROTEIN ANTIBODY FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYSTAL STRUCTURE OF SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/22/21,CRYSTAL STRUCTURE OF SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX COV11 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TOLBERT, W.D., PAZGIER, M.",X-RAY DIFFRACTION,NONE
7EAM,N,,IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6,"VIRAL PROTEIN, IMMUNE SYSTEM","SARS-COV-2, RECEPTOR BINDING DOMAIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM",CROSS-NEUTRALIZING ANTIBODIES BIND A SARS-COV-2 CRYPTIC SITE AND RESIST CIRCULATING VARIANTS.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,"VIRAL PROTEIN, IMMUNE SYSTEM",03/17/21,IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LI, T.T., GU, Y., LI, S.W.",X-RAY DIFFRACTION,NONE
7R8M,N,,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C032,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, RECEPTOR BINDING DOMAIN, RBD, NEUTRALIZING ANTIBODY, COVID-19, SPIKE, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","AFFINITY MATURATION OF SARS-COV-2 NEUTRALIZING ANTIBODIES CONFERS POTENCY, BREADTH, AND RESILIENCE TO VIRAL ESCAPE MUTATIONS.",,,H,L,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C032,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DELAITSCH, A.T., BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7KGJ,N,,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY (SB45) COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, RBD, ANTIBODY, NANOBODY, SYBODY, VIRAL PROTEIN, EPITOPES, NEUTRALIZATION",STRUCTURES OF SYNTHETIC NANOBODY-SARS-COV-2 RECEPTOR-BINDING DOMAIN COMPLEXES REVEAL DISTINCT SITES OF INTERACTION.,,,B,,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,10/16/20,CRYSTAL STRUCTURE OF SYNTHETIC NANOBODY COMPLEXES WITH SARS-COV-2 RECEPTOR BINDING DOMAIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYNTHETIC CONSTRUCT,SYNTHETIC CONSTRUCT,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"JIANG, J., AHMAD, J., NATARAJAN, K., BOYD, L.F., MARGULIES, D.H.",X-RAY DIFFRACTION,NONE
7VFB,N,,THE COMPLEX OF SARS-COV2 3CL AND NB2B4,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, 3CL, NANOBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN EXTENDED CONFORMATION OF SARS-COV-2 MAIN PROTEASE REVEALS ALLOSTERIC TARGETS.,,,B,,A,PROTEIN,3C-LIKE PROTEINASE,VIRAL PROTEIN/IMMUNE SYSTEM,03/30/22,THE COMPLEX OF SARS-COV2 3CL AND NB2B4,CAMELUS BACTRIANUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,CAMELUS BACTRIANUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GENG, Y., SUN, Z.C., WANG, L.",X-RAY DIFFRACTION,NONE
7K8V,N,"SPIKE GLYCOPROTEIN, C110 FAB HEAVY CHAIN, C110 FAB LIGHT CHAIN","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL ANTIBODY, NEUTRALIZING ANTIBODY, PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 NEUTRALIZING ANTIBODY STRUCTURES INFORM THERAPEUTIC STRATEGIES.,,,H,L,A | B,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/27/20,"STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DAM, K.A., BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7S6L,N,,J08 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (CONFORMATION 3),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID, SARS, COV-2, VIRAL GLYCOPROTEIN, SPIKE, STABILIZING MUTATIONS, CORONAVIRUS, ULTRAPOTENT ANTIBODY, NEUTRALIZING ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL INSIGHTS OF A HIGHLY POTENT PAN-NEUTRALIZING SARS-COV-2 HUMAN MONOCLONAL ANTIBODY.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/11/22,J08 FRAGMENT ANTIGEN BINDING IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (CONFORMATION 3),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"OZOROWSKI, G., TORRES, J.L., WARD, A.B.",ELECTRON MICROSCOPY,NONE
7EJY,N,,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD OF COVID-19,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZATION ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD OF COVID-19,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/13/22,COMPLEX STRUCTURE OF ANTIBODY BD-503 AND RBD OF COVID-19,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, H., WANG, B., ZHAO, T.N., SU, X.D.",X-RAY DIFFRACTION,NONE
7MY3,N,,CRYOEM STRUCTURE OF NEUTRALIZING NANOBODY NB12 IN COMPLEX WITH SARS-COV2 SPIKE,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV2, NANOBODY, NEUTRALIZING, SPIKE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",NANOBODIES FROM CAMELID MICE AND LLAMAS NEUTRALIZE SARS-COV-2 VARIANTS.,,,E,,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,06/16/21,CRYOEM STRUCTURE OF NEUTRALIZING NANOBODY NB12 IN COMPLEX WITH SARS-COV2 SPIKE,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XU, K., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
8DCE,N,,SARS-COV-2 RECEPTOR-BINDING DOMAIN SPEEDESIGN IMMUNOGEN 1 BOUND TO C144 SCFV,VIRAL PROTEIN/IMMUNE SYSTEM,"IMMUNOGEN, ANTIGEN, DESIGN, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",DESIGN OF THE SARS-COV-2 RBD VACCINE ANTIGEN IMPROVES NEUTRALIZING ANTIBODY RESPONSE,,,H,H,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/29/22,SARS-COV-2 RECEPTOR-BINDING DOMAIN SPEEDESIGN IMMUNOGEN 1 BOUND TO C144 SCFV,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"TANG, W.K., TOLIA, N.H.",X-RAY DIFFRACTION,NONE
8DM0,N,,CRYO-EM STRUCTURE OF SARS-COV-2 D614G SPIKE PROTEIN IN COMPLEX WITH VH AB6 (FOCUSED REFINEMENT OF NTD AND VH AB6),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, GLYCOPROTEIN, FUSION PROTEIN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VH AB6",SARS-COV-2 VARIANTS OF CONCERN: SPIKE PROTEIN MUTATIONAL ANALYSIS AND EPITOPE FOR BROAD NEUTRALIZATION.,,,H,,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/31/22,CRYO-EM STRUCTURE OF SARS-COV-2 D614G SPIKE PROTEIN IN COMPLEX WITH VH AB6 (FOCUSED REFINEMENT OF NTD AND VH AB6),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHU, X., MANNAR, D., SAVILLE, J.W., SRIVASTAVA, S.S., BEREZUK, A.M., ZHOU, S., TUTTLE, K.S., SUBRAMANIAM, S.",ELECTRON MICROSCOPY,NONE
7L7E,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH HUMAN MONOCLONAL ANTIBODIES AZD8895 AND AZD1061,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN, HUMAN MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",GENETIC AND STRUCTURAL BASIS FOR SARS-COV-2 VARIANT NEUTRALIZATION BY A TWO-ANTIBODY COCKTAIL.,,,T,U,B,PROTEIN,UNKNOWN,VIRAL PROTEIN/IMMUNE SYSTEM,09/01/21,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH HUMAN MONOCLONAL ANTIBODIES AZD8895 AND AZD1061,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DONG, J., CROWE, J.E.",X-RAY DIFFRACTION,NONE
7E9O,N,,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(3 UP RBDS, STATE2)","VIRAL PROTEIN,IMMUNE SYSTEM","VIRAL PROTEIN, IMMUNE SYSTEM",A POTENT HUMAN MONOCLONAL ANTIBODY WITH PAN-NEUTRALIZING ACTIVITIES DIRECTLY DISLOCATES S TRIMER OF SARS-COV-2 THROUGH BINDING BOTH UP AND DOWN FORMS OF RBD,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,"VIRAL PROTEIN,IMMUNE SYSTEM",03/09/22,"CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH 35B5 FAB(3 UP RBDS, STATE2)",SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X.F., ZHU, Y.Q.",ELECTRON MICROSCOPY,NONE
7Z85,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 NANOBODY COMPLEX,ANTIVIRAL PROTEIN,"COMPLEX, SPIKE GLYCOPROTEIN, NANOBODY H11-B5, ANTIVIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 NANOBODY COMPLEX,,,F,,C,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",ANTIVIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 NANOBODY COMPLEX,ESCHERICHIA VIRUS T4; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ESCHERICHIA VIRUS T4 ","WECKENER, M., NAISMITH, J.H.",ELECTRON MICROSCOPY,NONE
7LD1,N,,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047,IMMUNE SYSTEM,"RBD ANTIBODY, DH1047, SARS, COVID-19, SARS-COV-2 2P S ECTODOMAIN, VIRAL PROTEIN, IMMUNE SYSTEM",IN VITRO AND IN VIVO FUNCTIONS OF SARS-COV-2 INFECTION-ENHANCING AND NEUTRALIZING ANTIBODIES.,,,M,N,C,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,01/12/21,STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MANNE, K., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7QNW,N,,THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 OMICRON VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-55 AND EY6A FABS,VIRAL PROTEIN,"SARS-COV-2, BETA VARIANT, OMICRON VARIANT, B.1.351, B.1.1.529, ANTIBODY, RBD, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",OMICRON-B.1.1.529 LEADS TO WIDESPREAD ESCAPE FROM NEUTRALIZING ANTIBODY RESPONSES.,,,H,L,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,01/19/22,THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 OMICRON VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-55 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7THT,N,,CRYOEM STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1042,VIRAL PROTEIN/IMMUNE SYSTEM,"RBD ANTIBODY, DH1042, SARS, COVID-19, SARS-COV-2 2P S ECTODOMAIN, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL DIVERSITY OF THE SARS-COV-2 OMICRON SPIKE.,,,H,L,C,PROTEIN,DH1042 LIGHT CHAIN,VIRAL PROTEIN/IMMUNE SYSTEM,02/16/22,CRYOEM STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1042,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MANNE, K., MAY, A., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7K9J,N,,SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION),VIRAL PROTEIN/IMMUNE SYSTEM,"COMPLEX, NEUTRALIZING ANTIBODY, ACE2-NON-COMPETITIVE, RECEPTOR-BINDING DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID",STRUCTURAL MECHANISM OF SARS-COV-2 NEUTRALIZATION BY TWO MURINE ANTIBODIES TARGETING THE RBD.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,09/29/21,SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ERRICO, J.M., FREMONT, D.H., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",ELECTRON MICROSCOPY,NONE
5DHZ,,"ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, HEAVY CHAIN, ANTI-REV ANTIBODY FAB SINGLE-CHAIN VARIABLE FRAGMENT, LIGHT CHAIN, PROTEIN REV",HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,IMMUNE SYSTEM,"HIV, HELICAL HAIRPIN, NUCLEAR EXPORT, RNA-BINDING, IMMUNE SYSTEM",THE STRUCTURE OF HIV-1 REV FILAMENTS SUGGESTS A BILATERAL MODEL FOR REV-RRE ASSEMBLY.,,,H,L,M,PROTEIN,PROTEIN REV,IMMUNE SYSTEM,08/31/15,HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1,"DIMATTIA, M.A., WATTS, N.R., WINGFIELD, P.T., GRIMES, J.M., STUART, D.I., STEVEN, A.C.",X-RAY DIFFRACTION,NONE
7N4M,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2151.,VIRAL PROTEIN/IMMUNE SYSTEM,"NEUTRALIZING ANTIBODY, SARS-COV-2, WRAIR-2151, RECEPTOR BINDING DOMAIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",LOW-DOSE IN VIVO PROTECTION AND NEUTRALIZATION ACROSS SARS-COV-2 VARIANTS BY MONOCLONAL ANTIBODY COMBINATIONS.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,11/10/21,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY WRAIR-2151.,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SANKHALA, R.S., JOYCE, M.G.",X-RAY DIFFRACTION,NONE
7QNY,N,,THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-58 AND COVOX-158 FABS,VIRAL PROTEIN,"SARS-COV-2, BETA VARIANT, OMICRON VARIANT, B.1.351, B.1.1.529, ANTIBODY, RBD, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",OMICRON-B.1.1.529 LEADS TO WIDESPREAD ESCAPE FROM NEUTRALIZING ANTIBODY RESPONSES.,,,H,L,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,01/19/22,THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-58 AND COVOX-158 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7JMP,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-39,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, RBD, ANTIBODY, SARS, SPIKE, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",AN ALTERNATIVE BINDING MODE OF IGHV3-53 ANTIBODIES TO THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/02/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-39,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WU, N.C., YUAN, M., LIU, H., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7SJS,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE STEM HELIX PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY CC40.8,IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, SPIKE, S2, STEM HELIX, IMMUNE SYSTEM",A HUMAN ANTIBODY REVEALS A CONSERVED SITE ON BETA-CORONAVIRUS SPIKE PROTEINS AND CONFERS PROTECTION AGAINST SARS-COV-2 INFECTION.,,,H,L,C,PEPTIDE,STEM HELIX PEPTIDE OF SPIKE PROTEIN S2',IMMUNE SYSTEM,01/12/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE STEM HELIX PEPTIDE IN COMPLEX WITH NEUTRALIZING ANTIBODY CC40.8,HOMO SAPIENS; SYNTHETIC CONSTRUCT,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
6XDG,N,"SPIKE GLYCOPROTEIN, REGN10933 ANTIBODY FAB FRAGMENT LIGHT CHAIN, REGN10933 ANTIBODY FAB FRAGMENT HEAVY CHAIN, REGN10987 ANTIBODY FAB HEAVY CHAIN, REGN10987 ANTIBODY FAB FRAGMENT LIGHT CHAIN",COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, THERAPEUTIC ANTIBODY, ANTIVIRAL, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STUDIES IN HUMANIZED MICE AND CONVALESCENT HUMANS YIELD A SARS-COV-2 ANTIBODY COCKTAIL.,,,B,D,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,06/24/20,COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FRANKLIN, M.C., SAOTOME, K., ROMERO HERNANDEZ, A., ZHOU, Y.",ELECTRON MICROSCOPY,NONE
7CZR,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,H,K,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7BEM,N,"COVOX-269 VH DOMAIN, COVOX-269 VL DOMAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 SCFV,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, ANTIBODY, GERMLINE, V-GENE, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, PROTECTION, GLYCOSYLATION, VALENCY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIGENIC ANATOMY OF SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,03/03/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 SCFV,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., REN, J., STUART, D.",X-RAY DIFFRACTION,NONE
7R6W,N,,SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX WITH S2X35 FAB AND S309 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 RBD ANTIBODIES THAT MAXIMIZE BREADTH AND RESISTANCE TO ESCAPE.,,,A,B,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,07/21/21,SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD) IN COMPLEX WITH S2X35 FAB AND S309 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SNELL, G., CZUDNOCHOWSKI, N., HERNANDEZ, P., NIX, J.C., CROLL, T.I., CORTI, D., CAMERONI, E., PINTO, D., BELTRAMELLO, M.",X-RAY DIFFRACTION,NONE
4UIF,,"DENGUE VIRUS SEROTYPE 2 STRAIN PVP94 07 - ENVELOPE PROTEIN, DENGUE VIRUS SEROTYPE 2 STRAIN STRAIN PVP94 07 - MEMBRANE PROTEIN, ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN, ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN",CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22,VIRAL PROTEIN,"VIRAL PROTEIN, DENGUE VIRUS, HUMAN ANTIBODY, CRYO-EM, NEUTRALIZATION",CRYO-EM STRUCTURE OF AN ANTIBODY THAT NEUTRALIZES DENGUE VIRUS TYPE 2 BY LOCKING E PROTEIN DIMERS.,,"CA ATOMS ONLY, CHAIN A, C, E, B, D, F, G, I, K, H, J, L",K,L,C,PROTEIN,DENGUE VIRUS SEROTYPE 2 STRAIN PVP94 07 - ENVELOPEPROTEIN ,,03/30/15,CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN- BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22,DENGUE VIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,DENGUE VIRUS 2,"FIBRIANSAH, G., IBARRA, K.D., NG, T.-S., SMITH, S.A., TAN, J.L., LIM, X.-N., OOI, J.S.G., KOSTYUCHENKO, V.A., WANG, J., DE SILVA, A.M., HARRIS, E., CROWE JUNIOR, J.E., LOK, S.-M.",ELECTRON MICROSCOPY,NONE
7F15,N,,A SARS-COV-2 NEUTRALIZING ANTIBODY,VIRAL PROTEIN/ANTIVIRAL PROTEIN,"NEUTRALIZING ANTIBODY, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX","A SARS-COV-2 NEUTRALIZING
ANTIBODY",,,B,B,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,06/15/22,A SARS-COV-2 NEUTRALIZING ANTIBODY,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, G., LI, X., GUO, Y., WANG, Y., YUAN, S.",X-RAY DIFFRACTION,NONE
6Z43,N,"SPIKE GLYCOPROTEIN, NANOBODY",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-D4 NANOBODY COMPLEX,VIRAL PROTEIN,"SPIKE, NANOBODY, VHH, SARS-COV-2, COVID-19, VIRAL PROTEIN",STRUCTURAL BASIS FOR A POTENT NEUTRALISING SINGLE-DOMAIN ANTIBODY THAT BLOCKS SARS-COV-2 BINDING TO ITS RECEPTOR ACE2,,,Y,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/03/20,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-D4 NANOBODY COMPLEX,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"RUZA, R.R., DUYVESTEYN, H.M.E., SHAH, P., CARRIQUE, L., REN, J., MALINAUSKAS, T., ZHOU, D., STUART, D.I., NAISMITH, J.H.",ELECTRON MICROSCOPY,NONE
7L56,N,"SPIKE GLYCOPROTEIN, FAB 2-43 VARIABLE DOMAIN HEAVY CHAIN, FAB 2-43 VARIABLE DOMAIN LIGHT CHAIN",CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-43,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, GLYCOPROTEIN, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MODULAR BASIS FOR POTENT SARS-COV-2 NEUTRALIZATION BY A PREVALENT VH1-2-DERIVED ANTIBODY CLASS.,,,J,K,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,04/14/21,CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-43,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"RAPP, M., SHAPIRO, L.",ELECTRON MICROSCOPY,NONE
7X7D,N,,SARS-COV-2 DELTA RBD AND NB22,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2 DELTA RBD AND NB22, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 DELTA RBD AND NB22,,,B,,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,04/13/22,SARS-COV-2 DELTA RBD AND NB22,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, Y., YE, S.",X-RAY DIFFRACTION,NONE
7SN3,N,,STRUCTURE OF HUMAN SARS-COV-2 SPIKE GLYCOPROTEIN TRIMER BOUND BY NEUTRALIZING ANTIBODY C1C-A3 FAB (VARIABLE REGION),VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING ANTIBODY, NEUTRALIZATION ESCAPE, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR CONTINUED ANTIBODY EVASION BY THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,,E,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/08/21,STRUCTURE OF HUMAN SARS-COV-2 SPIKE GLYCOPROTEIN TRIMER BOUND BY NEUTRALIZING ANTIBODY C1C-A3 FAB (VARIABLE REGION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PAN, J., ABRAHAM, J., SHANKAR, S.",ELECTRON MICROSCOPY,NONE
2GHW,,"SPIKE GLYCOPROTEIN, ANTI-TUMOR SCFV ANTIBODY","CRYSTAL STRUCTURE OF SARS SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, 80R",VIRUS/VIRAL PROTEIN/ANTIBIOTIC,"SARS, S PROTEIN, NEUTRALIZING ANTIBODY, VIRUS-VIRAL PROTEIN-ANTIBIOTIC COMPLEX","STRUCTURAL BASIS OF NEUTRALIZATION BY A HUMAN ANTI-SEVERE ACUTE RESPIRATORY SYNDROME SPIKE PROTEIN ANTIBODY, 80R.",,,B,B,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRUS/VIRAL PROTEIN/ANTIBIOTIC,03/27/06,"CRYSTAL STRUCTURE OF SARS SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, 80R",SARS CORONAVIRUS; HOMO SAPIENS,HOMO SAPIENS,,SARS CORONAVIRUS,"HWANG, W.C., LIN, Y., SANTELLI, E., SUI, J., JAROSZEWSKI, L., STEC, B., FARZAN, M., MARASCO, W.A., LIDDINGTON, R.C.",X-RAY DIFFRACTION,NONE
6XC4,N,"SPIKE PROTEIN S1, CC12.3 HEAVY CHAIN, CC12.3 LIGHT CHAIN",CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3,IMMUNE SYSTEM/VIRAL PROTEIN,"ANTIBODY, SARS-COV-2, CORONAVIRUS, SPIKE, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",STRUCTURAL BASIS OF A SHARED ANTIBODY RESPONSE TO SARS-COV-2.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,06/08/20,CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YUAN, M., LIU, H., WU, N.C., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7R7N,N,,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2D106 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND S2D106),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, COVID-19, SPIKE GLYCOPROTEIN, FUSION PROTEIN, NEUTRALIZING ANTIBODIES, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, INHIBITOR, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SARS-COV-2 RBD ANTIBODIES THAT MAXIMIZE BREADTH AND RESISTANCE TO ESCAPE.,,,H,L,E,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,07/21/21,SARS-COV-2 SPIKE IN COMPLEX WITH THE S2D106 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND S2D106),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PARK, Y.J., VEESLER, D., SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID)",ELECTRON MICROSCOPY,NONE
7WWL,N,,S PROTEIN OF DELTA VARIANT IN COMPLEX WITH ZWD12,VIRAL PROTEIN,"SARS-COV-2, VIRAL PROTEIN",BROADLY NEUTRALIZING ANTIBODIES AGAINST OMICRON-INCLUDED SARS-COV-2 VARIANTS INDUCED BY VACCINATION.,,,J,N,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/01/22,S PROTEIN OF DELTA VARIANT IN COMPLEX WITH ZWD12,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"GUO, Y.Y., ZHANG, Y.Y., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
6XCN,N,"SPIKE GLYCOPROTEIN, C105 FAB HEAVY CHAIN, C105 FAB LIGHT CHAIN",STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE GLYCOPROTEIN, COVID-19, MONOCLONAL NEUTRALIZING ANTIBODY, FABS, NSEMPEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURES OF HUMAN ANTIBODIES BOUND TO SARS-COV-2 SPIKE REVEAL COMMON EPITOPES AND RECURRENT FEATURES OF ANTIBODIES.,,,H,L,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,06/08/20,STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"BARNES, C.O., BJORKMAN, P.J.",ELECTRON MICROSCOPY,NONE
7TN0,N,,SARS-COV-2 OMICRON RBD IN COMPLEX WITH HUMAN ACE2 AND S304 FAB AND S309 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING MONOCLONAL ANTIBODY, SARS-COV-2 RECEPTOR HUMAN ACE2, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID",STRUCTURAL BASIS OF SARS-COV-2 OMICRON IMMUNE EVASION AND RECEPTOR ENGAGEMENT.,,,M,N,S,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,02/02/22,SARS-COV-2 OMICRON RBD IN COMPLEX WITH HUMAN ACE2 AND S304 FAB AND S309 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SNELL, G., MCCALLUM, M., VEESLER, D., NIX, J.C., CROLL, T.I., DILLEN, J.R., CZUDNOCHOWSKI, N.",X-RAY DIFFRACTION,NONE
7MZH,N,,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 119,VIRAL PROTEIN,"SARS-COV-2, SPIKE, RBD, HUMAN ANTIBODY, VIRAL PROTEIN",LANDSCAPE OF HUMAN ANTIBODY RECOGNITION OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,B,C,A,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,10/06/21,SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 119,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"PYMM, P., TAN, L.L., DIETRICH, M.H., CHAN, L.J., THAM, W.H.",X-RAY DIFFRACTION,NONE
7FAF,N,,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P36-5D2 (STATE1),VIRAL PROTEIN/IMMUNE SYSTEM,"ANTIBODY, SARS-COV-2 SPIKE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A POTENT AND PROTECTIVE HUMAN NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 VARIANTS.,,,G,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,12/22/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P36-5D2 (STATE1),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, L., WANG, X., ZHANG, S., SHAN, S.",ELECTRON MICROSCOPY,NONE
6ZER,N,,CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"EY6A, RBD, SPIKE GLYCOPROTEIN, SARS-COV-2, HUMAN NEUTRALIZING ANTIBODY, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL BASIS FOR THE NEUTRALIZATION OF SARS-COV-2 BY AN ANTIBODY FROM A CONVALESCENT PATIENT.,,,F,G,D,PROTEIN,RBD,VIRAL PROTEIN/IMMUNE SYSTEM,06/16/20,CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., ZHAO, Y., FRY, E.E., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7JN5,N,"CR3022 HEAVY CHAIN, CR3022 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF SARS-COV RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS, CORONAVIRUS, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A NATURAL MUTATION BETWEEN SARS-COV-2 AND SARS-COV DETERMINES NEUTRALIZATION BY A CROSS-REACTIVE ANTIBODY.,,,H,L,F,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/03/20,CRYSTAL STRUCTURE OF SARS-COV RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022,HOMO SAPIENS; HUMAN SARS CORONAVIRUS,HOMO SAPIENS,HOMO SAPIENS,HUMAN SARS CORONAVIRUS,"WU, N.C., YUAN, M., ZHU, X., WILSON, I.A.",X-RAY DIFFRACTION,NONE
6VSR,N,,CRYSTAL STRUCTURE OF MACAQUE ANTI-HIV-1 ANTIBODY RM20F,IMMUNE SYSTEM,"HIV, ANTIBODY, NON-HUMAN PRIMATES, IMMUNE SYSTEM",MAPPING THE IMMUNOGENIC LANDSCAPE OF NEAR-NATIVE HIV-1 ENVELOPE TRIMERS IN NON-HUMAN PRIMATES.,,,A,B,,,,IMMUNE SYSTEM,02/11/20,CRYSTAL STRUCTURE OF MACAQUE ANTI-HIV-1 ANTIBODY RM20F,MACACA MULATTA,MACACA MULATTA,MACACA MULATTA,,"OYEN, D., YUAN, M., WILSON, I.A.",X-RAY DIFFRACTION,NONE
6OLP,N,"ENVELOPE GLYCOPROTEIN GP120, ENVELOPE GLYCOPROTEIN GP41, IMMUNOGLOBULIN G PGT151 FAB, HEAVY CHAIN, IMMUNOGLOBULIN G PGT151 FAB, LIGHT CHAIN",FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB,VIRAL PROTEIN/IMMUNE SYSTEM,"HIV-1, ANTIBODY, GLYCOPROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",SIMILARITIES AND DIFFERENCES BETWEEN NATIVE HIV-1 ENVELOPE GLYCOPROTEIN TRIMERS AND STABILIZED SOLUBLE TRIMER MIMETICS.,,,G,I,D | C | B,PROTEIN | PROTEIN | PROTEIN,ENVELOPE GLYCOPROTEIN GP41 | ENVELOPE GLYCOPROTEIN GP120 | ENVELOPE GLYCOPROTEIN GP41,VIRAL PROTEIN/IMMUNE SYSTEM,04/16/19,FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB,HUMAN IMMUNODEFICIENCY VIRUS 1; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HUMAN IMMUNODEFICIENCY VIRUS 1 | HUMAN IMMUNODEFICIENCY VIRUS 1 | HUMAN IMMUNODEFICIENCY VIRUS 1,"RANTALAINEN, K., COTTRELL, C.A.",ELECTRON MICROSCOPY,NONE
7W9E,N,,SARS-COV-2 DELTA S-8D3,VIRAL PROTEIN,"SARS-COV-2 DELTA VARIANT SPIKE PROTEIN, VIRAL PROTEIN",STRUCTURAL BASIS FOR SARS-COV-2 DELTA VARIANT RECOGNITION OF ACE2 RECEPTOR AND BROADLY NEUTRALIZING ANTIBODIES.,,,D,E,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,01/12/22,SARS-COV-2 DELTA S-8D3,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; MUS MUSCULUS,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"CONG, Y., LIU, C.X.",ELECTRON MICROSCOPY,NONE
7WE8,N,,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB XGV265,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON, SPIKE-FAB COMPLEX, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FROM TRIPLE VACCINEES AGAINST DIVERSE SARS-COV-2 VARIANTS.,,,H,L,A | C | B,PROTEIN | PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/04/22,SARS-COV-2 OMICRON VARIANT SPIKE PROTEIN IN COMPLEX WITH FAB XGV265,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., WANG, L.",ELECTRON MICROSCOPY,NONE
7FJO,N,,CRYO-EM STRUCTURE OF SOUTH AFRICAN (B.1.351) SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THREE T6 FAB,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",RBD TRIMER MRNA VACCINE ELICITS BROAD AND PROTECTIVE IMMUNE RESPONSES AGAINST SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM/VIRAL PROTEIN,04/13/22,CRYO-EM STRUCTURE OF SOUTH AFRICAN (B.1.351) SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THREE T6 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, X., ZHANG, L., ZHANG, S., LIANG, Q.",ELECTRON MICROSCOPY,NONE
7QNX,N,,THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-55 AND EY6A FABS,VIRAL PROTEIN,"SARS-COV-2, BETA VARIANT, OMICRON VARIANT, B.1.351, B.1.1.529, ANTIBODY, RBD, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",OMICRON-B.1.1.529 LEADS TO WIDESPREAD ESCAPE FROM NEUTRALIZING ANTIBODY RESPONSES.,,,A,B,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,01/19/22,THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-55 AND EY6A FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
6ZH9,N,"CR3022 HEAVY, CR3022 LIGHT CHAIN, SPIKE GLYCOPROTEIN, NANOBODY H11-H4",TERNARY COMPLEX CR3022 H11-H4 AND RBD (SARS-COV-2),ANTIVIRAL PROTEIN,"COVID19, NANOBODY, SARS-COV-2, ANTIVIRAL PROTEIN",NEUTRALIZING NANOBODIES BIND SARS-COV-2 SPIKE RBD AND BLOCK INTERACTION WITH ACE2.,,,H,L,E,PROTEIN,UNKNOWN,ANTIVIRAL PROTEIN,06/21/20,TERNARY COMPLEX CR3022 H11-H4 AND RBD (SARS-COV-2),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; LAMA GLAMA,,,,"NAISMITH, J.H., MIKOLAJEK, H., LE BAS, A.",X-RAY DIFFRACTION,NONE
7DEO,N,"ANTIBODY SCFV, SPIKE GLYCOPROTEIN",CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV,VIRAL PROTEIN/ANTIVIRAL PROTEIN,"SARS-COV-2, RBD, ANTIBODY, VIRAL PROTEIN, ANTIVIRAL PROTEIN, VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX",STRUCTURAL BASIS FOR SARS-COV-2 NEUTRALIZING ANTIBODIES WITH NOVEL BINDING EPITOPES.,,,A,A,B,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/ANTIVIRAL PROTEIN,03/31/21,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"FU, D., ZHANG, G., LI, X., RAO, Z., GUO, Y.",X-RAY DIFFRACTION,NONE
6XCA,N,"C105 HEAVY CHAIN, C105 LIGHT CHAIN","CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C105",IMMUNE SYSTEM,"ANTIBODY, SARS-COV-2, SARS2, CORONAVIRUS, NEUTRALIZING, IMMUNE SYSTEM",STRUCTURES OF HUMAN ANTIBODIES BOUND TO SARS-COV-2 SPIKE REVEAL COMMON EPITOPES AND RECURRENT FEATURES OF ANTIBODIES.,,,H,L,,,,IMMUNE SYSTEM,06/08/20,"CRYSTAL STRUCTURE OF AN ANTI-SARS-COV-2 HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C105",HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"SHARAF, N.G., BARNES, C.O., BJORKMAN, P.J.",X-RAY DIFFRACTION,NONE
7L09,N,"2G12 HEAVY CHAIN, 2G12 LIGHT CHAIN, SPIKE GLYCOPROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT,VIRAL PROTEIN/IMMUNE SYSTEM,"FAB-DIMERIZED, GLYCAN-REACTIVE, ANTIBODIES, SARS, COVID19, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX SARS-COV-2 2P S ECTODOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",FAB-DIMERIZED GLYCAN-REACTIVE ANTIBODIES ARE A STRUCTURAL CATEGORY OF NATURAL ANTIBODIES.,,,H,L,T,CARBOHYDRATE,ALPHA-D-MANNOSE,VIRAL PROTEIN/IMMUNE SYSTEM,12/11/20,CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"MANNE, K., HENDERSON, R., ACHARYA, P.",ELECTRON MICROSCOPY,NONE
7ZFF,N,,OMI-42 FAB,IMMUNE SYSTEM,"SARS-COV-2, OMICRON, BA.1, BA.2, RBD, ANTIBODY, FAB, OMI-42, IMMUNE SYSTEM",POTENT CROSS-REACTIVE ANTIBODIES FOLLOWING OMICRON BREAKTHROUGH IN VACCINEES.,,,H,L,,,,IMMUNE SYSTEM,06/01/22,OMI-42 FAB,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"ZHOU, D., HUO, J., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7Z9R,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E NANOBODY COMPLEX IN 2UP1DOWN CONFORMATION,ANTIVIRAL PROTEIN,"COMPLEX, SPIKE GLYCOPROTEIN, NANOBODY H11-H4 Q98R H100E, ANTIVIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E NANOBODY COMPLEX IN 2UP1DOWN CONFORMATION,,,Y,,B,PROTEIN,"SPIKE GLYCOPROTEIN,FIBRITIN",ANTIVIRAL PROTEIN,07/13/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E NANOBODY COMPLEX IN 2UP1DOWN CONFORMATION,ESCHERICHIA VIRUS T4; LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,"SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2, ESCHERICHIA VIRUS T4 ","WECKENER, M., NAISMITH, J.H.",ELECTRON MICROSCOPY,NONE
7MLZ,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY B1-182.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,IMMUNE SYSTEM/VIRAL PROTEIN,"SARS-COV-2, RECEPTOR-BINDING DOMAIN, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX",ULTRAPOTENT ANTIBODIES AGAINST DIVERSE AND HIGHLY TRANSMISSIBLE SARS-COV-2 VARIANTS.,,,H,L,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM/VIRAL PROTEIN,07/28/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY B1-182.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, T., TSYBOVSKY, T., KWONG, P.D.",ELECTRON MICROSCOPY,NONE
7KQE,N,"FAB 3D11 HEAVY CHAIN, FAB 3D11 LIGHT CHAIN, SPIKE GLYCOPROTEIN",SARS-COV-2 SPIKE GLYCOPROTEIN:FAB 3D11 COMPLEX,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, SPIKE, ANTIBODY, FAB, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",STRUCTURAL INSIGHT INTO SARS-COV-2 NEUTRALIZING ANTIBODIES AND MODULATION OF SYNCYTIA.,,,J,M,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,05/26/21,SARS-COV-2 SPIKE GLYCOPROTEIN:FAB 3D11 COMPLEX,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ASARNOW, D., CHARLES, C., CHENG, Y.",ELECTRON MICROSCOPY,NONE
7EJ5,N,"SPIKE GLYCOPROTEIN, RBD-CHAB45, HEAVY CHAIN, RBD-CHAB45, LIGHT CHAIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY RBD-CHAB-45,VIRAL PROTEIN,"SARS-COV-2, SPIKE PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN",CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY RBD-CHAB-45,,,J,N,C,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,06/23/21,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH A NEUTRALIZING ANTIBODY RBD-CHAB-45,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YANG, T.J., YU, P.Y., WU, H.C., HSU, S.T.D.",ELECTRON MICROSCOPY,NONE
7CWN,N,"SPIKE GLYCOPROTEIN, LIGHT CHAIN OF P17 FAB, HEAVY CHAIN OF P17 FAB, LIGHT CHAIN OF H014 FAB, HEAVY CHAIN OF H014 FAB",P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN,VIRAL PROTEIN,"COCKTAIL, COMPLEX, SARS-COV-2 SPIKE PROTEIN, FAB, VIRAL PROTEIN",RATIONAL DEVELOPMENT OF A HUMAN ANTIBODY COCKTAIL THAT DEPLOYS MULTIPLE FUNCTIONS TO CONFER PAN-SARS-COVS PROTECTION.,,,K,I,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,08/29/20,P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WANG, N., WANG, X.",ELECTRON MICROSCOPY,NONE
7PRZ,N,,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-22 FABS,VIRAL PROTEIN,"SARS-COV-2 ALPHA VARIANT, BETA VARIANT, GAMMA VARIANT, DELTA VARIANT, B.1.1.7, B.1.351, P.1, B.1.617.2, ANTIBODY, RECEPTOR-BINDING-DOMAIN, SPIKE, NEUTRALISATION, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,H,L,E,PROTEIN,SURFACE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-22 FABS,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHOU, D., REN, J., STUART, D.I.",X-RAY DIFFRACTION,NONE
7WJZ,N,,OMICRON SPIKE BITRIMER WITH 6M6 ANTIBODY,VIRAL PROTEIN,"OMICRON, SPIKE, ANTIBODY, VIRAL PROTEIN",A BROADLY NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 OMICRON VARIANT INFECTION EXHIBITING A NOVEL TRIMER DIMER CONFORMATION IN SPIKE PROTEIN BINDING.,,,E,O,J,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,07/13/22,OMICRON SPIKE BITRIMER WITH 6M6 ANTIBODY,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHAN, W.Q., ZHANG, X., CHEN, Z.G., SUN, L.",ELECTRON MICROSCOPY,NONE
7STS,N,,CRYSTAL STRUCTURE OF HUMAN FAB S24-1379 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS CORONAVIRUS 2, NUCLEOCAPSID PROTEIN, HUMAN ANTIBODY FAB, COVID-19, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYSTAL STRUCTURE OF HUMAN FAB S24-1379 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,,,H,L,C,PROTEIN,NUCLEOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/10/22,CRYSTAL STRUCTURE OF HUMAN FAB S24-1379 IN THE COMPLEX WITH THE N-TEMINAL DOMAIN OF NUCLEOCAPSID PROTEIN FROM SARS COV-2,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"KIM, Y., MALTSEVA, N., TESAR, C., JEDRZEJCZAK, R., DUGAN, H., STAMPER, C., WILSON, P., JOACHIMIAK, A., CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID)",X-RAY DIFFRACTION,NONE
7Z0Y,N,,THSC20.HVTR04 FAB BOUND TO SARS-COV-2 RECEPTOR BINDING DOMAIN,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM","NEUTRALIZING ANTIBODY, SARS-COV-2, SPIKE, RBD, ANTIVIRAL PROTEIN, IMMUNE SYSTEM",A COMBINATION OF POTENTLY NEUTRALIZING MONOCLONAL ANTIBODIES ISOLATED FROM AN INDIAN CONVALESCENT DONOR PROTECTS AGAINST THE SARS-COV-2 DELTA VARIANT.,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,"ANTIVIRAL PROTEIN, IMMUNE SYSTEM",04/13/22,THSC20.HVTR04 FAB BOUND TO SARS-COV-2 RECEPTOR BINDING DOMAIN,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WIBMER, C.K.",X-RAY DIFFRACTION,NONE
7VOA,N,,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH ARBD5,VIRAL PROTEIN/ANTIVIRAL PROTEIN,VIRAL PROTEIN-ANTIVIRAL PROTEIN COMPLEX,HETERO-BIVALENT NANOBODIES PROVIDE BROAD-SPECTRUM PROTECTION AGAINST SARS-COV-2 VARIANTS OF CONCERN INCLUDING OMICRON.,,,A,,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/ANTIVIRAL PROTEIN,08/10/22,CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH ARBD5,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VICUGNA PACOS,VICUGNA PACOS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"MA, H., ZENG, W.H., JIN, T.C.",X-RAY DIFFRACTION,NONE
6ZFO,N,,ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB,IMMUNE SYSTEM,"EY6A, RBD, SPIKE GLYCOPROTEIN, SARS-COV-2, HUMAN NEUTRALIZING ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM",STRUCTURAL BASIS FOR THE NEUTRALIZATION OF SARS-COV-2 BY AN ANTIBODY FROM A CONVALESCENT PATIENT.,,,B,C,A,PROTEIN,SPIKE GLYCOPROTEIN,IMMUNE SYSTEM,06/17/20,ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., ZHOU, D., ZHAO, Y., FRY, E.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
7QTI,N,,SARS-COV-2 S OMICRON SPIKE B.1.1.529 - 3-P2G3 AND 1-P5C3 FABS (GLOBAL),VIRAL PROTEIN,"SARS-COV-2 S OMICRON SPIKE B.1.1.529, VIRAL PROTEIN",PATIENT-DERIVED MONOCLONAL ANTIBODY NEUTRALIZES SARS-COV-2 OMICRON VARIANTS AND CONFERS FULL PROTECTION IN MONKEYS.,,,I,J,D,PROTEIN,"SPIKE GLYCOPROTEIN,ENVELOPE GLYCOPROTEIN",VIRAL PROTEIN,08/03/22,SARS-COV-2 S OMICRON SPIKE B.1.1.529 - 3-P2G3 AND 1-P5C3 FABS (GLOBAL),HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"NI, D., LAU, K., TURELLI, P., FENWICK, C., PEREZ, L., POJER, F., STAHLBERG, H., PANTALEO, G., TRONO, D.",ELECTRON MICROSCOPY,NONE
7CZX,N,"SPIKE GLYCOPROTEIN, HEAVY CHAIN OF 4A8, LIGHT CHAIN OF 4A8",S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9,VIRAL PROTEIN,"SARS-COV-2, ANTIBODY, VIRAL PROTEIN",STRUCTURAL BASIS FOR BIVALENT BINDING AND INHIBITION OF SARS-COV-2 INFECTION BY HUMAN POTENT NEUTRALIZING ANTIBODIES.,,,I,M,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,03/10/21,S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"YAN, R.H., ZHANG, Y.Y., LI, Y.N., ZHOU, Q.",ELECTRON MICROSCOPY,NONE
7X7T,N,,"CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",,,A,B,G,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,08/17/22,"CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH THREE NABS X01, X10 AND X17",MUS MUSCULUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,MUS MUSCULUS,MUS MUSCULUS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"SUN, H., LIU, L., ZHENG, Q., LI, S., ZHANG, T., XIA, N.",ELECTRON MICROSCOPY,NONE
7N64,N,,SARS-COV-2 SPIKE (2P) IN COMPLEX WITH G32R7 FAB (RBD AND NTD LOCAL RECONSTRUCTION),VIRAL PROTEIN/IMMUNE SYSTEM,"CORONAVIRUS, ANTIBODY, EPITOPE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FOR RECOGNITION OF EVOLVING SARS-COV-2 SPIKE.,,,H,L,B | A,PROTEIN | PROTEIN,SPIKE GLYCOPROTEIN | SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,SARS-COV-2 SPIKE (2P) IN COMPLEX WITH G32R7 FAB (RBD AND NTD LOCAL RECONSTRUCTION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WINDSOR, I.W., JENNI, S., TONG, P., GAUTAM, A.K., WESEMANN, D.R., HARRISON, S.C.",ELECTRON MICROSCOPY,NONE
8CWU,N,,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING NANOBODY 1-21,IMMUNE SYSTEM,"CROSS-NEUTRALIZING ANTIBODY; NANOBODY; SARS-COV-2; SARBECOVIRUS; IMMUNE SYSTEM; VHH, IMMUNE SYSTEM",SUPERIMMUNITY BY PAN-SARBECOVIRUS NANOBODIES.,,,B,,A,PROTEIN,SPIKE PROTEIN S1,IMMUNE SYSTEM,07/06/22,CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING NANOBODY 1-21,LAMA GLAMA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,LAMA GLAMA,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, H., WILSON, I.A.",X-RAY DIFFRACTION,NONE
7N62,N,,SARS-COV-2 SPIKE (2P) IN COMPLEX WITH C12C9 FAB (NTD LOCAL RECONSTRUCTION),VIRAL PROTEIN/IMMUNE SYSTEM,"CORONAVIRUS, ANTIBODY, EPITOPE, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",MEMORY B CELL REPERTOIRE FOR RECOGNITION OF EVOLVING SARS-COV-2 SPIKE.,,,H,L,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,08/04/21,SARS-COV-2 SPIKE (2P) IN COMPLEX WITH C12C9 FAB (NTD LOCAL RECONSTRUCTION),SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"WINDSOR, I.W., JENNI, S., BAJIC, G., TONG, P., GAUTAM, A.K., WESEMANN, D.R., HARRISON, S.C.",ELECTRON MICROSCOPY,NONE
7EY5,N,,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-771 FAB AND BD-821 FAB,VIRAL PROTEIN,"SARS-COV2, COMPLEX, ANTIBODY, VIRAL PROTEIN",STRUCTURES OF SARS-COV-2 B.1.351 NEUTRALIZING ANTIBODIES PROVIDE INSIGHTS INTO COCKTAIL DESIGN AGAINST CONCERNING VARIANTS.,,,B,C,A,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,09/08/21,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6PV2 IN COMPLEX WITH BD-771 FAB AND BD-821 FAB,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, Z.Y.",ELECTRON MICROSCOPY,NONE
7SN1,N,,STRUCTURE OF HUMAN SARS-COV-2 NEUTRALIZING ANTIBODY C1C-A3 FAB,IMMUNE SYSTEM,"COVID-19, SARS-COV-2, NEUTRALIZING ANTIBODY, NEUTRALIZATION ESCAPE, IMMUNE SYSTEM",STRUCTURAL BASIS FOR CONTINUED ANTIBODY EVASION BY THE SARS-COV-2 RECEPTOR BINDING DOMAIN.,,,H,L,,,,IMMUNE SYSTEM,12/08/21,STRUCTURE OF HUMAN SARS-COV-2 NEUTRALIZING ANTIBODY C1C-A3 FAB,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,,"PAN, J., ABRAHAM, J., CLARK, S.",X-RAY DIFFRACTION,NONE
7Q9J,N,,BETA-26 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV2, SPIKE, GLYCOPROTEIN, ANTIBODY, FAB, B.1.135, BETA VARIANT, COMPLEX, NEUTRALISING, CONVALESCENT SERA, VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE ANTIBODY RESPONSE TO SARS-COV-2 BETA UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER VARIANTS.,,,E,F,B,PROTEIN,SPIKE GLYCOPROTEIN,VIRAL PROTEIN,12/15/21,BETA-26 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DUYVESTEYN, H.M.E., REN, J., STUART, D.I.",ELECTRON MICROSCOPY,NONE
8E7M,N,,"STRUCTURE OF THE HUMAN ACE2 RECEPTOR IN COMPLEX WITH ANTIBODY FAB FRAGMENT, 05B04",ANTIVIRAL PROTEIN,"ACE2, ANTIBODY, SARS-COV-2, INHIBITION, ANTIVIRAL PROTEIN",HUMAN ANTI-ACE2 MONOCLONAL ANTIBODIES AS PAN-SARBECOVIRUS PROPHYLACTIC AGENTS,,,H,L,A,PROTEIN,ANGIOTENSIN-CONVERTING ENZYME 2,ANTIVIRAL PROTEIN,09/28/22,"STRUCTURE OF THE HUMAN ACE2 RECEPTOR IN COMPLEX WITH ANTIBODY FAB FRAGMENT, 05B04",HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"BARNES, C.O.",ELECTRON MICROSCOPY,NONE
7Y0W,N,,LOCAL STRUCTURE OF BD55-5514 AND BD55-5840 FAB AND OMICRON BA.1 RBD COMPLEX,VIRAL PROTEIN,"SARS-COV-2, OMICRON VARIANTS, ANTIBODY, VIRAL PROTEIN",LOCAL STRUCTURE OF BD55-5514 AND BD55-5840 FAB AND OMICRON BA.1 RBD COMPLEX,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,09/28/22,LOCAL STRUCTURE OF BD55-5514 AND BD55-5840 FAB AND OMICRON BA.1 RBD COMPLEX,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,HOMO SAPIENS,"ZHANG, Z., XIAO, J.",ELECTRON MICROSCOPY,NONE
7WRY,N,,LOCAL STRUCTURE OF BD55-3546 FAB AND SARS-COV2 DELTA RBD COMPLEX,VIRAL PROTEIN,"SARS-COV2 DELTA RBD, VIRAL PROTEIN",LOCAL STRUCTURE OF BD55-3546 FAB AND SARS-COV2 DELTA RBD COMPLEX,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,09/28/22,LOCAL STRUCTURE OF BD55-3546 FAB AND SARS-COV2 DELTA RBD COMPLEX,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,SARS CORONAVIRUS B012,"ZHANG, Z.Z., XIAO, J.J.",ELECTRON MICROSCOPY,NONE
7WRJ,N,,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.1.529) IN COMPLEX WITH BD55-4637 FAB,VIRAL PROTEIN,"ANTIBODY, COMPLEX, VIRAL PROTEIN",LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.1.529) IN COMPLEX WITH BD55-4637 FAB,,,A,B,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN,09/28/22,LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.1.529) IN COMPLEX WITH BD55-4637 FAB,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"DU, S., XIAO, J.Y.",ELECTRON MICROSCOPY,NONE
7Y0C,N,,CRYSTAL STRUCTURE OF BD55-1403 AND SARS-COV-2 OMICRON RBD,VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, OMICRON VARIANTS, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",CRYSTAL STRUCTURE OF BD55-1403 AND SARS-COV-2 OMICRON RBD,,,M,N,E,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/28/22,CRYSTAL STRUCTURE OF BD55-1403 AND SARS-COV-2 OMICRON RBD,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"ZHANG, Z., XIAO, J.",X-RAY DIFFRACTION,NONE
7Y0V,N,,THE CO-CRYSTAL STRUCTURE OF BA.1-RBD WITH FAB-5549,VIRAL PROTEIN/IMMUNE SYSTEM,"BA.1-RBD, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",THE CO-CRYSTAL STRUCTURE OF BA.1-RBD WITH FAB-5549,,,H,L,R,PROTEIN,SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,09/28/22,THE CO-CRYSTAL STRUCTURE OF BA.1-RBD WITH FAB-5549,HOMO SAPIENS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,HOMO SAPIENS,HOMO SAPIENS,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"XIAO, J.Y., ZHANG, Y.",X-RAY DIFFRACTION,NONE
7XRP,N,,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH NANOBODY C5G2 (LOCALIZED REFINEMENT),VIRAL PROTEIN/IMMUNE SYSTEM,"SARS-COV-2, NEUTRALIZING NANOBODY, CRYO-EM, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX",A POTENT SYNTHETIC NANOBODY WITH BROAD-SPECTRUM ACTIVITY NEUTRALIZES SARS-COV-2 VIRUS AND THE OMICRON VARIANT BA.1 THROUGH A UNIQUE BINDING MODE.,,,B,,F | A,PROTEIN | PROTEIN,SPIKE PROTEIN S1 | SPIKE PROTEIN S1,VIRAL PROTEIN/IMMUNE SYSTEM,10/05/22,CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH NANOBODY C5G2 (LOCALIZED REFINEMENT),CAMELUS DROMEDARIUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2,CAMELUS DROMEDARIUS,,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2  | SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS2 ,"LIU, L., SUN, H., JIANG, Y., LIU, X., ZHAO, D., ZHENG, Q., LI, S., XIA, N.",ELECTRON MICROSCOPY,NONE
7V6O,N,,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 111 (STATE 2),PROTEIN BINDING,"MERS, SPIKE, ANTIBODY, PROTEIN BINDING",MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 111 (STATE 2),,,E,D,A,PROTEIN,SPIKE GLYCOPROTEIN,PROTEIN BINDING,09/28/22,MERS S ECTODOMAIN TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 111 (STATE 2),HOMO SAPIENS; HUMAN BETACORONAVIRUS 2C EMC/2012,HOMO SAPIENS,HOMO SAPIENS,HUMAN BETACORONAVIRUS 2C EMC/2012,"WANG, X., ZHAO, J., WANG, Z., ZENG, J., ZHANG, S., WANG, Y.",ELECTRON MICROSCOPY,NONE
